data_2kp2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kp2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.42 ' HG2' ' HG1' ' A' ' 59' ' ' THR . 28.8 mt-10 . . . . . 0 N--CA 1.431 -1.398 0 CA-C-O 122.09 0.947 . . . . 0.0 111.813 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.549 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 62.7 mt -88.22 127.96 40.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.476 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.2 -176.42 20.04 Favored Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.06 -18.45 50.87 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.769 2.979 . . . . 0.0 113.792 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -94.8 -40.77 9.57 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.995 0.426 . . . . 0.0 110.818 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.2 p -86.18 -29.58 23.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -167.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -60.66 -37.5 81.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.654 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.5 m -67.9 -26.31 65.93 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.598 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -79.01 -34.57 43.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.414 0.626 . . . . 0.0 110.015 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -74.95 -28.37 60.56 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.486 ' SD ' HG23 ' A' ' 87' ' ' VAL . 7.4 tpp -79.67 -20.73 45.94 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.709 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 t -96.57 -5.51 39.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.862 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.27 -34.83 66.02 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.946 0.403 . . . . 0.0 110.202 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.21 -13.32 64.8 Favored Glycine 0 CA--C 1.51 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.27 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 16.5 pt -98.73 153.73 37.76 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 123.66 0.784 . . . . 0.0 109.475 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.69 145.77 94.51 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 123.53 2.82 . . . . 0.0 113.534 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.596 HD11 ' CE1' ' A' ' 28' ' ' TYR . 1.8 tt -110.98 127.25 55.45 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -176.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HB2' ' CE1' ' A' ' 82' ' ' PHE . . . -96.8 108.97 21.73 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 26' ' ' LEU . 23.0 m-85 -90.19 110.5 21.53 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 124.387 1.075 . . . . 0.0 109.462 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.494 HD13 ' CD2' ' A' ' 57' ' ' PHE . 3.5 mp -101.25 91.05 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 C-N-CA 118.811 -1.156 . . . . 0.0 109.521 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 81' ' ' ALA . 46.6 m-85 -76.43 128.24 34.43 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.493 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -143.48 119.42 10.63 Favored 'General case' 0 C--N 1.27 -2.862 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.576 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.437 ' HG3' ' HB2' ' A' ' 62' ' ' ALA . 49.1 mt-10 -84.99 -2.05 57.5 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.252 0.549 . . . . 0.0 109.747 173.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 7.3 p -91.61 123.54 35.09 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.877 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.99 -21.05 18.86 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.26 0.552 . . . . 0.0 110.655 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.435 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 37.1 mt-10 -86.07 -66.43 0.9 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.82 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 12.5 pt-20 -73.7 1.59 9.98 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 33' ' ' THR . 15.7 ttt180 -54.46 -43.03 71.34 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 124.223 1.009 . . . . 0.0 108.705 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 45.5 mtmt -60.6 -49.45 77.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.896 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -64.82 -43.82 91.87 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 123.609 0.568 . . . . 0.0 111.434 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -54.24 -52.68 60.56 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -178.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.609 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 7.9 m -76.21 -18.85 58.86 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.891 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 25.1 t70 -74.66 -31.34 61.91 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.45 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.601 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 46.2 mmtt -79.8 -29.35 40.26 Favored 'General case' 0 C--O 1.277 2.508 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 64.3 mt -70.02 -25.62 63.67 Favored 'General case' 0 N--CA 1.408 -2.573 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.373 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.609 ' HG3' ' O ' ' A' ' 41' ' ' SER . 87.9 mttt -61.14 -54.79 50.39 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 119.712 -0.185 . . . . 0.0 111.251 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 73.8 Cg_exo -69.16 -43.92 2.84 Favored 'Trans proline' 0 C--O 1.263 1.765 0 C-N-CA 122.856 2.371 . . . . 0.0 111.801 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.89 -24.12 35.0 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.063 0 C-N-CA 118.405 -1.318 . . . . 0.0 110.981 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -95.21 -20.99 18.76 Favored 'General case' 0 C--O 1.204 -1.316 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.724 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -66.3 -25.11 66.7 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.4 -11.83 59.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.794 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 2.8 pt20 -145.32 33.96 1.08 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.405 1.098 . . . . 0.0 110.488 -172.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -74.38 -7.97 54.7 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.287 -173.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.96 0.6 14.94 Favored Glycine 0 C--N 1.289 -2.074 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.76 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.51 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 13.2 p -121.85 -31.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.845 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 84.2 mt -123.17 140.45 46.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.594 -0.843 . . . . 0.0 110.47 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -86.17 117.17 24.82 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.494 ' CD2' HD13 ' A' ' 29' ' ' ILE . 1.8 m-85 -103.89 103.03 12.84 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.977 0.894 . . . . 0.0 112.874 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.549 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -123.65 128.43 6.92 Favored Glycine 0 N--CA 1.406 -3.345 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.72 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.42 ' HG1' ' HG2' ' A' ' 10' ' ' GLU . 29.3 p -92.36 127.69 37.93 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 7.8 tt -124.26 142.64 40.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.47 125.96 28.28 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.579 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.47 ' O ' ' HA3' ' A' ' 66' ' ' GLY . . . -92.9 7.34 44.3 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.221 -0.991 . . . . 0.0 111.507 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -104.78 -38.0 6.84 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.11 -42.48 9.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.611 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.73 26.99 8.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.454 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -70.82 -24.21 77.22 Favored Glycine 0 CA--C 1.488 -1.617 0 C-N-CA 120.779 -0.724 . . . . 0.0 114.683 -173.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.54 -28.6 46.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.436 0.636 . . . . 0.0 110.847 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -64.93 -23.09 67.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.234 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -64.08 -36.22 83.29 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.984 0.897 . . . . 0.0 110.4 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -105.09 7.47 44.21 Favored Glycine 0 C--N 1.281 -2.518 0 C-N-CA 117.568 -2.253 . . . . 0.0 114.835 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -74.76 -16.89 60.71 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 166.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 4.2 pp -104.22 -37.56 7.23 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.065 174.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.509 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 5.2 t-20 -176.35 -52.19 0.01 OUTLIER 'General case' 0 C--N 1.384 2.107 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.635 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.0 mm? -65.44 159.59 23.96 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -167.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -81.1 -4.28 54.77 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.461 HG21 ' HB1' ' A' ' 69' ' ' ALA . 80.3 p 56.43 17.41 2.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.268 1.027 . . . . 0.0 112.226 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.408 ' OD1' ' HG3' ' A' ' 75' ' ' LYS . 14.3 p-10 -94.39 -14.98 24.74 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -172.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 22.7 tptt -123.49 -165.29 1.31 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 118.503 -1.279 . . . . 0.0 113.273 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.507 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 96.5 m-85 -61.47 173.14 0.82 Allowed Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 125.925 1.69 . . . . 0.0 110.35 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 5.5 Cg_endo -40.15 131.21 2.24 Favored 'Trans proline' 0 C--N 1.414 3.993 0 C-N-CA 122.444 2.096 . . . . 0.0 115.557 -171.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -109.68 110.11 21.04 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.808 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 27' ' ' ALA . 53.5 t80 -88.84 112.45 23.25 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.723 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -121.0 120.35 35.16 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.2 mt -92.66 113.35 27.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.852 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.18 134.33 35.46 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 2.5 mm-40 -87.5 126.97 35.22 Favored 'General case' 0 C--N 1.266 -3.058 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.227 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.486 HG23 ' SD ' ' A' ' 20' ' ' MET . 41.2 t -95.31 -2.77 10.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.77 -44.12 3.52 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.438 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.83 -11.06 23.69 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.344 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 14.3 t-20 66.89 10.55 7.7 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 125.011 1.324 . . . . 0.0 110.247 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.458 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 1.5 tp60 -80.08 172.35 13.89 Favored 'General case' 0 CA--C 1.477 -1.856 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.356 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.601 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 65.4 mmtt -139.36 105.09 5.13 Favored 'General case' 0 N--CA 1.404 -2.733 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -100.28 86.4 0.63 Allowed Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.601 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 7.8 Cg_endo -101.96 152.63 0.32 Allowed 'Trans proline' 0 N--CA 1.429 -2.294 0 C-N-CA 122.477 2.118 . . . . 0.0 114.065 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.439 ' HD1' ' CD1' ' A' ' 109' ' ' PHE . 49.8 t80 -94.67 162.97 13.56 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 124.858 1.263 . . . . 0.0 107.746 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 10.7 m-20 -66.22 153.19 43.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.067 0.461 . . . . 0.0 110.32 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -102.22 0.96 35.31 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 8.6 pt-20 -132.38 28.45 4.36 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.146 -171.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 3.7 tppp? -113.63 -89.53 0.53 Allowed 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.739 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 176.39 127.33 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 124.062 0.945 . . . . 0.0 109.032 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.473 HG22 ' CG1' ' A' ' 106' ' ' ILE . 3.9 mp -102.62 105.37 18.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.42 -169.04 1.87 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.491 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.8 t80 -77.57 -53.23 7.84 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -60.39 -46.82 88.6 Favored 'General case' 0 N--CA 1.391 -3.393 0 CA-C-N 112.267 -2.242 . . . . 0.0 112.894 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.82 83.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.991 0.424 . . . . 0.0 111.149 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.473 ' CG1' HG22 ' A' ' 101' ' ' ILE . 36.9 mm -70.95 -44.37 75.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.863 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 22.7 ttmt -51.32 -52.64 43.46 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 124.044 0.84 . . . . 0.0 109.973 177.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.36 -43.87 92.77 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.947 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.533 ' O ' HD12 ' A' ' 118' ' ' ILE . 46.1 t80 -63.43 -59.9 4.07 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 124.411 1.084 . . . . 0.0 110.984 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 106' ' ' ILE . 27.5 m -58.59 -31.82 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 121.519 -0.738 . . . . 0.0 110.901 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 28.7 t70 -67.65 -47.74 68.69 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 123.886 0.874 . . . . 0.0 109.033 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.549 ' OD2' HG12 ' A' ' 118' ' ' ILE 0.299 0.1 OUTLIER -70.83 -23.77 62.41 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.545 -179.0 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.534 ' HB2' HD11 ' A' ' 118' ' ' ILE . 0.6 OUTLIER -71.18 -61.25 1.83 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.892 173.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -61.98 -25.25 36.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.163 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.35 -33.79 55.29 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.246 0.546 . . . . 0.0 109.777 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.17 25.86 2.87 Favored Glycine 0 CA--C 1.485 -1.794 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.953 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 20.3 ttpt -101.17 -32.67 10.44 Favored 'General case' 0 N--CA 1.396 -3.15 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.19 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.549 HG12 ' OD2' ' A' ' 112' ' ' ASP . 4.9 mt -74.45 142.26 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.31 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 . . . . . 0 C--N 1.285 -2.231 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.678 -172.855 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.514 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 51.6 mt -119.14 143.24 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.15 162.37 25.03 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -47.52 -34.05 19.08 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 124.14 3.227 . . . . 0.0 114.044 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -89.43 -26.91 20.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.953 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.1 p -78.85 -19.97 50.7 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.018 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.403 ' O ' ' HB2' ' A' ' 20' ' ' MET . 69.3 m-85 -50.19 -49.93 50.93 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 123.934 0.771 . . . . 0.0 109.685 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -62.37 -33.41 74.69 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.107 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -70.9 -44.64 65.82 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 120.937 0.398 . . . . 0.0 110.535 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -72.8 -30.45 64.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.458 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.41 -39.89 62.35 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.05 -178.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -81.58 -9.02 59.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.649 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.09 -19.06 60.72 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.202 0.525 . . . . 0.0 110.619 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.21 -4.16 63.76 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.823 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 11.1 pt -103.2 152.5 38.65 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -54.58 142.18 72.35 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 124.194 3.263 . . . . 0.0 114.064 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 tt -108.13 125.18 51.3 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HB2' ' CE1' ' A' ' 82' ' ' PHE . . . -95.67 103.06 14.92 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -83.83 114.84 21.92 Favored 'General case' 0 CA--C 1.47 -2.126 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.303 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 8.1 mt -102.6 84.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.252 -3.67 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 81' ' ' ALA . 48.7 m-85 -76.81 123.84 26.82 Favored 'General case' 0 CA--C 1.465 -2.324 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.98 123.61 19.77 Favored 'General case' 0 C--N 1.254 -3.584 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.445 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -79.64 -14.64 58.66 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 13.1 p -83.73 113.49 20.92 Favored 'General case' 0 N--CA 1.403 -2.78 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.107 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.71 -21.06 16.6 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.389 0.431 . . . . 0.0 110.918 -175.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -88.37 -54.2 4.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.742 0.782 . . . . 0.0 110.354 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.439 ' OE1' ' HB ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -84.84 3.13 39.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.823 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 33' ' ' THR . 52.2 ttt180 -49.27 -46.1 45.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.573 1.149 . . . . 0.0 110.018 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -65.31 -35.76 81.98 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.251 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -82.05 -31.27 30.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.894 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.7 tm? -61.48 -44.09 97.7 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 m -77.52 -17.0 58.36 Favored 'General case' 0 C--O 1.2 -1.542 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.576 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 20.5 t70 -76.67 -31.07 57.05 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.703 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.611 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -73.69 -36.59 65.3 Favored 'General case' 0 C--O 1.281 2.761 0 CA-C-O 123.109 1.433 . . . . 0.0 107.861 171.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 67.8 mt -72.63 -18.16 61.61 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.8 -1.545 . . . . 0.0 111.404 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 38.6 ttmt -63.74 -53.83 47.14 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 123.793 0.837 . . . . 0.0 111.759 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 52.4 Cg_exo -71.19 -37.22 6.19 Favored 'Trans proline' 0 CA--C 1.493 -1.553 0 C-N-CA 122.471 2.114 . . . . 0.0 109.784 175.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.536 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 86.0 mt -53.12 -38.41 29.99 Favored 'Isoleucine or valine' 0 C--N 1.37 1.461 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.856 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -93.35 -21.64 19.43 Favored 'General case' 0 C--O 1.195 -1.767 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.627 -172.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.475 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -68.45 -22.4 64.59 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 176.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.27 -11.3 57.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.977 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 2.8 pt20 -147.13 36.1 0.91 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.562 1.172 . . . . 0.0 110.749 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HD3' ' OE1' ' A' ' 49' ' ' GLU . 13.9 ptt180 -74.14 -18.6 60.77 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.988 -1.915 . . . . 0.0 110.778 -174.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.69 17.74 22.87 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.582 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.516 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.6 p -138.71 -33.26 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.551 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 88.7 mt -122.95 136.84 58.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.287 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.447 HD22 HG13 ' A' ' 24' ' ' ILE . 9.9 m-80 -94.48 96.39 9.45 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.74 141.94 40.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.521 0.677 . . . . 0.0 111.123 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.514 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -159.76 129.48 2.21 Favored Glycine 0 N--CA 1.412 -2.944 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.061 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.527 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 44.6 p -83.78 144.91 28.99 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.202 0.525 . . . . 0.0 111.445 174.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 4.8 tt -145.8 142.48 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.336 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD2' ' HB3' ' A' ' 63' ' ' LYS . 19.9 t70 -70.9 124.35 24.14 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -175.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.459 ' O ' ' HA3' ' A' ' 66' ' ' GLY . . . -86.85 4.04 42.9 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.218 -0.593 . . . . 0.0 112.277 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.54 ' HB3' ' HZ1' ' A' ' 63' ' ' LYS . 3.7 ttpm? -100.91 -44.72 5.66 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.45 -45.6 9.82 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.664 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -115.5 20.34 14.81 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.242 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -69.69 -20.48 75.8 Favored Glycine 0 CA--C 1.493 -1.308 0 N-CA-C 116.479 1.352 . . . . 0.0 116.479 -171.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.57 -27.74 64.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.982 0.891 . . . . 0.0 110.305 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -62.2 -24.74 67.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.601 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -65.75 -37.86 87.52 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 122.633 1.206 . . . . 0.0 109.024 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -96.94 11.02 66.16 Favored Glycine 0 C--N 1.284 -2.32 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.54 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.18 -8.29 59.64 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 3.1 pp -118.69 -34.97 3.82 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.464 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -168.07 -64.89 0.03 OUTLIER 'General case' 0 C--N 1.366 1.326 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.503 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.2 mm? -53.23 166.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -163.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -89.14 -12.3 41.43 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.578 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 69' ' ' ALA . 64.0 p 54.86 35.4 24.19 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.387 1.475 . . . . 0.0 112.992 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -117.44 -15.94 10.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -160.44 0.78 Allowed 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.944 -169.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.444 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 83.5 m-85 -59.99 170.66 1.11 Allowed Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.582 1.553 . . . . 0.0 109.635 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 2.4 Cg_endo -39.35 133.43 1.38 Allowed 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 122.765 2.31 . . . . 0.0 114.852 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -113.0 104.3 12.25 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.86 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 27' ' ' ALA . 65.1 t80 -85.39 108.17 17.72 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.6 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -114.88 115.28 26.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.4 mt -90.7 110.59 22.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -88.14 129.58 35.28 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -87.62 121.03 29.54 Favored 'General case' 0 C--N 1.28 -2.444 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.412 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 20' ' ' MET . 3.8 t -96.82 4.19 9.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.95 -36.24 3.89 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.824 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -99.08 -15.08 19.14 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.248 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 74.1 19.42 2.97 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 124.769 2.224 . . . . 0.0 108.414 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.531 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -96.0 170.09 9.52 Favored 'General case' 0 CA--C 1.464 -2.331 0 CA-C-N 111.828 -2.442 . . . . 0.0 110.851 -174.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 91' ' ' GLN . 70.1 mmtt -141.25 109.46 5.84 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 72.2 m-85 -109.02 88.65 5.79 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 2.6 Cg_endo -101.15 147.78 0.33 Allowed 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 122.43 2.086 . . . . 0.0 114.384 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -85.09 158.98 20.27 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.077 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 5.9 m-20 -64.72 143.91 57.6 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 123.827 0.851 . . . . 0.0 108.883 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -85.7 -1.24 56.97 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.644 -172.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.16 18.69 1.4 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.24 0.543 . . . . 0.0 112.109 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 4.3 tppp? -93.17 -3.74 53.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 68.84 126.55 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.472 1.509 . . . . 0.0 112.321 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.494 HG22 ' CG1' ' A' ' 106' ' ' ILE . 3.5 mp -89.77 102.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.065 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 p -122.43 170.52 9.88 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.476 ' O ' HD12 ' A' ' 47' ' ' ILE . 23.0 t80 -56.42 -59.37 5.07 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.554 0.692 . . . . 0.0 109.991 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.447 ' OE2' ' HB3' ' A' ' 105' ' ' ALA . 1.5 pp20? -57.44 -45.44 84.68 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.232 -1.349 . . . . 0.0 113.526 -175.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.447 ' HB3' ' OE2' ' A' ' 104' ' ' GLU . . . -59.43 -49.09 79.14 Favored 'General case' 0 C--N 1.254 -3.559 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.371 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.494 ' CG1' HG22 ' A' ' 101' ' ' ILE . 42.5 mm -75.0 -39.49 44.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.654 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 26.7 ttpp -58.22 -46.19 86.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.732 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.39 90.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.581 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.649 ' O ' HD12 ' A' ' 118' ' ' ILE . 70.6 t80 -64.49 -62.6 1.49 Allowed 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.537 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.7 m -58.67 -30.98 43.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 O-C-N 122.182 -0.324 . . . . 0.0 111.202 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 12.5 t70 -62.6 -50.47 71.14 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.333 1.053 . . . . 0.0 108.937 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.665 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 9.3 t70 -61.25 -43.11 99.42 Favored 'General case' 0 C--O 1.198 -1.649 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.21 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.546 ' N ' HG13 ' A' ' 118' ' ' ILE . 1.5 t80 -59.22 -63.96 1.12 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.465 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.6 -17.04 20.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.838 -175.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.96 -33.84 30.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.509 0.671 . . . . 0.0 109.395 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.5 21.5 6.13 Favored Glycine 0 CA--C 1.482 -1.993 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.665 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 7.0 ttmm -94.38 -43.09 8.55 Favored 'General case' 0 N--CA 1.395 -3.185 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.046 -174.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 109' ' ' PHE . 10.8 mt -72.14 146.04 11.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 C--N 1.283 -2.292 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.058 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.245 0.856 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.568 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 61.0 mt -96.71 120.76 46.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.096 0.474 . . . . 0.0 110.284 -177.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.17 167.75 12.98 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.625 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 14.8 Cg_endo -59.2 -25.69 79.05 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 122.812 2.341 . . . . 0.0 111.717 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -87.5 -12.11 46.89 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.816 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.6 p -105.03 -37.0 7.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.535 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.625 ' CE2' ' HA ' ' A' ' 13' ' ' PRO 0.293 10.0 p90 -62.18 -26.92 68.61 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 m -59.56 -32.41 70.32 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.206 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -78.08 -34.83 50.06 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.526 ' CD2' ' HA ' ' A' ' 16' ' ' TYR . 14.8 m-85 -73.13 -29.59 62.99 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.515 ' SD ' HG23 ' A' ' 87' ' ' VAL . 5.5 tpp -79.14 -24.05 43.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.01 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 t -92.1 -10.0 40.57 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.03 -21.03 43.97 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 121.955 -0.465 . . . . 0.0 111.43 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.18 8.98 87.31 Favored Glycine 0 C--O 1.235 0.189 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.956 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 12.2 pt -117.18 149.06 43.74 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 122.879 -0.189 . . . . 0.0 111.133 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.81 136.13 50.78 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 124.115 3.21 . . . . 0.0 113.82 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.17 125.53 51.11 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.53 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . . . -98.66 109.29 22.07 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-O 121.185 0.517 . . . . 0.0 109.731 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -89.28 117.82 28.51 Favored 'General case' 0 CA--C 1.468 -2.182 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.729 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.525 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.6 mt -106.87 84.4 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.54 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 81' ' ' ALA . 33.5 m-85 -75.54 134.9 40.63 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -149.76 120.04 7.32 Favored 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.578 176.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -72.23 -28.79 63.39 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-O 121.663 0.744 . . . . 0.0 109.365 173.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.652 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 2.3 p -89.31 103.78 16.38 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.622 -170.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.73 -25.16 41.2 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.791 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.06 -62.31 1.43 Allowed 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.528 ' OE1' ' HB ' ' A' ' 33' ' ' THR . 1.2 pm0 -83.2 4.07 28.31 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.652 ' HB2' ' O ' ' A' ' 33' ' ' THR . 3.9 tmm_? -60.47 -32.73 71.69 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -60.83 -49.38 77.7 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.182 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 14.3 pt-20 -81.83 -22.36 37.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.38 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.655 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -61.53 -52.58 63.87 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 21.8 m -71.59 -20.8 61.95 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.587 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 22.0 t70 -61.98 -41.4 97.99 Favored 'General case' 0 CA--C 1.486 -1.506 0 C-N-CA 123.553 0.741 . . . . 0.0 111.206 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.626 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 51.7 mmtt -77.53 -29.43 52.35 Favored 'General case' 0 C--O 1.27 2.132 0 CA-C-O 122.511 1.148 . . . . 0.0 108.606 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 67.0 mt -70.97 -23.6 62.24 Favored 'General case' 0 N--CA 1.406 -2.667 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.951 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 41' ' ' SER . 56.1 mtpt -63.41 -53.34 53.43 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 86.3 Cg_exo -67.63 -45.18 3.6 Favored 'Trans proline' 0 C--O 1.263 1.731 0 C-N-CA 123.169 2.579 . . . . 0.0 111.803 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.567 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 6.5 tp -61.22 -30.55 48.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.402 0 C-N-CA 117.934 -1.506 . . . . 0.0 109.706 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -88.81 -18.69 27.17 Favored 'General case' 0 C--O 1.182 -2.496 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.761 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.05 -24.77 65.12 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.32 -19.45 50.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.567 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 2.3 pt20 -139.96 35.19 1.95 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.249 1.023 . . . . 0.0 110.948 -171.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -69.49 -19.21 63.74 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.137 -1.847 . . . . 0.0 112.375 -173.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.21 14.58 11.01 Favored Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.526 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.56 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.7 p -129.31 -32.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.214 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.0 mt -122.55 134.45 65.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.838 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.425 HD22 HG13 ' A' ' 24' ' ' ILE . 10.5 m-80 -88.56 109.86 20.42 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -93.48 108.3 20.0 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.568 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -131.49 132.26 6.7 Favored Glycine 0 C--N 1.29 -2.005 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.693 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.525 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 42.2 p -91.65 150.17 21.28 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 122.686 0.394 . . . . 0.0 111.131 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 6.7 tt -151.6 147.27 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -68.39 130.45 42.92 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.69 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.456 ' O ' ' HA3' ' A' ' 66' ' ' GLY . . . -93.26 -3.72 53.15 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.819 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -86.1 -49.51 7.72 Favored 'General case' 0 N--CA 1.42 -1.943 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.771 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.54 -37.69 9.07 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -104.37 14.36 30.32 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.791 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -71.55 -19.9 78.09 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 -172.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.54 68.8 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 117.69 0.745 . . . . 0.0 110.008 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -64.91 -24.95 67.68 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.009 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -63.16 -34.76 78.31 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 122.303 1.049 . . . . 0.0 109.82 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -104.49 18.57 44.34 Favored Glycine 0 C--N 1.28 -2.576 0 C-N-CA 118.348 -1.882 . . . . 0.0 114.15 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.21 -22.26 55.47 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 4.3 pp -104.68 -33.33 8.51 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.396 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.513 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 12.9 t-20 -174.5 -56.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -176.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.609 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.0 mm? -59.51 162.84 4.57 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -165.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -83.03 -9.85 59.05 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.239 -174.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p 61.53 18.4 9.41 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.954 2.102 . . . . 0.0 114.744 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -113.39 -17.56 12.23 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -170.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 79' ' ' PHE . 19.4 ttmt -117.84 -160.84 0.8 Allowed 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.31 -167.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.41 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 88.9 m-85 -54.9 164.2 1.26 Allowed Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.974 1.31 . . . . 0.0 111.481 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -39.74 129.65 1.92 Allowed 'Trans proline' 0 C--N 1.403 3.44 0 C-N-CA 122.793 2.328 . . . . 0.0 114.886 -174.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -108.17 104.44 13.85 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.084 -172.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.53 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 69.0 t80 -87.47 113.28 23.03 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.79 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -118.88 121.61 40.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 43.4 mt -95.67 110.99 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.205 0.526 . . . . 0.0 109.858 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -100.03 126.35 46.22 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 1.9 mm-40 -88.6 140.48 29.41 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 120.897 0.38 . . . . 0.0 111.31 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.515 HG23 ' SD ' ' A' ' 20' ' ' MET . 22.1 t -99.89 -4.85 9.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.035 0.922 . . . . 0.0 108.633 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.52 -38.62 4.59 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.606 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.402 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 75.4 mmtt -91.06 -16.35 28.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.505 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 59.25 30.46 20.21 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 122.303 1.049 . . . . 0.0 109.715 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.533 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 5.5 tp-100 -109.85 167.85 9.86 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.727 -171.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.523 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 10.5 mptt -122.71 98.68 6.02 Favored 'General case' 1 N--CA 1.373 -4.324 0 CA-C-N 113.216 -1.811 . . . . 0.0 106.548 -176.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 38.0 m-85 -100.39 82.64 0.33 Allowed Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 5.6 Cg_endo -100.33 148.96 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.639 2.226 . . . . 0.0 113.573 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -82.78 162.29 21.74 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.444 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 6.4 m-20 -71.37 139.02 49.65 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -84.61 1.72 44.77 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.954 -173.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -137.86 13.33 2.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.392 0.615 . . . . 0.0 111.594 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.55 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 15.4 tppt? -90.73 -8.91 48.54 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.58 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 69.64 117.97 0.04 OUTLIER 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.45 1.1 . . . . 0.0 111.105 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.467 HG21 ' CG1' ' A' ' 106' ' ' ILE . 3.4 mp -85.05 125.78 40.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.409 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.7 p -139.34 175.37 9.62 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.48 ' HA ' ' HB3' ' A' ' 43' ' ' LYS . 54.0 t80 -55.18 -61.11 2.54 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 122.081 0.943 . . . . 0.0 110.064 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . 0.255 23.5 tp10 -60.76 -39.64 89.54 Favored 'General case' 1 N--CA 1.37 -4.435 0 C-N-CA 126.811 2.044 . . . . 0.0 111.968 -171.997 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.26 93.5 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 123.816 0.698 . . . . 0.0 110.528 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.467 ' CG1' HG21 ' A' ' 101' ' ' ILE . 34.9 mm -72.36 -41.74 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.237 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -55.33 -52.06 64.73 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 124.179 0.924 . . . . 0.0 108.895 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.03 83.63 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.507 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -68.59 -58.16 4.69 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.828 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 111' ' ' ASP . 35.5 m -60.23 -32.61 51.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.889 0 O-C-N 121.841 -0.537 . . . . 0.0 110.71 -177.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.414 ' N ' HG23 ' A' ' 110' ' ' VAL . 19.4 t70 -58.33 -53.8 54.21 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 124.958 1.303 . . . . 0.0 109.153 176.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.675 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 7.2 t70 -60.62 -43.63 97.25 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 113.687 -1.597 . . . . 0.0 108.002 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.511 ' HB2' HD13 ' A' ' 118' ' ' ILE . 2.7 t80 -59.51 -64.02 1.09 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.173 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.8 -21.03 27.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.068 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.48 -35.19 53.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.23 0.538 . . . . 0.0 109.86 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.54 30.4 3.31 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.675 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 5.5 mtmt -102.26 -45.19 5.19 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.504 -1.348 . . . . 0.0 109.283 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.511 HD13 ' HB2' ' A' ' 113' ' ' PHE . 31.8 mt -76.14 142.45 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 171.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--N 1.273 -2.747 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.734 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 . . . . . 0 C--O 1.24 0.592 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.554 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 51.7 mt -102.18 119.98 51.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.67 174.7 20.33 Favored Glycine 0 N--CA 1.41 -3.067 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.485 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 28.4 Cg_endo -61.4 -17.03 51.07 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.091 2.527 . . . . 0.0 112.793 -177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.8 -13.4 16.44 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 119.37 -0.347 . . . . 0.0 111.747 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.8 p -102.03 -32.47 10.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 119.489 -0.884 . . . . 0.0 112.641 -173.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 13' ' ' PRO 0.254 5.3 p90 -60.61 -32.8 71.91 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -177.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 m -59.92 -31.26 69.67 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 123.742 0.817 . . . . 0.0 110.462 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.27 -35.37 41.49 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -73.33 -28.6 62.16 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.504 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -78.1 -36.97 47.42 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.49 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.6 t -78.52 -10.5 59.74 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.946 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.21 64.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.198 0.523 . . . . 0.0 110.453 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.56 -15.88 62.33 Favored Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.833 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 7.0 pt -93.76 154.04 41.01 Favored Pre-proline 0 C--N 1.301 -1.537 0 C-N-CA 123.026 0.53 . . . . 0.0 110.249 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -54.22 145.36 55.19 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 124.115 3.21 . . . . 0.0 114.663 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tt -108.69 127.02 53.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -97.94 107.65 20.18 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -88.46 120.68 30.06 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.283 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.412 HG12 ' CD1' ' A' ' 44' ' ' LEU . 3.4 mp -110.74 89.11 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.824 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.043 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 48.6 m-85 -78.6 109.96 13.29 Favored 'General case' 0 CA--C 1.452 -2.791 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.98 119.2 31.87 Favored 'General case' 1 C--N 1.238 -4.266 0 CA-C-O 121.197 0.522 . . . . 0.0 109.816 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -70.22 -28.77 65.54 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.645 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 18.0 p -75.16 119.12 18.87 Favored 'General case' 0 N--CA 1.379 -3.988 0 CA-C-N 113.296 -1.775 . . . . 0.0 108.436 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . . . -99.05 -17.62 18.16 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.595 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -99.01 -53.16 3.34 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.701 0.763 . . . . 0.0 109.623 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.491 ' OE1' ' HB ' ' A' ' 33' ' ' THR . 0.5 OUTLIER -86.71 7.44 26.71 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.109 -175.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.645 ' HB3' ' O ' ' A' ' 33' ' ' THR . 6.7 ptp180 -71.71 -16.78 62.24 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.372 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -69.42 -45.03 70.17 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 1.6 mp0 -65.72 -35.12 79.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.393 0.616 . . . . 0.0 109.771 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -60.81 -49.08 78.93 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 14.5 m -75.36 -10.6 59.61 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.056 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.574 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 19.0 t70 -78.09 -37.4 46.54 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 123.163 0.585 . . . . 0.0 110.32 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.626 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -72.23 -33.26 67.42 Favored 'General case' 0 C--O 1.285 2.944 0 CA-C-O 123.166 1.46 . . . . 0.0 108.136 173.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.412 ' CD1' HG12 ' A' ' 29' ' ' ILE . 85.6 mt -73.67 -21.94 60.11 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.19 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -66.35 -50.09 50.35 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 6.9 Cg_exo -78.2 -34.14 1.72 Allowed 'Trans proline' 0 CA--C 1.491 -1.655 0 C-N-CA 121.923 1.749 . . . . 0.0 110.034 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.533 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -62.33 -28.86 45.44 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.94 -20.06 21.0 Favored 'General case' 0 C--O 1.186 -2.25 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.794 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.22 -19.11 63.17 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.2 -14.01 54.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.54 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 3.1 pt20 -146.64 36.28 0.96 Allowed 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.061 0.934 . . . . 0.0 111.128 -173.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -74.46 -19.47 60.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.701 -1.59 . . . . 0.0 111.065 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.32 20.91 18.24 Favored Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.41 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.483 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.8 p -139.77 -33.73 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.657 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 88.4 mt -124.75 134.62 66.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.109 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.429 HD22 HG13 ' A' ' 24' ' ' ILE . 21.4 m-80 -91.44 97.44 11.08 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -76.79 131.68 38.82 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.399 0.619 . . . . 0.0 111.278 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.554 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -144.06 123.55 2.04 Favored Glycine 0 N--CA 1.396 -3.974 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.388 176.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.403 HG23 ' OG ' ' A' ' 41' ' ' SER . 38.9 p -86.45 136.41 33.11 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 7.5 tt -141.04 145.48 25.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -177.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.02 126.97 31.22 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.518 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.75 0.09 53.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -102.28 -42.31 6.06 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.99 -51.44 6.35 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.919 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -112.16 18.36 18.73 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.754 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.38 -22.86 67.89 Favored Glycine 0 CA--C 1.497 -1.089 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.38 -35.18 60.04 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 122.991 0.516 . . . . 0.0 110.796 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -63.57 -22.22 66.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.291 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.626 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -65.54 -39.18 91.46 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.999 0.904 . . . . 0.0 109.227 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.644 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -103.61 6.12 48.61 Favored Glycine 0 C--N 1.283 -2.387 0 C-N-CA 118.114 -1.993 . . . . 0.0 114.904 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -32.68 72.6 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 166.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 3.2 pp -89.67 -37.58 14.5 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.433 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.523 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 21.2 t-20 -171.48 -60.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.644 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.4 mm? -56.55 167.97 0.64 Allowed 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -166.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -82.61 -16.54 48.01 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.762 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 p 61.36 21.81 12.3 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 126.357 1.863 . . . . 0.0 112.803 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -107.66 -23.77 11.99 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -172.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HG2' ' HB3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -106.42 -162.01 0.83 Allowed 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.104 -169.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.568 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 67.2 m-85 -72.9 -172.42 0.23 Allowed Pre-proline 0 CA--C 1.571 1.76 0 C-N-CA 125.036 1.334 . . . . 0.0 108.998 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 5.6 Cg_endo -47.48 133.59 20.67 Favored 'Trans proline' 0 C--N 1.408 3.708 0 CA-C-N 122.583 1.958 . . . . 0.0 115.61 -175.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.06 122.4 37.11 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.252 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.517 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 75.9 t80 -96.47 117.44 30.91 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.381 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -119.46 122.35 41.52 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 122.046 -0.409 . . . . 0.0 111.998 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 49.3 mt -95.13 116.28 36.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 45.6 tt0 -106.69 122.38 46.24 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 19.8 mt-10 -80.58 148.96 30.1 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.956 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 20' ' ' MET . 19.9 t -113.0 -0.42 9.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.1 -57.15 3.21 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.819 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.416 ' HB2' ' HZ1' ' A' ' 89' ' ' LYS . 10.0 mtmp? -111.33 -9.98 14.25 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.631 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 49.7 t-20 65.88 86.72 0.13 Allowed 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.225 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.555 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 5.9 tp-100 -139.69 164.15 30.71 Favored 'General case' 0 CA--C 1.464 -2.339 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.639 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.51 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 11.3 mptt -119.88 95.05 4.61 Favored 'General case' 1 N--CA 1.376 -4.174 0 O-C-N 125.056 1.473 . . . . 0.0 108.572 -174.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.521 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 28.9 m-85 -101.28 83.13 0.41 Allowed Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 172.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 5.8 Cg_endo -101.58 144.92 0.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.396 2.064 . . . . 0.0 114.572 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -85.3 173.56 10.25 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 126.37 1.868 . . . . 0.0 109.088 -174.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.5 m-20 -66.3 148.79 51.33 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -95.47 2.47 54.45 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.481 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 9.8 pt-20 -149.31 23.66 0.92 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.009 -172.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 18.0 ttmm -90.76 -81.79 0.3 Allowed 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.001 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 172.45 123.63 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.411 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.4 mp -99.88 94.57 3.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -122.68 167.74 13.07 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.435 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.416 ' HE2' ' HB2' ' A' ' 46' ' ' PRO . 39.5 t80 -51.73 -61.06 2.49 Favored 'General case' 0 CA--C 1.483 -1.618 0 O-C-N 124.061 0.851 . . . . 0.0 110.107 -176.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -69.17 -27.01 65.14 Favored 'General case' 1 N--CA 1.372 -4.361 0 C-N-CA 125.784 1.634 . . . . 0.0 112.778 -172.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.7 -44.44 42.16 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.543 0.687 . . . . 0.0 109.354 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.411 ' CG1' HG23 ' A' ' 101' ' ' ILE . 32.8 mm -68.88 -40.34 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.575 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -56.43 -51.55 68.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.672 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.02 -43.36 70.06 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.164 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.01 -59.3 3.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.52 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.417 ' O ' HG11 ' A' ' 114' ' ' VAL . 33.9 m -60.83 -33.19 54.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 O-C-N 121.777 -0.577 . . . . 0.0 111.508 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.86 -50.42 73.87 Favored 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 124.067 0.947 . . . . 0.0 109.258 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.651 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 1.9 t70 -58.77 -47.74 83.63 Favored 'General case' 0 C--O 1.2 -1.513 0 CA-C-N 113.16 -1.836 . . . . 0.0 107.441 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.505 ' HB2' HD11 ' A' ' 118' ' ' ILE . 2.1 t80 -57.53 -65.55 0.61 Allowed 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.473 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 110' ' ' VAL . 8.8 p -62.07 -24.57 34.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.79 -34.86 52.03 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.75 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.99 30.89 2.62 Favored Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.651 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 22.2 mtmt -99.88 -44.31 6.1 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 113.202 -1.499 . . . . 0.0 108.422 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' ' 113' ' ' PHE . 33.4 mt -83.0 146.74 6.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 170.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 C--N 1.291 -1.955 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -178.726 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.478 HG13 ' HB ' ' A' ' 60' ' ' ILE . 2.2 pt -120.44 154.88 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-O 121.482 0.658 . . . . 0.0 111.777 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.55 176.59 30.7 Favored Glycine 0 N--CA 1.403 -3.501 0 N-CA-C 107.751 -2.139 . . . . 0.0 107.751 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.5 -27.44 68.82 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.167 2.578 . . . . 0.0 113.648 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -89.23 -20.52 24.04 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.444 ' HG1' ' HA ' ' A' ' 11' ' ' ILE . 68.0 p -97.91 -36.36 10.19 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.534 -169.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -62.71 -29.42 70.65 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.976 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -24.77 67.07 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.2 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.29 -37.67 44.27 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.88 0.848 . . . . 0.0 109.882 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -76.06 -27.44 57.25 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.486 ' O ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.04 -35.31 71.91 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.358 175.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 t -74.7 -19.51 60.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.933 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.28 -30.12 57.68 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 120.95 0.405 . . . . 0.0 110.2 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.39 -23.67 26.45 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.947 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.446 HG13 HD22 ' A' ' 56' ' ' ASN . 6.6 pt -81.15 152.87 71.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.479 -0.361 . . . . 0.0 111.68 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 85' ' ' GLN . 10.6 Cg_endo -52.42 137.25 56.93 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.063 3.175 . . . . 0.0 114.442 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 tt -106.8 125.96 51.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.496 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . . . -97.56 104.86 16.92 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -86.96 120.71 28.52 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.446 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.445 ' HB ' HG21 ' A' ' 59' ' ' THR . 3.4 mp -110.69 94.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.361 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 34.7 m-85 -80.34 126.64 31.42 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -142.15 122.1 13.64 Favored 'General case' 0 C--N 1.252 -3.639 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.493 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.428 ' HG2' ' C ' ' A' ' 62' ' ' ALA . 32.2 mt-10 -73.15 -20.82 60.83 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.426 ' HB ' ' CG ' ' A' ' 36' ' ' GLU . 1.5 p -86.66 83.86 7.51 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.997 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 37' ' ' ARG . . . -87.31 -25.21 24.03 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.154 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.5 mp0 -63.23 -34.13 76.99 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.179 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' CG ' ' HB ' ' A' ' 33' ' ' THR . 11.1 pt-20 -116.48 13.55 15.42 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.412 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.424 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 7.5 ptp180 -57.73 -27.93 63.44 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.812 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -50.4 -49.46 54.5 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 123.608 0.763 . . . . 0.0 111.517 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.625 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 12.1 pt-20 -86.97 -24.4 24.73 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.435 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.7 tm? -63.98 -44.92 91.24 Favored 'General case' 0 C--O 1.261 1.701 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.548 ' OG ' HG22 ' A' ' 59' ' ' THR . 15.7 m -73.01 -17.33 61.46 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.456 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 23.4 t70 -70.99 -40.87 71.61 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.677 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HD2' ' O ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -65.24 -38.11 89.33 Favored 'General case' 0 C--O 1.27 2.177 0 CA-C-O 123.426 1.584 . . . . 0.0 106.848 173.308 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 94.0 mt -71.12 -19.06 62.49 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 112.884 -1.962 . . . . 0.0 113.065 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.518 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 24.3 ttpp -66.56 -55.42 18.72 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.68 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 81.6 Cg_exo -65.59 -38.94 22.92 Favored 'Trans proline' 0 CA--C 1.489 -1.733 0 C-N-CA 123.174 2.582 . . . . 0.0 110.508 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.51 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 93.7 mt -53.68 -38.47 34.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 O-C-N 124.052 0.845 . . . . 0.0 109.695 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.443 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -93.92 -16.84 23.61 Favored 'General case' 0 C--O 1.19 -2.053 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.217 -174.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 3.6 tt0 -74.42 -17.73 60.75 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.57 -20.79 30.92 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.933 177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 2.8 pt20 -137.66 37.84 2.43 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.495 1.14 . . . . 0.0 110.609 -171.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -65.92 -24.83 66.91 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.542 -2.117 . . . . 0.0 112.846 -172.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.54 9.22 17.08 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.314 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 p -122.86 -33.0 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.193 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 88.1 mt -122.86 134.64 65.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.211 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.446 HD22 HG13 ' A' ' 24' ' ' ILE . 9.2 m-80 -94.46 102.89 14.87 Favored 'General case' 0 C--O 1.207 -1.159 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -80.19 139.47 36.74 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.795 0.807 . . . . 0.0 111.851 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.425 ' C ' HG12 ' A' ' 11' ' ' ILE . . . -151.54 113.27 0.57 Allowed Glycine 0 C--N 1.275 -2.811 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.649 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.548 HG22 ' OG ' ' A' ' 41' ' ' SER . 40.3 p -84.64 132.19 34.51 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HB ' HG13 ' A' ' 11' ' ' ILE . 7.6 tt -131.73 145.24 35.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 63' ' ' LYS . 7.7 t0 -73.33 123.9 24.68 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.042 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.428 ' C ' ' HG2' ' A' ' 32' ' ' GLU . . . -92.54 1.99 56.94 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.042 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HB3' ' OD1' ' A' ' 61' ' ' ASP . 39.4 ttmt -100.33 -31.17 11.47 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.68 -44.53 7.07 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.217 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -120.42 26.67 9.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.476 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -70.44 -15.92 73.23 Favored Glycine 0 CA--C 1.489 -1.565 0 N-CA-C 116.206 1.242 . . . . 0.0 116.206 -170.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.16 -35.55 71.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.374 0.607 . . . . 0.0 110.007 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 71' ' ' ASN . 63.7 m-70 -60.49 -21.79 62.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.146 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.11 -31.87 72.37 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 121.506 0.67 . . . . 0.0 110.283 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.742 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -122.77 9.99 9.07 Favored Glycine 0 CA--C 1.479 -2.205 0 C-N-CA 118.26 -1.924 . . . . 0.0 115.089 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -73.95 -16.42 61.08 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 166.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' HE3' ' A' ' 92' ' ' LYS . 3.9 pp -99.13 -26.25 14.27 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.928 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 177.78 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.742 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 89.8 mt -53.04 159.23 1.24 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.793 2.145 . . . . 0.0 116.793 -171.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -71.15 -17.91 62.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.235 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 p 50.13 57.83 6.14 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -135.25 -17.98 1.78 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -119.54 -159.92 0.79 Allowed 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.867 -167.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.487 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 57.7 m-85 -61.47 -176.37 0.12 Allowed Pre-proline 0 N--CA 1.499 1.993 0 C-N-CA 126.485 1.914 . . . . 0.0 111.262 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.518 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 3.7 Cg_endo -45.92 135.87 13.8 Favored 'Trans proline' 1 C--N 1.422 4.444 0 CA-C-N 121.75 1.661 . . . . 0.0 113.079 177.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.539 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . . . -116.52 136.67 52.79 Favored 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.927 -171.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 77.6 t80 -120.11 120.09 35.23 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -125.12 123.46 39.73 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.359 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.87 109.15 21.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 25' ' ' PRO . 41.3 tt0 -95.25 127.38 41.25 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -86.0 132.28 34.1 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 20' ' ' MET . 12.0 t -94.49 -0.42 10.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-O 122.139 0.971 . . . . 0.0 108.727 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.95 -44.68 3.94 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.699 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -93.85 -12.36 29.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.54 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 2.3 p-10 56.28 33.43 22.23 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 123.258 1.504 . . . . 0.0 109.894 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.508 ' C ' ' HD3' ' A' ' 92' ' ' LYS . 8.1 tp60 -98.12 167.04 11.12 Favored 'General case' 0 CA--C 1.464 -2.354 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.957 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.626 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 3.6 mppt? -132.76 102.88 5.84 Favored 'General case' 1 N--CA 1.373 -4.317 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -176.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -98.91 83.83 0.33 Allowed Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 173.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.626 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 24.1 Cg_endo -100.18 149.42 0.45 Allowed 'Trans proline' 0 N--CA 1.42 -2.809 0 C-N-CA 121.935 1.757 . . . . 0.0 113.411 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.416 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 83.2 t80 -84.34 168.16 15.86 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.789 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 18.6 m-20 -70.65 143.3 51.47 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.451 ' NE2' ' HB3' ' A' ' 74' ' ' LEU . 31.4 mt-30 -84.75 2.38 42.34 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.012 -171.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -152.22 22.02 0.65 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 14.9 tppt? -90.65 -3.22 57.67 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 70.49 133.02 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.911 2.085 . . . . 0.0 112.716 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.451 HG21 HG13 ' A' ' 106' ' ' ILE . 2.4 mp -91.24 97.91 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.943 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.4 p -110.25 -165.93 1.04 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.148 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.9 t80 -84.46 -55.0 4.38 Favored 'General case' 0 CA--C 1.485 -1.558 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -58.85 -43.86 90.89 Favored 'General case' 0 N--CA 1.387 -3.607 0 CA-C-N 113.096 -1.865 . . . . 0.0 113.731 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.62 -49.94 73.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.067 0.46 . . . . 0.0 111.328 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.451 HG13 HG21 ' A' ' 101' ' ' ILE . 44.2 mm -72.11 -40.54 66.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.599 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 30.7 ttpt -57.71 -48.84 78.43 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.4 -42.6 98.99 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 123.914 0.759 . . . . 0.0 110.922 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.485 ' O ' HD11 ' A' ' 118' ' ' ILE . 63.4 t80 -61.56 -60.73 3.25 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.209 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 111' ' ' ASP . 35.9 m -59.48 -30.67 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.642 -0.661 . . . . 0.0 110.468 -177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 23.9 t70 -64.27 -53.18 52.96 Favored 'General case' 0 CA--C 1.479 -1.756 0 C-N-CA 124.629 1.171 . . . . 0.0 108.96 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.623 ' OD2' HG12 ' A' ' 118' ' ' ILE 0.265 0.1 OUTLIER -68.2 -25.12 65.06 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.959 -177.167 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.547 ' N ' HG13 ' A' ' 118' ' ' ILE . 1.4 t80 -68.97 -62.01 1.56 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.772 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.79 -25.42 38.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.335 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.64 -30.72 67.43 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 121.175 0.512 . . . . 0.0 109.934 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.71 7.06 10.95 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.77 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.571 ' HE2' ' OD2' ' A' ' 112' ' ' ASP . 25.1 ttpt -89.42 -37.07 15.09 Favored 'General case' 0 N--CA 1.393 -3.311 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.591 -172.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.623 HG12 ' OD2' ' A' ' 112' ' ' ASP . 4.2 mt -74.02 135.45 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 118.446 -1.302 . . . . 0.0 109.851 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--N 1.267 -3.015 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -178.89 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.437 -1.085 0 CA-C-O 121.437 0.636 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.575 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 62.9 mt -103.71 118.11 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.957 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.25 178.32 17.87 Favored Glycine 0 N--CA 1.408 -3.218 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.42 -29.49 84.64 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.264 2.643 . . . . 0.0 112.939 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.96 -8.94 23.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.2 p -102.21 -35.88 8.71 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.466 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -62.5 -32.04 72.89 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.217 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.8 t -63.19 -27.9 69.68 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.571 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.61 -38.19 59.22 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.599 0.714 . . . . 0.0 109.73 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.407 ' HB3' ' CG ' ' A' ' 56' ' ' ASN . 18.4 m-85 -76.94 -23.39 52.42 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.579 ' SD ' HG23 ' A' ' 87' ' ' VAL . 8.7 tpp -80.67 -21.92 40.91 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.214 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -92.18 -13.05 31.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.07 -31.1 68.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.05 11.48 73.0 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.526 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.426 HG13 HD22 ' A' ' 56' ' ' ASN . 9.5 pt -123.98 151.06 64.46 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.34 144.84 47.77 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 124.125 3.217 . . . . 0.0 114.067 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 tt -116.14 126.34 53.57 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.465 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.74 110.54 22.98 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -90.73 120.18 31.57 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.176 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 58' ' ' GLY . 3.2 mp -111.37 90.84 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.07 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 44.1 m-85 -79.41 133.37 36.55 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -142.99 120.32 11.59 Favored 'General case' 0 C--N 1.273 -2.719 0 O-C-N 123.314 0.384 . . . . 0.0 111.884 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.18 -32.01 66.44 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 3.1 p -83.08 109.59 17.27 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.202 -171.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.89 -16.95 45.5 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.424 0.63 . . . . 0.0 109.708 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -70.8 -59.6 2.71 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.425 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -97.93 8.59 44.49 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.693 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 33' ' ' THR . 53.6 ttt180 -55.69 -36.94 67.69 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -59.31 -48.48 81.45 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.096 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.648 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 12.4 pt-20 -79.37 -27.23 41.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.671 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.516 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.1 tm? -59.41 -50.01 75.6 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.474 ' HA ' HD11 ' A' ' 44' ' ' LEU . 9.2 m -74.88 -19.57 60.1 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.975 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.546 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 33.8 t70 -70.1 -39.97 75.2 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 122.866 0.466 . . . . 0.0 111.334 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.648 ' HE2' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -70.51 -35.43 73.2 Favored 'General case' 0 C--O 1.297 3.554 0 CA-C-O 123.177 1.465 . . . . 0.0 108.509 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 68.6 mt -70.79 -23.64 62.43 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 113.102 -1.863 . . . . 0.0 111.814 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 36.4 ttpt -63.61 -52.1 61.51 Favored Pre-proline 0 C--N 1.289 -2.03 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.182 -173.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 51.5 Cg_exo -71.83 -44.28 1.01 Allowed 'Trans proline' 0 CA--C 1.492 -1.598 0 C-N-CA 122.803 2.335 . . . . 0.0 111.095 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.423 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 2.4 pp -61.95 -22.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.375 1.68 0 C-N-CA 117.777 -1.569 . . . . 0.0 111.735 -176.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -99.23 -21.0 16.3 Favored 'General case' 0 C--O 1.202 -1.416 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.31 -177.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 22.4 tt0 -69.82 -23.07 63.25 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.76 -16.63 60.1 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.228 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 3.1 pt20 -142.34 31.8 1.52 Allowed 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.522 -172.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.81 -14.27 59.63 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.977 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.89 5.52 50.64 Favored Glycine 0 C--N 1.296 -1.684 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.853 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.05 -37.47 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.534 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.3 mt -117.87 145.39 23.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.426 HD22 HG13 ' A' ' 24' ' ' ILE . 10.4 m-80 -92.94 121.76 34.62 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -103.87 128.71 51.33 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.174 0.988 . . . . 0.0 112.825 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.575 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -145.9 131.9 4.32 Favored Glycine 0 N--CA 1.415 -2.734 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.252 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 44.9 p -96.08 143.59 27.08 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 8.2 tt -148.01 154.99 10.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.53 132.02 34.57 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.336 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.486 ' O ' ' HA3' ' A' ' 66' ' ' GLY . . . -87.48 -3.63 59.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.135 0.493 . . . . 0.0 111.776 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -103.77 -32.05 9.53 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.002 0.429 . . . . 0.0 110.153 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.69 -46.59 7.5 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.406 ' O ' ' HE2' ' A' ' 30' ' ' PHE . 92.1 m-85 -117.24 19.29 14.21 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.502 -178.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -66.95 -14.61 63.61 Favored Glycine 0 C--N 1.307 -1.036 0 N-CA-C 116.382 1.313 . . . . 0.0 116.382 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.29 -24.64 67.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.085 0.942 . . . . 0.0 109.993 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -74.77 -22.3 58.85 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.946 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.425 ' HB2' HG23 ' A' ' 76' ' ' THR . . . -61.07 -44.22 97.71 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 121.835 0.826 . . . . 0.0 109.408 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -112.56 24.0 14.36 Favored Glycine 0 C--N 1.272 -3.019 0 C-N-CA 117.987 -2.054 . . . . 0.0 115.381 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -14.36 59.46 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 169.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 73' ' ' ASN . 4.1 pp -100.37 -29.37 12.45 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.568 177.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.508 ' N ' HD12 ' A' ' 72' ' ' LEU . 3.2 t-20 -175.8 -60.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.683 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.4 mm? -53.62 155.49 3.07 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -169.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -78.37 -12.96 60.04 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.012 -1.449 . . . . 0.0 112.49 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.425 HG23 ' HB2' ' A' ' 69' ' ' ALA . 75.7 p 58.61 28.52 17.23 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 126.56 1.944 . . . . 0.0 113.635 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.07 -28.44 6.98 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -170.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.704 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -124.9 106.07 9.72 Favored 'General case' 0 C--O 1.197 -1.676 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.418 -167.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.541 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 12.9 m-85 60.07 -171.06 0.02 OUTLIER Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.838 168.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 10.2 Cg_endo -58.72 149.91 73.92 Favored 'Trans proline' 0 C--N 1.379 2.148 0 CA-C-N 120.79 1.318 . . . . 0.0 113.8 171.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.58 126.21 34.21 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.783 -176.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 77.5 t80 -105.45 119.01 38.03 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -126.96 117.34 22.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.4 mt -91.02 110.18 22.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -92.04 135.0 34.31 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.554 ' OE2' ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -90.61 132.94 35.45 Favored 'General case' 0 CA--C 1.461 -2.462 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.371 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.579 HG23 ' SD ' ' A' ' 20' ' ' MET . 22.0 t -101.05 -6.7 9.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.98 -46.15 5.45 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 119.771 -0.771 . . . . 0.0 109.575 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.554 ' HG2' ' OE2' ' A' ' 86' ' ' GLU . 43.6 mmtm -92.62 -25.45 18.29 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.505 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 63.0 t30 66.65 59.16 0.61 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 123.646 1.688 . . . . 0.0 106.799 -171.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.544 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -130.24 176.34 8.19 Favored 'General case' 0 CA--C 1.468 -2.183 0 CA-C-N 113.098 -1.864 . . . . 0.0 107.4 -172.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.544 ' HD3' ' O ' ' A' ' 91' ' ' GLN . 60.3 mmtt -142.52 111.04 6.15 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -106.63 87.96 3.12 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 2.9 Cg_endo -104.48 150.89 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 122.689 2.259 . . . . 0.0 114.675 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.463 ' HD1' ' CD1' ' A' ' 109' ' ' PHE . 57.2 t80 -98.51 149.88 22.26 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.437 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.434 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 3.4 m-20 -58.72 139.51 56.07 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-O 121.702 0.763 . . . . 0.0 111.196 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.704 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 45.3 mt-30 -77.71 -8.54 58.09 Favored 'General case' 0 C--N 1.265 -3.103 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.181 -176.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.43 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 6.4 pt-20 -130.29 16.58 5.52 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.528 0.68 . . . . 0.0 111.42 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.434 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 34.8 ttmt -107.21 9.07 30.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.374 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 66.68 117.31 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.666 1.587 . . . . 0.0 114.6 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.499 HG22 ' CG1' ' A' ' 106' ' ' ILE . 3.4 mp -83.06 106.35 13.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.498 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.7 p -129.83 175.69 8.64 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.546 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 31.2 t80 -51.45 -63.79 1.02 Allowed 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 124.147 0.904 . . . . 0.0 110.047 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -67.38 -42.06 84.01 Favored 'General case' 1 N--CA 1.373 -4.299 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.195 -172.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.05 92.46 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 123.646 0.591 . . . . 0.0 110.296 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.499 ' CG1' HG22 ' A' ' 101' ' ' ILE . 32.6 mm -75.3 -42.26 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.101 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 27.0 ttpp -55.28 -50.33 69.8 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 123.759 0.662 . . . . 0.0 109.996 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.0 -33.54 75.78 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.043 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.463 ' CD1' ' HD1' ' A' ' 95' ' ' PHE . 68.8 t80 -66.21 -60.76 2.48 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.855 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 106' ' ' ILE . 27.8 m -58.67 -31.3 43.86 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 122.033 -0.417 . . . . 0.0 110.411 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 23.0 t70 -61.48 -50.97 70.59 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.789 1.236 . . . . 0.0 109.69 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.689 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 4.4 t70 -61.65 -46.29 90.38 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-N 113.941 -1.482 . . . . 0.0 107.247 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.526 ' HB2' HD11 ' A' ' 118' ' ' ILE . 2.1 t80 -55.4 -65.14 0.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.01 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.88 -15.29 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 C-N-CA 123.661 0.785 . . . . 0.0 111.909 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.35 -25.39 25.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 0.0 110.17 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.56 26.67 6.74 Favored Glycine 0 CA--C 1.485 -1.782 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.689 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -98.09 -47.12 5.62 Favored 'General case' 0 N--CA 1.411 -2.414 0 CA-C-N 114.055 -1.073 . . . . 0.0 109.113 -176.226 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 113' ' ' PHE . 20.5 mt -74.5 145.66 10.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--N 1.283 -2.296 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.121 -179.417 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' HA ' ' H ' ' A' ' 59' ' ' THR . 10.6 pt-20 . . . . . 0 N--CA 1.429 -1.497 0 CA-C-O 121.041 0.448 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.484 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 69.2 mt -110.79 128.96 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 172.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.06 170.68 19.43 Favored Glycine 0 N--CA 1.416 -2.679 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.74 -18.23 54.54 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.278 2.652 . . . . 0.0 112.642 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.83 6.39 31.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.837 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -114.95 -25.98 7.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.374 -1.33 . . . . 0.0 111.981 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -41.75 -59.49 1.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.751 0.821 . . . . 0.0 112.248 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.6 m -54.3 -33.04 57.89 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.011 -1.449 . . . . 0.0 112.738 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.58 -26.99 31.82 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -74.68 -29.26 61.17 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.414 ' O ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -76.76 -35.79 57.48 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.731 178.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -70.87 -21.72 62.37 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.394 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.07 -24.23 59.48 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 120.831 0.348 . . . . 0.0 111.307 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.61 -15.49 30.29 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-O 121.443 0.468 . . . . 0.0 112.309 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 19.8 pt -90.07 153.35 46.91 Favored Pre-proline 0 C--N 1.293 -1.888 0 CA-C-N 115.175 -0.513 . . . . 0.0 109.98 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 21.4 Cg_exo -52.42 140.47 53.53 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.313 2.675 . . . . 0.0 113.879 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.412 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 2.7 tt -102.31 125.2 48.95 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.469 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.91 106.29 18.58 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.412 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 57.1 m-85 -87.88 113.92 23.99 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.12 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.44 HD12 ' CD2' ' A' ' 57' ' ' PHE . 3.1 mp -103.71 86.96 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.815 0 C-N-CA 118.379 -1.328 . . . . 0.0 108.958 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 41.5 m-85 -75.87 125.82 29.82 Favored 'General case' 0 CA--C 1.457 -2.609 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . . . -140.58 119.5 12.65 Favored 'General case' 0 C--N 1.258 -3.381 0 O-C-N 123.567 0.542 . . . . 0.0 111.489 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.99 -26.44 67.55 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.575 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 1.2 p -81.39 120.42 24.94 Favored 'General case' 0 N--CA 1.393 -3.287 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.914 -176.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.04 -16.75 12.58 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 173.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.0 mp0 -72.74 -45.49 58.45 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.764 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -116.28 12.99 15.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.137 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' A' ' 33' ' ' THR . 44.1 ttm180 -51.79 -41.25 61.55 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 13.2 ptmm? -54.75 -32.0 59.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 124.147 0.904 . . . . 0.0 111.751 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -73.81 -43.78 57.8 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.667 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.8 mm? -58.14 -48.42 80.29 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.445 ' HA ' HD12 ' A' ' 44' ' ' LEU . 1.8 m -72.4 -21.48 61.26 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.817 -173.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 18.4 t70 -72.43 -39.19 68.06 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.743 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.631 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -73.02 -32.13 64.91 Favored 'General case' 0 C--O 1.287 3.035 0 CA-C-O 123.015 1.388 . . . . 0.0 108.69 175.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 52.5 mt -70.53 -26.51 63.61 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.434 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 4.0 tppp? -65.51 -51.8 48.81 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.304 -174.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 89.2 Cg_exo -67.14 -43.62 6.12 Favored 'Trans proline' 0 C--O 1.27 2.098 0 C-N-CA 122.901 2.4 . . . . 0.0 111.571 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.13 -21.75 29.02 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 118.457 -1.297 . . . . 0.0 111.099 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -95.39 -24.26 16.79 Favored 'General case' 0 C--O 1.197 -1.681 0 O-C-N 123.677 0.611 . . . . 0.0 111.085 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.466 ' OE1' ' HD2' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -66.26 -21.39 66.28 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.41 -19.46 56.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.73 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.429 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 3.0 pt20 -139.04 35.73 2.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.267 1.032 . . . . 0.0 110.883 -171.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.466 ' HD2' ' OE1' ' A' ' 49' ' ' GLU . 14.3 ptm180 -73.05 -18.84 61.28 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.614 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.83 15.34 31.51 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.608 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.2 p -137.85 -29.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.866 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.6 mt -128.65 136.15 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 O-C-N 121.546 -0.721 . . . . 0.0 111.361 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.403 HD22 HG13 ' A' ' 24' ' ' ILE . 17.9 m-80 -88.88 109.35 20.14 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.44 ' CD2' HD12 ' A' ' 29' ' ' ILE . 5.0 m-85 -93.31 114.98 27.56 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.484 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -136.97 128.62 4.46 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.353 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.407 ' H ' ' HA ' ' A' ' 10' ' ' GLU . 55.3 p -87.84 132.36 34.21 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 6.8 tt -132.79 145.25 34.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.44 ' OD1' ' HB3' ' A' ' 63' ' ' LYS . 11.2 t70 -75.56 127.83 33.95 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.263 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 30' ' ' PHE . . . -90.98 -1.3 57.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.624 0.725 . . . . 0.0 111.285 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.44 ' HB3' ' OD1' ' A' ' 61' ' ' ASP . 39.1 ttmt -99.35 -34.19 10.41 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.38 -54.5 3.25 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.766 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.29 20.25 19.25 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 121.767 -0.583 . . . . 0.0 111.007 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -63.3 -20.4 63.08 Favored Glycine 0 C--N 1.309 -0.919 0 N-CA-C 116.246 1.258 . . . . 0.0 116.246 -172.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.04 -25.03 66.63 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.021 0.911 . . . . 0.0 110.591 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -73.09 -17.83 61.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.458 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.458 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -64.18 -33.58 76.11 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.623 1.202 . . . . 0.0 108.837 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.644 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -116.22 24.08 10.17 Favored Glycine 0 C--N 1.27 -3.111 0 C-N-CA 118.564 -1.779 . . . . 0.0 114.226 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -8.4 58.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 166.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 4.1 pp -112.71 -38.55 4.55 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 112.867 -1.97 . . . . 0.0 109.18 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.565 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 11.5 t-20 -169.23 -56.95 0.02 OUTLIER 'General case' 0 C--N 1.367 1.356 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.644 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.3 mm? -60.49 173.37 0.71 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -167.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.637 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 53.1 tttm -90.54 -9.75 46.05 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.588 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.2 p 74.7 -13.13 0.85 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 128.358 2.663 . . . . 0.0 115.714 168.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.637 ' OD1' ' HG2' ' A' ' 75' ' ' LYS . 17.7 p-10 -108.1 5.04 25.6 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -166.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 36.2 ttmt -129.23 103.98 7.26 Favored 'General case' 0 C--N 1.258 -3.395 0 C-N-CA 119.527 -0.869 . . . . 0.0 113.256 -173.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 31.6 m-85 56.52 -175.57 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 124.417 1.073 . . . . 0.0 113.195 167.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 9.2 Cg_endo -65.12 134.07 38.01 Favored 'Trans proline' 0 N--CA 1.424 -2.596 0 CA-C-N 119.978 1.028 . . . . 0.0 113.113 167.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.95 116.64 20.39 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 113.903 -1.498 . . . . 0.0 107.878 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.469 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 61.5 t80 -91.34 109.32 20.6 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.381 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -111.0 115.85 30.18 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.436 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 39.2 mt -90.93 109.38 20.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 25.4 tt0 -106.74 120.54 42.27 Favored 'General case' 0 N--CA 1.395 -3.203 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.436 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.744 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 13.1 mt-10 -75.38 148.23 39.37 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.885 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 20' ' ' MET . 16.4 t -113.72 -1.87 10.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.88 -55.9 3.63 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -97.36 -19.78 18.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.212 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.744 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 47.2 t-20 59.85 80.43 0.2 Allowed 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 125.119 1.368 . . . . 0.0 108.277 -170.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.526 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 5.3 tp60 -133.59 165.26 25.33 Favored 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 113.789 -1.55 . . . . 0.0 107.519 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 1.2 mptp? -125.25 99.85 6.26 Favored 'General case' 0 N--CA 1.4 -2.964 0 O-C-N 123.82 0.7 . . . . 0.0 109.242 -175.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.526 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 44.6 m-85 -104.57 83.45 0.77 Allowed Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.999 174.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 4.6 Cg_endo -100.74 148.42 0.37 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 C-N-CA 122.879 2.386 . . . . 0.0 114.354 -177.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -88.8 158.75 18.03 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.844 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.5 m-20 -65.99 145.79 55.46 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 121.514 0.673 . . . . 0.0 111.426 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.522 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 13.2 mt-30 -84.25 5.2 27.53 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.299 -174.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.3 22.63 2.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.037 0.923 . . . . 0.0 110.108 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 14.6 tppt? -104.03 170.23 8.04 Favored 'General case' 0 N--CA 1.401 -2.898 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -94.26 110.29 22.05 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 118.647 0.658 . . . . 0.0 111.503 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.71 101.59 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.637 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.3 p -125.29 -170.59 2.2 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.019 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.3 t80 -75.28 -54.24 7.42 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -174.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -55.18 -54.0 48.87 Favored 'General case' 0 N--CA 1.384 -3.767 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.777 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.68 -48.82 78.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 123.742 0.651 . . . . 0.0 112.265 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 47.7 mm -73.65 -40.55 54.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -59.13 -46.6 87.94 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.48 94.78 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.829 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -65.38 -58.67 5.3 Favored 'General case' 0 C--O 1.21 -0.987 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.276 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.92 -33.25 52.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 O-C-N 121.689 -0.632 . . . . 0.0 110.7 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.18 -51.91 67.97 Favored 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 124.241 1.016 . . . . 0.0 109.673 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.719 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 3.6 t70 -58.89 -47.12 86.08 Favored 'General case' 0 C--O 1.206 -1.197 0 CA-C-N 113.699 -1.591 . . . . 0.0 107.383 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.521 ' HB2' HD11 ' A' ' 118' ' ' ILE . 1.1 t80 -55.44 -64.48 0.83 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.059 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.99 -11.95 14.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.224 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.77 -30.14 23.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.435 0.636 . . . . 0.0 109.744 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.41 26.74 5.54 Favored Glycine 0 CA--C 1.481 -2.051 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.719 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -96.68 -52.32 3.97 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-N 114.131 -1.035 . . . . 0.0 109.157 -176.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 113' ' ' PHE . 18.5 mt -71.15 145.1 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--N 1.277 -2.57 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.75 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 N--CA 1.442 -0.873 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.552 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 57.1 mt -92.48 139.05 18.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.54 -179.65 18.87 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.79 -31.68 42.98 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.45 3.433 . . . . 0.0 114.582 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.24 -7.59 24.47 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.0 p -93.83 -27.26 16.54 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.985 -169.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -45.93 -51.43 13.29 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.884 0.85 . . . . 0.0 111.012 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -55.5 -34.4 64.57 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.387 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -71.04 -41.64 70.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.456 0.646 . . . . 0.0 110.096 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.433 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 41.9 m-85 -72.48 -28.94 63.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.35 1.071 . . . . 0.0 108.271 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.457 ' SD ' HG21 ' A' ' 87' ' ' VAL . 5.8 tpp -78.39 -19.96 52.2 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.315 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -87.79 -17.11 32.31 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.355 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.37 -41.7 72.75 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.025 0.441 . . . . 0.0 110.794 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.22 0.28 65.66 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.662 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 13.7 pt -107.8 152.48 41.59 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.25 138.91 64.18 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.923 3.082 . . . . 0.0 113.759 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.485 HD11 ' CZ ' ' A' ' 28' ' ' TYR . 2.5 tt -105.33 125.85 51.45 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.582 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -98.76 105.55 17.71 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.485 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 65.5 m-85 -86.72 112.43 21.66 Favored 'General case' 0 CA--C 1.467 -2.234 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.429 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.9 mt -101.09 85.08 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.596 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 43.6 m-85 -76.35 124.52 27.65 Favored 'General case' 0 CA--C 1.46 -2.515 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.64 121.17 21.62 Favored 'General case' 0 C--N 1.257 -3.447 0 O-C-N 123.456 0.473 . . . . 0.0 110.66 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -81.99 -16.69 49.49 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.6 p -97.11 100.55 12.03 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.722 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.64 -16.93 60.14 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.94 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -71.57 -56.67 5.43 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.164 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.552 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 15.0 pt-20 -91.0 8.49 35.04 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.561 -175.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . 0.275 0.1 OUTLIER -59.71 -32.85 70.91 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.159 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -77.46 -33.63 54.61 Favored 'General case' 0 C--O 1.2 -1.543 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.782 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.552 ' OE2' ' HA ' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -65.77 -43.92 87.38 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -56.92 -49.51 75.39 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.54 ' OG ' HG21 ' A' ' 59' ' ' THR . 15.0 m -73.63 -13.41 61.0 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.061 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.479 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 24.4 t70 -77.49 -38.32 49.36 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 123.138 0.575 . . . . 0.0 111.074 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.582 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -69.37 -36.34 76.74 Favored 'General case' 0 C--O 1.276 2.495 0 CA-C-O 123.271 1.51 . . . . 0.0 107.952 172.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 75.5 mt -73.22 -18.52 61.23 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 113.527 -1.67 . . . . 0.0 111.94 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.521 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 36.9 ttpt -62.37 -55.03 43.6 Favored Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 123.646 0.778 . . . . 0.0 111.382 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.582 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 51.6 Cg_exo -72.22 -36.97 4.99 Favored 'Trans proline' 0 CA--C 1.485 -1.926 0 C-N-CA 122.593 2.195 . . . . 0.0 109.795 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.562 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 27.3 mm -54.38 -36.64 34.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.383 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.33 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -91.05 -20.47 22.04 Favored 'General case' 0 C--O 1.195 -1.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.249 -174.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -69.9 -22.72 63.19 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.32 -9.62 59.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.757 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 3.0 pt20 -148.57 35.37 0.79 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.298 1.046 . . . . 0.0 110.644 -173.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.2 -19.23 61.14 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.805 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.13 21.68 11.9 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.679 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.479 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.7 p -138.84 -32.65 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.504 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.2 mt -122.85 137.6 55.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.812 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.433 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 20.9 m-80 -84.16 111.75 19.63 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' A' ' 29' ' ' ILE . 1.6 m-85 -97.67 105.82 18.03 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.552 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -130.62 130.46 6.16 Favored Glycine 0 N--CA 1.415 -2.747 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.867 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.54 HG21 ' OG ' ' A' ' 41' ' ' SER . 35.6 p -92.38 136.97 32.76 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 tt -137.31 156.92 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.485 ' OD2' ' HD1' ' A' ' 65' ' ' PHE . 3.4 p30 -75.28 149.71 38.73 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.347 0.594 . . . . 0.0 110.172 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.6 14.03 26.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.904 0.859 . . . . 0.0 108.764 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -84.43 -53.71 5.25 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.045 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.56 -48.6 3.21 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.3 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.485 ' HD1' ' OD2' ' A' ' 61' ' ' ASP . 96.0 m-85 -97.97 10.49 40.2 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.987 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.11 -24.63 61.1 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 115.881 1.113 . . . . 0.0 115.881 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.92 -20.83 65.98 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.399 1.099 . . . . 0.0 110.333 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -70.82 -20.72 62.54 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.552 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.39 89.99 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-O 122.343 1.068 . . . . 0.0 109.652 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.666 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -113.21 31.44 6.71 Favored Glycine 0 C--N 1.27 -3.101 0 C-N-CA 119.275 -1.441 . . . . 0.0 113.825 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.59 -17.46 38.71 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 168.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 73' ' ' ASN . 4.0 pp -102.82 -24.95 13.67 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.041 -1.891 . . . . 0.0 110.998 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.459 ' N ' HD12 ' A' ' 72' ' ' LEU . 2.2 t-20 -179.96 -59.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.666 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.6 mm? -54.41 158.71 2.29 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -168.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -75.42 -17.69 60.1 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.829 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.6 p 55.17 40.33 31.72 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.182 1.393 . . . . 0.0 113.42 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.44 ' OD2' ' HE2' ' A' ' 78' ' ' LYS . 20.6 p-10 -125.18 -23.13 4.25 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.164 0.507 . . . . 0.0 111.224 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HE2' ' OD2' ' A' ' 77' ' ' ASP . 33.6 mtmt -108.13 -174.69 2.58 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -170.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.524 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 95.7 m-85 -69.16 -172.45 0.17 Allowed Pre-proline 0 CA--C 1.572 1.822 0 C-N-CA 125.791 1.637 . . . . 0.0 109.967 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 1.3 Cg_endo -43.67 131.09 7.52 Favored 'Trans proline' 1 C--N 1.429 4.788 0 CA-C-N 122.415 1.898 . . . . 0.0 116.42 -170.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.85 116.05 20.27 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 113.101 -1.863 . . . . 0.0 107.93 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 71.5 t80 -95.14 109.85 21.88 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.971 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -112.07 117.1 31.72 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.2 mt -91.45 105.22 16.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.666 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -90.13 126.37 35.77 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 2.8 mm-40 -87.88 125.59 34.57 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.549 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.457 HG21 ' SD ' ' A' ' 20' ' ' MET . 15.1 t -98.12 1.22 10.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.39 -35.07 3.66 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.177 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 89' ' ' LYS . 5.9 tmtm? -95.83 -20.16 19.03 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 16.3 m120 67.52 36.72 3.66 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-O 122.847 1.308 . . . . 0.0 110.337 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.511 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 2.0 tp60 -121.14 -179.69 4.12 Favored 'General case' 0 CA--C 1.472 -2.048 0 CA-C-N 112.803 -1.999 . . . . 0.0 107.681 -172.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.525 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 57.3 mmtt -138.12 106.17 5.71 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -102.47 87.2 1.08 Allowed Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 10.8 Cg_endo -102.33 142.25 0.19 Allowed 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 122.572 2.182 . . . . 0.0 114.638 -176.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.437 ' HD1' ' CD1' ' A' ' 109' ' ' PHE . 86.4 t80 -84.58 170.49 13.35 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.34 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -72.42 159.49 33.89 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.122 0.969 . . . . 0.0 110.295 -177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -100.75 -11.67 19.72 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-O 121.83 0.824 . . . . 0.0 108.909 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -123.42 -0.18 8.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.347 -173.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -87.58 -3.18 58.99 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.869 -172.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 72.95 134.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.145 0.978 . . . . 0.0 111.703 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.46 HG21 HG13 ' A' ' 106' ' ' ILE . 2.8 mp -90.04 101.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 122.009 0.909 . . . . 0.0 109.846 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.7 p -109.33 -174.02 2.4 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -77.2 -51.14 11.45 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -59.95 -52.39 65.61 Favored 'General case' 0 N--CA 1.379 -3.985 0 CA-C-N 112.493 -2.14 . . . . 0.0 113.397 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.57 83.46 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.121 0.486 . . . . 0.0 111.39 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 110' ' ' VAL . 40.2 mm -73.05 -42.0 59.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.0 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 47' ' ' ILE . 33.8 ttpt -56.46 -50.56 71.38 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.34 92.63 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.143 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.668 ' O ' HD11 ' A' ' 118' ' ' ILE . 57.8 t80 -63.69 -59.92 3.98 Favored 'General case' 0 C--O 1.204 -1.305 0 O-C-N 124.02 0.825 . . . . 0.0 111.074 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 106' ' ' ILE . 31.4 m -58.87 -35.72 57.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 O-C-N 121.998 -0.438 . . . . 0.0 111.535 -176.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.88 -51.93 66.18 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.719 0.771 . . . . 0.0 109.036 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.699 ' OD1' ' HB3' ' A' ' 117' ' ' LYS . 5.6 t0 -57.35 -36.08 70.75 Favored 'General case' 0 C--O 1.196 -1.711 0 CA-C-N 113.45 -1.704 . . . . 0.0 109.731 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.5 ' HB2' HD13 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -71.25 -61.22 1.85 Allowed 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.89 177.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.09 -23.44 33.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.542 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.52 -22.19 44.26 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.605 0.717 . . . . 0.0 109.622 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.4 18.22 15.31 Favored Glycine 0 CA--C 1.466 -2.994 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.487 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.699 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 12.7 ttpp -93.04 -38.31 11.7 Favored 'General case' 0 N--CA 1.384 -3.753 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.609 -172.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.668 HD11 ' O ' ' A' ' 109' ' ' PHE . 9.9 mt -67.57 141.92 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.407 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--N 1.256 -3.471 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.23 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.423 -1.777 0 CA-C-O 121.46 0.648 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.481 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 62.1 mt -95.72 114.04 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -127.77 -178.92 15.56 Favored Glycine 0 N--CA 1.408 -3.199 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.29 -8.28 8.23 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.036 3.157 . . . . 0.0 115.67 -173.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -123.98 -18.36 5.98 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.018 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.8 p -85.23 -27.62 25.94 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.573 -172.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -62.09 -36.74 82.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.293 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 m -66.66 -27.31 67.57 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.867 0.867 . . . . 0.0 110.574 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.95 -39.07 61.55 Favored 'General case' 0 C--O 1.258 1.549 0 CA-C-O 121.704 0.764 . . . . 0.0 109.095 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -75.12 -26.15 58.98 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.461 ' SD ' HG22 ' A' ' 87' ' ' VAL . 8.8 tpp -77.76 -25.3 49.03 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.661 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -88.82 -10.75 46.98 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.405 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.27 -35.19 73.6 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 122.086 -0.384 . . . . 0.0 111.543 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.48 65.55 Favored Glycine 0 N--CA 1.461 0.304 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.366 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 9.1 pt -126.1 151.62 72.07 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -50.14 141.56 30.32 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.068 3.179 . . . . 0.0 114.037 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 28' ' ' TYR . 2.5 tt -110.4 124.81 52.42 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -94.1 105.46 17.46 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 26' ' ' LEU . 48.3 m-85 -87.59 110.7 20.57 Favored 'General case' 0 CA--C 1.471 -2.058 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.363 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.7 mt -100.23 85.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.319 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' A' ' 81' ' ' ALA . 31.5 m-85 -77.53 109.91 11.88 Favored 'General case' 0 CA--C 1.468 -2.181 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -124.06 119.75 30.39 Favored 'General case' 1 C--N 1.238 -4.245 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.701 177.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -74.54 -27.2 60.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.426 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 11.4 p -93.49 106.6 18.55 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.61 -173.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . -78.78 -21.28 48.1 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.909 -175.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -80.1 -48.51 13.12 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.042 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HG2' ' HB ' ' A' ' 33' ' ' THR . 12.5 pt-20 -90.7 1.18 57.07 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.553 -0.859 . . . . 0.0 112.158 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 12.2 ptm180 -60.19 -24.31 64.68 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -58.48 -57.9 10.92 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.53 -25.79 54.51 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.166 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.648 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -60.24 -50.98 71.5 Favored 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.407 ' HA ' HD11 ' A' ' 44' ' ' LEU . 9.9 m -75.11 -19.4 59.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.73 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.41 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 15.9 t70 -67.79 -43.39 79.84 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.836 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.639 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -70.37 -34.05 72.14 Favored 'General case' 0 C--O 1.278 2.597 0 CA-C-O 122.772 1.272 . . . . 0.0 108.463 176.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 56.9 mt -69.94 -20.51 63.33 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.716 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.535 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 17.4 tppt? -61.97 -57.29 24.8 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.843 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 72.8 Cg_exo -66.82 -39.42 14.84 Favored 'Trans proline' 0 CA--C 1.49 -1.696 0 C-N-CA 122.917 2.411 . . . . 0.0 110.351 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 103' ' ' PHE . 93.8 mt -52.67 -40.36 34.02 Favored 'Isoleucine or valine' 0 C--N 1.368 1.388 0 O-C-N 124.086 0.866 . . . . 0.0 109.208 176.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -94.26 -13.79 26.16 Favored 'General case' 0 C--O 1.177 -2.718 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.603 -173.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -71.94 -22.36 61.48 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.92 -23.45 33.51 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.906 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.535 ' OE1' HD11 ' A' ' 55' ' ' ILE . 5.4 pt20 -130.85 34.37 4.09 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.19 0.995 . . . . 0.0 112.373 -174.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -73.25 -18.58 61.21 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.393 -1.73 . . . . 0.0 111.858 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.38 4.4 28.17 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.418 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.405 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.8 p -124.15 -33.5 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.325 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.535 HD11 ' OE1' ' A' ' 51' ' ' GLN . 95.0 mt -124.39 136.81 59.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.034 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -84.83 104.65 14.97 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -90.16 102.67 15.39 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.573 0.701 . . . . 0.0 112.564 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.481 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -124.21 131.74 8.05 Favored Glycine 0 N--CA 1.415 -2.762 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.424 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.483 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 27.4 p -92.27 134.67 34.68 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 120.896 0.379 . . . . 0.0 110.515 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.476 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 8.7 tt -137.15 165.58 27.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -89.13 153.88 20.6 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-O 121.458 0.647 . . . . 0.0 110.922 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -110.48 19.83 18.36 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 173.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -102.82 -46.02 4.82 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 113.382 -1.735 . . . . 0.0 109.844 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.47 -43.58 3.48 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.139 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.422 ' O ' ' HE2' ' A' ' 30' ' ' PHE . 96.4 m-85 -99.21 10.12 42.07 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 122.124 -0.36 . . . . 0.0 110.68 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 62' ' ' ALA . . . -58.97 -30.04 66.0 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.01 -30.08 46.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.413 0.625 . . . . 0.0 111.303 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -69.15 -23.81 64.0 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.285 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.43 ' HB2' HG22 ' A' ' 76' ' ' THR . . . -63.02 -34.41 77.5 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-O 121.978 0.894 . . . . 0.0 109.861 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -109.28 5.34 31.7 Favored Glycine 0 C--N 1.279 -2.591 0 C-N-CA 117.403 -2.332 . . . . 0.0 115.502 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -76.57 -16.97 59.46 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 73' ' ' ASN . 4.2 pp -97.68 -31.38 12.3 Favored 'General case' 0 N--CA 1.399 -2.987 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.349 174.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.422 ' N ' HD13 ' A' ' 72' ' ' LEU . 2.2 t-20 179.51 -56.74 0.01 OUTLIER 'General case' 0 C--N 1.38 1.906 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.673 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.3 mm? -61.4 179.9 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -169.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.25 -0.68 20.72 Favored 'General case' 0 CA--C 1.486 -1.515 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.99 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.43 HG22 ' HB2' ' A' ' 69' ' ' ALA . 19.2 p 59.3 5.78 0.64 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 125.205 1.402 . . . . 0.0 112.401 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.92 -25.09 28.12 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -170.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 11.4 tptm -119.21 -158.68 0.74 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.672 -166.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.456 ' H ' ' HG3' ' A' ' 78' ' ' LYS . 89.5 m-85 -54.99 168.32 0.53 Allowed Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 125.054 1.341 . . . . 0.0 110.506 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 2.5 Cg_endo -40.63 130.44 2.64 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.998 2.465 . . . . 0.0 114.431 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -103.75 104.82 14.88 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.608 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 74.3 t80 -87.13 111.5 21.0 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.908 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -120.88 119.39 32.51 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.2 mt -89.41 104.84 15.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -86.18 132.77 33.94 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.15 141.89 29.87 Favored 'General case' 0 C--N 1.265 -3.098 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.017 175.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.461 HG22 ' SD ' ' A' ' 20' ' ' MET . 25.8 t -107.79 -2.06 10.0 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.38 -48.19 3.75 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.405 ' HD3' ' OE2' ' A' ' 86' ' ' GLU . 4.7 mptp? -89.38 -25.15 21.73 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.981 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.666 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 16.2 t-20 66.17 20.72 11.15 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.36 1.464 . . . . 0.0 108.465 -173.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.539 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 4.4 tp60 -85.95 178.7 7.19 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.609 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 56.7 mmtt -138.46 105.04 5.31 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -96.88 87.84 0.49 Allowed Pre-proline 0 N--CA 1.481 1.084 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 6.0 Cg_endo -104.82 145.7 0.12 Allowed 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.516 2.144 . . . . 0.0 115.01 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -86.0 158.78 19.78 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.595 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.475 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.3 m-20 -71.48 134.49 46.59 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.109 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -75.74 9.62 2.21 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.722 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -154.92 20.96 0.45 Allowed 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.177 0.513 . . . . 0.0 111.443 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 39.1 ttmt -97.86 9.89 41.57 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 74.09 120.46 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 113.562 -1.654 . . . . 0.0 112.025 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.2 mp -92.82 98.54 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.03 -164.47 1.32 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.923 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.484 ' O ' HD12 ' A' ' 47' ' ' ILE . 16.0 t80 -77.79 -58.62 3.17 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -174.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -52.84 -53.75 44.18 Favored 'General case' 0 N--CA 1.386 -3.638 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.527 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.83 -49.31 77.1 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 123.596 0.56 . . . . 0.0 112.371 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 110' ' ' VAL . 41.8 mm -72.96 -42.45 59.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.024 -177.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -54.52 -50.96 66.61 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.996 0.81 . . . . 0.0 109.241 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.11 93.73 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.559 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -65.32 -60.13 3.31 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.62 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 106' ' ' ILE . 27.6 m -57.62 -36.62 54.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 O-C-N 121.83 -0.544 . . . . 0.0 111.422 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.29 -46.37 87.07 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.216 0.531 . . . . 0.0 109.681 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.688 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 3.4 t70 -57.27 -48.98 77.5 Favored 'General case' 0 C--O 1.203 -1.39 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.532 ' HB2' HD11 ' A' ' 118' ' ' ILE . 2.7 t80 -57.02 -63.59 1.16 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.622 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 110' ' ' VAL . 90.6 t -52.48 -30.8 14.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 C-N-CA 124.311 1.044 . . . . 0.0 112.37 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.59 -38.95 58.7 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.676 0.751 . . . . 0.0 110.026 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.16 23.87 5.64 Favored Glycine 0 CA--C 1.473 -2.534 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.688 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 3.3 ttmm -92.39 -42.52 9.73 Favored 'General case' 0 N--CA 1.387 -3.579 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 113' ' ' PHE . 23.5 mt -81.37 143.35 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--N 1.272 -2.772 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 179.373 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 N--CA 1.426 -1.652 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.529 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 67.7 mt -105.69 120.9 57.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.56 179.75 18.57 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.54 5.36 4.3 Favored 'Trans proline' 0 C--O 1.221 -0.367 0 C-N-CA 123.029 2.486 . . . . 0.0 112.752 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -128.64 -6.18 5.18 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.869 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -100.27 -28.31 13.05 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.736 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -59.09 -38.38 79.38 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.9 0.381 . . . . 0.0 111.693 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 m -65.22 -27.09 68.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.717 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.81 -33.4 40.41 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.034 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HB3' ' CG ' ' A' ' 56' ' ' ASN . 21.1 m-85 -75.8 -27.21 57.88 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.551 ' SD ' HG23 ' A' ' 87' ' ' VAL . 8.7 tpp -77.07 -21.53 54.28 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 113.554 -1.657 . . . . 0.0 108.757 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.4 t -90.0 -12.77 37.66 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.8 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.26 60.39 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.226 0.536 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.63 2.85 78.46 Favored Glycine 0 C--N 1.32 -0.35 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.25 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 13.6 pt -112.04 148.64 39.47 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -51.29 142.21 37.63 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.834 3.022 . . . . 0.0 113.846 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.478 HD12 ' CE1' ' A' ' 28' ' ' TYR . 2.6 tt -108.98 126.91 53.6 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . . . -101.02 109.07 20.93 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.478 ' CE1' HD12 ' A' ' 26' ' ' LEU . 47.1 m-85 -89.58 109.61 20.54 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.365 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.465 HD12 ' CD2' ' A' ' 57' ' ' PHE . 2.5 mp -101.04 87.92 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.337 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 42.9 m-85 -73.02 133.73 44.36 Favored 'General case' 0 CA--C 1.467 -2.226 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . . . -148.19 117.08 6.73 Favored 'General case' 0 C--N 1.274 -2.693 0 O-C-N 123.593 0.558 . . . . 0.0 111.665 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.01 -22.8 59.44 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.852 0.834 . . . . 0.0 108.911 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.0 p -76.52 115.88 16.68 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.882 -173.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.33 -15.26 19.82 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.395 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -85.69 -63.72 1.27 Allowed 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -78.91 12.5 2.14 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.462 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.6 tpp85 -52.7 -39.07 61.64 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 169.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -67.03 -48.49 68.17 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.607 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 45.6 mt-10 -59.61 -50.52 73.55 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.217 0.532 . . . . 0.0 110.307 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -53.23 -54.42 36.43 Favored 'General case' 0 C--O 1.255 1.354 0 C-N-CA 124.653 1.181 . . . . 0.0 108.849 -176.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.3 m -73.6 -15.18 61.28 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.62 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 33.8 t70 -75.09 -35.59 61.79 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 122.954 0.501 . . . . 0.0 111.458 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -30.17 52.94 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 122.865 1.317 . . . . 0.0 108.81 173.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 45.8 mt -73.16 -30.97 63.95 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 113.626 -1.624 . . . . 0.0 113.713 -177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.525 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 24.8 ttpp -68.2 -46.4 39.84 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.694 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 73.5 Cg_endo -70.88 -42.56 2.18 Favored 'Trans proline' 0 C--O 1.26 1.593 0 C-N-CA 122.485 2.123 . . . . 0.0 110.996 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.15 -24.89 37.15 Favored 'Isoleucine or valine' 0 C--N 1.385 2.128 0 C-N-CA 118.11 -1.436 . . . . 0.0 109.99 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.409 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -92.85 -22.23 19.4 Favored 'General case' 0 C--O 1.194 -1.841 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.201 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 6.2 tt0 -69.84 -18.44 63.44 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.72 -21.56 51.71 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.971 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.409 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 2.7 pt20 -138.51 36.54 2.25 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.2 1.0 . . . . 0.0 111.108 -170.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 49' ' ' GLU . 9.1 ptm180 -76.85 -14.02 59.94 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.645 -172.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.6 6.68 22.54 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.632 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.6 p -125.6 -32.51 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.515 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.6 mt -122.2 136.31 59.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.412 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.414 HD22 HG13 ' A' ' 24' ' ' ILE . 16.7 m-80 -84.65 104.04 14.28 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.465 ' CD2' HD12 ' A' ' 29' ' ' ILE . 3.7 m-85 -90.75 103.61 16.29 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.529 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -124.34 130.88 7.69 Favored Glycine 0 N--CA 1.408 -3.22 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.412 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.7 p -92.01 127.82 37.62 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.517 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 9.3 tt -126.57 143.17 40.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.431 ' OD2' ' HB3' ' A' ' 63' ' ' LYS . 20.3 t70 -76.27 131.13 39.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.122 -175.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HA ' ' CA ' ' A' ' 66' ' ' GLY . . . -92.48 -1.08 57.23 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.343 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HB3' ' OD2' ' A' ' 61' ' ' ASP . 81.8 tttt -92.4 -43.61 9.13 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.52 -40.09 9.63 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.769 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -115.48 20.8 14.52 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.736 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 62' ' ' ALA . . . -69.31 -23.29 76.41 Favored Glycine 0 C--N 1.305 -1.181 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 -169.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.0 -21.69 63.81 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.254 0.55 . . . . 0.0 111.4 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -69.13 -25.35 64.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.666 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.513 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -59.56 -35.28 73.94 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.073 0.939 . . . . 0.0 111.362 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -109.54 13.49 32.88 Favored Glycine 0 C--N 1.27 -3.114 0 C-N-CA 117.596 -2.24 . . . . 0.0 115.895 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -24.25 58.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 169.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.564 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 4.0 pp -92.45 -37.53 12.49 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.385 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.506 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 20.9 t-20 -172.94 -57.88 0.02 OUTLIER 'General case' 0 C--N 1.369 1.452 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.688 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.5 mm? -54.58 164.79 0.67 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -167.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -81.06 -14.87 57.42 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.757 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.9 p 59.6 21.44 10.05 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.655 1.982 . . . . 0.0 114.076 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -105.39 -25.27 12.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.41 115.05 12.76 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -166.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.64 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 14.8 t80 60.39 179.74 0.04 OUTLIER Pre-proline 0 CA--C 1.581 2.16 0 O-C-N 125.126 1.516 . . . . 0.0 111.546 158.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.64 ' HD2' ' CG ' ' A' ' 79' ' ' PHE . 3.7 Cg_endo -55.81 134.52 64.54 Favored 'Trans proline' 0 C--N 1.378 2.095 0 CA-C-N 120.805 1.323 . . . . 0.0 113.837 167.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -125.8 113.17 16.91 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.45 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 62.5 t80 -90.25 111.3 22.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -116.27 118.05 31.71 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.7 mt -93.7 114.09 29.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.547 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -102.53 126.77 49.7 Favored 'General case' 0 N--CA 1.405 -2.717 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 0.7 OUTLIER -78.98 136.65 37.28 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.95 177.291 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.551 HG23 ' SD ' ' A' ' 20' ' ' MET . 23.6 t -104.3 -5.18 9.56 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.62 -38.17 6.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.368 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -101.88 -17.83 15.99 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.609 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 44.8 t-20 56.44 75.43 0.35 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 124.55 1.14 . . . . 0.0 108.507 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -144.17 174.34 10.97 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.087 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -126.97 102.35 6.95 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -177.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -107.93 80.7 1.07 Allowed Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 15.4 Cg_endo -101.17 144.84 0.28 Allowed 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.907 2.405 . . . . 0.0 114.077 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -85.01 165.55 17.45 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 125.247 1.419 . . . . 0.0 108.259 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.538 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 9.0 m-20 -73.78 145.39 45.08 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.441 ' O ' ' HB3' ' A' ' 79' ' ' PHE . 13.0 mt-30 -83.02 -5.47 59.11 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.233 -170.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -148.09 32.36 0.83 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.337 1.065 . . . . 0.0 110.685 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 17.2 tppt? -95.95 -6.76 38.29 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.206 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 74.24 127.69 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.967 1.307 . . . . 0.0 111.734 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.453 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.0 mp -93.65 116.89 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.369 -176.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 p -122.49 -174.69 2.97 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -76.73 -48.7 17.98 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.6 -55.8 30.21 Favored 'General case' 0 N--CA 1.387 -3.618 0 CA-C-N 112.099 -2.319 . . . . 0.0 112.38 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.44 74.51 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.654 0.596 . . . . 0.0 111.996 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.453 ' CG1' HG23 ' A' ' 101' ' ' ILE . 42.1 mm -74.08 -43.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.68 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -56.85 -48.24 78.54 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 124.118 0.886 . . . . 0.0 109.683 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.55 99.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.733 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.588 ' HA ' ' OD1' ' A' ' 112' ' ' ASP . 38.5 t80 -64.44 -58.13 7.31 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.495 1.118 . . . . 0.0 111.273 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 106' ' ' ILE . 26.8 m -58.95 -31.94 46.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 O-C-N 121.531 -0.731 . . . . 0.0 110.614 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.32 -52.93 50.7 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 123.828 0.851 . . . . 0.0 109.358 177.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 109' ' ' PHE 0.281 0.4 OUTLIER -67.48 -22.1 65.49 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.329 -177.027 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.533 ' HB2' HD11 ' A' ' 118' ' ' ILE . 0.6 OUTLIER -72.75 -63.7 1.11 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.524 172.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.05 -20.95 27.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.09 -174.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.1 -30.43 60.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.22 40.24 1.83 Allowed Glycine 0 CA--C 1.479 -2.211 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.665 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -117.58 -41.73 2.92 Favored 'General case' 0 N--CA 1.391 -3.391 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.739 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.55 HG12 ' OD2' ' A' ' 112' ' ' ASP . 6.6 mt -65.09 141.27 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.723 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--N 1.265 -3.091 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.467 -176.776 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.407 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -91.95 16.8 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.042 2.495 . . . . 0.0 112.592 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt -87.35 152.12 22.53 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.28 63.83 1.91 Allowed Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 m -66.99 152.98 95.39 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 122.924 0.489 . . . . 0.0 110.41 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.98 117.91 4.73 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 107.228 -1.874 . . . . 0.0 107.228 171.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.522 HD23 ' O ' ' A' ' 52' ' ' ARG . 15.1 tp -75.97 -24.1 55.38 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.235 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.643 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 5.2 mp -113.07 106.03 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.37 -144.3 4.14 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.42 ' HG2' ' HG1' ' A' ' 59' ' ' THR . 28.8 mt-10 -107.79 138.69 43.58 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 122.09 0.947 . . . . 0.0 111.813 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.549 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 62.7 mt -88.22 127.96 40.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.476 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.2 -176.42 20.04 Favored Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.06 -18.45 50.87 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.769 2.979 . . . . 0.0 113.792 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -94.8 -40.77 9.57 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.995 0.426 . . . . 0.0 110.818 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.2 p -86.18 -29.58 23.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -167.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -60.66 -37.5 81.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.654 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.5 m -67.9 -26.31 65.93 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.598 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -79.01 -34.57 43.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.414 0.626 . . . . 0.0 110.015 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -74.95 -28.37 60.56 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.486 ' SD ' HG23 ' A' ' 87' ' ' VAL . 7.4 tpp -79.67 -20.73 45.94 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.709 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 t -96.57 -5.51 39.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.862 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.27 -34.83 66.02 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.946 0.403 . . . . 0.0 110.202 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.21 -13.32 64.8 Favored Glycine 0 CA--C 1.51 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.27 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 16.5 pt -98.73 153.73 37.76 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 123.66 0.784 . . . . 0.0 109.475 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.69 145.77 94.51 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 123.53 2.82 . . . . 0.0 113.534 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.596 HD11 ' CE1' ' A' ' 28' ' ' TYR . 1.8 tt -110.98 127.25 55.45 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -176.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HB2' ' CE1' ' A' ' 82' ' ' PHE . . . -96.8 108.97 21.73 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 26' ' ' LEU . 23.0 m-85 -90.19 110.5 21.53 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 124.387 1.075 . . . . 0.0 109.462 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.494 HD13 ' CD2' ' A' ' 57' ' ' PHE . 3.5 mp -101.25 91.05 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 C-N-CA 118.811 -1.156 . . . . 0.0 109.521 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 81' ' ' ALA . 46.6 m-85 -76.43 128.24 34.43 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.493 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -143.48 119.42 10.63 Favored 'General case' 0 C--N 1.27 -2.862 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.576 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.437 ' HG3' ' HB2' ' A' ' 62' ' ' ALA . 49.1 mt-10 -84.99 -2.05 57.5 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.252 0.549 . . . . 0.0 109.747 173.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 7.3 p -91.61 123.54 35.09 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.877 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.99 -21.05 18.86 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.26 0.552 . . . . 0.0 110.655 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.435 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 37.1 mt-10 -86.07 -66.43 0.9 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.82 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 12.5 pt-20 -73.7 1.59 9.98 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 33' ' ' THR . 15.7 ttt180 -54.46 -43.03 71.34 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 124.223 1.009 . . . . 0.0 108.705 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 45.5 mtmt -60.6 -49.45 77.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.896 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -64.82 -43.82 91.87 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 123.609 0.568 . . . . 0.0 111.434 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -54.24 -52.68 60.56 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -178.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.609 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 7.9 m -76.21 -18.85 58.86 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.891 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 25.1 t70 -74.66 -31.34 61.91 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.45 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.601 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 46.2 mmtt -79.8 -29.35 40.26 Favored 'General case' 0 C--O 1.277 2.508 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 64.3 mt -70.02 -25.62 63.67 Favored 'General case' 0 N--CA 1.408 -2.573 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.373 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.609 ' HG3' ' O ' ' A' ' 41' ' ' SER . 87.9 mttt -61.14 -54.79 50.39 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 119.712 -0.185 . . . . 0.0 111.251 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 73.8 Cg_exo -69.16 -43.92 2.84 Favored 'Trans proline' 0 C--O 1.263 1.765 0 C-N-CA 122.856 2.371 . . . . 0.0 111.801 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.89 -24.12 35.0 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.063 0 C-N-CA 118.405 -1.318 . . . . 0.0 110.981 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -95.21 -20.99 18.76 Favored 'General case' 0 C--O 1.204 -1.316 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.724 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -66.3 -25.11 66.7 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.4 -11.83 59.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.794 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 2.8 pt20 -145.32 33.96 1.08 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.405 1.098 . . . . 0.0 110.488 -172.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.522 ' O ' HD23 ' A' ' 7' ' ' LEU . 15.1 ptt180 -74.38 -7.97 54.7 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.287 -173.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.96 0.6 14.94 Favored Glycine 0 C--N 1.289 -2.074 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.76 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.51 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 13.2 p -121.85 -31.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.845 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 84.2 mt -123.17 140.45 46.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.594 -0.843 . . . . 0.0 110.47 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -86.17 117.17 24.82 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 1.8 m-85 -103.89 103.03 12.84 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.977 0.894 . . . . 0.0 112.874 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.549 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -123.65 128.43 6.92 Favored Glycine 0 N--CA 1.406 -3.345 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.72 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.42 ' HG1' ' HG2' ' A' ' 10' ' ' GLU . 29.3 p -92.36 127.69 37.93 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 7.8 tt -124.26 142.64 40.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.47 125.96 28.28 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.579 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.47 ' O ' ' HA3' ' A' ' 66' ' ' GLY . . . -92.9 7.34 44.3 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.221 -0.991 . . . . 0.0 111.507 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -104.78 -38.0 6.84 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.11 -42.48 9.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.611 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.73 26.99 8.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.454 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -70.82 -24.21 77.22 Favored Glycine 0 CA--C 1.488 -1.617 0 C-N-CA 120.779 -0.724 . . . . 0.0 114.683 -173.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.54 -28.6 46.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.436 0.636 . . . . 0.0 110.847 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -64.93 -23.09 67.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.234 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -64.08 -36.22 83.29 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.984 0.897 . . . . 0.0 110.4 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -105.09 7.47 44.21 Favored Glycine 0 C--N 1.281 -2.518 0 C-N-CA 117.568 -2.253 . . . . 0.0 114.835 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -74.76 -16.89 60.71 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 166.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 4.2 pp -104.22 -37.56 7.23 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.065 174.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.509 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 5.2 t-20 -176.35 -52.19 0.01 OUTLIER 'General case' 0 C--N 1.384 2.107 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.635 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.0 mm? -65.44 159.59 23.96 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -167.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -81.1 -4.28 54.77 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.461 HG21 ' HB1' ' A' ' 69' ' ' ALA . 80.3 p 56.43 17.41 2.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.268 1.027 . . . . 0.0 112.226 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.408 ' OD1' ' HG3' ' A' ' 75' ' ' LYS . 14.3 p-10 -94.39 -14.98 24.74 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -172.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 22.7 tptt -123.49 -165.29 1.31 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 118.503 -1.279 . . . . 0.0 113.273 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.507 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 96.5 m-85 -61.47 173.14 0.82 Allowed Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 125.925 1.69 . . . . 0.0 110.35 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 5.5 Cg_endo -40.15 131.21 2.24 Favored 'Trans proline' 0 C--N 1.414 3.993 0 C-N-CA 122.444 2.096 . . . . 0.0 115.557 -171.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -109.68 110.11 21.04 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.808 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 27' ' ' ALA . 53.5 t80 -88.84 112.45 23.25 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.723 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -121.0 120.35 35.16 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.2 mt -92.66 113.35 27.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.852 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.18 134.33 35.46 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 2.5 mm-40 -87.5 126.97 35.22 Favored 'General case' 0 C--N 1.266 -3.058 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.227 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.486 HG23 ' SD ' ' A' ' 20' ' ' MET . 41.2 t -95.31 -2.77 10.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.77 -44.12 3.52 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.438 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -97.83 -11.06 23.69 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.344 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 14.3 t-20 66.89 10.55 7.7 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 125.011 1.324 . . . . 0.0 110.247 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.458 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 1.5 tp60 -80.08 172.35 13.89 Favored 'General case' 0 CA--C 1.477 -1.856 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.356 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.601 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 65.4 mmtt -139.36 105.09 5.13 Favored 'General case' 0 N--CA 1.404 -2.733 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -100.28 86.4 0.63 Allowed Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.601 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 7.8 Cg_endo -101.96 152.63 0.32 Allowed 'Trans proline' 0 N--CA 1.429 -2.294 0 C-N-CA 122.477 2.118 . . . . 0.0 114.065 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.439 ' HD1' ' CD1' ' A' ' 109' ' ' PHE . 49.8 t80 -94.67 162.97 13.56 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 124.858 1.263 . . . . 0.0 107.746 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 10.7 m-20 -66.22 153.19 43.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.067 0.461 . . . . 0.0 110.32 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -102.22 0.96 35.31 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 8.6 pt-20 -132.38 28.45 4.36 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.146 -171.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 3.7 tppp? -113.63 -89.53 0.53 Allowed 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.739 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 176.39 127.33 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 124.062 0.945 . . . . 0.0 109.032 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.473 HG22 ' CG1' ' A' ' 106' ' ' ILE . 3.9 mp -102.62 105.37 18.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.42 -169.04 1.87 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.491 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.8 t80 -77.57 -53.23 7.84 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -60.39 -46.82 88.6 Favored 'General case' 0 N--CA 1.391 -3.393 0 CA-C-N 112.267 -2.242 . . . . 0.0 112.894 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.82 83.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.991 0.424 . . . . 0.0 111.149 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.473 ' CG1' HG22 ' A' ' 101' ' ' ILE . 36.9 mm -70.95 -44.37 75.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.863 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 22.7 ttmt -51.32 -52.64 43.46 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 124.044 0.84 . . . . 0.0 109.973 177.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.36 -43.87 92.77 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.947 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.533 ' O ' HD12 ' A' ' 118' ' ' ILE . 46.1 t80 -63.43 -59.9 4.07 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 124.411 1.084 . . . . 0.0 110.984 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 106' ' ' ILE . 27.5 m -58.59 -31.82 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 121.519 -0.738 . . . . 0.0 110.901 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 28.7 t70 -67.65 -47.74 68.69 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 123.886 0.874 . . . . 0.0 109.033 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.549 ' OD2' HG12 ' A' ' 118' ' ' ILE 0.299 0.1 OUTLIER -70.83 -23.77 62.41 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.545 -179.0 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.534 ' HB2' HD11 ' A' ' 118' ' ' ILE . 0.6 OUTLIER -71.18 -61.25 1.83 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.892 173.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -61.98 -25.25 36.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.163 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.35 -33.79 55.29 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.246 0.546 . . . . 0.0 109.777 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.17 25.86 2.87 Favored Glycine 0 CA--C 1.485 -1.794 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.953 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 20.3 ttpt -101.17 -32.67 10.44 Favored 'General case' 0 N--CA 1.396 -3.15 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.19 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.549 HG12 ' OD2' ' A' ' 112' ' ' ASP . 4.9 mt -74.45 142.26 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.31 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -124.41 168.82 12.01 Favored Pre-proline 0 C--N 1.285 -2.231 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.678 -172.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.06 111.5 1.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.506 1.471 . . . . 0.0 110.138 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.5 m -56.58 -36.84 69.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.187 0.595 . . . . 0.0 112.415 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.7 pt -146.86 -110.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 118.978 -0.534 . . . . 0.0 109.947 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.7 tttp 66.22 109.81 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.597 0.759 . . . . 0.0 111.659 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.9 m -61.94 107.14 0.8 Allowed 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.807 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -135.63 98.73 12.01 Favored Pre-proline 0 N--CA 1.415 -2.223 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.43 151.04 22.54 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.054 1.836 . . . . 0.0 114.243 -170.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.08 94.58 13.2 Favored Pre-proline 0 N--CA 1.43 -1.432 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -86.06 164.61 10.06 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 122.302 2.001 . . . . 0.0 111.435 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.84 117.39 11.37 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.307 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -101.1 170.47 8.24 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -106.81 175.99 5.32 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -66.42 -34.39 77.85 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.967 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -178.754 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.715 0 CA-C-O 119.032 -0.871 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.37 -30.24 51.78 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.403 2.735 . . . . 0.0 113.035 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.4 mt -123.73 149.91 44.99 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.68 -40.41 2.58 Favored Glycine 0 C--N 1.315 -0.63 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.5 p -133.01 173.84 5.41 Favored Pre-proline 0 C--N 1.286 -2.191 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -71.38 168.75 22.58 Favored 'Trans proline' 0 C--O 1.253 1.231 0 CA-C-N 120.696 1.284 . . . . 0.0 109.163 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.53 -43.16 99.49 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.457 ' HB ' ' N ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -91.34 132.98 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 173.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.51 -19.57 0.91 Allowed Glycine 0 N--CA 1.42 -2.402 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.568 -175.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -135.79 148.57 48.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 122.297 -0.531 . . . . 0.0 109.575 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.514 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 51.6 mt -119.14 143.24 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.15 162.37 25.03 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -47.52 -34.05 19.08 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 124.14 3.227 . . . . 0.0 114.044 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -89.43 -26.91 20.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.953 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.1 p -78.85 -19.97 50.7 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.018 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.403 ' O ' ' HB2' ' A' ' 20' ' ' MET . 69.3 m-85 -50.19 -49.93 50.93 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 123.934 0.771 . . . . 0.0 109.685 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -62.37 -33.41 74.69 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.107 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -70.9 -44.64 65.82 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 120.937 0.398 . . . . 0.0 110.535 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -72.8 -30.45 64.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.458 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.41 -39.89 62.35 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.05 -178.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -81.58 -9.02 59.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.649 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.09 -19.06 60.72 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.202 0.525 . . . . 0.0 110.619 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.21 -4.16 63.76 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.823 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 11.1 pt -103.2 152.5 38.65 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -54.58 142.18 72.35 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 124.194 3.263 . . . . 0.0 114.064 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 tt -108.13 125.18 51.3 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HB2' ' CE1' ' A' ' 82' ' ' PHE . . . -95.67 103.06 14.92 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -83.83 114.84 21.92 Favored 'General case' 0 CA--C 1.47 -2.126 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.303 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 8.1 mt -102.6 84.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.252 -3.67 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 81' ' ' ALA . 48.7 m-85 -76.81 123.84 26.82 Favored 'General case' 0 CA--C 1.465 -2.324 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.98 123.61 19.77 Favored 'General case' 0 C--N 1.254 -3.584 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.445 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -79.64 -14.64 58.66 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 13.1 p -83.73 113.49 20.92 Favored 'General case' 0 N--CA 1.403 -2.78 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.107 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.71 -21.06 16.6 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.389 0.431 . . . . 0.0 110.918 -175.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -88.37 -54.2 4.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.742 0.782 . . . . 0.0 110.354 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' OE1' ' HB ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -84.84 3.13 39.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.823 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 33' ' ' THR . 52.2 ttt180 -49.27 -46.1 45.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.573 1.149 . . . . 0.0 110.018 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -65.31 -35.76 81.98 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.251 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -82.05 -31.27 30.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.894 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.7 tm? -61.48 -44.09 97.7 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 m -77.52 -17.0 58.36 Favored 'General case' 0 C--O 1.2 -1.542 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.576 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 20.5 t70 -76.67 -31.07 57.05 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.703 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.611 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -73.69 -36.59 65.3 Favored 'General case' 0 C--O 1.281 2.761 0 CA-C-O 123.109 1.433 . . . . 0.0 107.861 171.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 67.8 mt -72.63 -18.16 61.61 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.8 -1.545 . . . . 0.0 111.404 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 38.6 ttmt -63.74 -53.83 47.14 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 123.793 0.837 . . . . 0.0 111.759 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 52.4 Cg_exo -71.19 -37.22 6.19 Favored 'Trans proline' 0 CA--C 1.493 -1.553 0 C-N-CA 122.471 2.114 . . . . 0.0 109.784 175.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.536 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 86.0 mt -53.12 -38.41 29.99 Favored 'Isoleucine or valine' 0 C--N 1.37 1.461 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.856 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -93.35 -21.64 19.43 Favored 'General case' 0 C--O 1.195 -1.767 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.627 -172.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.475 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -68.45 -22.4 64.59 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 176.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.27 -11.3 57.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.977 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 2.8 pt20 -147.13 36.1 0.91 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.562 1.172 . . . . 0.0 110.749 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HD3' ' OE1' ' A' ' 49' ' ' GLU . 13.9 ptt180 -74.14 -18.6 60.77 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.988 -1.915 . . . . 0.0 110.778 -174.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.69 17.74 22.87 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.582 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.516 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.6 p -138.71 -33.26 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.551 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 88.7 mt -122.95 136.84 58.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.287 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.447 HD22 HG13 ' A' ' 24' ' ' ILE . 9.9 m-80 -94.48 96.39 9.45 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.457 ' N ' ' HB ' ' A' ' 8' ' ' ILE . 8.8 m-85 -76.74 141.94 40.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.521 0.677 . . . . 0.0 111.123 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.514 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -159.76 129.48 2.21 Favored Glycine 0 N--CA 1.412 -2.944 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.061 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.527 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 44.6 p -83.78 144.91 28.99 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.202 0.525 . . . . 0.0 111.445 174.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 4.8 tt -145.8 142.48 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.336 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD2' ' HB3' ' A' ' 63' ' ' LYS . 19.9 t70 -70.9 124.35 24.14 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -175.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.459 ' O ' ' HA3' ' A' ' 66' ' ' GLY . . . -86.85 4.04 42.9 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.218 -0.593 . . . . 0.0 112.277 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.54 ' HB3' ' HZ1' ' A' ' 63' ' ' LYS . 3.7 ttpm? -100.91 -44.72 5.66 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.45 -45.6 9.82 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.664 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -115.5 20.34 14.81 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.242 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -69.69 -20.48 75.8 Favored Glycine 0 CA--C 1.493 -1.308 0 N-CA-C 116.479 1.352 . . . . 0.0 116.479 -171.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.57 -27.74 64.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.982 0.891 . . . . 0.0 110.305 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -62.2 -24.74 67.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.601 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -65.75 -37.86 87.52 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 122.633 1.206 . . . . 0.0 109.024 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -96.94 11.02 66.16 Favored Glycine 0 C--N 1.284 -2.32 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.54 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.18 -8.29 59.64 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 3.1 pp -118.69 -34.97 3.82 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.464 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -168.07 -64.89 0.03 OUTLIER 'General case' 0 C--N 1.366 1.326 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.503 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.2 mm? -53.23 166.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -163.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -89.14 -12.3 41.43 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.578 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 69' ' ' ALA . 64.0 p 54.86 35.4 24.19 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.387 1.475 . . . . 0.0 112.992 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -117.44 -15.94 10.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -160.44 0.78 Allowed 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.944 -169.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.444 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 83.5 m-85 -59.99 170.66 1.11 Allowed Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.582 1.553 . . . . 0.0 109.635 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 2.4 Cg_endo -39.35 133.43 1.38 Allowed 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 122.765 2.31 . . . . 0.0 114.852 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -113.0 104.3 12.25 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.86 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 27' ' ' ALA . 65.1 t80 -85.39 108.17 17.72 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.6 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -114.88 115.28 26.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.4 mt -90.7 110.59 22.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -88.14 129.58 35.28 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -87.62 121.03 29.54 Favored 'General case' 0 C--N 1.28 -2.444 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.412 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 20' ' ' MET . 3.8 t -96.82 4.19 9.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.95 -36.24 3.89 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.824 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -99.08 -15.08 19.14 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.248 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 74.1 19.42 2.97 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 124.769 2.224 . . . . 0.0 108.414 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.531 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -96.0 170.09 9.52 Favored 'General case' 0 CA--C 1.464 -2.331 0 CA-C-N 111.828 -2.442 . . . . 0.0 110.851 -174.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 91' ' ' GLN . 70.1 mmtt -141.25 109.46 5.84 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 72.2 m-85 -109.02 88.65 5.79 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 2.6 Cg_endo -101.15 147.78 0.33 Allowed 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 122.43 2.086 . . . . 0.0 114.384 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -85.09 158.98 20.27 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.077 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 5.9 m-20 -64.72 143.91 57.6 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 123.827 0.851 . . . . 0.0 108.883 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -85.7 -1.24 56.97 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.644 -172.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.16 18.69 1.4 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.24 0.543 . . . . 0.0 112.109 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 4.3 tppp? -93.17 -3.74 53.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 68.84 126.55 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.472 1.509 . . . . 0.0 112.321 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.494 HG22 ' CG1' ' A' ' 106' ' ' ILE . 3.5 mp -89.77 102.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.065 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 p -122.43 170.52 9.88 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.476 ' O ' HD12 ' A' ' 47' ' ' ILE . 23.0 t80 -56.42 -59.37 5.07 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.554 0.692 . . . . 0.0 109.991 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.447 ' OE2' ' HB3' ' A' ' 105' ' ' ALA . 1.5 pp20? -57.44 -45.44 84.68 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.232 -1.349 . . . . 0.0 113.526 -175.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.447 ' HB3' ' OE2' ' A' ' 104' ' ' GLU . . . -59.43 -49.09 79.14 Favored 'General case' 0 C--N 1.254 -3.559 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.371 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.494 ' CG1' HG22 ' A' ' 101' ' ' ILE . 42.5 mm -75.0 -39.49 44.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.654 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 26.7 ttpp -58.22 -46.19 86.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.732 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.39 90.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.581 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.649 ' O ' HD12 ' A' ' 118' ' ' ILE . 70.6 t80 -64.49 -62.6 1.49 Allowed 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.537 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.7 m -58.67 -30.98 43.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 O-C-N 122.182 -0.324 . . . . 0.0 111.202 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 12.5 t70 -62.6 -50.47 71.14 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.333 1.053 . . . . 0.0 108.937 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.665 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 9.3 t70 -61.25 -43.11 99.42 Favored 'General case' 0 C--O 1.198 -1.649 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.21 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.546 ' N ' HG13 ' A' ' 118' ' ' ILE . 1.5 t80 -59.22 -63.96 1.12 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.465 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.6 -17.04 20.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.838 -175.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.96 -33.84 30.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.509 0.671 . . . . 0.0 109.395 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.5 21.5 6.13 Favored Glycine 0 CA--C 1.482 -1.993 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.665 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 7.0 ttmm -94.38 -43.09 8.55 Favored 'General case' 0 N--CA 1.395 -3.185 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.046 -174.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 109' ' ' PHE . 10.8 mt -72.14 146.04 11.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -127.58 160.38 60.92 Favored Pre-proline 0 C--N 1.283 -2.292 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -61.07 112.36 1.35 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.197 1.264 . . . . 0.0 109.73 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.8 t -61.41 -49.78 75.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.5 pt -147.21 151.23 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.0 tptm 161.62 135.37 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 O-C-N 125.142 1.526 . . . . 0.0 106.993 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.1 m -77.77 107.48 10.31 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-O 121.412 0.625 . . . . 0.0 109.491 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -125.44 91.68 48.37 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.453 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 89.0 Cg_endo -80.07 140.69 14.3 Favored 'Trans proline' 0 N--CA 1.418 -2.914 0 C-N-CA 121.0 1.133 . . . . 0.0 111.525 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.0 mm -112.45 98.27 43.12 Favored Pre-proline 0 C--N 1.291 -1.943 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.331 -175.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 126' ' ' PRO . 20.2 Cg_exo -67.15 133.62 31.35 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.718 2.279 . . . . 0.0 111.656 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -91.39 178.53 5.93 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.997 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -92.51 73.45 5.15 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.469 1.128 . . . . 0.0 109.564 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -85.85 137.8 32.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.633 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -101.1 132.01 46.76 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.893 0 CA-C-O 118.25 -1.306 . . . . 0.0 110.504 -177.205 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.544 0 N-CA-C 111.609 -0.597 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -86.51 157.3 9.28 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.741 2.294 . . . . 0.0 112.318 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.06 114.03 10.76 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.37 51.12 0.2 Allowed Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.3 m -102.17 138.03 19.62 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.73 86.55 1.04 Allowed 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.016 1.811 . . . . 0.0 112.164 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.2 mt -99.65 -26.12 14.18 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 94.0 mt -127.75 133.54 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 114.049 -1.432 . . . . 0.0 107.886 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.13 -116.57 0.73 Allowed Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.72 144.65 48.13 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.568 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 61.0 mt -96.71 120.76 46.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.096 0.474 . . . . 0.0 110.284 -177.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.17 167.75 12.98 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.625 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 14.8 Cg_endo -59.2 -25.69 79.05 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 122.812 2.341 . . . . 0.0 111.717 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -87.5 -12.11 46.89 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.816 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.6 p -105.03 -37.0 7.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.535 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.625 ' CE2' ' HA ' ' A' ' 13' ' ' PRO 0.293 10.0 p90 -62.18 -26.92 68.61 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 m -59.56 -32.41 70.32 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.206 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -78.08 -34.83 50.06 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.526 ' CD2' ' HA ' ' A' ' 16' ' ' TYR . 14.8 m-85 -73.13 -29.59 62.99 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.515 ' SD ' HG23 ' A' ' 87' ' ' VAL . 5.5 tpp -79.14 -24.05 43.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.01 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 t -92.1 -10.0 40.57 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.03 -21.03 43.97 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 121.955 -0.465 . . . . 0.0 111.43 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.18 8.98 87.31 Favored Glycine 0 C--O 1.235 0.189 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.956 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 12.2 pt -117.18 149.06 43.74 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 122.879 -0.189 . . . . 0.0 111.133 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.81 136.13 50.78 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 124.115 3.21 . . . . 0.0 113.82 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.17 125.53 51.11 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.53 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . . . -98.66 109.29 22.07 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-O 121.185 0.517 . . . . 0.0 109.731 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -89.28 117.82 28.51 Favored 'General case' 0 CA--C 1.468 -2.182 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.729 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.525 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.6 mt -106.87 84.4 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.54 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 81' ' ' ALA . 33.5 m-85 -75.54 134.9 40.63 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -149.76 120.04 7.32 Favored 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.578 176.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -72.23 -28.79 63.39 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-O 121.663 0.744 . . . . 0.0 109.365 173.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.652 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 2.3 p -89.31 103.78 16.38 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.622 -170.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.73 -25.16 41.2 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.791 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.06 -62.31 1.43 Allowed 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.528 ' OE1' ' HB ' ' A' ' 33' ' ' THR . 1.2 pm0 -83.2 4.07 28.31 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.652 ' HB2' ' O ' ' A' ' 33' ' ' THR . 3.9 tmm_? -60.47 -32.73 71.69 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -60.83 -49.38 77.7 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.182 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 14.3 pt-20 -81.83 -22.36 37.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.38 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.655 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -61.53 -52.58 63.87 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 21.8 m -71.59 -20.8 61.95 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.587 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 22.0 t70 -61.98 -41.4 97.99 Favored 'General case' 0 CA--C 1.486 -1.506 0 C-N-CA 123.553 0.741 . . . . 0.0 111.206 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.626 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 51.7 mmtt -77.53 -29.43 52.35 Favored 'General case' 0 C--O 1.27 2.132 0 CA-C-O 122.511 1.148 . . . . 0.0 108.606 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 67.0 mt -70.97 -23.6 62.24 Favored 'General case' 0 N--CA 1.406 -2.667 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.951 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 41' ' ' SER . 56.1 mtpt -63.41 -53.34 53.43 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 86.3 Cg_exo -67.63 -45.18 3.6 Favored 'Trans proline' 0 C--O 1.263 1.731 0 C-N-CA 123.169 2.579 . . . . 0.0 111.803 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.567 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 6.5 tp -61.22 -30.55 48.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.402 0 C-N-CA 117.934 -1.506 . . . . 0.0 109.706 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -88.81 -18.69 27.17 Favored 'General case' 0 C--O 1.182 -2.496 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.761 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.05 -24.77 65.12 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.32 -19.45 50.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.567 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 2.3 pt20 -139.96 35.19 1.95 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.249 1.023 . . . . 0.0 110.948 -171.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -69.49 -19.21 63.74 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.137 -1.847 . . . . 0.0 112.375 -173.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.21 14.58 11.01 Favored Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.526 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.56 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.7 p -129.31 -32.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.214 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 79.0 mt -122.55 134.45 65.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.838 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.425 HD22 HG13 ' A' ' 24' ' ' ILE . 10.5 m-80 -88.56 109.86 20.42 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.568 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 7.9 m-85 -93.48 108.3 20.0 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.568 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -131.49 132.26 6.7 Favored Glycine 0 C--N 1.29 -2.005 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.693 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.525 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 42.2 p -91.65 150.17 21.28 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 122.686 0.394 . . . . 0.0 111.131 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 6.7 tt -151.6 147.27 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -68.39 130.45 42.92 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.69 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.456 ' O ' ' HA3' ' A' ' 66' ' ' GLY . . . -93.26 -3.72 53.15 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.819 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -86.1 -49.51 7.72 Favored 'General case' 0 N--CA 1.42 -1.943 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.771 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.54 -37.69 9.07 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -104.37 14.36 30.32 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.791 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -71.55 -19.9 78.09 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 -172.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.54 68.8 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 117.69 0.745 . . . . 0.0 110.008 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -64.91 -24.95 67.68 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.009 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -63.16 -34.76 78.31 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 122.303 1.049 . . . . 0.0 109.82 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -104.49 18.57 44.34 Favored Glycine 0 C--N 1.28 -2.576 0 C-N-CA 118.348 -1.882 . . . . 0.0 114.15 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.21 -22.26 55.47 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 4.3 pp -104.68 -33.33 8.51 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.396 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.513 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 12.9 t-20 -174.5 -56.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -176.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.609 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.0 mm? -59.51 162.84 4.57 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -165.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -83.03 -9.85 59.05 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.239 -174.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p 61.53 18.4 9.41 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.954 2.102 . . . . 0.0 114.744 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -113.39 -17.56 12.23 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -170.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 79' ' ' PHE . 19.4 ttmt -117.84 -160.84 0.8 Allowed 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.31 -167.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.41 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 88.9 m-85 -54.9 164.2 1.26 Allowed Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.974 1.31 . . . . 0.0 111.481 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -39.74 129.65 1.92 Allowed 'Trans proline' 0 C--N 1.403 3.44 0 C-N-CA 122.793 2.328 . . . . 0.0 114.886 -174.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -108.17 104.44 13.85 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.084 -172.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.53 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 69.0 t80 -87.47 113.28 23.03 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.79 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -118.88 121.61 40.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 43.4 mt -95.67 110.99 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.205 0.526 . . . . 0.0 109.858 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -100.03 126.35 46.22 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 1.9 mm-40 -88.6 140.48 29.41 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 120.897 0.38 . . . . 0.0 111.31 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.515 HG23 ' SD ' ' A' ' 20' ' ' MET . 22.1 t -99.89 -4.85 9.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.035 0.922 . . . . 0.0 108.633 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.52 -38.62 4.59 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.606 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.402 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 75.4 mmtt -91.06 -16.35 28.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.505 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 59.25 30.46 20.21 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 122.303 1.049 . . . . 0.0 109.715 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.533 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 5.5 tp-100 -109.85 167.85 9.86 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.727 -171.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.523 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 10.5 mptt -122.71 98.68 6.02 Favored 'General case' 1 N--CA 1.373 -4.324 0 CA-C-N 113.216 -1.811 . . . . 0.0 106.548 -176.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 38.0 m-85 -100.39 82.64 0.33 Allowed Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 5.6 Cg_endo -100.33 148.96 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.639 2.226 . . . . 0.0 113.573 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -82.78 162.29 21.74 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.444 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 6.4 m-20 -71.37 139.02 49.65 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -84.61 1.72 44.77 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.954 -173.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -137.86 13.33 2.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.392 0.615 . . . . 0.0 111.594 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.55 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 15.4 tppt? -90.73 -8.91 48.54 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.58 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 69.64 117.97 0.04 OUTLIER 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.45 1.1 . . . . 0.0 111.105 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.467 HG21 ' CG1' ' A' ' 106' ' ' ILE . 3.4 mp -85.05 125.78 40.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.409 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.7 p -139.34 175.37 9.62 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.48 ' HA ' ' HB3' ' A' ' 43' ' ' LYS . 54.0 t80 -55.18 -61.11 2.54 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 122.081 0.943 . . . . 0.0 110.064 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . 0.255 23.5 tp10 -60.76 -39.64 89.54 Favored 'General case' 1 N--CA 1.37 -4.435 0 C-N-CA 126.811 2.044 . . . . 0.0 111.968 -171.997 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.26 93.5 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 123.816 0.698 . . . . 0.0 110.528 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.467 ' CG1' HG21 ' A' ' 101' ' ' ILE . 34.9 mm -72.36 -41.74 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.237 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -55.33 -52.06 64.73 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 124.179 0.924 . . . . 0.0 108.895 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.03 83.63 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.507 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -68.59 -58.16 4.69 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.828 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 111' ' ' ASP . 35.5 m -60.23 -32.61 51.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.889 0 O-C-N 121.841 -0.537 . . . . 0.0 110.71 -177.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.414 ' N ' HG23 ' A' ' 110' ' ' VAL . 19.4 t70 -58.33 -53.8 54.21 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 124.958 1.303 . . . . 0.0 109.153 176.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.675 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 7.2 t70 -60.62 -43.63 97.25 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 113.687 -1.597 . . . . 0.0 108.002 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.511 ' HB2' HD13 ' A' ' 118' ' ' ILE . 2.7 t80 -59.51 -64.02 1.09 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.173 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.8 -21.03 27.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.068 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.48 -35.19 53.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.23 0.538 . . . . 0.0 109.86 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.54 30.4 3.31 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.675 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 5.5 mtmt -102.26 -45.19 5.19 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.504 -1.348 . . . . 0.0 109.283 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.511 HD13 ' HB2' ' A' ' 113' ' ' PHE . 31.8 mt -76.14 142.45 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 171.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -124.29 166.87 17.37 Favored Pre-proline 0 C--N 1.273 -2.747 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -38.98 118.51 0.38 Allowed 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 123.621 2.881 . . . . 0.0 113.216 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.8 t -61.35 -47.18 87.07 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.683 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.77 -54.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.43 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.7 tttp 58.11 72.58 0.51 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.457 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.9 m -80.61 88.01 5.74 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.719 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -142.03 94.21 7.17 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.72 175.91 10.78 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.154 1.902 . . . . 0.0 112.128 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 11.3 tt -118.0 86.95 26.86 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-O 121.75 0.786 . . . . 0.0 110.486 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.419 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 66.4 Cg_endo -95.26 164.28 1.57 Allowed 'Trans proline' 0 N--CA 1.424 -2.567 0 C-N-CA 122.249 1.966 . . . . 0.0 112.477 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -122.68 127.44 49.29 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.111 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 62.38 20.17 11.64 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.025 0.93 . . . . 0.0 112.949 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -125.69 164.68 20.09 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.419 ' OE2' ' HG3' ' A' ' 128' ' ' PRO . 44.8 mt-10 68.89 115.77 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.736 1.272 . . . . 0.0 112.282 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.027 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -176.141 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.205 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -68.8 109.99 2.25 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.941 2.427 . . . . 0.0 111.945 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.3 tp -148.21 87.05 1.58 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.117 0.961 . . . . 0.0 109.55 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.31 47.99 0.04 OUTLIER Glycine 0 C--N 1.28 -2.557 0 N-CA-C 105.583 -3.007 . . . . 0.0 105.583 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.7 m -85.23 114.56 56.85 Favored Pre-proline 0 N--CA 1.422 -1.841 0 CA-C-N 113.296 -1.452 . . . . 0.0 111.979 -169.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -91.35 105.27 0.26 Allowed 'Trans proline' 0 N--CA 1.426 -2.461 0 C-N-CA 122.207 1.938 . . . . 0.0 108.965 172.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.63 -30.32 61.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.731 0.777 . . . . 0.0 109.102 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -101.36 160.44 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.81 -83.98 0.1 Allowed Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.347 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -126.83 147.17 50.04 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -175.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.554 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 51.7 mt -102.18 119.98 51.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.67 174.7 20.33 Favored Glycine 0 N--CA 1.41 -3.067 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.485 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 28.4 Cg_endo -61.4 -17.03 51.07 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.091 2.527 . . . . 0.0 112.793 -177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.8 -13.4 16.44 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 119.37 -0.347 . . . . 0.0 111.747 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.8 p -102.03 -32.47 10.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 119.489 -0.884 . . . . 0.0 112.641 -173.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 13' ' ' PRO 0.254 5.3 p90 -60.61 -32.8 71.91 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -177.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 m -59.92 -31.26 69.67 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 123.742 0.817 . . . . 0.0 110.462 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.27 -35.37 41.49 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -73.33 -28.6 62.16 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.504 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -78.1 -36.97 47.42 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.49 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.6 t -78.52 -10.5 59.74 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.946 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.21 64.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.198 0.523 . . . . 0.0 110.453 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.56 -15.88 62.33 Favored Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.833 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 7.0 pt -93.76 154.04 41.01 Favored Pre-proline 0 C--N 1.301 -1.537 0 C-N-CA 123.026 0.53 . . . . 0.0 110.249 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -54.22 145.36 55.19 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 124.115 3.21 . . . . 0.0 114.663 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tt -108.69 127.02 53.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -97.94 107.65 20.18 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -88.46 120.68 30.06 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.283 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.412 HG12 ' CD1' ' A' ' 44' ' ' LEU . 3.4 mp -110.74 89.11 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.824 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.043 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 48.6 m-85 -78.6 109.96 13.29 Favored 'General case' 0 CA--C 1.452 -2.791 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.98 119.2 31.87 Favored 'General case' 1 C--N 1.238 -4.266 0 CA-C-O 121.197 0.522 . . . . 0.0 109.816 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -70.22 -28.77 65.54 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.645 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 18.0 p -75.16 119.12 18.87 Favored 'General case' 0 N--CA 1.379 -3.988 0 CA-C-N 113.296 -1.775 . . . . 0.0 108.436 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.421 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . . . -99.05 -17.62 18.16 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.595 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -99.01 -53.16 3.34 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.701 0.763 . . . . 0.0 109.623 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.491 ' OE1' ' HB ' ' A' ' 33' ' ' THR . 0.5 OUTLIER -86.71 7.44 26.71 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.109 -175.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.645 ' HB3' ' O ' ' A' ' 33' ' ' THR . 6.7 ptp180 -71.71 -16.78 62.24 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.372 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -69.42 -45.03 70.17 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 1.6 mp0 -65.72 -35.12 79.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.393 0.616 . . . . 0.0 109.771 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -60.81 -49.08 78.93 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 14.5 m -75.36 -10.6 59.61 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.056 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.574 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 19.0 t70 -78.09 -37.4 46.54 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 123.163 0.585 . . . . 0.0 110.32 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.626 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -72.23 -33.26 67.42 Favored 'General case' 0 C--O 1.285 2.944 0 CA-C-O 123.166 1.46 . . . . 0.0 108.136 173.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' CD1' HG12 ' A' ' 29' ' ' ILE . 85.6 mt -73.67 -21.94 60.11 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.19 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -66.35 -50.09 50.35 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 6.9 Cg_exo -78.2 -34.14 1.72 Allowed 'Trans proline' 0 CA--C 1.491 -1.655 0 C-N-CA 121.923 1.749 . . . . 0.0 110.034 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.533 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -62.33 -28.86 45.44 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.94 -20.06 21.0 Favored 'General case' 0 C--O 1.186 -2.25 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.794 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.22 -19.11 63.17 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.2 -14.01 54.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.54 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 3.1 pt20 -146.64 36.28 0.96 Allowed 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.061 0.934 . . . . 0.0 111.128 -173.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -74.46 -19.47 60.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.701 -1.59 . . . . 0.0 111.065 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.32 20.91 18.24 Favored Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.41 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.483 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.8 p -139.77 -33.73 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.657 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 88.4 mt -124.75 134.62 66.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.109 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.429 HD22 HG13 ' A' ' 24' ' ' ILE . 21.4 m-80 -91.44 97.44 11.08 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.412 ' O ' ' HB ' ' A' ' 8' ' ' ILE . 15.0 m-85 -76.79 131.68 38.82 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.399 0.619 . . . . 0.0 111.278 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.554 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -144.06 123.55 2.04 Favored Glycine 0 N--CA 1.396 -3.974 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.388 176.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.403 HG23 ' OG ' ' A' ' 41' ' ' SER . 38.9 p -86.45 136.41 33.11 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 7.5 tt -141.04 145.48 25.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -177.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.02 126.97 31.22 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.518 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.75 0.09 53.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -102.28 -42.31 6.06 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.99 -51.44 6.35 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.919 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -112.16 18.36 18.73 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.754 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.38 -22.86 67.89 Favored Glycine 0 CA--C 1.497 -1.089 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.38 -35.18 60.04 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 122.991 0.516 . . . . 0.0 110.796 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -63.57 -22.22 66.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.291 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.626 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -65.54 -39.18 91.46 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.999 0.904 . . . . 0.0 109.227 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.644 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -103.61 6.12 48.61 Favored Glycine 0 C--N 1.283 -2.387 0 C-N-CA 118.114 -1.993 . . . . 0.0 114.904 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -32.68 72.6 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 166.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 3.2 pp -89.67 -37.58 14.5 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.433 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.523 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 21.2 t-20 -171.48 -60.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.644 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.4 mm? -56.55 167.97 0.64 Allowed 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -166.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -82.61 -16.54 48.01 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.762 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 p 61.36 21.81 12.3 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 126.357 1.863 . . . . 0.0 112.803 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -107.66 -23.77 11.99 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -172.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HG2' ' HB3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -106.42 -162.01 0.83 Allowed 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.104 -169.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.568 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 67.2 m-85 -72.9 -172.42 0.23 Allowed Pre-proline 0 CA--C 1.571 1.76 0 C-N-CA 125.036 1.334 . . . . 0.0 108.998 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 5.6 Cg_endo -47.48 133.59 20.67 Favored 'Trans proline' 0 C--N 1.408 3.708 0 CA-C-N 122.583 1.958 . . . . 0.0 115.61 -175.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.06 122.4 37.11 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.252 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.517 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 75.9 t80 -96.47 117.44 30.91 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.381 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -119.46 122.35 41.52 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 122.046 -0.409 . . . . 0.0 111.998 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 49.3 mt -95.13 116.28 36.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 45.6 tt0 -106.69 122.38 46.24 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 19.8 mt-10 -80.58 148.96 30.1 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.956 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 20' ' ' MET . 19.9 t -113.0 -0.42 9.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.1 -57.15 3.21 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.819 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.416 ' HB2' ' HZ1' ' A' ' 89' ' ' LYS . 10.0 mtmp? -111.33 -9.98 14.25 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.631 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 49.7 t-20 65.88 86.72 0.13 Allowed 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.225 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.555 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 5.9 tp-100 -139.69 164.15 30.71 Favored 'General case' 0 CA--C 1.464 -2.339 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.639 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.51 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 11.3 mptt -119.88 95.05 4.61 Favored 'General case' 1 N--CA 1.376 -4.174 0 O-C-N 125.056 1.473 . . . . 0.0 108.572 -174.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.521 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 28.9 m-85 -101.28 83.13 0.41 Allowed Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 172.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 5.8 Cg_endo -101.58 144.92 0.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.396 2.064 . . . . 0.0 114.572 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -85.3 173.56 10.25 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 126.37 1.868 . . . . 0.0 109.088 -174.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.5 m-20 -66.3 148.79 51.33 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -95.47 2.47 54.45 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.481 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 9.8 pt-20 -149.31 23.66 0.92 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.009 -172.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 18.0 ttmm -90.76 -81.79 0.3 Allowed 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.001 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 172.45 123.63 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.411 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.4 mp -99.88 94.57 3.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -122.68 167.74 13.07 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.435 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.416 ' HE2' ' HB2' ' A' ' 46' ' ' PRO . 39.5 t80 -51.73 -61.06 2.49 Favored 'General case' 0 CA--C 1.483 -1.618 0 O-C-N 124.061 0.851 . . . . 0.0 110.107 -176.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -69.17 -27.01 65.14 Favored 'General case' 1 N--CA 1.372 -4.361 0 C-N-CA 125.784 1.634 . . . . 0.0 112.778 -172.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.7 -44.44 42.16 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.543 0.687 . . . . 0.0 109.354 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.411 ' CG1' HG23 ' A' ' 101' ' ' ILE . 32.8 mm -68.88 -40.34 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.575 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -56.43 -51.55 68.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.672 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.02 -43.36 70.06 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.164 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.01 -59.3 3.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.52 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.417 ' O ' HG11 ' A' ' 114' ' ' VAL . 33.9 m -60.83 -33.19 54.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 O-C-N 121.777 -0.577 . . . . 0.0 111.508 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.86 -50.42 73.87 Favored 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 124.067 0.947 . . . . 0.0 109.258 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.651 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 1.9 t70 -58.77 -47.74 83.63 Favored 'General case' 0 C--O 1.2 -1.513 0 CA-C-N 113.16 -1.836 . . . . 0.0 107.441 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.505 ' HB2' HD11 ' A' ' 118' ' ' ILE . 2.1 t80 -57.53 -65.55 0.61 Allowed 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.473 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 110' ' ' VAL . 8.8 p -62.07 -24.57 34.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.79 -34.86 52.03 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.75 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.99 30.89 2.62 Favored Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.651 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 22.2 mtmt -99.88 -44.31 6.1 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 113.202 -1.499 . . . . 0.0 108.422 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' ' 113' ' ' PHE . 33.4 mt -83.0 146.74 6.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 170.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.408 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 10.4 pt-20 -134.72 168.53 17.33 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 119' ' ' GLU . 65.8 Cg_exo -43.93 126.27 5.88 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.4 2.733 . . . . 0.0 113.179 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.4 m -92.81 -28.1 16.77 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.945 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 16.3 pt -126.83 -54.42 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.141 0.496 . . . . 0.0 112.275 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.54 ' HB2' HE22 ' A' ' 91' ' ' GLN . 31.2 mmmt -90.27 71.44 7.17 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.6 m -86.55 73.76 10.02 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.952 0.882 . . . . 0.0 108.75 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -143.6 89.7 7.36 Favored Pre-proline 0 N--CA 1.42 -1.926 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.15 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.37 168.24 14.92 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 121.556 1.504 . . . . 0.0 110.775 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.0 mt -111.32 89.4 10.2 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.71 153.56 11.67 Favored 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 122.179 1.92 . . . . 0.0 112.759 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 69.53 151.94 0.09 Allowed 'General case' 0 C--O 1.243 0.752 0 C-N-CA 125.752 1.621 . . . . 0.0 112.787 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . 0.271 58.8 pttt -88.89 74.58 8.21 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 122.599 1.19 . . . . 0.0 112.937 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -158.34 149.36 20.73 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 112.886 -1.961 . . . . 0.0 106.31 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.75 135.24 45.61 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.897 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.102 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.302 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.1 129.72 35.88 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 123.27 2.647 . . . . 0.0 112.063 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.14 -59.75 2.46 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.37 -53.71 2.1 Favored Glycine 0 C--N 1.31 -0.897 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.653 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m -138.4 155.92 73.69 Favored Pre-proline 0 C--N 1.291 -1.97 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.07 136.77 61.99 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 122.729 2.286 . . . . 0.0 110.015 175.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.2 -54.12 10.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.81 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.441 ' HB ' ' N ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -90.04 152.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.09 -70.43 0.26 Allowed Glycine 0 CA--C 1.474 -2.498 0 C-N-CA 119.373 -1.394 . . . . 0.0 111.718 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -125.92 147.71 49.42 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.478 HG13 ' HB ' ' A' ' 60' ' ' ILE . 2.2 pt -120.44 154.88 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-O 121.482 0.658 . . . . 0.0 111.777 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.55 176.59 30.7 Favored Glycine 0 N--CA 1.403 -3.501 0 N-CA-C 107.751 -2.139 . . . . 0.0 107.751 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.5 -27.44 68.82 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.167 2.578 . . . . 0.0 113.648 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -89.23 -20.52 24.04 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.444 ' HG1' ' HA ' ' A' ' 11' ' ' ILE . 68.0 p -97.91 -36.36 10.19 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.534 -169.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -62.71 -29.42 70.65 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.976 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -24.77 67.07 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.2 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.29 -37.67 44.27 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.88 0.848 . . . . 0.0 109.882 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -76.06 -27.44 57.25 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.486 ' O ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.04 -35.31 71.91 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.358 175.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 t -74.7 -19.51 60.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.933 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.28 -30.12 57.68 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 120.95 0.405 . . . . 0.0 110.2 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.39 -23.67 26.45 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.947 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.446 HG13 HD22 ' A' ' 56' ' ' ASN . 6.6 pt -81.15 152.87 71.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.479 -0.361 . . . . 0.0 111.68 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 85' ' ' GLN . 10.6 Cg_endo -52.42 137.25 56.93 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.063 3.175 . . . . 0.0 114.442 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 tt -106.8 125.96 51.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.496 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . . . -97.56 104.86 16.92 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -86.96 120.71 28.52 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.446 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.445 ' HB ' HG21 ' A' ' 59' ' ' THR . 3.4 mp -110.69 94.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.361 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 34.7 m-85 -80.34 126.64 31.42 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -142.15 122.1 13.64 Favored 'General case' 0 C--N 1.252 -3.639 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.493 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.428 ' HG2' ' C ' ' A' ' 62' ' ' ALA . 32.2 mt-10 -73.15 -20.82 60.83 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.426 ' HB ' ' CG ' ' A' ' 36' ' ' GLU . 1.5 p -86.66 83.86 7.51 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.997 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 37' ' ' ARG . . . -87.31 -25.21 24.03 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.154 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.5 mp0 -63.23 -34.13 76.99 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.179 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' CG ' ' HB ' ' A' ' 33' ' ' THR . 11.1 pt-20 -116.48 13.55 15.42 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.412 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.424 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 7.5 ptp180 -57.73 -27.93 63.44 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.812 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -50.4 -49.46 54.5 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 123.608 0.763 . . . . 0.0 111.517 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.625 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 12.1 pt-20 -86.97 -24.4 24.73 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.435 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.7 tm? -63.98 -44.92 91.24 Favored 'General case' 0 C--O 1.261 1.701 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.548 ' OG ' HG22 ' A' ' 59' ' ' THR . 15.7 m -73.01 -17.33 61.46 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.456 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 23.4 t70 -70.99 -40.87 71.61 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.677 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HD2' ' O ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -65.24 -38.11 89.33 Favored 'General case' 0 C--O 1.27 2.177 0 CA-C-O 123.426 1.584 . . . . 0.0 106.848 173.308 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 94.0 mt -71.12 -19.06 62.49 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 112.884 -1.962 . . . . 0.0 113.065 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.518 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 24.3 ttpp -66.56 -55.42 18.72 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.68 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 81.6 Cg_exo -65.59 -38.94 22.92 Favored 'Trans proline' 0 CA--C 1.489 -1.733 0 C-N-CA 123.174 2.582 . . . . 0.0 110.508 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.51 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 93.7 mt -53.68 -38.47 34.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 O-C-N 124.052 0.845 . . . . 0.0 109.695 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.443 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -93.92 -16.84 23.61 Favored 'General case' 0 C--O 1.19 -2.053 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.217 -174.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 3.6 tt0 -74.42 -17.73 60.75 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.57 -20.79 30.92 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.933 177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 2.8 pt20 -137.66 37.84 2.43 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.495 1.14 . . . . 0.0 110.609 -171.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -65.92 -24.83 66.91 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.542 -2.117 . . . . 0.0 112.846 -172.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.54 9.22 17.08 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.314 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 p -122.86 -33.0 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.193 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 88.1 mt -122.86 134.64 65.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.211 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.446 HD22 HG13 ' A' ' 24' ' ' ILE . 9.2 m-80 -94.46 102.89 14.87 Favored 'General case' 0 C--O 1.207 -1.159 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.441 ' N ' ' HB ' ' A' ' 8' ' ' ILE . 7.8 m-85 -80.19 139.47 36.74 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.795 0.807 . . . . 0.0 111.851 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.425 ' C ' HG12 ' A' ' 11' ' ' ILE . . . -151.54 113.27 0.57 Allowed Glycine 0 C--N 1.275 -2.811 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.649 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.548 HG22 ' OG ' ' A' ' 41' ' ' SER . 40.3 p -84.64 132.19 34.51 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HB ' HG13 ' A' ' 11' ' ' ILE . 7.6 tt -131.73 145.24 35.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 63' ' ' LYS . 7.7 t0 -73.33 123.9 24.68 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.042 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.428 ' C ' ' HG2' ' A' ' 32' ' ' GLU . . . -92.54 1.99 56.94 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.042 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HB3' ' OD1' ' A' ' 61' ' ' ASP . 39.4 ttmt -100.33 -31.17 11.47 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.68 -44.53 7.07 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.217 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -120.42 26.67 9.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.476 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -70.44 -15.92 73.23 Favored Glycine 0 CA--C 1.489 -1.565 0 N-CA-C 116.206 1.242 . . . . 0.0 116.206 -170.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.16 -35.55 71.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.374 0.607 . . . . 0.0 110.007 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 71' ' ' ASN . 63.7 m-70 -60.49 -21.79 62.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.146 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.11 -31.87 72.37 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 121.506 0.67 . . . . 0.0 110.283 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.742 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -122.77 9.99 9.07 Favored Glycine 0 CA--C 1.479 -2.205 0 C-N-CA 118.26 -1.924 . . . . 0.0 115.089 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -73.95 -16.42 61.08 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 166.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' HE3' ' A' ' 92' ' ' LYS . 3.9 pp -99.13 -26.25 14.27 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.928 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 177.78 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.742 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 89.8 mt -53.04 159.23 1.24 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.793 2.145 . . . . 0.0 116.793 -171.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -71.15 -17.91 62.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.235 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 p 50.13 57.83 6.14 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -135.25 -17.98 1.78 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -119.54 -159.92 0.79 Allowed 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.867 -167.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.487 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 57.7 m-85 -61.47 -176.37 0.12 Allowed Pre-proline 0 N--CA 1.499 1.993 0 C-N-CA 126.485 1.914 . . . . 0.0 111.262 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.518 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 3.7 Cg_endo -45.92 135.87 13.8 Favored 'Trans proline' 1 C--N 1.422 4.444 0 CA-C-N 121.75 1.661 . . . . 0.0 113.079 177.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.539 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . . . -116.52 136.67 52.79 Favored 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.927 -171.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 77.6 t80 -120.11 120.09 35.23 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -125.12 123.46 39.73 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.359 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.87 109.15 21.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 25' ' ' PRO . 41.3 tt0 -95.25 127.38 41.25 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -86.0 132.28 34.1 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 20' ' ' MET . 12.0 t -94.49 -0.42 10.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-O 122.139 0.971 . . . . 0.0 108.727 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.95 -44.68 3.94 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.699 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -93.85 -12.36 29.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.54 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 2.3 p-10 56.28 33.43 22.23 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 123.258 1.504 . . . . 0.0 109.894 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.508 ' C ' ' HD3' ' A' ' 92' ' ' LYS . 8.1 tp60 -98.12 167.04 11.12 Favored 'General case' 0 CA--C 1.464 -2.354 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.957 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.626 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 3.6 mppt? -132.76 102.88 5.84 Favored 'General case' 1 N--CA 1.373 -4.317 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -176.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -98.91 83.83 0.33 Allowed Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 173.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.626 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 24.1 Cg_endo -100.18 149.42 0.45 Allowed 'Trans proline' 0 N--CA 1.42 -2.809 0 C-N-CA 121.935 1.757 . . . . 0.0 113.411 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.416 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 83.2 t80 -84.34 168.16 15.86 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.789 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 18.6 m-20 -70.65 143.3 51.47 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.451 ' NE2' ' HB3' ' A' ' 74' ' ' LEU . 31.4 mt-30 -84.75 2.38 42.34 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.012 -171.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -152.22 22.02 0.65 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 14.9 tppt? -90.65 -3.22 57.67 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 70.49 133.02 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.911 2.085 . . . . 0.0 112.716 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.451 HG21 HG13 ' A' ' 106' ' ' ILE . 2.4 mp -91.24 97.91 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.943 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.4 p -110.25 -165.93 1.04 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.148 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.9 t80 -84.46 -55.0 4.38 Favored 'General case' 0 CA--C 1.485 -1.558 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -58.85 -43.86 90.89 Favored 'General case' 0 N--CA 1.387 -3.607 0 CA-C-N 113.096 -1.865 . . . . 0.0 113.731 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.62 -49.94 73.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.067 0.46 . . . . 0.0 111.328 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.451 HG13 HG21 ' A' ' 101' ' ' ILE . 44.2 mm -72.11 -40.54 66.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.599 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 30.7 ttpt -57.71 -48.84 78.43 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.4 -42.6 98.99 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 123.914 0.759 . . . . 0.0 110.922 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.485 ' O ' HD11 ' A' ' 118' ' ' ILE . 63.4 t80 -61.56 -60.73 3.25 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.209 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 111' ' ' ASP . 35.9 m -59.48 -30.67 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.642 -0.661 . . . . 0.0 110.468 -177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 23.9 t70 -64.27 -53.18 52.96 Favored 'General case' 0 CA--C 1.479 -1.756 0 C-N-CA 124.629 1.171 . . . . 0.0 108.96 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.623 ' OD2' HG12 ' A' ' 118' ' ' ILE 0.265 0.1 OUTLIER -68.2 -25.12 65.06 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.959 -177.167 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.547 ' N ' HG13 ' A' ' 118' ' ' ILE . 1.4 t80 -68.97 -62.01 1.56 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.772 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.79 -25.42 38.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.335 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.64 -30.72 67.43 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 121.175 0.512 . . . . 0.0 109.934 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.71 7.06 10.95 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.77 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.571 ' HE2' ' OD2' ' A' ' 112' ' ' ASP . 25.1 ttpt -89.42 -37.07 15.09 Favored 'General case' 0 N--CA 1.393 -3.311 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.591 -172.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.623 HG12 ' OD2' ' A' ' 112' ' ' ASP . 4.2 mt -74.02 135.45 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 118.446 -1.302 . . . . 0.0 109.851 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -127.53 168.44 15.06 Favored Pre-proline 0 C--N 1.267 -3.015 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.58 122.04 9.58 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.931 1.754 . . . . 0.0 111.003 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.1 t -66.9 -52.91 37.54 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 35.0 pt -147.46 169.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -139.88 105.6 5.14 Favored 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.2 m -154.57 89.07 1.23 Allowed 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.033 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -126.93 103.3 23.88 Favored Pre-proline 0 CA--C 1.484 -1.595 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -84.88 179.85 4.04 Favored 'Trans proline' 0 N--CA 1.431 -2.156 0 C-N-CA 122.117 1.878 . . . . 0.0 112.951 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 pt -51.2 112.32 2.95 Favored Pre-proline 0 C--O 1.248 1.016 0 O-C-N 124.695 1.247 . . . . 0.0 112.52 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -47.37 139.28 16.99 Favored 'Trans proline' 0 C--O 1.251 1.167 0 C-N-CA 123.672 2.915 . . . . 0.0 110.83 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.07 103.63 0.12 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 124.447 1.092 . . . . 0.0 110.787 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -83.77 125.25 31.73 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.92 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -102.49 140.96 36.09 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -60.37 131.16 49.9 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 124.152 0.908 . . . . 0.0 111.471 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.433 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -177.229 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.709 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.59 123.01 10.81 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.506 2.137 . . . . 0.0 112.488 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.7 tp -102.4 166.61 10.45 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.51 73.54 0.6 Allowed Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 m -89.84 133.27 34.31 Favored Pre-proline 0 N--CA 1.416 -2.171 0 C-N-CA 123.801 0.84 . . . . 0.0 109.113 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.25 103.86 0.56 Allowed 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.225 1.95 . . . . 0.0 111.494 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.5 mt -124.1 -44.54 2.03 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.461 HG13 ' HB2' ' A' ' 57' ' ' PHE . 5.4 mp -121.0 90.79 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 169.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.81 -130.58 2.84 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.994 -173.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -122.67 143.56 49.7 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.437 0.636 . . . . 0.0 110.669 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.575 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 62.9 mt -103.71 118.11 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.957 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.25 178.32 17.87 Favored Glycine 0 N--CA 1.408 -3.218 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.42 -29.49 84.64 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.264 2.643 . . . . 0.0 112.939 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.96 -8.94 23.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.2 p -102.21 -35.88 8.71 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.466 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -62.5 -32.04 72.89 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.217 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.8 t -63.19 -27.9 69.68 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.571 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.61 -38.19 59.22 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.599 0.714 . . . . 0.0 109.73 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.407 ' HB3' ' CG ' ' A' ' 56' ' ' ASN . 18.4 m-85 -76.94 -23.39 52.42 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.579 ' SD ' HG23 ' A' ' 87' ' ' VAL . 8.7 tpp -80.67 -21.92 40.91 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.214 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -92.18 -13.05 31.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.07 -31.1 68.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.05 11.48 73.0 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.526 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.426 HG13 HD22 ' A' ' 56' ' ' ASN . 9.5 pt -123.98 151.06 64.46 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.34 144.84 47.77 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 124.125 3.217 . . . . 0.0 114.067 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 tt -116.14 126.34 53.57 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.465 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.74 110.54 22.98 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -90.73 120.18 31.57 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.176 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 58' ' ' GLY . 3.2 mp -111.37 90.84 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.07 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 44.1 m-85 -79.41 133.37 36.55 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -142.99 120.32 11.59 Favored 'General case' 0 C--N 1.273 -2.719 0 O-C-N 123.314 0.384 . . . . 0.0 111.884 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.18 -32.01 66.44 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 3.1 p -83.08 109.59 17.27 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.202 -171.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.89 -16.95 45.5 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.424 0.63 . . . . 0.0 109.708 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -70.8 -59.6 2.71 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.425 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -97.93 8.59 44.49 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.693 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 33' ' ' THR . 53.6 ttt180 -55.69 -36.94 67.69 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -59.31 -48.48 81.45 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.096 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.648 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 12.4 pt-20 -79.37 -27.23 41.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.671 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.516 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.1 tm? -59.41 -50.01 75.6 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.474 ' HA ' HD11 ' A' ' 44' ' ' LEU . 9.2 m -74.88 -19.57 60.1 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.975 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.546 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 33.8 t70 -70.1 -39.97 75.2 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 122.866 0.466 . . . . 0.0 111.334 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.648 ' HE2' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -70.51 -35.43 73.2 Favored 'General case' 0 C--O 1.297 3.554 0 CA-C-O 123.177 1.465 . . . . 0.0 108.509 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 68.6 mt -70.79 -23.64 62.43 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 113.102 -1.863 . . . . 0.0 111.814 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.5 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 36.4 ttpt -63.61 -52.1 61.51 Favored Pre-proline 0 C--N 1.289 -2.03 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.182 -173.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 51.5 Cg_exo -71.83 -44.28 1.01 Allowed 'Trans proline' 0 CA--C 1.492 -1.598 0 C-N-CA 122.803 2.335 . . . . 0.0 111.095 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.423 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 2.4 pp -61.95 -22.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.375 1.68 0 C-N-CA 117.777 -1.569 . . . . 0.0 111.735 -176.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -99.23 -21.0 16.3 Favored 'General case' 0 C--O 1.202 -1.416 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.31 -177.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 22.4 tt0 -69.82 -23.07 63.25 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.76 -16.63 60.1 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.228 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 3.1 pt20 -142.34 31.8 1.52 Allowed 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.522 -172.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.81 -14.27 59.63 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.977 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.89 5.52 50.64 Favored Glycine 0 C--N 1.296 -1.684 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.853 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.05 -37.47 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.534 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.3 mt -117.87 145.39 23.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.426 HD22 HG13 ' A' ' 24' ' ' ILE . 10.4 m-80 -92.94 121.76 34.62 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.461 ' HB2' HG13 ' A' ' 8' ' ' ILE . 6.4 m-85 -103.87 128.71 51.33 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.174 0.988 . . . . 0.0 112.825 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.575 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -145.9 131.9 4.32 Favored Glycine 0 N--CA 1.415 -2.734 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.252 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 44.9 p -96.08 143.59 27.08 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 8.2 tt -148.01 154.99 10.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.53 132.02 34.57 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.336 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.486 ' O ' ' HA3' ' A' ' 66' ' ' GLY . . . -87.48 -3.63 59.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.135 0.493 . . . . 0.0 111.776 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -103.77 -32.05 9.53 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.002 0.429 . . . . 0.0 110.153 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.69 -46.59 7.5 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.406 ' O ' ' HE2' ' A' ' 30' ' ' PHE . 92.1 m-85 -117.24 19.29 14.21 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.502 -178.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -66.95 -14.61 63.61 Favored Glycine 0 C--N 1.307 -1.036 0 N-CA-C 116.382 1.313 . . . . 0.0 116.382 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.29 -24.64 67.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.085 0.942 . . . . 0.0 109.993 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -74.77 -22.3 58.85 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.946 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.425 ' HB2' HG23 ' A' ' 76' ' ' THR . . . -61.07 -44.22 97.71 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 121.835 0.826 . . . . 0.0 109.408 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -112.56 24.0 14.36 Favored Glycine 0 C--N 1.272 -3.019 0 C-N-CA 117.987 -2.054 . . . . 0.0 115.381 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -14.36 59.46 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 169.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 73' ' ' ASN . 4.1 pp -100.37 -29.37 12.45 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.568 177.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.508 ' N ' HD12 ' A' ' 72' ' ' LEU . 3.2 t-20 -175.8 -60.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.683 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.4 mm? -53.62 155.49 3.07 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -169.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -78.37 -12.96 60.04 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.012 -1.449 . . . . 0.0 112.49 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.425 HG23 ' HB2' ' A' ' 69' ' ' ALA . 75.7 p 58.61 28.52 17.23 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 126.56 1.944 . . . . 0.0 113.635 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.07 -28.44 6.98 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -170.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.704 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -124.9 106.07 9.72 Favored 'General case' 0 C--O 1.197 -1.676 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.418 -167.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.541 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 12.9 m-85 60.07 -171.06 0.02 OUTLIER Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.838 168.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 10.2 Cg_endo -58.72 149.91 73.92 Favored 'Trans proline' 0 C--N 1.379 2.148 0 CA-C-N 120.79 1.318 . . . . 0.0 113.8 171.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.58 126.21 34.21 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.783 -176.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 77.5 t80 -105.45 119.01 38.03 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -126.96 117.34 22.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.4 mt -91.02 110.18 22.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -92.04 135.0 34.31 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.554 ' OE2' ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -90.61 132.94 35.45 Favored 'General case' 0 CA--C 1.461 -2.462 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.371 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.579 HG23 ' SD ' ' A' ' 20' ' ' MET . 22.0 t -101.05 -6.7 9.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.98 -46.15 5.45 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 119.771 -0.771 . . . . 0.0 109.575 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.554 ' HG2' ' OE2' ' A' ' 86' ' ' GLU . 43.6 mmtm -92.62 -25.45 18.29 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.505 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 63.0 t30 66.65 59.16 0.61 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 123.646 1.688 . . . . 0.0 106.799 -171.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.544 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -130.24 176.34 8.19 Favored 'General case' 0 CA--C 1.468 -2.183 0 CA-C-N 113.098 -1.864 . . . . 0.0 107.4 -172.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.544 ' HD3' ' O ' ' A' ' 91' ' ' GLN . 60.3 mmtt -142.52 111.04 6.15 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -106.63 87.96 3.12 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 2.9 Cg_endo -104.48 150.89 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 122.689 2.259 . . . . 0.0 114.675 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' HD1' ' CD1' ' A' ' 109' ' ' PHE . 57.2 t80 -98.51 149.88 22.26 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.437 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.434 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 3.4 m-20 -58.72 139.51 56.07 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-O 121.702 0.763 . . . . 0.0 111.196 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.704 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 45.3 mt-30 -77.71 -8.54 58.09 Favored 'General case' 0 C--N 1.265 -3.103 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.181 -176.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.43 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 6.4 pt-20 -130.29 16.58 5.52 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.528 0.68 . . . . 0.0 111.42 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 34.8 ttmt -107.21 9.07 30.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.374 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 66.68 117.31 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.666 1.587 . . . . 0.0 114.6 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.499 HG22 ' CG1' ' A' ' 106' ' ' ILE . 3.4 mp -83.06 106.35 13.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.498 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.7 p -129.83 175.69 8.64 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.546 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 31.2 t80 -51.45 -63.79 1.02 Allowed 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 124.147 0.904 . . . . 0.0 110.047 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -67.38 -42.06 84.01 Favored 'General case' 1 N--CA 1.373 -4.299 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.195 -172.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.05 92.46 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 123.646 0.591 . . . . 0.0 110.296 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.499 ' CG1' HG22 ' A' ' 101' ' ' ILE . 32.6 mm -75.3 -42.26 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.101 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 27.0 ttpp -55.28 -50.33 69.8 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 123.759 0.662 . . . . 0.0 109.996 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.0 -33.54 75.78 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.043 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.463 ' CD1' ' HD1' ' A' ' 95' ' ' PHE . 68.8 t80 -66.21 -60.76 2.48 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.855 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 106' ' ' ILE . 27.8 m -58.67 -31.3 43.86 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 122.033 -0.417 . . . . 0.0 110.411 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 23.0 t70 -61.48 -50.97 70.59 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.789 1.236 . . . . 0.0 109.69 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.689 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 4.4 t70 -61.65 -46.29 90.38 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-N 113.941 -1.482 . . . . 0.0 107.247 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.526 ' HB2' HD11 ' A' ' 118' ' ' ILE . 2.1 t80 -55.4 -65.14 0.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.01 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.88 -15.29 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 C-N-CA 123.661 0.785 . . . . 0.0 111.909 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.35 -25.39 25.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 0.0 110.17 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.56 26.67 6.74 Favored Glycine 0 CA--C 1.485 -1.782 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.689 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -98.09 -47.12 5.62 Favored 'General case' 0 N--CA 1.411 -2.414 0 CA-C-N 114.055 -1.073 . . . . 0.0 109.113 -176.226 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 113' ' ' PHE . 20.5 mt -74.5 145.66 10.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.03 151.41 78.26 Favored Pre-proline 0 C--N 1.283 -2.296 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.121 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.59 106.85 2.35 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.609 1.539 . . . . 0.0 112.792 -175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.402 ' O ' HG22 ' A' ' 122' ' ' ILE . 17.0 t -85.04 75.54 10.36 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 121' ' ' SER . 3.0 pt 179.67 -45.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 C-N-CA 128.355 2.662 . . . . 0.0 107.292 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -90.39 97.93 11.47 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.768 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.435 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.8 m -135.29 105.83 6.45 Favored 'General case' 0 C--N 1.273 -2.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -111.62 94.02 21.94 Favored Pre-proline 0 N--CA 1.42 -1.936 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 124' ' ' SER . 44.4 Cg_endo -95.24 173.22 1.22 Allowed 'Trans proline' 0 N--CA 1.413 -3.246 0 C-N-CA 121.513 1.475 . . . . 0.0 112.635 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.4 pt -114.83 94.57 38.19 Favored Pre-proline 0 C--N 1.301 -1.542 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.558 175.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.85 132.85 50.09 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.471 2.114 . . . . 0.0 109.7 174.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -85.43 95.91 9.41 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.178 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 68.75 108.63 0.05 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.317 1.447 . . . . 0.0 111.968 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 132' ' ' GLU . 13.8 tt0 -141.17 168.6 19.38 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.426 ' N ' ' HG2' ' A' ' 131' ' ' GLN . 5.0 mp0 -77.95 154.75 31.32 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.579 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.718 -177.936 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.754 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -65.72 -43.01 10.65 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.346 2.031 . . . . 0.0 109.067 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt -141.22 165.29 27.94 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.12 -12.29 75.68 Favored Glycine 0 C--N 1.316 -0.545 0 O-C-N 123.503 0.502 . . . . 0.0 112.512 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.4 t -148.28 139.11 13.38 Favored Pre-proline 0 N--CA 1.416 -2.152 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.28 -49.56 3.49 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.0 1.8 . . . . 0.0 110.757 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.7 tp -169.73 -61.21 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 79.9 mt -99.03 117.65 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.736 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.4 -99.44 0.15 Allowed Glycine 0 N--CA 1.418 -2.565 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' HA ' ' H ' ' A' ' 59' ' ' THR . 10.6 pt-20 -118.09 167.68 11.25 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.041 0.448 . . . . 0.0 109.957 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.484 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 69.2 mt -110.79 128.96 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 172.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.06 170.68 19.43 Favored Glycine 0 N--CA 1.416 -2.679 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.74 -18.23 54.54 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.278 2.652 . . . . 0.0 112.642 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.83 6.39 31.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.837 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -114.95 -25.98 7.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.374 -1.33 . . . . 0.0 111.981 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -41.75 -59.49 1.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.751 0.821 . . . . 0.0 112.248 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.6 m -54.3 -33.04 57.89 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.011 -1.449 . . . . 0.0 112.738 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.58 -26.99 31.82 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -74.68 -29.26 61.17 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.414 ' O ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -76.76 -35.79 57.48 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.731 178.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -70.87 -21.72 62.37 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.394 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.07 -24.23 59.48 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 120.831 0.348 . . . . 0.0 111.307 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.61 -15.49 30.29 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-O 121.443 0.468 . . . . 0.0 112.309 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 19.8 pt -90.07 153.35 46.91 Favored Pre-proline 0 C--N 1.293 -1.888 0 CA-C-N 115.175 -0.513 . . . . 0.0 109.98 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 21.4 Cg_exo -52.42 140.47 53.53 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.313 2.675 . . . . 0.0 113.879 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.412 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 2.7 tt -102.31 125.2 48.95 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.469 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.91 106.29 18.58 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.412 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 57.1 m-85 -87.88 113.92 23.99 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.12 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.44 HD12 ' CD2' ' A' ' 57' ' ' PHE . 3.1 mp -103.71 86.96 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.815 0 C-N-CA 118.379 -1.328 . . . . 0.0 108.958 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 41.5 m-85 -75.87 125.82 29.82 Favored 'General case' 0 CA--C 1.457 -2.609 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . . . -140.58 119.5 12.65 Favored 'General case' 0 C--N 1.258 -3.381 0 O-C-N 123.567 0.542 . . . . 0.0 111.489 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.99 -26.44 67.55 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.575 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 1.2 p -81.39 120.42 24.94 Favored 'General case' 0 N--CA 1.393 -3.287 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.914 -176.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.04 -16.75 12.58 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 173.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.0 mp0 -72.74 -45.49 58.45 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.764 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -116.28 12.99 15.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.137 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' A' ' 33' ' ' THR . 44.1 ttm180 -51.79 -41.25 61.55 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 13.2 ptmm? -54.75 -32.0 59.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 124.147 0.904 . . . . 0.0 111.751 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -73.81 -43.78 57.8 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.667 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.8 mm? -58.14 -48.42 80.29 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.445 ' HA ' HD12 ' A' ' 44' ' ' LEU . 1.8 m -72.4 -21.48 61.26 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.817 -173.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 18.4 t70 -72.43 -39.19 68.06 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.743 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.631 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -73.02 -32.13 64.91 Favored 'General case' 0 C--O 1.287 3.035 0 CA-C-O 123.015 1.388 . . . . 0.0 108.69 175.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 52.5 mt -70.53 -26.51 63.61 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.434 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 4.0 tppp? -65.51 -51.8 48.81 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.304 -174.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 89.2 Cg_exo -67.14 -43.62 6.12 Favored 'Trans proline' 0 C--O 1.27 2.098 0 C-N-CA 122.901 2.4 . . . . 0.0 111.571 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.13 -21.75 29.02 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 118.457 -1.297 . . . . 0.0 111.099 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -95.39 -24.26 16.79 Favored 'General case' 0 C--O 1.197 -1.681 0 O-C-N 123.677 0.611 . . . . 0.0 111.085 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.466 ' OE1' ' HD2' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -66.26 -21.39 66.28 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.41 -19.46 56.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.73 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.429 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 3.0 pt20 -139.04 35.73 2.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.267 1.032 . . . . 0.0 110.883 -171.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.466 ' HD2' ' OE1' ' A' ' 49' ' ' GLU . 14.3 ptm180 -73.05 -18.84 61.28 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.614 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.83 15.34 31.51 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.608 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.2 p -137.85 -29.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.866 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.6 mt -128.65 136.15 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 O-C-N 121.546 -0.721 . . . . 0.0 111.361 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.403 HD22 HG13 ' A' ' 24' ' ' ILE . 17.9 m-80 -88.88 109.35 20.14 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 5.0 m-85 -93.31 114.98 27.56 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.484 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -136.97 128.62 4.46 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.353 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.407 ' H ' ' HA ' ' A' ' 10' ' ' GLU . 55.3 p -87.84 132.36 34.21 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 6.8 tt -132.79 145.25 34.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.44 ' OD1' ' HB3' ' A' ' 63' ' ' LYS . 11.2 t70 -75.56 127.83 33.95 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.263 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 30' ' ' PHE . . . -90.98 -1.3 57.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.624 0.725 . . . . 0.0 111.285 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.44 ' HB3' ' OD1' ' A' ' 61' ' ' ASP . 39.1 ttmt -99.35 -34.19 10.41 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.38 -54.5 3.25 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.766 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.29 20.25 19.25 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 121.767 -0.583 . . . . 0.0 111.007 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -63.3 -20.4 63.08 Favored Glycine 0 C--N 1.309 -0.919 0 N-CA-C 116.246 1.258 . . . . 0.0 116.246 -172.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.04 -25.03 66.63 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.021 0.911 . . . . 0.0 110.591 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -73.09 -17.83 61.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.458 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.458 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -64.18 -33.58 76.11 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.623 1.202 . . . . 0.0 108.837 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.644 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -116.22 24.08 10.17 Favored Glycine 0 C--N 1.27 -3.111 0 C-N-CA 118.564 -1.779 . . . . 0.0 114.226 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -8.4 58.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 166.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 4.1 pp -112.71 -38.55 4.55 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 112.867 -1.97 . . . . 0.0 109.18 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.565 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 11.5 t-20 -169.23 -56.95 0.02 OUTLIER 'General case' 0 C--N 1.367 1.356 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.644 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.3 mm? -60.49 173.37 0.71 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -167.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.637 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 53.1 tttm -90.54 -9.75 46.05 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.588 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.2 p 74.7 -13.13 0.85 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 128.358 2.663 . . . . 0.0 115.714 168.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.637 ' OD1' ' HG2' ' A' ' 75' ' ' LYS . 17.7 p-10 -108.1 5.04 25.6 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -166.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 36.2 ttmt -129.23 103.98 7.26 Favored 'General case' 0 C--N 1.258 -3.395 0 C-N-CA 119.527 -0.869 . . . . 0.0 113.256 -173.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 97' ' ' GLN . 31.6 m-85 56.52 -175.57 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 124.417 1.073 . . . . 0.0 113.195 167.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 9.2 Cg_endo -65.12 134.07 38.01 Favored 'Trans proline' 0 N--CA 1.424 -2.596 0 CA-C-N 119.978 1.028 . . . . 0.0 113.113 167.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.95 116.64 20.39 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 113.903 -1.498 . . . . 0.0 107.878 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.469 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 61.5 t80 -91.34 109.32 20.6 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.381 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -111.0 115.85 30.18 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.436 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 39.2 mt -90.93 109.38 20.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 25.4 tt0 -106.74 120.54 42.27 Favored 'General case' 0 N--CA 1.395 -3.203 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.436 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.744 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 13.1 mt-10 -75.38 148.23 39.37 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.885 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 20' ' ' MET . 16.4 t -113.72 -1.87 10.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.88 -55.9 3.63 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -97.36 -19.78 18.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.212 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.744 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 47.2 t-20 59.85 80.43 0.2 Allowed 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 125.119 1.368 . . . . 0.0 108.277 -170.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.526 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 5.3 tp60 -133.59 165.26 25.33 Favored 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 113.789 -1.55 . . . . 0.0 107.519 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 1.2 mptp? -125.25 99.85 6.26 Favored 'General case' 0 N--CA 1.4 -2.964 0 O-C-N 123.82 0.7 . . . . 0.0 109.242 -175.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.526 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 44.6 m-85 -104.57 83.45 0.77 Allowed Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.999 174.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 4.6 Cg_endo -100.74 148.42 0.37 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 C-N-CA 122.879 2.386 . . . . 0.0 114.354 -177.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -88.8 158.75 18.03 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.844 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.516 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.5 m-20 -65.99 145.79 55.46 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 121.514 0.673 . . . . 0.0 111.426 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.522 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 13.2 mt-30 -84.25 5.2 27.53 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.299 -174.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.3 22.63 2.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.037 0.923 . . . . 0.0 110.108 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 14.6 tppt? -104.03 170.23 8.04 Favored 'General case' 0 N--CA 1.401 -2.898 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -94.26 110.29 22.05 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 118.647 0.658 . . . . 0.0 111.503 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.71 101.59 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.637 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.3 p -125.29 -170.59 2.2 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.019 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.3 t80 -75.28 -54.24 7.42 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -174.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -55.18 -54.0 48.87 Favored 'General case' 0 N--CA 1.384 -3.767 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.777 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.68 -48.82 78.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 123.742 0.651 . . . . 0.0 112.265 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 47.7 mm -73.65 -40.55 54.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -59.13 -46.6 87.94 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.48 94.78 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.829 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -65.38 -58.67 5.3 Favored 'General case' 0 C--O 1.21 -0.987 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.276 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.92 -33.25 52.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 O-C-N 121.689 -0.632 . . . . 0.0 110.7 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.18 -51.91 67.97 Favored 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 124.241 1.016 . . . . 0.0 109.673 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.719 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 3.6 t70 -58.89 -47.12 86.08 Favored 'General case' 0 C--O 1.206 -1.197 0 CA-C-N 113.699 -1.591 . . . . 0.0 107.383 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.521 ' HB2' HD11 ' A' ' 118' ' ' ILE . 1.1 t80 -55.44 -64.48 0.83 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.059 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.99 -11.95 14.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.224 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.77 -30.14 23.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.435 0.636 . . . . 0.0 109.744 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.41 26.74 5.54 Favored Glycine 0 CA--C 1.481 -2.051 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.719 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -96.68 -52.32 3.97 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-N 114.131 -1.035 . . . . 0.0 109.157 -176.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 113' ' ' PHE . 18.5 mt -71.15 145.1 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.56 150.94 74.29 Favored Pre-proline 0 C--N 1.277 -2.57 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -46.33 122.23 5.38 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.569 2.846 . . . . 0.0 112.845 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.9 t -82.88 40.0 0.66 Allowed 'General case' 0 CA--C 1.56 1.338 0 CA-C-O 122.33 1.062 . . . . 0.0 110.425 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 1.1 pt -156.89 -82.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 125.32 1.448 . . . . 0.0 109.193 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 49.9 mmtm -80.96 79.18 7.68 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.545 0.688 . . . . 0.0 110.775 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -156.26 102.84 2.13 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -114.2 92.94 28.81 Favored Pre-proline 0 N--CA 1.415 -2.182 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.517 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 40.2 Cg_endo -85.53 -173.15 1.29 Allowed 'Trans proline' 0 N--CA 1.436 -1.897 0 C-N-CA 122.268 1.979 . . . . 0.0 112.747 -173.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.4 pt -110.39 95.74 23.78 Favored Pre-proline 0 N--CA 1.431 -1.421 0 CA-C-O 121.662 0.744 . . . . 0.0 113.004 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 126' ' ' PRO . 2.4 Cg_endo -82.66 -172.02 1.3 Allowed 'Trans proline' 0 N--CA 1.428 -2.366 0 C-N-CA 122.078 1.852 . . . . 0.0 107.466 169.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -130.67 168.18 17.56 Favored 'General case' 0 C--N 1.274 -2.707 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.514 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.71 129.54 41.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.828 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -74.86 146.17 42.16 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -73.64 -27.84 61.47 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.061 0.458 . . . . 0.0 111.391 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.0 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.523 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.693 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.44 -34.29 54.47 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.763 2.309 . . . . 0.0 112.924 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -122.3 80.8 1.76 Allowed 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.47 170.06 46.11 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.759 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.565 ' OG ' ' HD3' ' A' ' 6' ' ' PRO 0.271 2.9 p -134.26 -65.27 0.02 OUTLIER Pre-proline 0 CA--C 1.566 1.593 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 178.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.565 ' HD3' ' OG ' ' A' ' 5' ' ' SER . 51.7 Cg_endo -107.63 50.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.902 2.401 . . . . 0.0 111.537 -176.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -45.02 -48.23 11.62 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.627 1.171 . . . . 0.0 113.808 -174.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 92.4 mt -126.04 128.68 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.63 -117.92 0.81 Allowed Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -119.81 136.0 54.64 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.552 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 57.1 mt -92.48 139.05 18.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.54 -179.65 18.87 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.79 -31.68 42.98 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.45 3.433 . . . . 0.0 114.582 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.24 -7.59 24.47 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.0 p -93.83 -27.26 16.54 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.985 -169.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -45.93 -51.43 13.29 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.884 0.85 . . . . 0.0 111.012 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -55.5 -34.4 64.57 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.387 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -71.04 -41.64 70.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.456 0.646 . . . . 0.0 110.096 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.433 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 41.9 m-85 -72.48 -28.94 63.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.35 1.071 . . . . 0.0 108.271 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.457 ' SD ' HG21 ' A' ' 87' ' ' VAL . 5.8 tpp -78.39 -19.96 52.2 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.315 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -87.79 -17.11 32.31 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.355 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.37 -41.7 72.75 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.025 0.441 . . . . 0.0 110.794 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.22 0.28 65.66 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.662 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 13.7 pt -107.8 152.48 41.59 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.25 138.91 64.18 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.923 3.082 . . . . 0.0 113.759 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.485 HD11 ' CZ ' ' A' ' 28' ' ' TYR . 2.5 tt -105.33 125.85 51.45 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.582 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -98.76 105.55 17.71 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.485 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 65.5 m-85 -86.72 112.43 21.66 Favored 'General case' 0 CA--C 1.467 -2.234 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.429 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.9 mt -101.09 85.08 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.596 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 43.6 m-85 -76.35 124.52 27.65 Favored 'General case' 0 CA--C 1.46 -2.515 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.64 121.17 21.62 Favored 'General case' 0 C--N 1.257 -3.447 0 O-C-N 123.456 0.473 . . . . 0.0 110.66 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -81.99 -16.69 49.49 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.6 p -97.11 100.55 12.03 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.722 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.64 -16.93 60.14 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.94 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -71.57 -56.67 5.43 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.164 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.552 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 15.0 pt-20 -91.0 8.49 35.04 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.561 -175.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . 0.275 0.1 OUTLIER -59.71 -32.85 70.91 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.159 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -77.46 -33.63 54.61 Favored 'General case' 0 C--O 1.2 -1.543 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.782 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.552 ' OE2' ' HA ' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -65.77 -43.92 87.38 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -56.92 -49.51 75.39 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.54 ' OG ' HG21 ' A' ' 59' ' ' THR . 15.0 m -73.63 -13.41 61.0 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.061 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.479 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 24.4 t70 -77.49 -38.32 49.36 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 123.138 0.575 . . . . 0.0 111.074 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.582 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -69.37 -36.34 76.74 Favored 'General case' 0 C--O 1.276 2.495 0 CA-C-O 123.271 1.51 . . . . 0.0 107.952 172.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 75.5 mt -73.22 -18.52 61.23 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 113.527 -1.67 . . . . 0.0 111.94 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.521 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 36.9 ttpt -62.37 -55.03 43.6 Favored Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 123.646 0.778 . . . . 0.0 111.382 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.582 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 51.6 Cg_exo -72.22 -36.97 4.99 Favored 'Trans proline' 0 CA--C 1.485 -1.926 0 C-N-CA 122.593 2.195 . . . . 0.0 109.795 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.562 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 27.3 mm -54.38 -36.64 34.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.383 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.33 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -91.05 -20.47 22.04 Favored 'General case' 0 C--O 1.195 -1.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.249 -174.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -69.9 -22.72 63.19 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.32 -9.62 59.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.757 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 3.0 pt20 -148.57 35.37 0.79 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.298 1.046 . . . . 0.0 110.644 -173.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.2 -19.23 61.14 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.805 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.13 21.68 11.9 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.679 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.479 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.7 p -138.84 -32.65 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.504 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.2 mt -122.85 137.6 55.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.812 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.433 ' HB3' ' CD1' ' A' ' 19' ' ' TYR . 20.9 m-80 -84.16 111.75 19.63 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 1.6 m-85 -97.67 105.82 18.03 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.552 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -130.62 130.46 6.16 Favored Glycine 0 N--CA 1.415 -2.747 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.867 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.54 HG21 ' OG ' ' A' ' 41' ' ' SER . 35.6 p -92.38 136.97 32.76 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 tt -137.31 156.92 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.485 ' OD2' ' HD1' ' A' ' 65' ' ' PHE . 3.4 p30 -75.28 149.71 38.73 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.347 0.594 . . . . 0.0 110.172 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.6 14.03 26.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.904 0.859 . . . . 0.0 108.764 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -84.43 -53.71 5.25 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.045 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.56 -48.6 3.21 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.3 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.485 ' HD1' ' OD2' ' A' ' 61' ' ' ASP . 96.0 m-85 -97.97 10.49 40.2 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.987 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.11 -24.63 61.1 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 115.881 1.113 . . . . 0.0 115.881 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.92 -20.83 65.98 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.399 1.099 . . . . 0.0 110.333 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -70.82 -20.72 62.54 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.552 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.39 89.99 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-O 122.343 1.068 . . . . 0.0 109.652 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.666 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -113.21 31.44 6.71 Favored Glycine 0 C--N 1.27 -3.101 0 C-N-CA 119.275 -1.441 . . . . 0.0 113.825 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.59 -17.46 38.71 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 168.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 73' ' ' ASN . 4.0 pp -102.82 -24.95 13.67 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.041 -1.891 . . . . 0.0 110.998 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.521 ' ND2' HG12 ' A' ' 122' ' ' ILE . 2.2 t-20 -179.96 -59.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.666 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.6 mm? -54.41 158.71 2.29 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -168.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -75.42 -17.69 60.1 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.829 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.6 p 55.17 40.33 31.72 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.182 1.393 . . . . 0.0 113.42 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.44 ' OD2' ' HE2' ' A' ' 78' ' ' LYS . 20.6 p-10 -125.18 -23.13 4.25 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.164 0.507 . . . . 0.0 111.224 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HE2' ' OD2' ' A' ' 77' ' ' ASP . 33.6 mtmt -108.13 -174.69 2.58 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -170.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.524 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 95.7 m-85 -69.16 -172.45 0.17 Allowed Pre-proline 0 CA--C 1.572 1.822 0 C-N-CA 125.791 1.637 . . . . 0.0 109.967 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 1.3 Cg_endo -43.67 131.09 7.52 Favored 'Trans proline' 1 C--N 1.429 4.788 0 CA-C-N 122.415 1.898 . . . . 0.0 116.42 -170.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.85 116.05 20.27 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 113.101 -1.863 . . . . 0.0 107.93 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 71.5 t80 -95.14 109.85 21.88 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.971 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -112.07 117.1 31.72 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.2 mt -91.45 105.22 16.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.666 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -90.13 126.37 35.77 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 2.8 mm-40 -87.88 125.59 34.57 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.549 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.457 HG21 ' SD ' ' A' ' 20' ' ' MET . 15.1 t -98.12 1.22 10.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.39 -35.07 3.66 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.177 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 89' ' ' LYS . 5.9 tmtm? -95.83 -20.16 19.03 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 16.3 m120 67.52 36.72 3.66 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-O 122.847 1.308 . . . . 0.0 110.337 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.511 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 2.0 tp60 -121.14 -179.69 4.12 Favored 'General case' 0 CA--C 1.472 -2.048 0 CA-C-N 112.803 -1.999 . . . . 0.0 107.681 -172.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.525 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 57.3 mmtt -138.12 106.17 5.71 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -102.47 87.2 1.08 Allowed Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 10.8 Cg_endo -102.33 142.25 0.19 Allowed 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 122.572 2.182 . . . . 0.0 114.638 -176.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.437 ' HD1' ' CD1' ' A' ' 109' ' ' PHE . 86.4 t80 -84.58 170.49 13.35 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.34 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -72.42 159.49 33.89 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.122 0.969 . . . . 0.0 110.295 -177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -100.75 -11.67 19.72 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-O 121.83 0.824 . . . . 0.0 108.909 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -123.42 -0.18 8.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.347 -173.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -87.58 -3.18 58.99 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.869 -172.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 72.95 134.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.145 0.978 . . . . 0.0 111.703 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.46 HG21 HG13 ' A' ' 106' ' ' ILE . 2.8 mp -90.04 101.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 122.009 0.909 . . . . 0.0 109.846 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.7 p -109.33 -174.02 2.4 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -77.2 -51.14 11.45 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -59.95 -52.39 65.61 Favored 'General case' 0 N--CA 1.379 -3.985 0 CA-C-N 112.493 -2.14 . . . . 0.0 113.397 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.57 83.46 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.121 0.486 . . . . 0.0 111.39 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 110' ' ' VAL . 40.2 mm -73.05 -42.0 59.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.0 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 47' ' ' ILE . 33.8 ttpt -56.46 -50.56 71.38 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.34 92.63 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.143 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.668 ' O ' HD11 ' A' ' 118' ' ' ILE . 57.8 t80 -63.69 -59.92 3.98 Favored 'General case' 0 C--O 1.204 -1.305 0 O-C-N 124.02 0.825 . . . . 0.0 111.074 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 106' ' ' ILE . 31.4 m -58.87 -35.72 57.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 O-C-N 121.998 -0.438 . . . . 0.0 111.535 -176.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.88 -51.93 66.18 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.719 0.771 . . . . 0.0 109.036 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.699 ' OD1' ' HB3' ' A' ' 117' ' ' LYS . 5.6 t0 -57.35 -36.08 70.75 Favored 'General case' 0 C--O 1.196 -1.711 0 CA-C-N 113.45 -1.704 . . . . 0.0 109.731 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.5 ' HB2' HD13 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -71.25 -61.22 1.85 Allowed 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.89 177.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.09 -23.44 33.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.542 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.52 -22.19 44.26 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.605 0.717 . . . . 0.0 109.622 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.4 18.22 15.31 Favored Glycine 0 CA--C 1.466 -2.994 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.487 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.699 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 12.7 ttpp -93.04 -38.31 11.7 Favored 'General case' 0 N--CA 1.384 -3.753 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.609 -172.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.668 HD11 ' O ' ' A' ' 109' ' ' PHE . 9.9 mt -67.57 141.92 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.407 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -118.55 135.67 23.75 Favored Pre-proline 0 C--N 1.256 -3.471 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.14 124.13 15.22 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.982 2.455 . . . . 0.0 112.368 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.1 m -57.52 -29.92 64.74 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.553 0.741 . . . . 0.0 112.605 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.521 HG12 ' ND2' ' A' ' 73' ' ' ASN . 19.5 pt -121.35 -39.71 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 O-C-N 122.004 -0.435 . . . . 0.0 111.656 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 124' ' ' SER . 72.6 tttt 74.14 -157.79 0.07 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.416 ' H ' ' HG2' ' A' ' 123' ' ' LYS . 24.3 m 69.26 126.91 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.023 0.916 . . . . 0.0 112.022 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -117.08 95.91 48.04 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.76 140.86 16.75 Favored 'Trans proline' 0 N--CA 1.425 -2.508 0 C-N-CA 121.702 1.601 . . . . 0.0 114.097 -170.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.1 tp -147.0 83.55 7.89 Favored Pre-proline 0 C--N 1.282 -2.352 0 CA-C-N 114.051 -1.432 . . . . 0.0 109.231 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.96 -175.47 2.69 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.101 1.867 . . . . 0.0 110.733 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -71.84 132.69 44.78 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -69.39 95.22 0.78 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.251 0.548 . . . . 0.0 111.727 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -82.5 152.6 25.98 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -88.07 152.91 21.68 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.195 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.553 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -175.498 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.838 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.97 -26.11 9.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.035 1.823 . . . . 0.0 112.878 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 57.1 72.29 0.52 Allowed 'General case' 0 C--O 1.249 1.037 0 CA-C-O 122.067 0.936 . . . . 0.0 109.56 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.39 128.5 3.28 Favored Glycine 0 N--CA 1.411 -2.975 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.888 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 p -156.88 116.42 2.05 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.44 -12.45 27.74 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 123.095 2.53 . . . . 0.0 113.591 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.74 -11.51 21.84 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 57' ' ' PHE . 85.4 mt -126.1 142.22 43.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.976 -0.452 . . . . 0.0 111.061 -174.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.16 -125.99 1.73 Allowed Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.91 176.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -118.56 144.56 46.0 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.46 0.648 . . . . 0.0 110.272 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.481 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 62.1 mt -95.72 114.04 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -127.77 -178.92 15.56 Favored Glycine 0 N--CA 1.408 -3.199 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.29 -8.28 8.23 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.036 3.157 . . . . 0.0 115.67 -173.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -123.98 -18.36 5.98 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.018 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.8 p -85.23 -27.62 25.94 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.573 -172.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -62.09 -36.74 82.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.293 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 m -66.66 -27.31 67.57 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.867 0.867 . . . . 0.0 110.574 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.95 -39.07 61.55 Favored 'General case' 0 C--O 1.258 1.549 0 CA-C-O 121.704 0.764 . . . . 0.0 109.095 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -75.12 -26.15 58.98 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.461 ' SD ' HG22 ' A' ' 87' ' ' VAL . 8.8 tpp -77.76 -25.3 49.03 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.661 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -88.82 -10.75 46.98 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.405 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.27 -35.19 73.6 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 122.086 -0.384 . . . . 0.0 111.543 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.48 65.55 Favored Glycine 0 N--CA 1.461 0.304 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.366 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 9.1 pt -126.1 151.62 72.07 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -50.14 141.56 30.32 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.068 3.179 . . . . 0.0 114.037 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 28' ' ' TYR . 2.5 tt -110.4 124.81 52.42 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -94.1 105.46 17.46 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 26' ' ' LEU . 48.3 m-85 -87.59 110.7 20.57 Favored 'General case' 0 CA--C 1.471 -2.058 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.363 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.7 mt -100.23 85.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.319 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' A' ' 81' ' ' ALA . 31.5 m-85 -77.53 109.91 11.88 Favored 'General case' 0 CA--C 1.468 -2.181 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -124.06 119.75 30.39 Favored 'General case' 1 C--N 1.238 -4.245 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.701 177.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -74.54 -27.2 60.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.426 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 11.4 p -93.49 106.6 18.55 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.61 -173.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . -78.78 -21.28 48.1 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.909 -175.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -80.1 -48.51 13.12 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.042 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HG2' ' HB ' ' A' ' 33' ' ' THR . 12.5 pt-20 -90.7 1.18 57.07 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.553 -0.859 . . . . 0.0 112.158 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 12.2 ptm180 -60.19 -24.31 64.68 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -58.48 -57.9 10.92 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.53 -25.79 54.51 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.166 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.648 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -60.24 -50.98 71.5 Favored 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.407 ' HA ' HD11 ' A' ' 44' ' ' LEU . 9.9 m -75.11 -19.4 59.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.73 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.41 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 15.9 t70 -67.79 -43.39 79.84 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.836 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.639 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -70.37 -34.05 72.14 Favored 'General case' 0 C--O 1.278 2.597 0 CA-C-O 122.772 1.272 . . . . 0.0 108.463 176.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 56.9 mt -69.94 -20.51 63.33 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.716 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.535 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 17.4 tppt? -61.97 -57.29 24.8 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.843 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 72.8 Cg_exo -66.82 -39.42 14.84 Favored 'Trans proline' 0 CA--C 1.49 -1.696 0 C-N-CA 122.917 2.411 . . . . 0.0 110.351 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 103' ' ' PHE . 93.8 mt -52.67 -40.36 34.02 Favored 'Isoleucine or valine' 0 C--N 1.368 1.388 0 O-C-N 124.086 0.866 . . . . 0.0 109.208 176.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -94.26 -13.79 26.16 Favored 'General case' 0 C--O 1.177 -2.718 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.603 -173.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -71.94 -22.36 61.48 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.92 -23.45 33.51 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.906 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.535 ' OE1' HD11 ' A' ' 55' ' ' ILE . 5.4 pt20 -130.85 34.37 4.09 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.19 0.995 . . . . 0.0 112.373 -174.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -73.25 -18.58 61.21 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.393 -1.73 . . . . 0.0 111.858 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.38 4.4 28.17 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.418 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.405 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.8 p -124.15 -33.5 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.325 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.535 HD11 ' OE1' ' A' ' 51' ' ' GLN . 95.0 mt -124.39 136.81 59.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.034 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -84.83 104.65 14.97 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.45 ' HB2' HG12 ' A' ' 8' ' ' ILE . 5.2 m-85 -90.16 102.67 15.39 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.573 0.701 . . . . 0.0 112.564 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.481 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -124.21 131.74 8.05 Favored Glycine 0 N--CA 1.415 -2.762 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.424 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.483 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 27.4 p -92.27 134.67 34.68 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 120.896 0.379 . . . . 0.0 110.515 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.476 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 8.7 tt -137.15 165.58 27.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -89.13 153.88 20.6 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-O 121.458 0.647 . . . . 0.0 110.922 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -110.48 19.83 18.36 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 173.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -102.82 -46.02 4.82 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 113.382 -1.735 . . . . 0.0 109.844 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.47 -43.58 3.48 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.139 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.422 ' O ' ' HE2' ' A' ' 30' ' ' PHE . 96.4 m-85 -99.21 10.12 42.07 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 122.124 -0.36 . . . . 0.0 110.68 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 62' ' ' ALA . . . -58.97 -30.04 66.0 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.01 -30.08 46.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.413 0.625 . . . . 0.0 111.303 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -69.15 -23.81 64.0 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.285 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.43 ' HB2' HG22 ' A' ' 76' ' ' THR . . . -63.02 -34.41 77.5 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-O 121.978 0.894 . . . . 0.0 109.861 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -109.28 5.34 31.7 Favored Glycine 0 C--N 1.279 -2.591 0 C-N-CA 117.403 -2.332 . . . . 0.0 115.502 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -76.57 -16.97 59.46 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 73' ' ' ASN . 4.2 pp -97.68 -31.38 12.3 Favored 'General case' 0 N--CA 1.399 -2.987 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.349 174.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.422 ' N ' HD13 ' A' ' 72' ' ' LEU . 2.2 t-20 179.51 -56.74 0.01 OUTLIER 'General case' 0 C--N 1.38 1.906 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.673 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.3 mm? -61.4 179.9 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -169.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.25 -0.68 20.72 Favored 'General case' 0 CA--C 1.486 -1.515 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.99 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.43 HG22 ' HB2' ' A' ' 69' ' ' ALA . 19.2 p 59.3 5.78 0.64 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 125.205 1.402 . . . . 0.0 112.401 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.92 -25.09 28.12 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -170.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 11.4 tptm -119.21 -158.68 0.74 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.672 -166.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.456 ' H ' ' HG3' ' A' ' 78' ' ' LYS . 89.5 m-85 -54.99 168.32 0.53 Allowed Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 125.054 1.341 . . . . 0.0 110.506 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 2.5 Cg_endo -40.63 130.44 2.64 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.998 2.465 . . . . 0.0 114.431 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -103.75 104.82 14.88 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.608 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.537 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 74.3 t80 -87.13 111.5 21.0 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.908 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -120.88 119.39 32.51 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.2 mt -89.41 104.84 15.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -86.18 132.77 33.94 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.15 141.89 29.87 Favored 'General case' 0 C--N 1.265 -3.098 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.017 175.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.461 HG22 ' SD ' ' A' ' 20' ' ' MET . 25.8 t -107.79 -2.06 10.0 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.38 -48.19 3.75 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.405 ' HD3' ' OE2' ' A' ' 86' ' ' GLU . 4.7 mptp? -89.38 -25.15 21.73 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.981 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.666 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 16.2 t-20 66.17 20.72 11.15 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.36 1.464 . . . . 0.0 108.465 -173.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.539 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 4.4 tp60 -85.95 178.7 7.19 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.609 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 56.7 mmtt -138.46 105.04 5.31 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -96.88 87.84 0.49 Allowed Pre-proline 0 N--CA 1.481 1.084 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 6.0 Cg_endo -104.82 145.7 0.12 Allowed 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.516 2.144 . . . . 0.0 115.01 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -86.0 158.78 19.78 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.595 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.475 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.3 m-20 -71.48 134.49 46.59 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.109 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -75.74 9.62 2.21 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.722 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -154.92 20.96 0.45 Allowed 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.177 0.513 . . . . 0.0 111.443 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 39.1 ttmt -97.86 9.89 41.57 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 74.09 120.46 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 113.562 -1.654 . . . . 0.0 112.025 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.2 mp -92.82 98.54 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.03 -164.47 1.32 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.923 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.484 ' O ' HD12 ' A' ' 47' ' ' ILE . 16.0 t80 -77.79 -58.62 3.17 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -174.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -52.84 -53.75 44.18 Favored 'General case' 0 N--CA 1.386 -3.638 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.527 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.83 -49.31 77.1 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 123.596 0.56 . . . . 0.0 112.371 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 110' ' ' VAL . 41.8 mm -72.96 -42.45 59.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.024 -177.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -54.52 -50.96 66.61 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.996 0.81 . . . . 0.0 109.241 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.11 93.73 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.559 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -65.32 -60.13 3.31 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.62 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 106' ' ' ILE . 27.6 m -57.62 -36.62 54.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 O-C-N 121.83 -0.544 . . . . 0.0 111.422 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.29 -46.37 87.07 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.216 0.531 . . . . 0.0 109.681 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.688 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 3.4 t70 -57.27 -48.98 77.5 Favored 'General case' 0 C--O 1.203 -1.39 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.532 ' HB2' HD11 ' A' ' 118' ' ' ILE . 2.7 t80 -57.02 -63.59 1.16 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.622 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 110' ' ' VAL . 90.6 t -52.48 -30.8 14.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 C-N-CA 124.311 1.044 . . . . 0.0 112.37 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.59 -38.95 58.7 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.676 0.751 . . . . 0.0 110.026 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.16 23.87 5.64 Favored Glycine 0 CA--C 1.473 -2.534 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.688 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 3.3 ttmm -92.39 -42.52 9.73 Favored 'General case' 0 N--CA 1.387 -3.579 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 113' ' ' PHE . 23.5 mt -81.37 143.35 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.05 175.44 3.68 Favored Pre-proline 0 C--N 1.272 -2.772 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.9 108.67 0.26 Allowed 'Trans proline' 0 CA--C 1.544 1.018 0 CA-C-N 121.174 1.455 . . . . 0.0 110.305 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.5 m -49.37 -54.66 16.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.938 1.295 . . . . 0.0 113.85 -172.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.9 pt -138.55 -50.75 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.928 0.394 . . . . 0.0 109.986 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -66.01 110.3 2.87 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.759 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -149.67 135.19 18.39 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -143.13 88.03 8.38 Favored Pre-proline 0 N--CA 1.428 -1.559 0 CA-C-O 122.0 0.905 . . . . 0.0 110.472 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -99.83 169.43 0.46 Allowed 'Trans proline' 0 N--CA 1.427 -2.4 0 C-N-CA 122.128 1.885 . . . . 0.0 112.563 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.7 pt -125.16 80.26 64.77 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.73 147.82 86.06 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 123.419 2.746 . . . . 0.0 113.854 -174.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.36 -168.33 0.2 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.445 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -147.33 169.52 19.25 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -107.47 142.72 36.91 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -80.47 -54.19 5.91 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.466 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.612 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -175.877 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.684 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.08 -70.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 123.244 2.629 . . . . 0.0 113.029 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.441 ' H ' HD22 ' A' ' 3' ' ' LEU . 2.1 pt? -83.68 131.38 34.95 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.27 -161.03 34.1 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.9 m -143.46 93.4 6.37 Favored Pre-proline 0 C--N 1.291 -1.973 0 CA-C-N 117.585 0.693 . . . . 0.0 110.923 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -85.33 -31.56 0.36 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.104 1.869 . . . . 0.0 112.099 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.7 mt -138.93 -59.04 0.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 49.0 mt -110.12 138.35 38.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.399 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.32 -121.34 1.12 Allowed Glycine 0 N--CA 1.425 -2.053 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -118.23 155.12 31.1 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.529 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 67.7 mt -105.69 120.9 57.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.56 179.75 18.57 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.54 5.36 4.3 Favored 'Trans proline' 0 C--O 1.221 -0.367 0 C-N-CA 123.029 2.486 . . . . 0.0 112.752 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -128.64 -6.18 5.18 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.869 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -100.27 -28.31 13.05 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.736 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -59.09 -38.38 79.38 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.9 0.381 . . . . 0.0 111.693 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 m -65.22 -27.09 68.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.717 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.81 -33.4 40.41 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.034 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HB3' ' CG ' ' A' ' 56' ' ' ASN . 21.1 m-85 -75.8 -27.21 57.88 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.551 ' SD ' HG23 ' A' ' 87' ' ' VAL . 8.7 tpp -77.07 -21.53 54.28 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 113.554 -1.657 . . . . 0.0 108.757 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.4 t -90.0 -12.77 37.66 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.8 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.26 60.39 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.226 0.536 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.63 2.85 78.46 Favored Glycine 0 C--N 1.32 -0.35 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.25 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 13.6 pt -112.04 148.64 39.47 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -51.29 142.21 37.63 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.834 3.022 . . . . 0.0 113.846 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.478 HD12 ' CE1' ' A' ' 28' ' ' TYR . 2.6 tt -108.98 126.91 53.6 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . . . -101.02 109.07 20.93 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.478 ' CE1' HD12 ' A' ' 26' ' ' LEU . 47.1 m-85 -89.58 109.61 20.54 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.365 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.465 HD12 ' CD2' ' A' ' 57' ' ' PHE . 2.5 mp -101.04 87.92 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.337 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 42.9 m-85 -73.02 133.73 44.36 Favored 'General case' 0 CA--C 1.467 -2.226 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . . . -148.19 117.08 6.73 Favored 'General case' 0 C--N 1.274 -2.693 0 O-C-N 123.593 0.558 . . . . 0.0 111.665 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.01 -22.8 59.44 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.852 0.834 . . . . 0.0 108.911 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.0 p -76.52 115.88 16.68 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.882 -173.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.33 -15.26 19.82 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.395 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -85.69 -63.72 1.27 Allowed 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -78.91 12.5 2.14 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.462 178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.6 tpp85 -52.7 -39.07 61.64 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 169.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -67.03 -48.49 68.17 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.607 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 45.6 mt-10 -59.61 -50.52 73.55 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.217 0.532 . . . . 0.0 110.307 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -53.23 -54.42 36.43 Favored 'General case' 0 C--O 1.255 1.354 0 C-N-CA 124.653 1.181 . . . . 0.0 108.849 -176.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.3 m -73.6 -15.18 61.28 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.62 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 33.8 t70 -75.09 -35.59 61.79 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 122.954 0.501 . . . . 0.0 111.458 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -30.17 52.94 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 122.865 1.317 . . . . 0.0 108.81 173.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 45.8 mt -73.16 -30.97 63.95 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 113.626 -1.624 . . . . 0.0 113.713 -177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.525 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 24.8 ttpp -68.2 -46.4 39.84 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.694 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 73.5 Cg_endo -70.88 -42.56 2.18 Favored 'Trans proline' 0 C--O 1.26 1.593 0 C-N-CA 122.485 2.123 . . . . 0.0 110.996 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.15 -24.89 37.15 Favored 'Isoleucine or valine' 0 C--N 1.385 2.128 0 C-N-CA 118.11 -1.436 . . . . 0.0 109.99 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.409 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -92.85 -22.23 19.4 Favored 'General case' 0 C--O 1.194 -1.841 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.201 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 6.2 tt0 -69.84 -18.44 63.44 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.72 -21.56 51.71 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.971 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.409 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 2.7 pt20 -138.51 36.54 2.25 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.2 1.0 . . . . 0.0 111.108 -170.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 49' ' ' GLU . 9.1 ptm180 -76.85 -14.02 59.94 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.645 -172.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.6 6.68 22.54 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.632 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.553 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.6 p -125.6 -32.51 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.515 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 94.6 mt -122.2 136.31 59.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.412 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.414 HD22 HG13 ' A' ' 24' ' ' ILE . 16.7 m-80 -84.65 104.04 14.28 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 3.7 m-85 -90.75 103.61 16.29 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.529 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -124.34 130.88 7.69 Favored Glycine 0 N--CA 1.408 -3.22 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.412 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.7 p -92.01 127.82 37.62 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.517 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 9.3 tt -126.57 143.17 40.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.431 ' OD2' ' HB3' ' A' ' 63' ' ' LYS . 20.3 t70 -76.27 131.13 39.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.122 -175.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HA ' ' CA ' ' A' ' 66' ' ' GLY . . . -92.48 -1.08 57.23 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.343 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HB3' ' OD2' ' A' ' 61' ' ' ASP . 81.8 tttt -92.4 -43.61 9.13 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.52 -40.09 9.63 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.769 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -115.48 20.8 14.52 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.736 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 62' ' ' ALA . . . -69.31 -23.29 76.41 Favored Glycine 0 C--N 1.305 -1.181 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 -169.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.0 -21.69 63.81 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.254 0.55 . . . . 0.0 111.4 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -69.13 -25.35 64.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.666 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.513 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -59.56 -35.28 73.94 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.073 0.939 . . . . 0.0 111.362 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -109.54 13.49 32.88 Favored Glycine 0 C--N 1.27 -3.114 0 C-N-CA 117.596 -2.24 . . . . 0.0 115.895 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -24.25 58.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 169.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.564 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 4.0 pp -92.45 -37.53 12.49 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.385 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.506 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 20.9 t-20 -172.94 -57.88 0.02 OUTLIER 'General case' 0 C--N 1.369 1.452 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.688 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.5 mm? -54.58 164.79 0.67 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -167.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -81.06 -14.87 57.42 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.757 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.9 p 59.6 21.44 10.05 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.655 1.982 . . . . 0.0 114.076 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -105.39 -25.27 12.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.41 115.05 12.76 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -166.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.64 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 14.8 t80 60.39 179.74 0.04 OUTLIER Pre-proline 0 CA--C 1.581 2.16 0 O-C-N 125.126 1.516 . . . . 0.0 111.546 158.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.64 ' HD2' ' CG ' ' A' ' 79' ' ' PHE . 3.7 Cg_endo -55.81 134.52 64.54 Favored 'Trans proline' 0 C--N 1.378 2.095 0 CA-C-N 120.805 1.323 . . . . 0.0 113.837 167.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -125.8 113.17 16.91 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.45 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 62.5 t80 -90.25 111.3 22.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -116.27 118.05 31.71 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.7 mt -93.7 114.09 29.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.547 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -102.53 126.77 49.7 Favored 'General case' 0 N--CA 1.405 -2.717 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 0.7 OUTLIER -78.98 136.65 37.28 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.95 177.291 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.551 HG23 ' SD ' ' A' ' 20' ' ' MET . 23.6 t -104.3 -5.18 9.56 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.62 -38.17 6.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.368 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.408 ' HZ2' ' CD ' ' A' ' 125' ' ' GLU . 23.1 ttmm -101.88 -17.83 15.99 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.609 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 44.8 t-20 56.44 75.43 0.35 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 124.55 1.14 . . . . 0.0 108.507 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -144.17 174.34 10.97 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.087 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -126.97 102.35 6.95 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -177.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -107.93 80.7 1.07 Allowed Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 15.4 Cg_endo -101.17 144.84 0.28 Allowed 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.907 2.405 . . . . 0.0 114.077 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -85.01 165.55 17.45 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 125.247 1.419 . . . . 0.0 108.259 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.538 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 9.0 m-20 -73.78 145.39 45.08 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.441 ' O ' ' HB3' ' A' ' 79' ' ' PHE . 13.0 mt-30 -83.02 -5.47 59.11 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.233 -170.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -148.09 32.36 0.83 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.337 1.065 . . . . 0.0 110.685 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 17.2 tppt? -95.95 -6.76 38.29 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.206 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 74.24 127.69 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.967 1.307 . . . . 0.0 111.734 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.453 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.0 mp -93.65 116.89 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.369 -176.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 p -122.49 -174.69 2.97 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -76.73 -48.7 17.98 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.6 -55.8 30.21 Favored 'General case' 0 N--CA 1.387 -3.618 0 CA-C-N 112.099 -2.319 . . . . 0.0 112.38 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.44 74.51 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.654 0.596 . . . . 0.0 111.996 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.453 ' CG1' HG23 ' A' ' 101' ' ' ILE . 42.1 mm -74.08 -43.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.68 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -56.85 -48.24 78.54 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 124.118 0.886 . . . . 0.0 109.683 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.55 99.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.733 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.588 ' HA ' ' OD1' ' A' ' 112' ' ' ASP . 38.5 t80 -64.44 -58.13 7.31 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.495 1.118 . . . . 0.0 111.273 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 106' ' ' ILE . 26.8 m -58.95 -31.94 46.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 O-C-N 121.531 -0.731 . . . . 0.0 110.614 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.32 -52.93 50.7 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 123.828 0.851 . . . . 0.0 109.358 177.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 109' ' ' PHE 0.281 0.4 OUTLIER -67.48 -22.1 65.49 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.329 -177.027 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.533 ' HB2' HD11 ' A' ' 118' ' ' ILE . 0.6 OUTLIER -72.75 -63.7 1.11 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.524 172.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.05 -20.95 27.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.09 -174.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.1 -30.43 60.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.22 40.24 1.83 Allowed Glycine 0 CA--C 1.479 -2.211 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.665 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -117.58 -41.73 2.92 Favored 'General case' 0 N--CA 1.391 -3.391 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.739 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.55 HG12 ' OD2' ' A' ' 112' ' ' ASP . 6.6 mt -65.09 141.27 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.723 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -124.26 160.14 53.93 Favored Pre-proline 0 C--N 1.265 -3.091 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.467 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -74.54 147.4 36.03 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 121.374 1.383 . . . . 0.0 110.978 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.4 p -98.94 27.52 4.94 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.663 0.744 . . . . 0.0 110.51 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.9 pt -147.8 -41.11 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.121 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -124.08 -175.79 3.33 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.9 t -157.08 178.16 10.67 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.408 ' CD ' ' HZ2' ' A' ' 89' ' ' LYS . 39.8 mt-10 -124.16 89.01 52.29 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -88.54 159.25 6.53 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 121.887 1.724 . . . . 0.0 111.046 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.3 mt -114.11 93.13 29.1 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -69.72 166.95 25.81 Favored 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.952 1.768 . . . . 0.0 109.964 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 68.19 115.97 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 O-C-N 124.336 1.022 . . . . 0.0 110.118 -173.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -74.05 104.37 4.86 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.524 -174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -159.84 169.3 23.87 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -123.72 138.45 54.52 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.66 0 CA-C-O 117.96 -1.466 . . . . 0.0 109.971 178.951 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 N--CA 1.431 -1.398 0 CA-C-O 122.09 0.947 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.569 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 62.7 mt -88.22 127.96 40.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.476 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.2 -176.42 20.04 Favored Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.06 -18.45 50.87 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.769 2.979 . . . . 0.0 113.792 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -94.8 -40.77 9.57 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.995 0.426 . . . . 0.0 110.818 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.2 p -86.18 -29.58 23.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -167.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -60.66 -37.5 81.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.654 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.5 m -67.9 -26.31 65.93 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.598 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -79.01 -34.57 43.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.414 0.626 . . . . 0.0 110.015 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -74.95 -28.37 60.56 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.489 ' SD ' HG22 ' A' ' 87' ' ' VAL . 7.4 tpp -79.67 -20.73 45.94 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.709 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 t -96.57 -5.51 39.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.862 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.27 -34.83 66.02 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.946 0.403 . . . . 0.0 110.202 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.21 -13.32 64.8 Favored Glycine 0 CA--C 1.51 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.27 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 16.5 pt -98.73 153.73 37.76 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 123.66 0.784 . . . . 0.0 109.475 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HG2' HG12 ' A' ' 55' ' ' ILE . 18.3 Cg_endo -58.69 145.77 94.51 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 123.53 2.82 . . . . 0.0 113.534 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.607 HD13 ' CE1' ' A' ' 28' ' ' TYR . 1.8 tt -110.98 127.25 55.45 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -176.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.453 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.8 108.97 21.73 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CE1' HD13 ' A' ' 26' ' ' LEU . 23.0 m-85 -90.19 110.5 21.53 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 124.387 1.075 . . . . 0.0 109.462 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.531 HD11 ' CD2' ' A' ' 57' ' ' PHE . 3.5 mp -101.25 91.05 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 C-N-CA 118.811 -1.156 . . . . 0.0 109.521 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.625 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 46.6 m-85 -76.43 128.24 34.43 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -143.48 119.42 10.63 Favored 'General case' 0 C--N 1.27 -2.862 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.576 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.44 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 49.1 mt-10 -84.99 -2.05 57.5 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.252 0.549 . . . . 0.0 109.747 173.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 7.3 p -91.61 123.54 35.09 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.877 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.99 -21.05 18.86 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.26 0.552 . . . . 0.0 110.655 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 37.1 mt-10 -86.07 -66.43 0.9 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.82 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 12.5 pt-20 -73.7 1.59 9.98 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 33' ' ' THR . 15.7 ttt180 -54.46 -43.03 71.34 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 124.223 1.009 . . . . 0.0 108.705 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 45.5 mtmt -60.6 -49.45 77.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.896 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -64.82 -43.82 91.87 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 123.609 0.568 . . . . 0.0 111.434 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -54.24 -52.68 60.56 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -178.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.625 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 7.9 m -76.21 -18.85 58.86 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.891 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 25.1 t70 -74.66 -31.34 61.91 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.45 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.625 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 46.2 mmtt -79.8 -29.35 40.26 Favored 'General case' 0 C--O 1.277 2.508 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 64.3 mt -70.02 -25.62 63.67 Favored 'General case' 0 N--CA 1.408 -2.573 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.373 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 41' ' ' SER . 87.9 mttt -61.14 -54.79 50.39 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 119.712 -0.185 . . . . 0.0 111.251 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 73.8 Cg_exo -69.16 -43.92 2.84 Favored 'Trans proline' 0 C--O 1.263 1.765 0 C-N-CA 122.856 2.371 . . . . 0.0 111.801 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.456 HG13 ' HA ' ' A' ' 44' ' ' LEU . 2.3 pp -63.89 -24.12 35.0 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.063 0 C-N-CA 118.405 -1.318 . . . . 0.0 110.981 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.21 -20.99 18.76 Favored 'General case' 0 C--O 1.204 -1.316 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.724 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -66.3 -25.11 66.7 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.4 -11.83 59.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.794 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 9.3 pt20 -145.32 33.96 1.08 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.405 1.098 . . . . 0.0 110.488 -172.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -74.38 -7.97 54.7 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.287 -173.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.96 0.6 14.94 Favored Glycine 0 C--N 1.289 -2.074 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.76 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.522 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 13.2 p -121.85 -31.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.845 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.431 HG12 ' HG2' ' A' ' 25' ' ' PRO . 84.2 mt -123.17 140.45 46.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.594 -0.843 . . . . 0.0 110.47 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -86.17 117.17 24.82 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.531 ' CD2' HD11 ' A' ' 29' ' ' ILE . 1.8 m-85 -103.89 103.03 12.84 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.977 0.894 . . . . 0.0 112.874 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.569 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -123.65 128.43 6.92 Favored Glycine 0 N--CA 1.406 -3.345 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.72 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.3 p -92.36 127.69 37.93 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 7.8 tt -124.26 142.64 40.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.47 125.96 28.28 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.579 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -92.9 7.34 44.3 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.221 -0.991 . . . . 0.0 111.507 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -104.78 -38.0 6.84 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.11 -42.48 9.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.611 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.73 26.99 8.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.454 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -70.82 -24.21 77.22 Favored Glycine 0 CA--C 1.488 -1.617 0 C-N-CA 120.779 -0.724 . . . . 0.0 114.683 -173.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.54 -28.6 46.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.436 0.636 . . . . 0.0 110.847 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -64.93 -23.09 67.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.234 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.604 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -64.08 -36.22 83.29 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.984 0.897 . . . . 0.0 110.4 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.468 ' HA2' ' H ' ' A' ' 73' ' ' ASN . . . -105.09 7.47 44.21 Favored Glycine 0 C--N 1.281 -2.518 0 C-N-CA 117.568 -2.253 . . . . 0.0 114.835 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -74.76 -16.89 60.71 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 166.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 4.2 pp -104.22 -37.56 7.23 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.065 174.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.468 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 5.2 t-20 -176.35 -52.19 0.01 OUTLIER 'General case' 0 C--N 1.384 2.107 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.485 HD22 ' H ' ' A' ' 74' ' ' LEU . 2.0 mm? -65.44 159.59 23.96 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -167.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -81.1 -4.28 54.77 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 69' ' ' ALA . 80.3 p 56.43 17.41 2.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.268 1.027 . . . . 0.0 112.226 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.408 ' OD1' ' HG3' ' A' ' 75' ' ' LYS . 14.3 p-10 -94.39 -14.98 24.74 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -172.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 98' ' ' GLU . 22.7 tptt -123.49 -165.29 1.31 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 118.503 -1.279 . . . . 0.0 113.273 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.64 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 96.5 m-85 -61.47 173.14 0.82 Allowed Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 125.925 1.69 . . . . 0.0 110.35 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 5.5 Cg_endo -40.15 131.21 2.24 Favored 'Trans proline' 0 C--N 1.414 3.993 0 C-N-CA 122.444 2.096 . . . . 0.0 115.557 -171.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -109.68 110.11 21.04 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.808 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.453 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 53.5 t80 -88.84 112.45 23.25 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.723 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -121.0 120.35 35.16 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.409 HD11 HG12 ' A' ' 110' ' ' VAL . 59.2 mt -92.66 113.35 27.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.852 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.18 134.33 35.46 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 89' ' ' LYS . 2.5 mm-40 -87.5 126.97 35.22 Favored 'General case' 0 C--N 1.266 -3.058 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.227 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.489 HG22 ' SD ' ' A' ' 20' ' ' MET . 41.2 t -95.31 -2.77 10.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.77 -44.12 3.52 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.438 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 36.3 mtmm -97.83 -11.06 23.69 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.344 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 66.89 10.55 7.7 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 125.011 1.324 . . . . 0.0 110.247 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.444 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 1.5 tp60 -80.08 172.35 13.89 Favored 'General case' 0 CA--C 1.477 -1.856 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.356 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.615 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 65.4 mmtt -139.36 105.09 5.13 Favored 'General case' 0 N--CA 1.404 -2.733 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 62.4 m-85 -100.28 86.4 0.63 Allowed Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 7.8 Cg_endo -101.96 152.63 0.32 Allowed 'Trans proline' 0 N--CA 1.429 -2.294 0 C-N-CA 122.477 2.118 . . . . 0.0 114.065 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.438 ' HD1' ' CD1' ' A' ' 109' ' ' PHE . 49.8 t80 -94.67 162.97 13.56 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 124.858 1.263 . . . . 0.0 107.746 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 10.7 m-20 -66.22 153.19 43.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.067 0.461 . . . . 0.0 110.32 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -102.22 0.96 35.31 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.432 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 8.6 pt-20 -132.38 28.45 4.36 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.146 -171.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 3.7 tppp? -113.63 -89.53 0.53 Allowed 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.739 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 176.39 127.33 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 124.062 0.945 . . . . 0.0 109.032 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.484 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.9 mp -102.62 105.37 18.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.42 -169.04 1.87 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.596 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.8 t80 -77.57 -53.23 7.84 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -60.39 -46.82 88.6 Favored 'General case' 0 N--CA 1.391 -3.393 0 CA-C-N 112.267 -2.242 . . . . 0.0 112.894 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.82 83.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.991 0.424 . . . . 0.0 111.149 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.484 ' CG1' HG23 ' A' ' 101' ' ' ILE . 36.9 mm -70.95 -44.37 75.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.863 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -51.32 -52.64 43.46 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 124.044 0.84 . . . . 0.0 109.973 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.36 -43.87 92.77 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.947 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.507 ' HA ' ' OD1' ' A' ' 112' ' ' ASP . 46.1 t80 -63.43 -59.9 4.07 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 124.411 1.084 . . . . 0.0 110.984 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 106' ' ' ILE . 27.5 m -58.59 -31.82 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 121.519 -0.738 . . . . 0.0 110.901 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.65 -47.74 68.69 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 123.886 0.874 . . . . 0.0 109.033 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.507 ' OD1' ' HA ' ' A' ' 109' ' ' PHE 0.299 0.1 OUTLIER -70.83 -23.77 62.41 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.545 -179.0 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.523 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.6 OUTLIER -71.18 -61.25 1.83 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.892 173.363 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -61.98 -25.25 36.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.163 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.35 -33.79 55.29 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.246 0.546 . . . . 0.0 109.777 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.17 25.86 2.87 Favored Glycine 0 CA--C 1.485 -1.794 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.953 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -101.17 -32.67 10.44 Favored 'General case' 0 N--CA 1.396 -3.15 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.19 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 113' ' ' PHE . 4.9 mt -74.45 142.26 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.31 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 . . . . . 0 C--N 1.285 -2.231 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.678 -172.855 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.518 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 51.6 mt -119.14 143.24 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.15 162.37 25.03 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -47.52 -34.05 19.08 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 124.14 3.227 . . . . 0.0 114.044 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -89.43 -26.91 20.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.953 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.1 p -78.85 -19.97 50.7 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.018 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' A' ' 20' ' ' MET . 69.3 m-85 -50.19 -49.93 50.93 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 123.934 0.771 . . . . 0.0 109.685 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -62.37 -33.41 74.69 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.107 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -70.9 -44.64 65.82 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 120.937 0.398 . . . . 0.0 110.535 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -72.8 -30.45 64.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.445 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.41 -39.89 62.35 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.05 -178.458 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -81.58 -9.02 59.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.649 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.09 -19.06 60.72 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.202 0.525 . . . . 0.0 110.619 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.21 -4.16 63.76 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.823 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 11.1 pt -103.2 152.5 38.65 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HG2' HG12 ' A' ' 55' ' ' ILE . 17.5 Cg_endo -54.58 142.18 72.35 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 124.194 3.263 . . . . 0.0 114.064 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.408 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 3.6 tt -108.13 125.18 51.3 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.615 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -95.67 103.06 14.92 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.408 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 53.5 m-85 -83.83 114.84 21.92 Favored 'General case' 0 CA--C 1.47 -2.126 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.303 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.584 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 8.1 mt -102.6 84.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.252 -3.67 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.614 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 48.7 m-85 -76.81 123.84 26.82 Favored 'General case' 0 CA--C 1.465 -2.324 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.98 123.61 19.77 Favored 'General case' 0 C--N 1.254 -3.584 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.445 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -79.64 -14.64 58.66 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.553 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 13.1 p -83.73 113.49 20.92 Favored 'General case' 0 N--CA 1.403 -2.78 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.107 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.71 -21.06 16.6 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.389 0.431 . . . . 0.0 110.918 -175.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -88.37 -54.2 4.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.742 0.782 . . . . 0.0 110.354 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.453 ' OE1' ' HB ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -84.84 3.13 39.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.823 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 33' ' ' THR . 52.2 ttt180 -49.27 -46.1 45.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.573 1.149 . . . . 0.0 110.018 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -65.31 -35.76 81.98 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.251 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -82.05 -31.27 30.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.894 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.528 HD21 ' HB ' ' A' ' 101' ' ' ILE . 1.7 tm? -61.48 -44.09 97.7 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.417 ' HA ' HD12 ' A' ' 44' ' ' LEU . 11.9 m -77.52 -17.0 58.36 Favored 'General case' 0 C--O 1.2 -1.542 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.576 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 20.5 t70 -76.67 -31.07 57.05 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.703 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.627 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -73.69 -36.59 65.3 Favored 'General case' 0 C--O 1.281 2.761 0 CA-C-O 123.109 1.433 . . . . 0.0 107.861 171.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 67.8 mt -72.63 -18.16 61.61 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.8 -1.545 . . . . 0.0 111.404 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.609 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 38.6 ttmt -63.74 -53.83 47.14 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 123.793 0.837 . . . . 0.0 111.759 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 52.4 Cg_exo -71.19 -37.22 6.19 Favored 'Trans proline' 0 CA--C 1.493 -1.553 0 C-N-CA 122.471 2.114 . . . . 0.0 109.784 175.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.669 HD11 ' HA ' ' A' ' 103' ' ' PHE . 86.0 mt -53.12 -38.41 29.99 Favored 'Isoleucine or valine' 0 C--N 1.37 1.461 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.856 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.35 -21.64 19.43 Favored 'General case' 0 C--O 1.195 -1.767 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.627 -172.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.497 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -68.45 -22.4 64.59 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 176.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.27 -11.3 57.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.977 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 9.5 pt20 -147.13 36.1 0.91 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.562 1.172 . . . . 0.0 110.749 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HD3' ' OE1' ' A' ' 49' ' ' GLU . 13.9 ptt180 -74.14 -18.6 60.77 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.988 -1.915 . . . . 0.0 110.778 -174.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.69 17.74 22.87 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.582 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.6 p -138.71 -33.26 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.551 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.431 HG12 ' HG2' ' A' ' 25' ' ' PRO . 88.7 mt -122.95 136.84 58.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.287 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -94.48 96.39 9.45 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.74 141.94 40.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.521 0.677 . . . . 0.0 111.123 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.518 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -159.76 129.48 2.21 Favored Glycine 0 N--CA 1.412 -2.944 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.061 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.584 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 44.6 p -83.78 144.91 28.99 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.202 0.525 . . . . 0.0 111.445 174.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 4.8 tt -145.8 142.48 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.336 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 63' ' ' LYS . 19.9 t70 -70.9 124.35 24.14 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -175.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -86.85 4.04 42.9 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.218 -0.593 . . . . 0.0 112.277 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HB3' ' OD2' ' A' ' 61' ' ' ASP . 3.7 ttpm? -100.91 -44.72 5.66 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.45 -45.6 9.82 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.664 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -115.5 20.34 14.81 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.242 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -69.69 -20.48 75.8 Favored Glycine 0 CA--C 1.493 -1.308 0 N-CA-C 116.479 1.352 . . . . 0.0 116.479 -171.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.57 -27.74 64.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.982 0.891 . . . . 0.0 110.305 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -62.2 -24.74 67.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.601 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.625 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -65.75 -37.86 87.52 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 122.633 1.206 . . . . 0.0 109.024 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.94 11.02 66.16 Favored Glycine 0 C--N 1.284 -2.32 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.54 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.18 -8.29 59.64 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.729 HD12 ' HB2' ' A' ' 73' ' ' ASN . 3.1 pp -118.69 -34.97 3.82 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.729 ' HB2' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -168.07 -64.89 0.03 OUTLIER 'General case' 0 C--N 1.366 1.326 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.444 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.561 HD21 ' HB2' ' A' ' 94' ' ' PRO . 2.2 mm? -53.23 166.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -163.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -89.14 -12.3 41.43 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.578 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 69' ' ' ALA . 64.0 p 54.86 35.4 24.19 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.387 1.475 . . . . 0.0 112.992 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -117.44 -15.94 10.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -160.44 0.78 Allowed 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.944 -169.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.531 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 83.5 m-85 -59.99 170.66 1.11 Allowed Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.582 1.553 . . . . 0.0 109.635 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 2.4 Cg_endo -39.35 133.43 1.38 Allowed 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 122.765 2.31 . . . . 0.0 114.852 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.497 ' HB1' ' HG ' ' A' ' 74' ' ' LEU . . . -113.0 104.3 12.25 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.86 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.615 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 65.1 t80 -85.39 108.17 17.72 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.6 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -114.88 115.28 26.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.537 HD11 HG12 ' A' ' 110' ' ' VAL . 42.4 mt -90.7 110.59 22.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -88.14 129.58 35.28 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HB3' ' H ' ' A' ' 89' ' ' LYS . 4.2 mm-40 -87.62 121.03 29.54 Favored 'General case' 0 C--N 1.28 -2.444 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.412 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 20' ' ' MET . 3.8 t -96.82 4.19 9.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.95 -36.24 3.89 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.824 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 29.5 mmmt -99.08 -15.08 19.14 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.248 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 74.1 19.42 2.97 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 124.769 2.224 . . . . 0.0 108.414 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.506 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -96.0 170.09 9.52 Favored 'General case' 0 CA--C 1.464 -2.331 0 CA-C-N 111.828 -2.442 . . . . 0.0 110.851 -174.563 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.6 ' HB3' HD13 ' A' ' 72' ' ' LEU . 70.1 mmtt -141.25 109.46 5.84 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 72.2 m-85 -109.02 88.65 5.79 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.561 ' HB2' HD21 ' A' ' 74' ' ' LEU . 2.6 Cg_endo -101.15 147.78 0.33 Allowed 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 122.43 2.086 . . . . 0.0 114.384 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -85.09 158.98 20.27 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.077 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.625 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 5.9 m-20 -64.72 143.91 57.6 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 123.827 0.851 . . . . 0.0 108.883 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -85.7 -1.24 56.97 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.644 -172.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.16 18.69 1.4 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.24 0.543 . . . . 0.0 112.109 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.625 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 4.3 tppp? -93.17 -3.74 53.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 68.84 126.55 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.472 1.509 . . . . 0.0 112.321 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.534 HG23 HG13 ' A' ' 106' ' ' ILE . 3.5 mp -89.77 102.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.065 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 p -122.43 170.52 9.88 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.669 ' HA ' HD11 ' A' ' 47' ' ' ILE . 23.0 t80 -56.42 -59.37 5.07 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.554 0.692 . . . . 0.0 109.991 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -57.44 -45.44 84.68 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.232 -1.349 . . . . 0.0 113.526 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.43 -49.09 79.14 Favored 'General case' 0 C--N 1.254 -3.559 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.371 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.534 HG13 HG23 ' A' ' 101' ' ' ILE . 42.5 mm -75.0 -39.49 44.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.654 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 26.7 ttpp -58.22 -46.19 86.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.732 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.39 90.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.581 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.473 ' O ' HD11 ' A' ' 118' ' ' ILE . 70.6 t80 -64.49 -62.6 1.49 Allowed 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.537 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.537 HG12 HD11 ' A' ' 84' ' ' ILE . 34.7 m -58.67 -30.98 43.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 O-C-N 122.182 -0.324 . . . . 0.0 111.202 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 12.5 t70 -62.6 -50.47 71.14 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.333 1.053 . . . . 0.0 108.937 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.671 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 9.3 t70 -61.25 -43.11 99.42 Favored 'General case' 0 C--O 1.198 -1.649 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.21 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.577 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.5 t80 -59.22 -63.96 1.12 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.465 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.6 -17.04 20.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.838 -175.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.96 -33.84 30.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.509 0.671 . . . . 0.0 109.395 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.5 21.5 6.13 Favored Glycine 0 CA--C 1.482 -1.993 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.671 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 7.0 ttmm -94.38 -43.09 8.55 Favored 'General case' 0 N--CA 1.395 -3.185 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.046 -174.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.577 HD12 ' HB2' ' A' ' 113' ' ' PHE . 10.8 mt -72.14 146.04 11.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 C--N 1.283 -2.292 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.058 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.245 0.856 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.6 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 61.0 mt -96.71 120.76 46.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.096 0.474 . . . . 0.0 110.284 -177.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.17 167.75 12.98 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.635 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 14.8 Cg_endo -59.2 -25.69 79.05 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 122.812 2.341 . . . . 0.0 111.717 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -87.5 -12.11 46.89 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.816 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.6 p -105.03 -37.0 7.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.535 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' HA ' ' A' ' 13' ' ' PRO 0.293 10.0 p90 -62.18 -26.92 68.61 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 m -59.56 -32.41 70.32 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.206 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -78.08 -34.83 50.06 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.535 ' CD2' ' HA ' ' A' ' 16' ' ' TYR . 14.8 m-85 -73.13 -29.59 62.99 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.517 ' SD ' HG22 ' A' ' 87' ' ' VAL . 5.5 tpp -79.14 -24.05 43.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.01 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 t -92.1 -10.0 40.57 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.03 -21.03 43.97 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 121.955 -0.465 . . . . 0.0 111.43 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.18 8.98 87.31 Favored Glycine 0 C--O 1.235 0.189 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.956 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 12.2 pt -117.18 149.06 43.74 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 122.879 -0.189 . . . . 0.0 111.133 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HG2' HG12 ' A' ' 55' ' ' ILE . 9.2 Cg_endo -51.81 136.13 50.78 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 124.115 3.21 . . . . 0.0 113.82 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.17 125.53 51.11 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.534 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -98.66 109.29 22.07 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-O 121.185 0.517 . . . . 0.0 109.731 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -89.28 117.82 28.51 Favored 'General case' 0 CA--C 1.468 -2.182 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.729 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.6 mt -106.87 84.4 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.54 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 33.5 m-85 -75.54 134.9 40.63 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -149.76 120.04 7.32 Favored 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.578 176.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.405 ' N ' ' HB3' ' A' ' 62' ' ' ALA . 29.3 mt-10 -72.23 -28.79 63.39 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-O 121.663 0.744 . . . . 0.0 109.365 173.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.644 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 2.3 p -89.31 103.78 16.38 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.622 -170.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.73 -25.16 41.2 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.791 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.06 -62.31 1.43 Allowed 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.538 ' OE1' ' HB ' ' A' ' 33' ' ' THR . 1.2 pm0 -83.2 4.07 28.31 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 33' ' ' THR . 3.9 tmm_? -60.47 -32.73 71.69 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -60.83 -49.38 77.7 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.182 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 14.3 pt-20 -81.83 -22.36 37.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.38 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.657 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -61.53 -52.58 63.87 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.739 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 21.8 m -71.59 -20.8 61.95 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.587 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 22.0 t70 -61.98 -41.4 97.99 Favored 'General case' 0 CA--C 1.486 -1.506 0 C-N-CA 123.553 0.741 . . . . 0.0 111.206 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.64 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 51.7 mmtt -77.53 -29.43 52.35 Favored 'General case' 0 C--O 1.27 2.132 0 CA-C-O 122.511 1.148 . . . . 0.0 108.606 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 67.0 mt -70.97 -23.6 62.24 Favored 'General case' 0 N--CA 1.406 -2.667 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.951 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.483 ' HB2' ' HD3' ' A' ' 46' ' ' PRO . 56.1 mtpt -63.41 -53.34 53.43 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 86.3 Cg_exo -67.63 -45.18 3.6 Favored 'Trans proline' 0 C--O 1.263 1.731 0 C-N-CA 123.169 2.579 . . . . 0.0 111.803 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.617 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 6.5 tp -61.22 -30.55 48.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.402 0 C-N-CA 117.934 -1.506 . . . . 0.0 109.706 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.81 -18.69 27.17 Favored 'General case' 0 C--O 1.182 -2.496 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.761 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.05 -24.77 65.12 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.32 -19.45 50.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.567 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 9.1 pt20 -139.96 35.19 1.95 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.249 1.023 . . . . 0.0 110.948 -171.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -69.49 -19.21 63.74 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.137 -1.847 . . . . 0.0 112.375 -173.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.21 14.58 11.01 Favored Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.526 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.582 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.7 p -129.31 -32.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.214 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.472 HG12 ' HG2' ' A' ' 25' ' ' PRO . 79.0 mt -122.55 134.45 65.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.838 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -88.56 109.86 20.42 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -93.48 108.3 20.0 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.6 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -131.49 132.26 6.7 Favored Glycine 0 C--N 1.29 -2.005 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.693 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.567 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 42.2 p -91.65 150.17 21.28 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 122.686 0.394 . . . . 0.0 111.131 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 6.7 tt -151.6 147.27 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -68.39 130.45 42.92 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.69 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -93.26 -3.72 53.15 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.819 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -86.1 -49.51 7.72 Favored 'General case' 0 N--CA 1.42 -1.943 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.771 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.54 -37.69 9.07 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -104.37 14.36 30.32 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.791 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -71.55 -19.9 78.09 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 -172.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.54 68.8 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 117.69 0.745 . . . . 0.0 110.008 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -64.91 -24.95 67.68 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.009 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.494 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -63.16 -34.76 78.31 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 122.303 1.049 . . . . 0.0 109.82 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.527 ' HA2' ' H ' ' A' ' 73' ' ' ASN . . . -104.49 18.57 44.34 Favored Glycine 0 C--N 1.28 -2.576 0 C-N-CA 118.348 -1.882 . . . . 0.0 114.15 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.21 -22.26 55.47 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.495 HD12 ' CB ' ' A' ' 73' ' ' ASN . 4.3 pp -104.68 -33.33 8.51 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.396 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 12.9 t-20 -174.5 -56.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.477 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.0 mm? -59.51 162.84 4.57 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -165.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -83.03 -9.85 59.05 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.239 -174.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p 61.53 18.4 9.41 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.954 2.102 . . . . 0.0 114.744 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -113.39 -17.56 12.23 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -170.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 19.4 ttmt -117.84 -160.84 0.8 Allowed 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.31 -167.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.497 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 88.9 m-85 -54.9 164.2 1.26 Allowed Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.974 1.31 . . . . 0.0 111.481 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.505 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -39.74 129.65 1.92 Allowed 'Trans proline' 0 C--N 1.403 3.44 0 C-N-CA 122.793 2.328 . . . . 0.0 114.886 -174.787 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -108.17 104.44 13.85 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.084 -172.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.534 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 69.0 t80 -87.47 113.28 23.03 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.79 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -118.88 121.61 40.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.523 HD11 HG12 ' A' ' 110' ' ' VAL . 43.4 mt -95.67 110.99 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.205 0.526 . . . . 0.0 109.858 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -100.03 126.35 46.22 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.494 ' HB3' ' H ' ' A' ' 89' ' ' LYS . 1.9 mm-40 -88.6 140.48 29.41 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 120.897 0.38 . . . . 0.0 111.31 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.517 HG22 ' SD ' ' A' ' 20' ' ' MET . 22.1 t -99.89 -4.85 9.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.035 0.922 . . . . 0.0 108.633 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.52 -38.62 4.59 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.606 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.494 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 75.4 mmtt -91.06 -16.35 28.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.505 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 59.25 30.46 20.21 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 122.303 1.049 . . . . 0.0 109.715 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.546 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 26.0 tp60 -109.85 167.85 9.86 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.727 -171.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 10.5 mptt -122.71 98.68 6.02 Favored 'General case' 1 N--CA 1.373 -4.324 0 CA-C-N 113.216 -1.811 . . . . 0.0 106.548 -176.043 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.546 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 38.0 m-85 -100.39 82.64 0.33 Allowed Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 5.6 Cg_endo -100.33 148.96 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.639 2.226 . . . . 0.0 113.573 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -82.78 162.29 21.74 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.444 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.742 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 6.4 m-20 -71.37 139.02 49.65 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -84.61 1.72 44.77 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.954 -173.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 8.9 pt-20 -137.86 13.33 2.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.392 0.615 . . . . 0.0 111.594 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 15.4 tppt? -90.73 -8.91 48.54 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.58 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 69.64 117.97 0.04 OUTLIER 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.45 1.1 . . . . 0.0 111.105 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.482 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.4 mp -85.05 125.78 40.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.409 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.7 p -139.34 175.37 9.62 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.553 ' HE1' ' HB2' ' A' ' 46' ' ' PRO . 54.0 t80 -55.18 -61.11 2.54 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 122.081 0.943 . . . . 0.0 110.064 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . 0.255 23.5 tp10 -60.76 -39.64 89.54 Favored 'General case' 1 N--CA 1.37 -4.435 0 C-N-CA 126.811 2.044 . . . . 0.0 111.968 -171.997 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.26 93.5 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 123.816 0.698 . . . . 0.0 110.528 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.482 ' CG1' HG23 ' A' ' 101' ' ' ILE . 34.9 mm -72.36 -41.74 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.237 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.434 ' HG3' HD13 ' A' ' 47' ' ' ILE . 12.4 ttpt -55.33 -52.06 64.73 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 124.179 0.924 . . . . 0.0 108.895 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.03 83.63 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.507 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -68.59 -58.16 4.69 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.828 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.523 HG12 HD11 ' A' ' 84' ' ' ILE . 35.5 m -60.23 -32.61 51.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.889 0 O-C-N 121.841 -0.537 . . . . 0.0 110.71 -177.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.33 -53.8 54.21 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 124.958 1.303 . . . . 0.0 109.153 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.654 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 7.2 t70 -60.62 -43.63 97.25 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 113.687 -1.597 . . . . 0.0 108.002 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.532 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.7 t80 -59.51 -64.02 1.09 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.173 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.8 -21.03 27.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.068 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.48 -35.19 53.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.23 0.538 . . . . 0.0 109.86 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.54 30.4 3.31 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.654 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 5.5 mtmt -102.26 -45.19 5.19 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.504 -1.348 . . . . 0.0 109.283 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 113' ' ' PHE . 31.8 mt -76.14 142.45 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 171.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--N 1.273 -2.747 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.734 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 . . . . . 0 C--O 1.24 0.592 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.556 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 51.7 mt -102.18 119.98 51.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.67 174.7 20.33 Favored Glycine 0 N--CA 1.41 -3.067 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.508 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 28.4 Cg_endo -61.4 -17.03 51.07 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.091 2.527 . . . . 0.0 112.793 -177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.8 -13.4 16.44 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 119.37 -0.347 . . . . 0.0 111.747 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.8 p -102.03 -32.47 10.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 119.489 -0.884 . . . . 0.0 112.641 -173.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CE2' ' HA ' ' A' ' 13' ' ' PRO 0.254 5.3 p90 -60.61 -32.8 71.91 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -177.27 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 m -59.92 -31.26 69.67 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 123.742 0.817 . . . . 0.0 110.462 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.27 -35.37 41.49 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -73.33 -28.6 62.16 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.513 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -78.1 -36.97 47.42 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.49 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.6 t -78.52 -10.5 59.74 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.946 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.21 64.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.198 0.523 . . . . 0.0 110.453 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.56 -15.88 62.33 Favored Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.833 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 7.0 pt -93.76 154.04 41.01 Favored Pre-proline 0 C--N 1.301 -1.537 0 C-N-CA 123.026 0.53 . . . . 0.0 110.249 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HG2' HG12 ' A' ' 55' ' ' ILE . 15.0 Cg_endo -54.22 145.36 55.19 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 124.115 3.21 . . . . 0.0 114.663 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tt -108.69 127.02 53.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -97.94 107.65 20.18 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -88.46 120.68 30.06 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.283 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.631 HG12 HD13 ' A' ' 44' ' ' LEU . 3.4 mp -110.74 89.11 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.824 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.043 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.567 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 48.6 m-85 -78.6 109.96 13.29 Favored 'General case' 0 CA--C 1.452 -2.791 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -120.98 119.2 31.87 Favored 'General case' 1 C--N 1.238 -4.266 0 CA-C-O 121.197 0.522 . . . . 0.0 109.816 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -70.22 -28.77 65.54 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.651 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 18.0 p -75.16 119.12 18.87 Favored 'General case' 0 N--CA 1.379 -3.988 0 CA-C-N 113.296 -1.775 . . . . 0.0 108.436 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.434 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . . . -99.05 -17.62 18.16 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.595 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -99.01 -53.16 3.34 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.701 0.763 . . . . 0.0 109.623 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -86.71 7.44 26.71 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.109 -175.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.651 ' HB3' ' O ' ' A' ' 33' ' ' THR . 6.7 ptp180 -71.71 -16.78 62.24 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.372 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -69.42 -45.03 70.17 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 1.6 mp0 -65.72 -35.12 79.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.393 0.616 . . . . 0.0 109.771 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.513 HD21 ' HB ' ' A' ' 101' ' ' ILE . 1.2 tm? -60.81 -49.08 78.93 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.466 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 14.5 m -75.36 -10.6 59.61 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.056 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.601 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 19.0 t70 -78.09 -37.4 46.54 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 123.163 0.585 . . . . 0.0 110.32 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.623 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -72.23 -33.26 67.42 Favored 'General case' 0 C--O 1.285 2.944 0 CA-C-O 123.166 1.46 . . . . 0.0 108.136 173.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.631 HD13 HG12 ' A' ' 29' ' ' ILE . 85.6 mt -73.67 -21.94 60.11 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.19 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -66.35 -50.09 50.35 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 6.9 Cg_exo -78.2 -34.14 1.72 Allowed 'Trans proline' 0 CA--C 1.491 -1.655 0 C-N-CA 121.923 1.749 . . . . 0.0 110.034 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -62.33 -28.86 45.44 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.94 -20.06 21.0 Favored 'General case' 0 C--O 1.186 -2.25 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.794 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.22 -19.11 63.17 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.2 -14.01 54.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.54 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 10.1 pt20 -146.64 36.28 0.96 Allowed 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.061 0.934 . . . . 0.0 111.128 -173.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -74.46 -19.47 60.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.701 -1.59 . . . . 0.0 111.065 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.32 20.91 18.24 Favored Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.41 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.8 p -139.77 -33.73 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.657 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 25' ' ' PRO . 88.4 mt -124.75 134.62 66.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.109 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -91.44 97.44 11.08 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -76.79 131.68 38.82 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.399 0.619 . . . . 0.0 111.278 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.556 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -144.06 123.55 2.04 Favored Glycine 0 N--CA 1.396 -3.974 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.388 176.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.42 HG21 ' OG ' ' A' ' 41' ' ' SER . 38.9 p -86.45 136.41 33.11 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 7.5 tt -141.04 145.48 25.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -177.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.02 126.97 31.22 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.518 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -85.75 0.09 53.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -102.28 -42.31 6.06 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.99 -51.44 6.35 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.919 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -112.16 18.36 18.73 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.754 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.38 -22.86 67.89 Favored Glycine 0 CA--C 1.497 -1.089 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.38 -35.18 60.04 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 122.991 0.516 . . . . 0.0 110.796 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -63.57 -22.22 66.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.291 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.627 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -65.54 -39.18 91.46 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.999 0.904 . . . . 0.0 109.227 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.486 ' HA2' ' N ' ' A' ' 74' ' ' LEU . . . -103.61 6.12 48.61 Favored Glycine 0 C--N 1.283 -2.387 0 C-N-CA 118.114 -1.993 . . . . 0.0 114.904 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -32.68 72.6 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 166.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 3.2 pp -89.67 -37.58 14.5 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.433 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.457 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 21.2 t-20 -171.48 -60.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.486 ' N ' ' HA2' ' A' ' 70' ' ' GLY . 2.4 mm? -56.55 167.97 0.64 Allowed 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -166.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -82.61 -16.54 48.01 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.762 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 p 61.36 21.81 12.3 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 126.357 1.863 . . . . 0.0 112.803 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -107.66 -23.77 11.99 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -172.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.567 ' HG2' ' HB3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -106.42 -162.01 0.83 Allowed 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.104 -169.152 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.731 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 67.2 m-85 -72.9 -172.42 0.23 Allowed Pre-proline 0 CA--C 1.571 1.76 0 C-N-CA 125.036 1.334 . . . . 0.0 108.998 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.731 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 5.6 Cg_endo -47.48 133.59 20.67 Favored 'Trans proline' 0 C--N 1.408 3.708 0 CA-C-N 122.583 1.958 . . . . 0.0 115.61 -175.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.06 122.4 37.11 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.252 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.531 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 75.9 t80 -96.47 117.44 30.91 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.381 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -119.46 122.35 41.52 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 122.046 -0.409 . . . . 0.0 111.998 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 49.3 mt -95.13 116.28 36.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 45.6 tt0 -106.69 122.38 46.24 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 19.8 mt-10 -80.58 148.96 30.1 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.956 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.513 HG11 ' O ' ' A' ' 20' ' ' MET . 19.9 t -113.0 -0.42 9.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.1 -57.15 3.21 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.819 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -111.33 -9.98 14.25 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.628 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 49.7 t-20 65.88 86.72 0.13 Allowed 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.225 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 29.8 tp60 -139.69 164.15 30.71 Favored 'General case' 0 CA--C 1.464 -2.339 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.639 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 11.3 mptt -119.88 95.05 4.61 Favored 'General case' 1 N--CA 1.376 -4.174 0 O-C-N 125.056 1.473 . . . . 0.0 108.572 -174.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 28.9 m-85 -101.28 83.13 0.41 Allowed Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 172.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 5.8 Cg_endo -101.58 144.92 0.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.396 2.064 . . . . 0.0 114.572 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -85.3 173.56 10.25 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 126.37 1.868 . . . . 0.0 109.088 -174.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.5 m-20 -66.3 148.79 51.33 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -95.47 2.47 54.45 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.567 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 9.8 pt-20 -149.31 23.66 0.92 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.009 -172.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.577 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 18.0 ttmm -90.76 -81.79 0.3 Allowed 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.001 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 172.45 123.63 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.513 ' HB ' HD21 ' A' ' 40' ' ' LEU . 3.4 mp -99.88 94.57 3.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -122.68 167.74 13.07 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.435 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.454 ' HE2' ' HB2' ' A' ' 46' ' ' PRO . 39.5 t80 -51.73 -61.06 2.49 Favored 'General case' 0 CA--C 1.483 -1.618 0 O-C-N 124.061 0.851 . . . . 0.0 110.107 -176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -69.17 -27.01 65.14 Favored 'General case' 1 N--CA 1.372 -4.361 0 C-N-CA 125.784 1.634 . . . . 0.0 112.778 -172.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.7 -44.44 42.16 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.543 0.687 . . . . 0.0 109.354 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.412 ' CG1' HG23 ' A' ' 101' ' ' ILE . 32.8 mm -68.88 -40.34 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.575 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -56.43 -51.55 68.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.672 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.02 -43.36 70.06 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.164 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.01 -59.3 3.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.52 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 84' ' ' ILE . 33.9 m -60.83 -33.19 54.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 O-C-N 121.777 -0.577 . . . . 0.0 111.508 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.86 -50.42 73.87 Favored 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 124.067 0.947 . . . . 0.0 109.258 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.633 ' HB3' HG13 ' A' ' 118' ' ' ILE . 1.9 t70 -58.77 -47.74 83.63 Favored 'General case' 0 C--O 1.2 -1.513 0 CA-C-N 113.16 -1.836 . . . . 0.0 107.441 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.514 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.1 t80 -57.53 -65.55 0.61 Allowed 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.473 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 110' ' ' VAL . 8.8 p -62.07 -24.57 34.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.79 -34.86 52.03 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.75 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.99 30.89 2.62 Favored Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.577 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 22.2 mtmt -99.88 -44.31 6.1 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 113.202 -1.499 . . . . 0.0 108.422 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.633 HG13 ' HB3' ' A' ' 112' ' ' ASP . 33.4 mt -83.0 146.74 6.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 170.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 C--N 1.291 -1.955 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -178.726 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.517 HG13 ' HB ' ' A' ' 60' ' ' ILE . 2.2 pt -120.44 154.88 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-O 121.482 0.658 . . . . 0.0 111.777 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.55 176.59 30.7 Favored Glycine 0 N--CA 1.403 -3.501 0 N-CA-C 107.751 -2.139 . . . . 0.0 107.751 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.5 -27.44 68.82 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.167 2.578 . . . . 0.0 113.648 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -89.23 -20.52 24.04 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.0 p -97.91 -36.36 10.19 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.534 -169.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -62.71 -29.42 70.65 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.976 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -24.77 67.07 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.2 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.29 -37.67 44.27 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.88 0.848 . . . . 0.0 109.882 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -76.06 -27.44 57.25 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.493 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.04 -35.31 71.91 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.358 175.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 t -74.7 -19.51 60.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.933 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.28 -30.12 57.68 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 120.95 0.405 . . . . 0.0 110.2 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.39 -23.67 26.45 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.947 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 6.6 pt -81.15 152.87 71.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.479 -0.361 . . . . 0.0 111.68 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.452 ' HG2' HG12 ' A' ' 55' ' ' ILE . 10.6 Cg_endo -52.42 137.25 56.93 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.063 3.175 . . . . 0.0 114.442 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 tt -106.8 125.96 51.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.507 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -97.56 104.86 16.92 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -86.96 120.71 28.52 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.446 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.653 HG12 HD13 ' A' ' 44' ' ' LEU . 3.4 mp -110.69 94.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.361 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.691 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 34.7 m-85 -80.34 126.64 31.42 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -142.15 122.1 13.64 Favored 'General case' 0 C--N 1.252 -3.639 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.493 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.446 ' HG2' ' C ' ' A' ' 62' ' ' ALA . 32.2 mt-10 -73.15 -20.82 60.83 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.445 ' HB ' ' CG ' ' A' ' 36' ' ' GLU . 1.5 p -86.66 83.86 7.51 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.997 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 37' ' ' ARG . . . -87.31 -25.21 24.03 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.154 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.5 mp0 -63.23 -34.13 76.99 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.179 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.445 ' CG ' ' HB ' ' A' ' 33' ' ' THR . 11.1 pt-20 -116.48 13.55 15.42 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.412 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.443 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 7.5 ptp180 -57.73 -27.93 63.44 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.812 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -50.4 -49.46 54.5 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 123.608 0.763 . . . . 0.0 111.517 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.627 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 12.1 pt-20 -86.97 -24.4 24.73 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.435 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.496 HD21 ' HB ' ' A' ' 101' ' ' ILE . 1.7 tm? -63.98 -44.92 91.24 Favored 'General case' 0 C--O 1.261 1.701 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.578 ' OG ' HG21 ' A' ' 59' ' ' THR . 15.7 m -73.01 -17.33 61.46 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.456 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.455 ' CB ' ' HA ' ' A' ' 39' ' ' GLU . 23.4 t70 -70.99 -40.87 71.61 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.677 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.632 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -65.24 -38.11 89.33 Favored 'General case' 0 C--O 1.27 2.177 0 CA-C-O 123.426 1.584 . . . . 0.0 106.848 173.308 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.653 HD13 HG12 ' A' ' 29' ' ' ILE . 94.0 mt -71.12 -19.06 62.49 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 112.884 -1.962 . . . . 0.0 113.065 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.573 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 24.3 ttpp -66.56 -55.42 18.72 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.68 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 81.6 Cg_exo -65.59 -38.94 22.92 Favored 'Trans proline' 0 CA--C 1.489 -1.733 0 C-N-CA 123.174 2.582 . . . . 0.0 110.508 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.549 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 93.7 mt -53.68 -38.47 34.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 O-C-N 124.052 0.845 . . . . 0.0 109.695 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.92 -16.84 23.61 Favored 'General case' 0 C--O 1.19 -2.053 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.217 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 3.6 tt0 -74.42 -17.73 60.75 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.57 -20.79 30.92 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.933 177.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 9.9 pt20 -137.66 37.84 2.43 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.495 1.14 . . . . 0.0 110.609 -171.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -65.92 -24.83 66.91 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.542 -2.117 . . . . 0.0 112.846 -172.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.54 9.22 17.08 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.314 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.415 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 13.0 p -122.86 -33.0 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.452 HG12 ' HG2' ' A' ' 25' ' ' PRO . 88.1 mt -122.86 134.64 65.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.211 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -94.46 102.89 14.87 Favored 'General case' 0 C--O 1.207 -1.159 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -80.19 139.47 36.74 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.795 0.807 . . . . 0.0 111.851 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 11' ' ' ILE . . . -151.54 113.27 0.57 Allowed Glycine 0 C--N 1.275 -2.811 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.649 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.578 HG21 ' OG ' ' A' ' 41' ' ' SER . 40.3 p -84.64 132.19 34.51 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.517 ' HB ' HG13 ' A' ' 11' ' ' ILE . 7.6 tt -131.73 145.24 35.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 63' ' ' LYS . 7.7 t0 -73.33 123.9 24.68 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.042 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.691 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -92.54 1.99 56.94 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.042 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HB3' ' OD1' ' A' ' 61' ' ' ASP . 39.4 ttmt -100.33 -31.17 11.47 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.68 -44.53 7.07 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.217 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -120.42 26.67 9.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.476 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -70.44 -15.92 73.23 Favored Glycine 0 CA--C 1.489 -1.565 0 N-CA-C 116.206 1.242 . . . . 0.0 116.206 -170.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.16 -35.55 71.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.374 0.607 . . . . 0.0 110.007 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 71' ' ' ASN . 63.7 m-70 -60.49 -21.79 62.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.146 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.413 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -62.11 -31.87 72.37 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 121.506 0.67 . . . . 0.0 110.283 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -122.77 9.99 9.07 Favored Glycine 0 CA--C 1.479 -2.205 0 C-N-CA 118.26 -1.924 . . . . 0.0 115.089 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 7.9 m-20 -73.95 -16.42 61.08 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 166.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.436 ' O ' ' HE3' ' A' ' 92' ' ' LYS . 3.9 pp -99.13 -26.25 14.27 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.928 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.415 ' CB ' HD12 ' A' ' 72' ' ' LEU . 3.3 t-20 177.78 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.599 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 89.8 mt -53.04 159.23 1.24 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.793 2.145 . . . . 0.0 116.793 -171.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -71.15 -17.91 62.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.235 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.413 HG22 ' HB3' ' A' ' 69' ' ' ALA . 13.8 p 50.13 57.83 6.14 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -135.25 -17.98 1.78 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -119.54 -159.92 0.79 Allowed 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.867 -167.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.637 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 57.7 m-85 -61.47 -176.37 0.12 Allowed Pre-proline 0 N--CA 1.499 1.993 0 C-N-CA 126.485 1.914 . . . . 0.0 111.262 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 3.7 Cg_endo -45.92 135.87 13.8 Favored 'Trans proline' 1 C--N 1.422 4.444 0 CA-C-N 121.75 1.661 . . . . 0.0 113.079 177.338 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -116.52 136.67 52.79 Favored 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.927 -171.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.507 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 77.6 t80 -120.11 120.09 35.23 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.12 123.46 39.73 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.359 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.486 HD11 HG12 ' A' ' 110' ' ' VAL . 56.3 mt -93.87 109.15 21.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 25' ' ' PRO . 41.3 tt0 -95.25 127.38 41.25 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -86.0 132.28 34.1 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.493 HG11 ' O ' ' A' ' 20' ' ' MET . 12.0 t -94.49 -0.42 10.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-O 122.139 0.971 . . . . 0.0 108.727 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.95 -44.68 3.94 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.699 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.431 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 58.1 mttp -93.85 -12.36 29.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.54 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 2.3 p-10 56.28 33.43 22.23 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 123.258 1.504 . . . . 0.0 109.894 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.506 ' C ' ' HD3' ' A' ' 92' ' ' LYS . 8.1 tp60 -98.12 167.04 11.12 Favored 'General case' 0 CA--C 1.464 -2.354 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.957 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.634 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 3.6 mppt? -132.76 102.88 5.84 Favored 'General case' 1 N--CA 1.373 -4.317 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -176.294 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 50.6 m-85 -98.91 83.83 0.33 Allowed Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 173.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 24.1 Cg_endo -100.18 149.42 0.45 Allowed 'Trans proline' 0 N--CA 1.42 -2.809 0 C-N-CA 121.935 1.757 . . . . 0.0 113.411 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 83.2 t80 -84.34 168.16 15.86 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.789 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.648 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 18.6 m-20 -70.65 143.3 51.47 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.471 ' NE2' ' HB3' ' A' ' 74' ' ' LEU . 31.4 mt-30 -84.75 2.38 42.34 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.012 -171.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 7.7 pt-20 -152.22 22.02 0.65 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 14.9 tppt? -90.65 -3.22 57.67 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 70.49 133.02 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.911 2.085 . . . . 0.0 112.716 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.549 HG23 HG13 ' A' ' 106' ' ' ILE . 2.4 mp -91.24 97.91 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.943 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.4 p -110.25 -165.93 1.04 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.148 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.9 t80 -84.46 -55.0 4.38 Favored 'General case' 0 CA--C 1.485 -1.558 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -58.85 -43.86 90.89 Favored 'General case' 0 N--CA 1.387 -3.607 0 CA-C-N 113.096 -1.865 . . . . 0.0 113.731 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.62 -49.94 73.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.067 0.46 . . . . 0.0 111.328 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 101' ' ' ILE . 44.2 mm -72.11 -40.54 66.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.599 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 30.7 ttpt -57.71 -48.84 78.43 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 111' ' ' ASP . . . -61.4 -42.6 98.99 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 123.914 0.759 . . . . 0.0 110.922 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.426 ' HA ' ' OD1' ' A' ' 112' ' ' ASP . 63.4 t80 -61.56 -60.73 3.25 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.209 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.486 HG12 HD11 ' A' ' 84' ' ' ILE . 35.9 m -59.48 -30.67 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.642 -0.661 . . . . 0.0 110.468 -177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 23.9 t70 -64.27 -53.18 52.96 Favored 'General case' 0 CA--C 1.479 -1.756 0 C-N-CA 124.629 1.171 . . . . 0.0 108.96 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.586 ' OD2' HG12 ' A' ' 118' ' ' ILE 0.265 0.1 OUTLIER -68.2 -25.12 65.06 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.959 -177.167 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.541 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.4 t80 -68.97 -62.01 1.56 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.772 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.79 -25.42 38.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.335 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.64 -30.72 67.43 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 121.175 0.512 . . . . 0.0 109.934 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.71 7.06 10.95 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.77 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.583 ' HE2' ' OD2' ' A' ' 112' ' ' ASP . 25.1 ttpt -89.42 -37.07 15.09 Favored 'General case' 0 N--CA 1.393 -3.311 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.591 -172.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.586 HG12 ' OD2' ' A' ' 112' ' ' ASP . 4.2 mt -74.02 135.45 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 118.446 -1.302 . . . . 0.0 109.851 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--N 1.267 -3.015 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -178.89 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.437 -1.085 0 CA-C-O 121.437 0.636 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.632 HG13 ' HA3' ' A' ' 58' ' ' GLY . 62.9 mt -103.71 118.11 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.957 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.25 178.32 17.87 Favored Glycine 0 N--CA 1.408 -3.218 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.42 -29.49 84.64 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.264 2.643 . . . . 0.0 112.939 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.96 -8.94 23.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.2 p -102.21 -35.88 8.71 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.466 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -62.5 -32.04 72.89 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.217 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.8 t -63.19 -27.9 69.68 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.571 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.61 -38.19 59.22 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.599 0.714 . . . . 0.0 109.73 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.404 ' HB3' ' CG ' ' A' ' 56' ' ' ASN . 18.4 m-85 -76.94 -23.39 52.42 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.582 ' SD ' HG22 ' A' ' 87' ' ' VAL . 8.7 tpp -80.67 -21.92 40.91 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.214 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -92.18 -13.05 31.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.07 -31.1 68.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.05 11.48 73.0 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.526 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 9.5 pt -123.98 151.06 64.46 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HG2' HG12 ' A' ' 55' ' ' ILE . 11.6 Cg_endo -53.34 144.84 47.77 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 124.125 3.217 . . . . 0.0 114.067 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 tt -116.14 126.34 53.57 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.74 110.54 22.98 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -90.73 120.18 31.57 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.176 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.532 HG12 HD13 ' A' ' 44' ' ' LEU . 3.2 mp -111.37 90.84 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.07 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.699 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 44.1 m-85 -79.41 133.37 36.55 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.546 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -142.99 120.32 11.59 Favored 'General case' 0 C--N 1.273 -2.719 0 O-C-N 123.314 0.384 . . . . 0.0 111.884 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.18 -32.01 66.44 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 3.1 p -83.08 109.59 17.27 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.202 -171.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.89 -16.95 45.5 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.424 0.63 . . . . 0.0 109.708 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -70.8 -59.6 2.71 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.425 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -97.93 8.59 44.49 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.693 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 33' ' ' THR . 53.6 ttt180 -55.69 -36.94 67.69 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -59.31 -48.48 81.45 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.096 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.661 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 12.4 pt-20 -79.37 -27.23 41.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.671 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.513 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.1 tm? -59.41 -50.01 75.6 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.545 ' HA ' HD12 ' A' ' 44' ' ' LEU . 9.2 m -74.88 -19.57 60.1 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.975 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.577 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 33.8 t70 -70.1 -39.97 75.2 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 122.866 0.466 . . . . 0.0 111.334 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.661 ' HE2' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -70.51 -35.43 73.2 Favored 'General case' 0 C--O 1.297 3.554 0 CA-C-O 123.177 1.465 . . . . 0.0 108.509 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 41' ' ' SER . 68.6 mt -70.79 -23.64 62.43 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 113.102 -1.863 . . . . 0.0 111.814 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.526 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 36.4 ttpt -63.61 -52.1 61.51 Favored Pre-proline 0 C--N 1.289 -2.03 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.182 -173.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 51.5 Cg_exo -71.83 -44.28 1.01 Allowed 'Trans proline' 0 CA--C 1.492 -1.598 0 C-N-CA 122.803 2.335 . . . . 0.0 111.095 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.484 HG13 ' HA ' ' A' ' 44' ' ' LEU . 2.4 pp -61.95 -22.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.375 1.68 0 C-N-CA 117.777 -1.569 . . . . 0.0 111.735 -176.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.23 -21.0 16.3 Favored 'General case' 0 C--O 1.202 -1.416 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.31 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 22.4 tt0 -69.82 -23.07 63.25 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.76 -16.63 60.1 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.228 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.484 HE22 HG21 ' A' ' 110' ' ' VAL . 9.8 pt20 -142.34 31.8 1.52 Allowed 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.522 -172.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.81 -14.27 59.63 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.977 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.89 5.52 50.64 Favored Glycine 0 C--N 1.296 -1.684 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.853 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 11.8 p -130.05 -37.47 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.534 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.438 HG12 ' HG2' ' A' ' 25' ' ' PRO . 92.3 mt -117.87 145.39 23.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.404 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 8.2 m120 -92.94 121.76 34.62 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.446 ' CD2' HD11 ' A' ' 29' ' ' ILE . 6.4 m-85 -103.87 128.71 51.33 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.174 0.988 . . . . 0.0 112.825 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.632 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -145.9 131.9 4.32 Favored Glycine 0 N--CA 1.415 -2.734 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.252 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 44.9 p -96.08 143.59 27.08 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 8.2 tt -148.01 154.99 10.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.53 132.02 34.57 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.336 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -87.48 -3.63 59.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.135 0.493 . . . . 0.0 111.776 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -103.77 -32.05 9.53 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.002 0.429 . . . . 0.0 110.153 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.69 -46.59 7.5 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -117.24 19.29 14.21 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.502 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -66.95 -14.61 63.61 Favored Glycine 0 C--N 1.307 -1.036 0 N-CA-C 116.382 1.313 . . . . 0.0 116.382 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.29 -24.64 67.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.085 0.942 . . . . 0.0 109.993 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -74.77 -22.3 58.85 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.946 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.475 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -61.07 -44.22 97.71 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 121.835 0.826 . . . . 0.0 109.408 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -112.56 24.0 14.36 Favored Glycine 0 C--N 1.272 -3.019 0 C-N-CA 117.987 -2.054 . . . . 0.0 115.381 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -14.36 59.46 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 169.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 73' ' ' ASN . 4.1 pp -100.37 -29.37 12.45 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.568 177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.506 ' N ' HD12 ' A' ' 72' ' ' LEU . 3.2 t-20 -175.8 -60.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.627 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.4 mm? -53.62 155.49 3.07 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -169.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -78.37 -12.96 60.04 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.012 -1.449 . . . . 0.0 112.49 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.475 HG22 ' HB3' ' A' ' 69' ' ' ALA . 75.7 p 58.61 28.52 17.23 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 126.56 1.944 . . . . 0.0 113.635 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.07 -28.44 6.98 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -170.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.717 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -124.9 106.07 9.72 Favored 'General case' 0 C--O 1.197 -1.676 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.418 -167.177 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.683 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 12.9 m-85 60.07 -171.06 0.02 OUTLIER Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.838 168.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.683 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 10.2 Cg_endo -58.72 149.91 73.92 Favored 'Trans proline' 0 C--N 1.379 2.148 0 CA-C-N 120.79 1.318 . . . . 0.0 113.8 171.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.58 126.21 34.21 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.783 -176.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 77.5 t80 -105.45 119.01 38.03 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -126.96 117.34 22.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.541 HD11 HG12 ' A' ' 110' ' ' VAL . 51.4 mt -91.02 110.18 22.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -92.04 135.0 34.31 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.575 ' OE2' ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -90.61 132.94 35.45 Favored 'General case' 0 CA--C 1.461 -2.462 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.371 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.582 HG22 ' SD ' ' A' ' 20' ' ' MET . 22.0 t -101.05 -6.7 9.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.98 -46.15 5.45 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 119.771 -0.771 . . . . 0.0 109.575 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.575 ' HG2' ' OE2' ' A' ' 86' ' ' GLU . 43.6 mmtm -92.62 -25.45 18.29 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.505 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 63.0 t30 66.65 59.16 0.61 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 123.646 1.688 . . . . 0.0 106.799 -171.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.552 ' HB2' ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -130.24 176.34 8.19 Favored 'General case' 0 CA--C 1.468 -2.183 0 CA-C-N 113.098 -1.864 . . . . 0.0 107.4 -172.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 91' ' ' GLN . 60.3 mmtt -142.52 111.04 6.15 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -106.63 87.96 3.12 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HB2' HD21 ' A' ' 74' ' ' LEU . 2.9 Cg_endo -104.48 150.89 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 122.689 2.259 . . . . 0.0 114.675 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 57.2 t80 -98.51 149.88 22.26 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.437 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 3.4 m-20 -58.72 139.51 56.07 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-O 121.702 0.763 . . . . 0.0 111.196 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.717 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 45.3 mt-30 -77.71 -8.54 58.09 Favored 'General case' 0 C--N 1.265 -3.103 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.181 -176.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 6.4 pt-20 -130.29 16.58 5.52 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.528 0.68 . . . . 0.0 111.42 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 34.8 ttmt -107.21 9.07 30.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.374 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 66.68 117.31 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.666 1.587 . . . . 0.0 114.6 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.543 HG23 HG13 ' A' ' 106' ' ' ILE . 3.4 mp -83.06 106.35 13.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.498 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.7 p -129.83 175.69 8.64 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.649 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 31.2 t80 -51.45 -63.79 1.02 Allowed 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 124.147 0.904 . . . . 0.0 110.047 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -67.38 -42.06 84.01 Favored 'General case' 1 N--CA 1.373 -4.299 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.195 -172.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.05 92.46 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 123.646 0.591 . . . . 0.0 110.296 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.543 HG13 HG23 ' A' ' 101' ' ' ILE . 32.6 mm -75.3 -42.26 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.101 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 27.0 ttpp -55.28 -50.33 69.8 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 123.759 0.662 . . . . 0.0 109.996 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.0 -33.54 75.78 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.043 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.462 ' CD1' ' HD1' ' A' ' 95' ' ' PHE . 68.8 t80 -66.21 -60.76 2.48 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.855 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.541 HG12 HD11 ' A' ' 84' ' ' ILE . 27.8 m -58.67 -31.3 43.86 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 122.033 -0.417 . . . . 0.0 110.411 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 23.0 t70 -61.48 -50.97 70.59 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.789 1.236 . . . . 0.0 109.69 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.696 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 4.4 t70 -61.65 -46.29 90.38 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-N 113.941 -1.482 . . . . 0.0 107.247 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.498 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.1 t80 -55.4 -65.14 0.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.01 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.88 -15.29 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 C-N-CA 123.661 0.785 . . . . 0.0 111.909 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.35 -25.39 25.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 0.0 110.17 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.56 26.67 6.74 Favored Glycine 0 CA--C 1.485 -1.782 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.696 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -98.09 -47.12 5.62 Favored 'General case' 0 N--CA 1.411 -2.414 0 CA-C-N 114.055 -1.073 . . . . 0.0 109.113 -176.226 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.556 HG13 ' HB3' ' A' ' 112' ' ' ASP . 20.5 mt -74.5 145.66 10.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--N 1.283 -2.296 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.121 -179.417 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HA ' ' H ' ' A' ' 59' ' ' THR . 10.6 pt-20 . . . . . 0 N--CA 1.429 -1.497 0 CA-C-O 121.041 0.448 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.509 HG13 ' HA3' ' A' ' 58' ' ' GLY . 69.2 mt -110.79 128.96 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 172.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.06 170.68 19.43 Favored Glycine 0 N--CA 1.416 -2.679 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.74 -18.23 54.54 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.278 2.652 . . . . 0.0 112.642 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.83 6.39 31.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.837 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -114.95 -25.98 7.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.374 -1.33 . . . . 0.0 111.981 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -41.75 -59.49 1.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.751 0.821 . . . . 0.0 112.248 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.6 m -54.3 -33.04 57.89 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.011 -1.449 . . . . 0.0 112.738 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.58 -26.99 31.82 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -74.68 -29.26 61.17 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.418 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -76.76 -35.79 57.48 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.731 178.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -70.87 -21.72 62.37 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.394 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.07 -24.23 59.48 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 120.831 0.348 . . . . 0.0 111.307 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.61 -15.49 30.29 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-O 121.443 0.468 . . . . 0.0 112.309 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.612 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 19.8 pt -90.07 153.35 46.91 Favored Pre-proline 0 C--N 1.293 -1.888 0 CA-C-N 115.175 -0.513 . . . . 0.0 109.98 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 21.4 Cg_exo -52.42 140.47 53.53 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.313 2.675 . . . . 0.0 113.879 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.435 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 2.7 tt -102.31 125.2 48.95 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.91 106.29 18.58 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.435 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 57.1 m-85 -87.88 113.92 23.99 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.12 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.607 HG12 HD13 ' A' ' 44' ' ' LEU . 3.1 mp -103.71 86.96 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.815 0 C-N-CA 118.379 -1.328 . . . . 0.0 108.958 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.63 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 41.5 m-85 -75.87 125.82 29.82 Favored 'General case' 0 CA--C 1.457 -2.609 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . . . -140.58 119.5 12.65 Favored 'General case' 0 C--N 1.258 -3.381 0 O-C-N 123.567 0.542 . . . . 0.0 111.489 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.99 -26.44 67.55 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.57 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 1.2 p -81.39 120.42 24.94 Favored 'General case' 0 N--CA 1.393 -3.287 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.914 -176.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.04 -16.75 12.58 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 173.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.0 mp0 -72.74 -45.49 58.45 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.764 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -116.28 12.99 15.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.137 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.574 ' HA ' HD23 ' A' ' 40' ' ' LEU . 44.1 ttm180 -51.79 -41.25 61.55 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 13.2 ptmm? -54.75 -32.0 59.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 124.147 0.904 . . . . 0.0 111.751 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -73.81 -43.78 57.8 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.674 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.8 mm? -58.14 -48.42 80.29 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.518 ' HA ' HD12 ' A' ' 44' ' ' LEU . 1.8 m -72.4 -21.48 61.26 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.817 -173.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 18.4 t70 -72.43 -39.19 68.06 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.743 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.62 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -73.02 -32.13 64.91 Favored 'General case' 0 C--O 1.287 3.035 0 CA-C-O 123.015 1.388 . . . . 0.0 108.69 175.59 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 52.5 mt -70.53 -26.51 63.61 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.434 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 4.0 tppp? -65.51 -51.8 48.81 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.304 -174.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 89.2 Cg_exo -67.14 -43.62 6.12 Favored 'Trans proline' 0 C--O 1.27 2.098 0 C-N-CA 122.901 2.4 . . . . 0.0 111.571 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.506 HG13 ' HA ' ' A' ' 44' ' ' LEU . 2.2 pp -63.13 -21.75 29.02 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 118.457 -1.297 . . . . 0.0 111.099 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.39 -24.26 16.79 Favored 'General case' 0 C--O 1.197 -1.681 0 O-C-N 123.677 0.611 . . . . 0.0 111.085 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.506 ' OE1' ' HD2' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -66.26 -21.39 66.28 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.41 -19.46 56.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.73 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 8.7 pt20 -139.04 35.73 2.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.267 1.032 . . . . 0.0 110.883 -171.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.506 ' HD2' ' OE1' ' A' ' 49' ' ' GLU . 14.3 ptm180 -73.05 -18.84 61.28 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.614 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.83 15.34 31.51 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.612 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.2 p -137.85 -29.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.866 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.6 mt -128.65 136.15 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 O-C-N 121.546 -0.721 . . . . 0.0 111.361 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -88.88 109.35 20.14 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.485 ' CD2' HD11 ' A' ' 29' ' ' ILE . 5.0 m-85 -93.31 114.98 27.56 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.509 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -136.97 128.62 4.46 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.353 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.471 ' H ' ' HA ' ' A' ' 10' ' ' GLU . 55.3 p -87.84 132.36 34.21 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 6.8 tt -132.79 145.25 34.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 63' ' ' LYS . 11.2 t70 -75.56 127.83 33.95 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.263 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -90.98 -1.3 57.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.624 0.725 . . . . 0.0 111.285 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HB3' ' OD1' ' A' ' 61' ' ' ASP . 39.1 ttmt -99.35 -34.19 10.41 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.38 -54.5 3.25 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.766 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.29 20.25 19.25 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 121.767 -0.583 . . . . 0.0 111.007 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -63.3 -20.4 63.08 Favored Glycine 0 C--N 1.309 -0.919 0 N-CA-C 116.246 1.258 . . . . 0.0 116.246 -172.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.04 -25.03 66.63 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.021 0.911 . . . . 0.0 110.591 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -73.09 -17.83 61.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.458 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.438 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -64.18 -33.58 76.11 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.623 1.202 . . . . 0.0 108.837 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.571 ' HA2' ' H ' ' A' ' 73' ' ' ASN . . . -116.22 24.08 10.17 Favored Glycine 0 C--N 1.27 -3.111 0 C-N-CA 118.564 -1.779 . . . . 0.0 114.226 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -8.4 58.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 166.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.483 HD12 ' CB ' ' A' ' 73' ' ' ASN . 4.1 pp -112.71 -38.55 4.55 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 112.867 -1.97 . . . . 0.0 109.18 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.571 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 11.5 t-20 -169.23 -56.95 0.02 OUTLIER 'General case' 0 C--N 1.367 1.356 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.5 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.3 mm? -60.49 173.37 0.71 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -167.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.605 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 53.1 tttm -90.54 -9.75 46.05 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.588 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.2 p 74.7 -13.13 0.85 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 128.358 2.663 . . . . 0.0 115.714 168.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.605 ' OD1' ' HG2' ' A' ' 75' ' ' LYS . 17.7 p-10 -108.1 5.04 25.6 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -166.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 36.2 ttmt -129.23 103.98 7.26 Favored 'General case' 0 C--N 1.258 -3.395 0 C-N-CA 119.527 -0.869 . . . . 0.0 113.256 -173.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.547 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 31.6 m-85 56.52 -175.57 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 124.417 1.073 . . . . 0.0 113.195 167.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 9.2 Cg_endo -65.12 134.07 38.01 Favored 'Trans proline' 0 N--CA 1.424 -2.596 0 CA-C-N 119.978 1.028 . . . . 0.0 113.113 167.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.95 116.64 20.39 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 113.903 -1.498 . . . . 0.0 107.878 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 61.5 t80 -91.34 109.32 20.6 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.381 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -111.0 115.85 30.18 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 39.2 mt -90.93 109.38 20.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 25.4 tt0 -106.74 120.54 42.27 Favored 'General case' 0 N--CA 1.395 -3.203 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.436 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 13.1 mt-10 -75.38 148.23 39.37 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.885 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 20' ' ' MET . 16.4 t -113.72 -1.87 10.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.88 -55.9 3.63 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -97.36 -19.78 18.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.212 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.759 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 47.2 t-20 59.85 80.43 0.2 Allowed 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 125.119 1.368 . . . . 0.0 108.277 -170.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.558 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 5.3 tp60 -133.59 165.26 25.33 Favored 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 113.789 -1.55 . . . . 0.0 107.519 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.504 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 1.2 mptp? -125.25 99.85 6.26 Favored 'General case' 0 N--CA 1.4 -2.964 0 O-C-N 123.82 0.7 . . . . 0.0 109.242 -175.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 44.6 m-85 -104.57 83.45 0.77 Allowed Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.999 174.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 4.6 Cg_endo -100.74 148.42 0.37 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 C-N-CA 122.879 2.386 . . . . 0.0 114.354 -177.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -88.8 158.75 18.03 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.844 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.5 m-20 -65.99 145.79 55.46 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 121.514 0.673 . . . . 0.0 111.426 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 13.2 mt-30 -84.25 5.2 27.53 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.299 -174.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.3 22.63 2.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.037 0.923 . . . . 0.0 110.108 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 14.6 tppt? -104.03 170.23 8.04 Favored 'General case' 0 N--CA 1.401 -2.898 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -94.26 110.29 22.05 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 118.647 0.658 . . . . 0.0 111.503 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.71 101.59 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.637 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.3 p -125.29 -170.59 2.2 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.019 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.3 t80 -75.28 -54.24 7.42 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -174.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -55.18 -54.0 48.87 Favored 'General case' 0 N--CA 1.384 -3.767 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.777 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.68 -48.82 78.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 123.742 0.651 . . . . 0.0 112.265 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 47.7 mm -73.65 -40.55 54.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -59.13 -46.6 87.94 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.48 94.78 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.829 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -65.38 -58.67 5.3 Favored 'General case' 0 C--O 1.21 -0.987 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.276 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.402 HG12 HD11 ' A' ' 84' ' ' ILE . 35.0 m -59.92 -33.25 52.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 O-C-N 121.689 -0.632 . . . . 0.0 110.7 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.18 -51.91 67.97 Favored 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 124.241 1.016 . . . . 0.0 109.673 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.667 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 3.6 t70 -58.89 -47.12 86.08 Favored 'General case' 0 C--O 1.206 -1.197 0 CA-C-N 113.699 -1.591 . . . . 0.0 107.383 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.47 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.1 t80 -55.44 -64.48 0.83 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.059 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.99 -11.95 14.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.224 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.77 -30.14 23.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.435 0.636 . . . . 0.0 109.744 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.41 26.74 5.54 Favored Glycine 0 CA--C 1.481 -2.051 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.667 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -96.68 -52.32 3.97 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-N 114.131 -1.035 . . . . 0.0 109.157 -176.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 112' ' ' ASP . 18.5 mt -71.15 145.1 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--N 1.277 -2.57 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.75 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 N--CA 1.442 -0.873 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.573 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 57.1 mt -92.48 139.05 18.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.54 -179.65 18.87 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.79 -31.68 42.98 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.45 3.433 . . . . 0.0 114.582 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.24 -7.59 24.47 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.0 p -93.83 -27.26 16.54 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.985 -169.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -45.93 -51.43 13.29 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.884 0.85 . . . . 0.0 111.012 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -55.5 -34.4 64.57 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.387 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -71.04 -41.64 70.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.456 0.646 . . . . 0.0 110.096 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 41.9 m-85 -72.48 -28.94 63.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.35 1.071 . . . . 0.0 108.271 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.464 ' SD ' HG22 ' A' ' 87' ' ' VAL . 5.8 tpp -78.39 -19.96 52.2 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.315 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -87.79 -17.11 32.31 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.355 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.37 -41.7 72.75 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.025 0.441 . . . . 0.0 110.794 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.22 0.28 65.66 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.662 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 13.7 pt -107.8 152.48 41.59 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HG2' HG12 ' A' ' 55' ' ' ILE . 9.9 Cg_endo -53.25 138.91 64.18 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.923 3.082 . . . . 0.0 113.759 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.488 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 2.5 tt -105.33 125.85 51.45 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.591 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -98.76 105.55 17.71 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.488 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 65.5 m-85 -86.72 112.43 21.66 Favored 'General case' 0 CA--C 1.467 -2.234 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.429 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.9 mt -101.09 85.08 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.596 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 43.6 m-85 -76.35 124.52 27.65 Favored 'General case' 0 CA--C 1.46 -2.515 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.64 121.17 21.62 Favored 'General case' 0 C--N 1.257 -3.447 0 O-C-N 123.456 0.473 . . . . 0.0 110.66 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -81.99 -16.69 49.49 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 17.6 p -97.11 100.55 12.03 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.722 -174.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.64 -16.93 60.14 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.94 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -71.57 -56.67 5.43 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.164 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.565 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 15.0 pt-20 -91.0 8.49 35.04 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.561 -175.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 33' ' ' THR 0.275 0.1 OUTLIER -59.71 -32.85 70.91 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.159 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -77.46 -33.63 54.61 Favored 'General case' 0 C--O 1.2 -1.543 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.782 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.565 ' OE2' ' HA ' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -65.77 -43.92 87.38 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.323 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.492 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -56.92 -49.51 75.39 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.552 ' OG ' HG21 ' A' ' 59' ' ' THR . 15.0 m -73.63 -13.41 61.0 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.061 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 24.4 t70 -77.49 -38.32 49.36 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 123.138 0.575 . . . . 0.0 111.074 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.597 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -69.37 -36.34 76.74 Favored 'General case' 0 C--O 1.276 2.495 0 CA-C-O 123.271 1.51 . . . . 0.0 107.952 172.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 75.5 mt -73.22 -18.52 61.23 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 113.527 -1.67 . . . . 0.0 111.94 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.622 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 36.9 ttpt -62.37 -55.03 43.6 Favored Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 123.646 0.778 . . . . 0.0 111.382 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.622 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 51.6 Cg_exo -72.22 -36.97 4.99 Favored 'Trans proline' 0 CA--C 1.485 -1.926 0 C-N-CA 122.593 2.195 . . . . 0.0 109.795 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.611 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 27.3 mm -54.38 -36.64 34.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.383 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.33 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.05 -20.47 22.04 Favored 'General case' 0 C--O 1.195 -1.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.249 -174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -69.9 -22.72 63.19 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.32 -9.62 59.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.757 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 9.3 pt20 -148.57 35.37 0.79 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.298 1.046 . . . . 0.0 110.644 -173.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.2 -19.23 61.14 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.805 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.13 21.68 11.9 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.679 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.496 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.7 p -138.84 -32.65 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.504 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.475 HG12 ' HG2' ' A' ' 25' ' ' PRO . 95.2 mt -122.85 137.6 55.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.812 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 13.1 m120 -84.16 111.75 19.63 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 29' ' ' ILE . 1.6 m-85 -97.67 105.82 18.03 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.573 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -130.62 130.46 6.16 Favored Glycine 0 N--CA 1.415 -2.747 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.867 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.567 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 35.6 p -92.38 136.97 32.76 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 tt -137.31 156.92 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD2' ' HD1' ' A' ' 65' ' ' PHE . 3.4 p30 -75.28 149.71 38.73 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.347 0.594 . . . . 0.0 110.172 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.6 14.03 26.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.904 0.859 . . . . 0.0 108.764 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -84.43 -53.71 5.25 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.045 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.56 -48.6 3.21 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.3 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.482 ' HD1' ' OD2' ' A' ' 61' ' ' ASP . 96.0 m-85 -97.97 10.49 40.2 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.987 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.11 -24.63 61.1 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 115.881 1.113 . . . . 0.0 115.881 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.92 -20.83 65.98 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.399 1.099 . . . . 0.0 110.333 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -70.82 -20.72 62.54 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.552 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -61.19 -39.39 89.99 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-O 122.343 1.068 . . . . 0.0 109.652 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -113.21 31.44 6.71 Favored Glycine 0 C--N 1.27 -3.101 0 C-N-CA 119.275 -1.441 . . . . 0.0 113.825 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.59 -17.46 38.71 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 168.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.457 HD12 ' N ' ' A' ' 73' ' ' ASN . 4.0 pp -102.82 -24.95 13.67 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.041 -1.891 . . . . 0.0 110.998 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.457 ' N ' HD12 ' A' ' 72' ' ' LEU . 2.2 t-20 -179.96 -59.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.604 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.6 mm? -54.41 158.71 2.29 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -168.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -75.42 -17.69 60.1 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.829 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.428 HG22 ' HB3' ' A' ' 69' ' ' ALA . 48.6 p 55.17 40.33 31.72 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.182 1.393 . . . . 0.0 113.42 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' OD2' ' HE2' ' A' ' 78' ' ' LYS . 20.6 p-10 -125.18 -23.13 4.25 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.164 0.507 . . . . 0.0 111.224 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HE2' ' OD2' ' A' ' 77' ' ' ASP . 33.6 mtmt -108.13 -174.69 2.58 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -170.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.729 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 95.7 m-85 -69.16 -172.45 0.17 Allowed Pre-proline 0 CA--C 1.572 1.822 0 C-N-CA 125.791 1.637 . . . . 0.0 109.967 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.729 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 1.3 Cg_endo -43.67 131.09 7.52 Favored 'Trans proline' 1 C--N 1.429 4.788 0 CA-C-N 122.415 1.898 . . . . 0.0 116.42 -170.476 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.423 ' HB1' ' HG ' ' A' ' 74' ' ' LEU . . . -126.85 116.05 20.27 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 113.101 -1.863 . . . . 0.0 107.93 -175.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.591 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 71.5 t80 -95.14 109.85 21.88 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.971 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -112.07 117.1 31.72 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.478 HD11 HG12 ' A' ' 110' ' ' VAL . 56.2 mt -91.45 105.22 16.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.666 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -90.13 126.37 35.77 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 2.8 mm-40 -87.88 125.59 34.57 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.549 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.464 HG22 ' SD ' ' A' ' 20' ' ' MET . 15.1 t -98.12 1.22 10.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.39 -35.07 3.66 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.177 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 89' ' ' LYS . 5.9 tmtm? -95.83 -20.16 19.03 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.3 m120 67.52 36.72 3.66 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-O 122.847 1.308 . . . . 0.0 110.337 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.505 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 2.0 tp60 -121.14 -179.69 4.12 Favored 'General case' 0 CA--C 1.472 -2.048 0 CA-C-N 112.803 -1.999 . . . . 0.0 107.681 -172.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.541 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 57.3 mmtt -138.12 106.17 5.71 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -102.47 87.2 1.08 Allowed Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 10.8 Cg_endo -102.33 142.25 0.19 Allowed 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 122.572 2.182 . . . . 0.0 114.638 -176.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.451 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 86.4 t80 -84.58 170.49 13.35 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.34 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 9.3 m-20 -72.42 159.49 33.89 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.122 0.969 . . . . 0.0 110.295 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -100.75 -11.67 19.72 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-O 121.83 0.824 . . . . 0.0 108.909 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -123.42 -0.18 8.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.347 -173.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 33.3 ttmt -87.58 -3.18 58.99 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.869 -172.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 72.95 134.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.145 0.978 . . . . 0.0 111.703 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.567 HG23 HG13 ' A' ' 106' ' ' ILE . 2.8 mp -90.04 101.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 122.009 0.909 . . . . 0.0 109.846 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.7 p -109.33 -174.02 2.4 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 18.9 t80 -77.2 -51.14 11.45 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -59.95 -52.39 65.61 Favored 'General case' 0 N--CA 1.379 -3.985 0 CA-C-N 112.493 -2.14 . . . . 0.0 113.397 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.57 83.46 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.121 0.486 . . . . 0.0 111.39 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.567 HG13 HG23 ' A' ' 101' ' ' ILE . 40.2 mm -73.05 -42.0 59.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.0 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 47' ' ' ILE . 33.8 ttpt -56.46 -50.56 71.38 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.34 92.63 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.143 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.496 ' O ' HD11 ' A' ' 118' ' ' ILE . 57.8 t80 -63.69 -59.92 3.98 Favored 'General case' 0 C--O 1.204 -1.305 0 O-C-N 124.02 0.825 . . . . 0.0 111.074 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 106' ' ' ILE . 31.4 m -58.87 -35.72 57.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 O-C-N 121.998 -0.438 . . . . 0.0 111.535 -176.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.88 -51.93 66.18 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.719 0.771 . . . . 0.0 109.036 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.69 ' OD1' ' HB3' ' A' ' 117' ' ' LYS . 5.6 t0 -57.35 -36.08 70.75 Favored 'General case' 0 C--O 1.196 -1.711 0 CA-C-N 113.45 -1.704 . . . . 0.0 109.731 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.693 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -71.25 -61.22 1.85 Allowed 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.89 177.484 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.09 -23.44 33.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.542 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.52 -22.19 44.26 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.605 0.717 . . . . 0.0 109.622 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.4 18.22 15.31 Favored Glycine 0 CA--C 1.466 -2.994 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.487 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.69 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 12.7 ttpp -93.04 -38.31 11.7 Favored 'General case' 0 N--CA 1.384 -3.753 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.609 -172.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.693 HD12 ' HB2' ' A' ' 113' ' ' PHE . 9.9 mt -67.57 141.92 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.407 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--N 1.256 -3.471 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.23 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.423 -1.777 0 CA-C-O 121.46 0.648 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.533 HG13 ' HA3' ' A' ' 58' ' ' GLY . 62.1 mt -95.72 114.04 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -127.77 -178.92 15.56 Favored Glycine 0 N--CA 1.408 -3.199 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.29 -8.28 8.23 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.036 3.157 . . . . 0.0 115.67 -173.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -123.98 -18.36 5.98 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.018 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.8 p -85.23 -27.62 25.94 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.573 -172.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -62.09 -36.74 82.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.293 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 m -66.66 -27.31 67.57 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.867 0.867 . . . . 0.0 110.574 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.95 -39.07 61.55 Favored 'General case' 0 C--O 1.258 1.549 0 CA-C-O 121.704 0.764 . . . . 0.0 109.095 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -75.12 -26.15 58.98 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.463 ' SD ' HG22 ' A' ' 87' ' ' VAL . 8.8 tpp -77.76 -25.3 49.03 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.661 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -88.82 -10.75 46.98 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.405 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.27 -35.19 73.6 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 122.086 -0.384 . . . . 0.0 111.543 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.48 65.55 Favored Glycine 0 N--CA 1.461 0.304 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.366 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 9.1 pt -126.1 151.62 72.07 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HG2' HG12 ' A' ' 55' ' ' ILE . 8.0 Cg_endo -50.14 141.56 30.32 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.068 3.179 . . . . 0.0 114.037 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.448 HD13 ' CE1' ' A' ' 28' ' ' TYR . 2.5 tt -110.4 124.81 52.42 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.548 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -94.1 105.46 17.46 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.448 ' CE1' HD13 ' A' ' 26' ' ' LEU . 48.3 m-85 -87.59 110.7 20.57 Favored 'General case' 0 CA--C 1.471 -2.058 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.363 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.7 mt -100.23 85.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.319 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.546 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 31.5 m-85 -77.53 109.91 11.88 Favored 'General case' 0 CA--C 1.468 -2.181 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -124.06 119.75 30.39 Favored 'General case' 1 C--N 1.238 -4.245 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.701 177.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -74.54 -27.2 60.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 11.4 p -93.49 106.6 18.55 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.61 -173.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . -78.78 -21.28 48.1 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.909 -175.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -80.1 -48.51 13.12 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.042 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.489 ' HG2' ' HB ' ' A' ' 33' ' ' THR . 12.5 pt-20 -90.7 1.18 57.07 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.553 -0.859 . . . . 0.0 112.158 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 12.2 ptm180 -60.19 -24.31 64.68 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -58.48 -57.9 10.92 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.53 -25.79 54.51 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.166 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.654 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -60.24 -50.98 71.5 Favored 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.416 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.457 ' HA ' HD12 ' A' ' 44' ' ' LEU . 9.9 m -75.11 -19.4 59.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.73 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.43 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 15.9 t70 -67.79 -43.39 79.84 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.836 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.626 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.6 OUTLIER -70.37 -34.05 72.14 Favored 'General case' 0 C--O 1.278 2.597 0 CA-C-O 122.772 1.272 . . . . 0.0 108.463 176.293 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 56.9 mt -69.94 -20.51 63.33 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.716 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.599 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 17.4 tppt? -61.97 -57.29 24.8 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.843 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 72.8 Cg_exo -66.82 -39.42 14.84 Favored 'Trans proline' 0 CA--C 1.49 -1.696 0 C-N-CA 122.917 2.411 . . . . 0.0 110.351 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.579 HD11 ' HA ' ' A' ' 103' ' ' PHE . 93.8 mt -52.67 -40.36 34.02 Favored 'Isoleucine or valine' 0 C--N 1.368 1.388 0 O-C-N 124.086 0.866 . . . . 0.0 109.208 176.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -94.26 -13.79 26.16 Favored 'General case' 0 C--O 1.177 -2.718 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.603 -173.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -71.94 -22.36 61.48 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.92 -23.45 33.51 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.906 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.524 ' OE1' HD12 ' A' ' 55' ' ' ILE . 5.4 pt20 -130.85 34.37 4.09 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.19 0.995 . . . . 0.0 112.373 -174.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -73.25 -18.58 61.21 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.393 -1.73 . . . . 0.0 111.858 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.38 4.4 28.17 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.418 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.8 p -124.15 -33.5 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.325 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.524 HD12 ' OE1' ' A' ' 51' ' ' GLN . 95.0 mt -124.39 136.81 59.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.034 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -84.83 104.65 14.97 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -90.16 102.67 15.39 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.573 0.701 . . . . 0.0 112.564 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.533 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -124.21 131.74 8.05 Favored Glycine 0 N--CA 1.415 -2.762 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.424 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 27.4 p -92.27 134.67 34.68 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 120.896 0.379 . . . . 0.0 110.515 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 8.7 tt -137.15 165.58 27.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -89.13 153.88 20.6 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-O 121.458 0.647 . . . . 0.0 110.922 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -110.48 19.83 18.36 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 173.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -102.82 -46.02 4.82 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 113.382 -1.735 . . . . 0.0 109.844 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.47 -43.58 3.48 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.139 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.421 ' O ' ' HE2' ' A' ' 30' ' ' PHE . 96.4 m-85 -99.21 10.12 42.07 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 122.124 -0.36 . . . . 0.0 110.68 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 62' ' ' ALA . . . -58.97 -30.04 66.0 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.01 -30.08 46.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.413 0.625 . . . . 0.0 111.303 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -69.15 -23.81 64.0 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.285 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.461 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -63.02 -34.41 77.5 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-O 121.978 0.894 . . . . 0.0 109.861 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.45 ' HA2' ' N ' ' A' ' 74' ' ' LEU . . . -109.28 5.34 31.7 Favored Glycine 0 C--N 1.279 -2.591 0 C-N-CA 117.403 -2.332 . . . . 0.0 115.502 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -76.57 -16.97 59.46 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 73' ' ' ASN . 4.2 pp -97.68 -31.38 12.3 Favored 'General case' 0 N--CA 1.399 -2.987 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.349 174.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.432 ' HB2' HD12 ' A' ' 72' ' ' LEU . 2.2 t-20 179.51 -56.74 0.01 OUTLIER 'General case' 0 C--N 1.38 1.906 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' A' ' 94' ' ' PRO . 2.3 mm? -61.4 179.9 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -169.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.25 -0.68 20.72 Favored 'General case' 0 CA--C 1.486 -1.515 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.99 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.467 ' N ' HE22 ' A' ' 97' ' ' GLN . 19.2 p 59.3 5.78 0.64 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 125.205 1.402 . . . . 0.0 112.401 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.92 -25.09 28.12 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -170.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 11.4 tptm -119.21 -158.68 0.74 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.672 -166.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.529 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 89.5 m-85 -54.99 168.32 0.53 Allowed Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 125.054 1.341 . . . . 0.0 110.506 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 2.5 Cg_endo -40.63 130.44 2.64 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.998 2.465 . . . . 0.0 114.431 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -103.75 104.82 14.88 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.608 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.548 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 74.3 t80 -87.13 111.5 21.0 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.908 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.88 119.39 32.51 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.518 HD11 HG12 ' A' ' 110' ' ' VAL . 55.2 mt -89.41 104.84 15.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -86.18 132.77 33.94 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.626 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.15 141.89 29.87 Favored 'General case' 0 C--N 1.265 -3.098 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.017 175.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.463 HG22 ' SD ' ' A' ' 20' ' ' MET . 25.8 t -107.79 -2.06 10.0 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.38 -48.19 3.75 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.42 ' HD3' ' OE2' ' A' ' 86' ' ' GLU . 4.7 mptp? -89.38 -25.15 21.73 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.981 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 16.2 t-20 66.17 20.72 11.15 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.36 1.464 . . . . 0.0 108.465 -173.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.539 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 4.4 tp60 -85.95 178.7 7.19 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.617 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 56.7 mmtt -138.46 105.04 5.31 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -96.88 87.84 0.49 Allowed Pre-proline 0 N--CA 1.481 1.084 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 6.0 Cg_endo -104.82 145.7 0.12 Allowed 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.516 2.144 . . . . 0.0 115.01 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.4 ' HD1' ' CD1' ' A' ' 109' ' ' PHE . 77.2 t80 -86.0 158.78 19.78 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.595 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.619 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.3 m-20 -71.48 134.49 46.59 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.109 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.467 HE22 ' N ' ' A' ' 76' ' ' THR . 48.1 mt-30 -75.74 9.62 2.21 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.722 -175.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -154.92 20.96 0.45 Allowed 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.177 0.513 . . . . 0.0 111.443 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.619 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 39.1 ttmt -97.86 9.89 41.57 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 74.09 120.46 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 113.562 -1.654 . . . . 0.0 112.025 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.2 mp -92.82 98.54 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.03 -164.47 1.32 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.923 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.579 ' HA ' HD11 ' A' ' 47' ' ' ILE . 16.0 t80 -77.79 -58.62 3.17 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -174.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -52.84 -53.75 44.18 Favored 'General case' 0 N--CA 1.386 -3.638 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.527 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.83 -49.31 77.1 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 123.596 0.56 . . . . 0.0 112.371 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 110' ' ' VAL . 41.8 mm -72.96 -42.45 59.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.024 -177.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.414 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 28.6 ttpt -54.52 -50.96 66.61 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.996 0.81 . . . . 0.0 109.241 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 112' ' ' ASP . . . -63.11 -39.11 93.73 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.559 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.4 ' CD1' ' HD1' ' A' ' 95' ' ' PHE . 66.7 t80 -65.32 -60.13 3.31 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.62 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.518 HG12 HD11 ' A' ' 84' ' ' ILE . 27.6 m -57.62 -36.62 54.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 O-C-N 121.83 -0.544 . . . . 0.0 111.422 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.29 -46.37 87.07 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.216 0.531 . . . . 0.0 109.681 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.69 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 3.4 t70 -57.27 -48.98 77.5 Favored 'General case' 0 C--O 1.203 -1.39 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.523 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.7 t80 -57.02 -63.59 1.16 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.622 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 110' ' ' VAL . 90.6 t -52.48 -30.8 14.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 C-N-CA 124.311 1.044 . . . . 0.0 112.37 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.59 -38.95 58.7 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.676 0.751 . . . . 0.0 110.026 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.16 23.87 5.64 Favored Glycine 0 CA--C 1.473 -2.534 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.69 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 3.3 ttmm -92.39 -42.52 9.73 Favored 'General case' 0 N--CA 1.387 -3.579 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.605 HG13 ' HB3' ' A' ' 112' ' ' ASP . 23.5 mt -81.37 143.35 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--N 1.272 -2.772 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 179.373 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.413 ' HG2' ' OG1' ' A' ' 59' ' ' THR . 42.4 mt-10 . . . . . 0 N--CA 1.426 -1.652 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.565 HG13 ' HA3' ' A' ' 58' ' ' GLY . 67.7 mt -105.69 120.9 57.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.56 179.75 18.57 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.54 5.36 4.3 Favored 'Trans proline' 0 C--O 1.221 -0.367 0 C-N-CA 123.029 2.486 . . . . 0.0 112.752 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -128.64 -6.18 5.18 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.869 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -100.27 -28.31 13.05 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.736 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -59.09 -38.38 79.38 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.9 0.381 . . . . 0.0 111.693 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 m -65.22 -27.09 68.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.717 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.81 -33.4 40.41 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.034 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.402 ' HB3' ' CG ' ' A' ' 56' ' ' ASN . 21.1 m-85 -75.8 -27.21 57.88 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.558 ' SD ' HG22 ' A' ' 87' ' ' VAL . 8.7 tpp -77.07 -21.53 54.28 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 113.554 -1.657 . . . . 0.0 108.757 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.4 t -90.0 -12.77 37.66 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.8 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.26 60.39 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.226 0.536 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.63 2.85 78.46 Favored Glycine 0 C--N 1.32 -0.35 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.25 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 13.6 pt -112.04 148.64 39.47 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.481 ' HG2' HG12 ' A' ' 55' ' ' ILE . 6.6 Cg_endo -51.29 142.21 37.63 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.834 3.022 . . . . 0.0 113.846 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.51 HD13 ' CE1' ' A' ' 28' ' ' TYR . 2.6 tt -108.98 126.91 53.6 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -101.02 109.07 20.93 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE1' HD13 ' A' ' 26' ' ' LEU . 47.1 m-85 -89.58 109.61 20.54 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.365 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.532 HD11 ' CD2' ' A' ' 57' ' ' PHE . 2.5 mp -101.04 87.92 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.337 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.586 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 42.9 m-85 -73.02 133.73 44.36 Favored 'General case' 0 CA--C 1.467 -2.226 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . . . -148.19 117.08 6.73 Favored 'General case' 0 C--N 1.274 -2.693 0 O-C-N 123.593 0.558 . . . . 0.0 111.665 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.01 -22.8 59.44 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.852 0.834 . . . . 0.0 108.911 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.452 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 17.0 p -76.52 115.88 16.68 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.882 -173.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.33 -15.26 19.82 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.395 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -85.69 -63.72 1.27 Allowed 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.452 ' HG2' ' HB ' ' A' ' 33' ' ' THR . 1.3 pm0 -78.91 12.5 2.14 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.462 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.6 tpp85 -52.7 -39.07 61.64 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 169.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -67.03 -48.49 68.17 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.607 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 45.6 mt-10 -59.61 -50.52 73.55 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.217 0.532 . . . . 0.0 110.307 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -53.23 -54.42 36.43 Favored 'General case' 0 C--O 1.255 1.354 0 C-N-CA 124.653 1.181 . . . . 0.0 108.849 -176.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.468 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 12.3 m -73.6 -15.18 61.28 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.62 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 33.8 t70 -75.09 -35.59 61.79 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 122.954 0.501 . . . . 0.0 111.458 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -77.49 -30.17 52.94 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 122.865 1.317 . . . . 0.0 108.81 173.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 45.8 mt -73.16 -30.97 63.95 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 113.626 -1.624 . . . . 0.0 113.713 -177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 24.8 ttpp -68.2 -46.4 39.84 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.694 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 73.5 Cg_endo -70.88 -42.56 2.18 Favored 'Trans proline' 0 C--O 1.26 1.593 0 C-N-CA 122.485 2.123 . . . . 0.0 110.996 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 107' ' ' LYS . 2.6 pp -63.15 -24.89 37.15 Favored 'Isoleucine or valine' 0 C--N 1.385 2.128 0 C-N-CA 118.11 -1.436 . . . . 0.0 109.99 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.85 -22.23 19.4 Favored 'General case' 0 C--O 1.194 -1.841 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.201 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 6.2 tt0 -69.84 -18.44 63.44 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.72 -21.56 51.71 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.971 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 9.3 pt20 -138.51 36.54 2.25 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.2 1.0 . . . . 0.0 111.108 -170.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 49' ' ' GLU . 9.1 ptm180 -76.85 -14.02 59.94 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.645 -172.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.6 6.68 22.54 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.632 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.567 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.6 p -125.6 -32.51 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.515 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.481 HG12 ' HG2' ' A' ' 25' ' ' PRO . 94.6 mt -122.2 136.31 59.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.412 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.402 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 11.3 m120 -84.65 104.04 14.28 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.532 ' CD2' HD11 ' A' ' 29' ' ' ILE . 3.7 m-85 -90.75 103.61 16.29 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.565 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -124.34 130.88 7.69 Favored Glycine 0 N--CA 1.408 -3.22 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.412 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.413 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 20.7 p -92.01 127.82 37.62 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 9.3 tt -126.57 143.17 40.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 63' ' ' LYS . 20.3 t70 -76.27 131.13 39.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.122 -175.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -92.48 -1.08 57.23 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.343 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HB3' ' OD2' ' A' ' 61' ' ' ASP . 81.8 tttt -92.4 -43.61 9.13 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.52 -40.09 9.63 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.769 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -115.48 20.8 14.52 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.736 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.437 ' CA ' ' HA ' ' A' ' 62' ' ' ALA . . . -69.31 -23.29 76.41 Favored Glycine 0 C--N 1.305 -1.181 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 -169.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.0 -21.69 63.81 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.254 0.55 . . . . 0.0 111.4 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -69.13 -25.35 64.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.666 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -59.56 -35.28 73.94 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.073 0.939 . . . . 0.0 111.362 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -109.54 13.49 32.88 Favored Glycine 0 C--N 1.27 -3.114 0 C-N-CA 117.596 -2.24 . . . . 0.0 115.895 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -24.25 58.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 169.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 4.0 pp -92.45 -37.53 12.49 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.385 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.502 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 20.9 t-20 -172.94 -57.88 0.02 OUTLIER 'General case' 0 C--N 1.369 1.452 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.536 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.5 mm? -54.58 164.79 0.67 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -167.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -81.06 -14.87 57.42 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.757 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.475 HG22 ' HB3' ' A' ' 69' ' ' ALA . 28.9 p 59.6 21.44 10.05 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.655 1.982 . . . . 0.0 114.076 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -105.39 -25.27 12.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -135.41 115.05 12.76 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -166.05 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.677 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 14.8 t80 60.39 179.74 0.04 OUTLIER Pre-proline 0 CA--C 1.581 2.16 0 O-C-N 125.126 1.516 . . . . 0.0 111.546 158.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.677 ' HD2' ' CG ' ' A' ' 79' ' ' PHE . 3.7 Cg_endo -55.81 134.52 64.54 Favored 'Trans proline' 0 C--N 1.378 2.095 0 CA-C-N 120.805 1.323 . . . . 0.0 113.837 167.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.421 ' HB1' ' HG ' ' A' ' 74' ' ' LEU . . . -125.8 113.17 16.91 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.45 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.454 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 62.5 t80 -90.25 111.3 22.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -116.27 118.05 31.71 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 58.7 mt -93.7 114.09 29.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.547 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -102.53 126.77 49.7 Favored 'General case' 0 N--CA 1.405 -2.717 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 0.7 OUTLIER -78.98 136.65 37.28 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.95 177.291 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.558 HG22 ' SD ' ' A' ' 20' ' ' MET . 23.6 t -104.3 -5.18 9.56 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.62 -38.17 6.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.368 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 23.1 ttmm -101.88 -17.83 15.99 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 44.8 t-20 56.44 75.43 0.35 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 124.55 1.14 . . . . 0.0 108.507 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -144.17 174.34 10.97 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.087 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -126.97 102.35 6.95 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -177.193 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.408 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 60.8 m-85 -107.93 80.7 1.07 Allowed Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 15.4 Cg_endo -101.17 144.84 0.28 Allowed 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.907 2.405 . . . . 0.0 114.077 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -85.01 165.55 17.45 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 125.247 1.419 . . . . 0.0 108.259 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.742 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 9.0 m-20 -73.78 145.39 45.08 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.446 ' O ' ' HB3' ' A' ' 79' ' ' PHE . 13.0 mt-30 -83.02 -5.47 59.11 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.233 -170.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -148.09 32.36 0.83 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.337 1.065 . . . . 0.0 110.685 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 17.2 tppt? -95.95 -6.76 38.29 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.206 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 74.24 127.69 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.967 1.307 . . . . 0.0 111.734 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.472 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.0 mp -93.65 116.89 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.369 -176.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 p -122.49 -174.69 2.97 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.411 ' HA ' ' HB3' ' A' ' 43' ' ' LYS . 20.2 t80 -76.73 -48.7 17.98 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.6 -55.8 30.21 Favored 'General case' 0 N--CA 1.387 -3.618 0 CA-C-N 112.099 -2.319 . . . . 0.0 112.38 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.44 74.51 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.654 0.596 . . . . 0.0 111.996 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.472 ' CG1' HG23 ' A' ' 101' ' ' ILE . 42.1 mm -74.08 -43.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.68 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.41 ' HB2' HG21 ' A' ' 47' ' ' ILE . 36.5 ttpt -56.85 -48.24 78.54 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 124.118 0.886 . . . . 0.0 109.683 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.55 99.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.733 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.605 ' HA ' ' OD1' ' A' ' 112' ' ' ASP . 38.5 t80 -64.44 -58.13 7.31 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.495 1.118 . . . . 0.0 111.273 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 106' ' ' ILE . 26.8 m -58.95 -31.94 46.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 O-C-N 121.531 -0.731 . . . . 0.0 110.614 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.32 -52.93 50.7 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 123.828 0.851 . . . . 0.0 109.358 177.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.605 ' OD1' ' HA ' ' A' ' 109' ' ' PHE 0.281 0.4 OUTLIER -67.48 -22.1 65.49 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.329 -177.027 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.53 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.6 OUTLIER -72.75 -63.7 1.11 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.524 172.501 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.05 -20.95 27.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.09 -174.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.1 -30.43 60.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.22 40.24 1.83 Allowed Glycine 0 CA--C 1.479 -2.211 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.665 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -117.58 -41.73 2.92 Favored 'General case' 0 N--CA 1.391 -3.391 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.739 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 113' ' ' PHE . 6.6 mt -65.09 141.27 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.723 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--N 1.265 -3.091 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.467 -176.776 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.407 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -91.95 16.8 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.042 2.495 . . . . 0.0 112.592 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt -87.35 152.12 22.53 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.28 63.83 1.91 Allowed Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 m -66.99 152.98 95.39 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 122.924 0.489 . . . . 0.0 110.41 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.98 117.91 4.73 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 107.228 -1.874 . . . . 0.0 107.228 171.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 52' ' ' ARG . 15.1 tp -75.97 -24.1 55.38 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.235 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 5.2 mp -113.07 106.03 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.37 -144.3 4.14 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -107.79 138.69 43.58 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 122.09 0.947 . . . . 0.0 111.813 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.569 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 62.7 mt -88.22 127.96 40.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.476 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.2 -176.42 20.04 Favored Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.06 -18.45 50.87 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.769 2.979 . . . . 0.0 113.792 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -94.8 -40.77 9.57 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.995 0.426 . . . . 0.0 110.818 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.2 p -86.18 -29.58 23.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -167.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -60.66 -37.5 81.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.654 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.5 m -67.9 -26.31 65.93 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.598 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -79.01 -34.57 43.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.414 0.626 . . . . 0.0 110.015 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -74.95 -28.37 60.56 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.489 ' SD ' HG22 ' A' ' 87' ' ' VAL . 7.4 tpp -79.67 -20.73 45.94 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.709 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 t -96.57 -5.51 39.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.862 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.27 -34.83 66.02 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.946 0.403 . . . . 0.0 110.202 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.21 -13.32 64.8 Favored Glycine 0 CA--C 1.51 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.27 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 16.5 pt -98.73 153.73 37.76 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 123.66 0.784 . . . . 0.0 109.475 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HG2' HG12 ' A' ' 55' ' ' ILE . 18.3 Cg_endo -58.69 145.77 94.51 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 123.53 2.82 . . . . 0.0 113.534 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.607 HD13 ' CE1' ' A' ' 28' ' ' TYR . 1.8 tt -110.98 127.25 55.45 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -176.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.453 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.8 108.97 21.73 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CE1' HD13 ' A' ' 26' ' ' LEU . 23.0 m-85 -90.19 110.5 21.53 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 124.387 1.075 . . . . 0.0 109.462 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.531 HD11 ' CD2' ' A' ' 57' ' ' PHE . 3.5 mp -101.25 91.05 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 C-N-CA 118.811 -1.156 . . . . 0.0 109.521 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.625 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 46.6 m-85 -76.43 128.24 34.43 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -143.48 119.42 10.63 Favored 'General case' 0 C--N 1.27 -2.862 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.576 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.44 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 49.1 mt-10 -84.99 -2.05 57.5 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.252 0.549 . . . . 0.0 109.747 173.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 7.3 p -91.61 123.54 35.09 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.877 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.99 -21.05 18.86 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.26 0.552 . . . . 0.0 110.655 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.453 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 37.1 mt-10 -86.07 -66.43 0.9 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.82 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 12.5 pt-20 -73.7 1.59 9.98 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 33' ' ' THR . 15.7 ttt180 -54.46 -43.03 71.34 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 124.223 1.009 . . . . 0.0 108.705 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 45.5 mtmt -60.6 -49.45 77.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.896 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -64.82 -43.82 91.87 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 123.609 0.568 . . . . 0.0 111.434 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -54.24 -52.68 60.56 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -178.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.625 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 7.9 m -76.21 -18.85 58.86 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.891 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 25.1 t70 -74.66 -31.34 61.91 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.45 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.625 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 46.2 mmtt -79.8 -29.35 40.26 Favored 'General case' 0 C--O 1.277 2.508 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 64.3 mt -70.02 -25.62 63.67 Favored 'General case' 0 N--CA 1.408 -2.573 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.373 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 41' ' ' SER . 87.9 mttt -61.14 -54.79 50.39 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 119.712 -0.185 . . . . 0.0 111.251 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 73.8 Cg_exo -69.16 -43.92 2.84 Favored 'Trans proline' 0 C--O 1.263 1.765 0 C-N-CA 122.856 2.371 . . . . 0.0 111.801 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.456 HG13 ' HA ' ' A' ' 44' ' ' LEU . 2.3 pp -63.89 -24.12 35.0 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.063 0 C-N-CA 118.405 -1.318 . . . . 0.0 110.981 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.21 -20.99 18.76 Favored 'General case' 0 C--O 1.204 -1.316 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.724 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -66.3 -25.11 66.7 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.4 -11.83 59.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.794 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 9.3 pt20 -145.32 33.96 1.08 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.405 1.098 . . . . 0.0 110.488 -172.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.528 ' O ' HD23 ' A' ' 7' ' ' LEU . 15.1 ptt180 -74.38 -7.97 54.7 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.287 -173.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.96 0.6 14.94 Favored Glycine 0 C--N 1.289 -2.074 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.76 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.522 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 13.2 p -121.85 -31.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.845 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.431 HG12 ' HG2' ' A' ' 25' ' ' PRO . 84.2 mt -123.17 140.45 46.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.594 -0.843 . . . . 0.0 110.47 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.444 ' OD1' HD11 ' A' ' 7' ' ' LEU . 13.8 m-80 -86.17 117.17 24.82 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 1.8 m-85 -103.89 103.03 12.84 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.977 0.894 . . . . 0.0 112.874 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.569 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -123.65 128.43 6.92 Favored Glycine 0 N--CA 1.406 -3.345 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.72 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.3 p -92.36 127.69 37.93 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 7.8 tt -124.26 142.64 40.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.47 125.96 28.28 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.579 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -92.9 7.34 44.3 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.221 -0.991 . . . . 0.0 111.507 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -104.78 -38.0 6.84 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.11 -42.48 9.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.611 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.73 26.99 8.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.454 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -70.82 -24.21 77.22 Favored Glycine 0 CA--C 1.488 -1.617 0 C-N-CA 120.779 -0.724 . . . . 0.0 114.683 -173.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.54 -28.6 46.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.436 0.636 . . . . 0.0 110.847 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -64.93 -23.09 67.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.234 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.604 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -64.08 -36.22 83.29 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.984 0.897 . . . . 0.0 110.4 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.468 ' HA2' ' H ' ' A' ' 73' ' ' ASN . . . -105.09 7.47 44.21 Favored Glycine 0 C--N 1.281 -2.518 0 C-N-CA 117.568 -2.253 . . . . 0.0 114.835 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -74.76 -16.89 60.71 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 166.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 4.2 pp -104.22 -37.56 7.23 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.065 174.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.468 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 5.2 t-20 -176.35 -52.19 0.01 OUTLIER 'General case' 0 C--N 1.384 2.107 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.485 HD22 ' H ' ' A' ' 74' ' ' LEU . 2.0 mm? -65.44 159.59 23.96 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -167.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -81.1 -4.28 54.77 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 69' ' ' ALA . 80.3 p 56.43 17.41 2.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.268 1.027 . . . . 0.0 112.226 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.408 ' OD1' ' HG3' ' A' ' 75' ' ' LYS . 14.3 p-10 -94.39 -14.98 24.74 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -172.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 98' ' ' GLU . 22.7 tptt -123.49 -165.29 1.31 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 118.503 -1.279 . . . . 0.0 113.273 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.64 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 96.5 m-85 -61.47 173.14 0.82 Allowed Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 125.925 1.69 . . . . 0.0 110.35 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 5.5 Cg_endo -40.15 131.21 2.24 Favored 'Trans proline' 0 C--N 1.414 3.993 0 C-N-CA 122.444 2.096 . . . . 0.0 115.557 -171.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -109.68 110.11 21.04 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.808 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.453 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 53.5 t80 -88.84 112.45 23.25 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.723 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -121.0 120.35 35.16 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.409 HD11 HG12 ' A' ' 110' ' ' VAL . 59.2 mt -92.66 113.35 27.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.852 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.18 134.33 35.46 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 89' ' ' LYS . 2.5 mm-40 -87.5 126.97 35.22 Favored 'General case' 0 C--N 1.266 -3.058 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.227 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.489 HG22 ' SD ' ' A' ' 20' ' ' MET . 41.2 t -95.31 -2.77 10.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.77 -44.12 3.52 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.438 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 36.3 mtmm -97.83 -11.06 23.69 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.344 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 66.89 10.55 7.7 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 125.011 1.324 . . . . 0.0 110.247 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.444 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 1.5 tp60 -80.08 172.35 13.89 Favored 'General case' 0 CA--C 1.477 -1.856 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.356 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.615 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 65.4 mmtt -139.36 105.09 5.13 Favored 'General case' 0 N--CA 1.404 -2.733 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 62.4 m-85 -100.28 86.4 0.63 Allowed Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 7.8 Cg_endo -101.96 152.63 0.32 Allowed 'Trans proline' 0 N--CA 1.429 -2.294 0 C-N-CA 122.477 2.118 . . . . 0.0 114.065 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' HD1' ' CD1' ' A' ' 109' ' ' PHE . 49.8 t80 -94.67 162.97 13.56 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 124.858 1.263 . . . . 0.0 107.746 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 10.7 m-20 -66.22 153.19 43.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.067 0.461 . . . . 0.0 110.32 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -102.22 0.96 35.31 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 8.6 pt-20 -132.38 28.45 4.36 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.146 -171.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 3.7 tppp? -113.63 -89.53 0.53 Allowed 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.739 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 176.39 127.33 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 124.062 0.945 . . . . 0.0 109.032 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.484 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.9 mp -102.62 105.37 18.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.42 -169.04 1.87 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.596 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.8 t80 -77.57 -53.23 7.84 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -60.39 -46.82 88.6 Favored 'General case' 0 N--CA 1.391 -3.393 0 CA-C-N 112.267 -2.242 . . . . 0.0 112.894 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.82 83.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.991 0.424 . . . . 0.0 111.149 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.484 ' CG1' HG23 ' A' ' 101' ' ' ILE . 36.9 mm -70.95 -44.37 75.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.863 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -51.32 -52.64 43.46 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 124.044 0.84 . . . . 0.0 109.973 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.36 -43.87 92.77 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.947 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.507 ' HA ' ' OD1' ' A' ' 112' ' ' ASP . 46.1 t80 -63.43 -59.9 4.07 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 124.411 1.084 . . . . 0.0 110.984 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 106' ' ' ILE . 27.5 m -58.59 -31.82 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 121.519 -0.738 . . . . 0.0 110.901 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.65 -47.74 68.69 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 123.886 0.874 . . . . 0.0 109.033 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.507 ' OD1' ' HA ' ' A' ' 109' ' ' PHE 0.299 0.1 OUTLIER -70.83 -23.77 62.41 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.545 -179.0 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.523 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.6 OUTLIER -71.18 -61.25 1.83 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.892 173.363 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -61.98 -25.25 36.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.163 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.35 -33.79 55.29 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.246 0.546 . . . . 0.0 109.777 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.17 25.86 2.87 Favored Glycine 0 CA--C 1.485 -1.794 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.953 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -101.17 -32.67 10.44 Favored 'General case' 0 N--CA 1.396 -3.15 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.19 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 113' ' ' PHE . 4.9 mt -74.45 142.26 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.31 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -124.41 168.82 12.01 Favored Pre-proline 0 C--N 1.285 -2.231 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.678 -172.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.06 111.5 1.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.506 1.471 . . . . 0.0 110.138 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.5 m -56.58 -36.84 69.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.187 0.595 . . . . 0.0 112.415 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.7 pt -146.86 -110.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 118.978 -0.534 . . . . 0.0 109.947 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.7 tttp 66.22 109.81 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.597 0.759 . . . . 0.0 111.659 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.9 m -61.94 107.14 0.8 Allowed 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.807 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -135.63 98.73 12.01 Favored Pre-proline 0 N--CA 1.415 -2.223 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.43 151.04 22.54 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.054 1.836 . . . . 0.0 114.243 -170.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.08 94.58 13.2 Favored Pre-proline 0 N--CA 1.43 -1.432 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -86.06 164.61 10.06 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 122.302 2.001 . . . . 0.0 111.435 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.84 117.39 11.37 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.307 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -101.1 170.47 8.24 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -106.81 175.99 5.32 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -66.42 -34.39 77.85 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.967 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -178.754 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.715 0 CA-C-O 119.032 -0.871 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.37 -30.24 51.78 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.403 2.735 . . . . 0.0 113.035 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.4 mt -123.73 149.91 44.99 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.68 -40.41 2.58 Favored Glycine 0 C--N 1.315 -0.63 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.5 p -133.01 173.84 5.41 Favored Pre-proline 0 C--N 1.286 -2.191 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -71.38 168.75 22.58 Favored 'Trans proline' 0 C--O 1.253 1.231 0 CA-C-N 120.696 1.284 . . . . 0.0 109.163 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.53 -43.16 99.49 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.468 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -91.34 132.98 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 173.062 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.51 -19.57 0.91 Allowed Glycine 0 N--CA 1.42 -2.402 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.568 -175.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -135.79 148.57 48.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 122.297 -0.531 . . . . 0.0 109.575 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.518 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 51.6 mt -119.14 143.24 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.15 162.37 25.03 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -47.52 -34.05 19.08 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 124.14 3.227 . . . . 0.0 114.044 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -89.43 -26.91 20.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.953 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.1 p -78.85 -19.97 50.7 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.018 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' A' ' 20' ' ' MET . 69.3 m-85 -50.19 -49.93 50.93 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 123.934 0.771 . . . . 0.0 109.685 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -62.37 -33.41 74.69 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.107 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -70.9 -44.64 65.82 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 120.937 0.398 . . . . 0.0 110.535 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -72.8 -30.45 64.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.445 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.41 -39.89 62.35 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.05 -178.458 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -81.58 -9.02 59.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.649 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.09 -19.06 60.72 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.202 0.525 . . . . 0.0 110.619 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.21 -4.16 63.76 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.823 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 11.1 pt -103.2 152.5 38.65 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HG2' HG12 ' A' ' 55' ' ' ILE . 17.5 Cg_endo -54.58 142.18 72.35 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 124.194 3.263 . . . . 0.0 114.064 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.408 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 3.6 tt -108.13 125.18 51.3 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.615 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -95.67 103.06 14.92 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.408 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 53.5 m-85 -83.83 114.84 21.92 Favored 'General case' 0 CA--C 1.47 -2.126 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.303 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.584 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 8.1 mt -102.6 84.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.252 -3.67 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.614 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 48.7 m-85 -76.81 123.84 26.82 Favored 'General case' 0 CA--C 1.465 -2.324 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.98 123.61 19.77 Favored 'General case' 0 C--N 1.254 -3.584 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.445 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -79.64 -14.64 58.66 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.553 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 13.1 p -83.73 113.49 20.92 Favored 'General case' 0 N--CA 1.403 -2.78 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.107 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.71 -21.06 16.6 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.389 0.431 . . . . 0.0 110.918 -175.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -88.37 -54.2 4.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.742 0.782 . . . . 0.0 110.354 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' OE1' ' HB ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -84.84 3.13 39.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.823 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 33' ' ' THR . 52.2 ttt180 -49.27 -46.1 45.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.573 1.149 . . . . 0.0 110.018 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -65.31 -35.76 81.98 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.251 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -82.05 -31.27 30.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.894 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.528 HD21 ' HB ' ' A' ' 101' ' ' ILE . 1.7 tm? -61.48 -44.09 97.7 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.417 ' HA ' HD12 ' A' ' 44' ' ' LEU . 11.9 m -77.52 -17.0 58.36 Favored 'General case' 0 C--O 1.2 -1.542 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.576 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 20.5 t70 -76.67 -31.07 57.05 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.703 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.627 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -73.69 -36.59 65.3 Favored 'General case' 0 C--O 1.281 2.761 0 CA-C-O 123.109 1.433 . . . . 0.0 107.861 171.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 67.8 mt -72.63 -18.16 61.61 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.8 -1.545 . . . . 0.0 111.404 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.609 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 38.6 ttmt -63.74 -53.83 47.14 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 123.793 0.837 . . . . 0.0 111.759 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 52.4 Cg_exo -71.19 -37.22 6.19 Favored 'Trans proline' 0 CA--C 1.493 -1.553 0 C-N-CA 122.471 2.114 . . . . 0.0 109.784 175.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.669 HD11 ' HA ' ' A' ' 103' ' ' PHE . 86.0 mt -53.12 -38.41 29.99 Favored 'Isoleucine or valine' 0 C--N 1.37 1.461 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.856 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.35 -21.64 19.43 Favored 'General case' 0 C--O 1.195 -1.767 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.627 -172.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.497 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -68.45 -22.4 64.59 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 176.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.27 -11.3 57.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.977 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 9.5 pt20 -147.13 36.1 0.91 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.562 1.172 . . . . 0.0 110.749 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HD3' ' OE1' ' A' ' 49' ' ' GLU . 13.9 ptt180 -74.14 -18.6 60.77 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.988 -1.915 . . . . 0.0 110.778 -174.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.69 17.74 22.87 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.582 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.6 p -138.71 -33.26 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.551 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.431 HG12 ' HG2' ' A' ' 25' ' ' PRO . 88.7 mt -122.95 136.84 58.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.287 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -94.48 96.39 9.45 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.456 ' N ' ' HB ' ' A' ' 8' ' ' ILE . 8.8 m-85 -76.74 141.94 40.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.521 0.677 . . . . 0.0 111.123 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.518 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -159.76 129.48 2.21 Favored Glycine 0 N--CA 1.412 -2.944 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.061 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.584 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 44.6 p -83.78 144.91 28.99 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.202 0.525 . . . . 0.0 111.445 174.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 4.8 tt -145.8 142.48 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.336 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 63' ' ' LYS . 19.9 t70 -70.9 124.35 24.14 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -175.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -86.85 4.04 42.9 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.218 -0.593 . . . . 0.0 112.277 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HB3' ' OD2' ' A' ' 61' ' ' ASP . 3.7 ttpm? -100.91 -44.72 5.66 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.45 -45.6 9.82 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.664 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -115.5 20.34 14.81 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.242 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -69.69 -20.48 75.8 Favored Glycine 0 CA--C 1.493 -1.308 0 N-CA-C 116.479 1.352 . . . . 0.0 116.479 -171.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.57 -27.74 64.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.982 0.891 . . . . 0.0 110.305 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -62.2 -24.74 67.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.601 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.625 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -65.75 -37.86 87.52 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 122.633 1.206 . . . . 0.0 109.024 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.94 11.02 66.16 Favored Glycine 0 C--N 1.284 -2.32 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.54 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.18 -8.29 59.64 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.729 HD12 ' HB2' ' A' ' 73' ' ' ASN . 3.1 pp -118.69 -34.97 3.82 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.729 ' HB2' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -168.07 -64.89 0.03 OUTLIER 'General case' 0 C--N 1.366 1.326 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.444 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.561 HD21 ' HB2' ' A' ' 94' ' ' PRO . 2.2 mm? -53.23 166.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -163.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -89.14 -12.3 41.43 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.578 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 69' ' ' ALA . 64.0 p 54.86 35.4 24.19 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.387 1.475 . . . . 0.0 112.992 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -117.44 -15.94 10.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -160.44 0.78 Allowed 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.944 -169.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.531 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 83.5 m-85 -59.99 170.66 1.11 Allowed Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.582 1.553 . . . . 0.0 109.635 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 2.4 Cg_endo -39.35 133.43 1.38 Allowed 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 122.765 2.31 . . . . 0.0 114.852 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.497 ' HB1' ' HG ' ' A' ' 74' ' ' LEU . . . -113.0 104.3 12.25 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.86 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.615 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 65.1 t80 -85.39 108.17 17.72 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.6 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -114.88 115.28 26.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.537 HD11 HG12 ' A' ' 110' ' ' VAL . 42.4 mt -90.7 110.59 22.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -88.14 129.58 35.28 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HB3' ' H ' ' A' ' 89' ' ' LYS . 4.2 mm-40 -87.62 121.03 29.54 Favored 'General case' 0 C--N 1.28 -2.444 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.412 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 20' ' ' MET . 3.8 t -96.82 4.19 9.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.95 -36.24 3.89 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.824 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 29.5 mmmt -99.08 -15.08 19.14 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.248 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 74.1 19.42 2.97 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 124.769 2.224 . . . . 0.0 108.414 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.506 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -96.0 170.09 9.52 Favored 'General case' 0 CA--C 1.464 -2.331 0 CA-C-N 111.828 -2.442 . . . . 0.0 110.851 -174.563 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.6 ' HB3' HD13 ' A' ' 72' ' ' LEU . 70.1 mmtt -141.25 109.46 5.84 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 72.2 m-85 -109.02 88.65 5.79 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.561 ' HB2' HD21 ' A' ' 74' ' ' LEU . 2.6 Cg_endo -101.15 147.78 0.33 Allowed 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 122.43 2.086 . . . . 0.0 114.384 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -85.09 158.98 20.27 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.077 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.625 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 5.9 m-20 -64.72 143.91 57.6 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 123.827 0.851 . . . . 0.0 108.883 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -85.7 -1.24 56.97 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.644 -172.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.16 18.69 1.4 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.24 0.543 . . . . 0.0 112.109 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.625 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 4.3 tppp? -93.17 -3.74 53.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 68.84 126.55 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.472 1.509 . . . . 0.0 112.321 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.534 HG23 HG13 ' A' ' 106' ' ' ILE . 3.5 mp -89.77 102.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.065 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 p -122.43 170.52 9.88 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.669 ' HA ' HD11 ' A' ' 47' ' ' ILE . 23.0 t80 -56.42 -59.37 5.07 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.554 0.692 . . . . 0.0 109.991 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -57.44 -45.44 84.68 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.232 -1.349 . . . . 0.0 113.526 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.43 -49.09 79.14 Favored 'General case' 0 C--N 1.254 -3.559 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.371 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.534 HG13 HG23 ' A' ' 101' ' ' ILE . 42.5 mm -75.0 -39.49 44.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.654 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 26.7 ttpp -58.22 -46.19 86.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.732 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.39 90.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.581 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.473 ' O ' HD11 ' A' ' 118' ' ' ILE . 70.6 t80 -64.49 -62.6 1.49 Allowed 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.537 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.537 HG12 HD11 ' A' ' 84' ' ' ILE . 34.7 m -58.67 -30.98 43.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 O-C-N 122.182 -0.324 . . . . 0.0 111.202 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 12.5 t70 -62.6 -50.47 71.14 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.333 1.053 . . . . 0.0 108.937 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.671 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 9.3 t70 -61.25 -43.11 99.42 Favored 'General case' 0 C--O 1.198 -1.649 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.21 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.577 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.5 t80 -59.22 -63.96 1.12 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.465 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.6 -17.04 20.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.838 -175.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.96 -33.84 30.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.509 0.671 . . . . 0.0 109.395 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.5 21.5 6.13 Favored Glycine 0 CA--C 1.482 -1.993 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.671 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 7.0 ttmm -94.38 -43.09 8.55 Favored 'General case' 0 N--CA 1.395 -3.185 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.046 -174.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.577 HD12 ' HB2' ' A' ' 113' ' ' PHE . 10.8 mt -72.14 146.04 11.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -127.58 160.38 60.92 Favored Pre-proline 0 C--N 1.283 -2.292 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -61.07 112.36 1.35 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.197 1.264 . . . . 0.0 109.73 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.8 t -61.41 -49.78 75.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.5 pt -147.21 151.23 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.0 tptm 161.62 135.37 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 O-C-N 125.142 1.526 . . . . 0.0 106.993 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.1 m -77.77 107.48 10.31 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-O 121.412 0.625 . . . . 0.0 109.491 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -125.44 91.68 48.37 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.468 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 89.0 Cg_endo -80.07 140.69 14.3 Favored 'Trans proline' 0 N--CA 1.418 -2.914 0 C-N-CA 121.0 1.133 . . . . 0.0 111.525 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.0 mm -112.45 98.27 43.12 Favored Pre-proline 0 C--N 1.291 -1.943 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.331 -175.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 126' ' ' PRO . 20.2 Cg_exo -67.15 133.62 31.35 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.718 2.279 . . . . 0.0 111.656 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -91.39 178.53 5.93 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.997 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -92.51 73.45 5.15 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.469 1.128 . . . . 0.0 109.564 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -85.85 137.8 32.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.633 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -101.1 132.01 46.76 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.893 0 CA-C-O 118.25 -1.306 . . . . 0.0 110.504 -177.205 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.544 0 N-CA-C 111.609 -0.597 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -86.51 157.3 9.28 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.741 2.294 . . . . 0.0 112.318 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.06 114.03 10.76 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.37 51.12 0.2 Allowed Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.3 m -102.17 138.03 19.62 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.73 86.55 1.04 Allowed 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.016 1.811 . . . . 0.0 112.164 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.2 mt -99.65 -26.12 14.18 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 94.0 mt -127.75 133.54 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 114.049 -1.432 . . . . 0.0 107.886 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.13 -116.57 0.73 Allowed Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.72 144.65 48.13 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.6 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 61.0 mt -96.71 120.76 46.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.096 0.474 . . . . 0.0 110.284 -177.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.17 167.75 12.98 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.635 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 14.8 Cg_endo -59.2 -25.69 79.05 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 122.812 2.341 . . . . 0.0 111.717 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -87.5 -12.11 46.89 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.816 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.6 p -105.03 -37.0 7.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.535 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' HA ' ' A' ' 13' ' ' PRO 0.293 10.0 p90 -62.18 -26.92 68.61 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 m -59.56 -32.41 70.32 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.206 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -78.08 -34.83 50.06 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.535 ' CD2' ' HA ' ' A' ' 16' ' ' TYR . 14.8 m-85 -73.13 -29.59 62.99 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.517 ' SD ' HG22 ' A' ' 87' ' ' VAL . 5.5 tpp -79.14 -24.05 43.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.01 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 t -92.1 -10.0 40.57 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.03 -21.03 43.97 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 121.955 -0.465 . . . . 0.0 111.43 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.18 8.98 87.31 Favored Glycine 0 C--O 1.235 0.189 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.956 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 12.2 pt -117.18 149.06 43.74 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 122.879 -0.189 . . . . 0.0 111.133 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HG2' HG12 ' A' ' 55' ' ' ILE . 9.2 Cg_endo -51.81 136.13 50.78 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 124.115 3.21 . . . . 0.0 113.82 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.17 125.53 51.11 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -98.66 109.29 22.07 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-O 121.185 0.517 . . . . 0.0 109.731 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -89.28 117.82 28.51 Favored 'General case' 0 CA--C 1.468 -2.182 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.729 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.6 mt -106.87 84.4 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.54 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 33.5 m-85 -75.54 134.9 40.63 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -149.76 120.04 7.32 Favored 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.578 176.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.405 ' N ' ' HB3' ' A' ' 62' ' ' ALA . 29.3 mt-10 -72.23 -28.79 63.39 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-O 121.663 0.744 . . . . 0.0 109.365 173.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.644 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 2.3 p -89.31 103.78 16.38 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.622 -170.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.73 -25.16 41.2 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.791 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.06 -62.31 1.43 Allowed 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.538 ' OE1' ' HB ' ' A' ' 33' ' ' THR . 1.2 pm0 -83.2 4.07 28.31 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 33' ' ' THR . 3.9 tmm_? -60.47 -32.73 71.69 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -60.83 -49.38 77.7 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.182 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 14.3 pt-20 -81.83 -22.36 37.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.38 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.657 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -61.53 -52.58 63.87 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.739 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 21.8 m -71.59 -20.8 61.95 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.587 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 22.0 t70 -61.98 -41.4 97.99 Favored 'General case' 0 CA--C 1.486 -1.506 0 C-N-CA 123.553 0.741 . . . . 0.0 111.206 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.64 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 51.7 mmtt -77.53 -29.43 52.35 Favored 'General case' 0 C--O 1.27 2.132 0 CA-C-O 122.511 1.148 . . . . 0.0 108.606 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 67.0 mt -70.97 -23.6 62.24 Favored 'General case' 0 N--CA 1.406 -2.667 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.951 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.483 ' HB2' ' HD3' ' A' ' 46' ' ' PRO . 56.1 mtpt -63.41 -53.34 53.43 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 86.3 Cg_exo -67.63 -45.18 3.6 Favored 'Trans proline' 0 C--O 1.263 1.731 0 C-N-CA 123.169 2.579 . . . . 0.0 111.803 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.617 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 6.5 tp -61.22 -30.55 48.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.402 0 C-N-CA 117.934 -1.506 . . . . 0.0 109.706 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.81 -18.69 27.17 Favored 'General case' 0 C--O 1.182 -2.496 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.761 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.05 -24.77 65.12 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.32 -19.45 50.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.567 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 9.1 pt20 -139.96 35.19 1.95 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.249 1.023 . . . . 0.0 110.948 -171.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -69.49 -19.21 63.74 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.137 -1.847 . . . . 0.0 112.375 -173.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.21 14.58 11.01 Favored Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.526 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.582 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.7 p -129.31 -32.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.214 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.472 HG12 ' HG2' ' A' ' 25' ' ' PRO . 79.0 mt -122.55 134.45 65.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.838 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -88.56 109.86 20.42 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 7.9 m-85 -93.48 108.3 20.0 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.6 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -131.49 132.26 6.7 Favored Glycine 0 C--N 1.29 -2.005 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.693 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.567 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 42.2 p -91.65 150.17 21.28 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 122.686 0.394 . . . . 0.0 111.131 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 6.7 tt -151.6 147.27 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -68.39 130.45 42.92 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.69 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -93.26 -3.72 53.15 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.819 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -86.1 -49.51 7.72 Favored 'General case' 0 N--CA 1.42 -1.943 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.771 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.54 -37.69 9.07 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -104.37 14.36 30.32 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.791 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -71.55 -19.9 78.09 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 -172.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.54 68.8 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 117.69 0.745 . . . . 0.0 110.008 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -64.91 -24.95 67.68 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.009 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.494 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -63.16 -34.76 78.31 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 122.303 1.049 . . . . 0.0 109.82 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.527 ' HA2' ' H ' ' A' ' 73' ' ' ASN . . . -104.49 18.57 44.34 Favored Glycine 0 C--N 1.28 -2.576 0 C-N-CA 118.348 -1.882 . . . . 0.0 114.15 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.21 -22.26 55.47 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.495 HD12 ' CB ' ' A' ' 73' ' ' ASN . 4.3 pp -104.68 -33.33 8.51 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.396 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 12.9 t-20 -174.5 -56.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.477 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.0 mm? -59.51 162.84 4.57 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -165.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -83.03 -9.85 59.05 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.239 -174.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p 61.53 18.4 9.41 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.954 2.102 . . . . 0.0 114.744 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -113.39 -17.56 12.23 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -170.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 19.4 ttmt -117.84 -160.84 0.8 Allowed 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.31 -167.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.497 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 88.9 m-85 -54.9 164.2 1.26 Allowed Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.974 1.31 . . . . 0.0 111.481 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.505 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -39.74 129.65 1.92 Allowed 'Trans proline' 0 C--N 1.403 3.44 0 C-N-CA 122.793 2.328 . . . . 0.0 114.886 -174.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -108.17 104.44 13.85 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.084 -172.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.534 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 69.0 t80 -87.47 113.28 23.03 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.79 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -118.88 121.61 40.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.523 HD11 HG12 ' A' ' 110' ' ' VAL . 43.4 mt -95.67 110.99 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.205 0.526 . . . . 0.0 109.858 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -100.03 126.35 46.22 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.494 ' HB3' ' H ' ' A' ' 89' ' ' LYS . 1.9 mm-40 -88.6 140.48 29.41 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 120.897 0.38 . . . . 0.0 111.31 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.517 HG22 ' SD ' ' A' ' 20' ' ' MET . 22.1 t -99.89 -4.85 9.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.035 0.922 . . . . 0.0 108.633 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.52 -38.62 4.59 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.606 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.494 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 75.4 mmtt -91.06 -16.35 28.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.505 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 59.25 30.46 20.21 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 122.303 1.049 . . . . 0.0 109.715 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.546 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 26.0 tp60 -109.85 167.85 9.86 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.727 -171.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 10.5 mptt -122.71 98.68 6.02 Favored 'General case' 1 N--CA 1.373 -4.324 0 CA-C-N 113.216 -1.811 . . . . 0.0 106.548 -176.043 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.546 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 38.0 m-85 -100.39 82.64 0.33 Allowed Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 5.6 Cg_endo -100.33 148.96 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.639 2.226 . . . . 0.0 113.573 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -82.78 162.29 21.74 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.444 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.742 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 6.4 m-20 -71.37 139.02 49.65 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -84.61 1.72 44.77 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.954 -173.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 8.9 pt-20 -137.86 13.33 2.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.392 0.615 . . . . 0.0 111.594 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 15.4 tppt? -90.73 -8.91 48.54 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.58 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 69.64 117.97 0.04 OUTLIER 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.45 1.1 . . . . 0.0 111.105 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.482 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.4 mp -85.05 125.78 40.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.409 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.7 p -139.34 175.37 9.62 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.553 ' HE1' ' HB2' ' A' ' 46' ' ' PRO . 54.0 t80 -55.18 -61.11 2.54 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 122.081 0.943 . . . . 0.0 110.064 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . 0.255 23.5 tp10 -60.76 -39.64 89.54 Favored 'General case' 1 N--CA 1.37 -4.435 0 C-N-CA 126.811 2.044 . . . . 0.0 111.968 -171.997 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.26 93.5 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 123.816 0.698 . . . . 0.0 110.528 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.482 ' CG1' HG23 ' A' ' 101' ' ' ILE . 34.9 mm -72.36 -41.74 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.237 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.434 ' HG3' HD13 ' A' ' 47' ' ' ILE . 12.4 ttpt -55.33 -52.06 64.73 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 124.179 0.924 . . . . 0.0 108.895 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.03 83.63 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.507 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -68.59 -58.16 4.69 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.828 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.523 HG12 HD11 ' A' ' 84' ' ' ILE . 35.5 m -60.23 -32.61 51.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.889 0 O-C-N 121.841 -0.537 . . . . 0.0 110.71 -177.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.33 -53.8 54.21 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 124.958 1.303 . . . . 0.0 109.153 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.654 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 7.2 t70 -60.62 -43.63 97.25 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 113.687 -1.597 . . . . 0.0 108.002 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.532 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.7 t80 -59.51 -64.02 1.09 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.173 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.8 -21.03 27.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.068 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.48 -35.19 53.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.23 0.538 . . . . 0.0 109.86 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.54 30.4 3.31 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.654 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 5.5 mtmt -102.26 -45.19 5.19 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.504 -1.348 . . . . 0.0 109.283 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 113' ' ' PHE . 31.8 mt -76.14 142.45 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 171.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.432 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 11.7 pt-20 -124.29 166.87 17.37 Favored Pre-proline 0 C--N 1.273 -2.747 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 119' ' ' GLU . 28.2 Cg_exo -38.98 118.51 0.38 Allowed 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 123.621 2.881 . . . . 0.0 113.216 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.8 t -61.35 -47.18 87.07 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.683 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.77 -54.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.43 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.7 tttp 58.11 72.58 0.51 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.457 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.9 m -80.61 88.01 5.74 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.719 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -142.03 94.21 7.17 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.72 175.91 10.78 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.154 1.902 . . . . 0.0 112.128 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 11.3 tt -118.0 86.95 26.86 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-O 121.75 0.786 . . . . 0.0 110.486 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.434 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 66.4 Cg_endo -95.26 164.28 1.57 Allowed 'Trans proline' 0 N--CA 1.424 -2.567 0 C-N-CA 122.249 1.966 . . . . 0.0 112.477 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -122.68 127.44 49.29 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.111 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 62.38 20.17 11.64 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.025 0.93 . . . . 0.0 112.949 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -125.69 164.68 20.09 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.434 ' OE2' ' HG3' ' A' ' 128' ' ' PRO . 44.8 mt-10 68.89 115.77 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.736 1.272 . . . . 0.0 112.282 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.027 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -176.141 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 CA--C 1.511 -0.205 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 1' ' ' GLY . 18.1 Cg_exo -68.8 109.99 2.25 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.941 2.427 . . . . 0.0 111.945 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.3 tp -148.21 87.05 1.58 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.117 0.961 . . . . 0.0 109.55 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.31 47.99 0.04 OUTLIER Glycine 0 C--N 1.28 -2.557 0 N-CA-C 105.583 -3.007 . . . . 0.0 105.583 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 9.7 m -85.23 114.56 56.85 Favored Pre-proline 0 N--CA 1.422 -1.841 0 CA-C-N 113.296 -1.452 . . . . 0.0 111.979 -169.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 10.4 Cg_endo -91.35 105.27 0.26 Allowed 'Trans proline' 0 N--CA 1.426 -2.461 0 C-N-CA 122.207 1.938 . . . . 0.0 108.965 172.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.63 -30.32 61.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.731 0.777 . . . . 0.0 109.102 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -101.36 160.44 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.81 -83.98 0.1 Allowed Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.347 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -126.83 147.17 50.04 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -175.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.556 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 51.7 mt -102.18 119.98 51.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.67 174.7 20.33 Favored Glycine 0 N--CA 1.41 -3.067 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.508 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 28.4 Cg_endo -61.4 -17.03 51.07 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.091 2.527 . . . . 0.0 112.793 -177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.8 -13.4 16.44 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 119.37 -0.347 . . . . 0.0 111.747 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.8 p -102.03 -32.47 10.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 119.489 -0.884 . . . . 0.0 112.641 -173.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CE2' ' HA ' ' A' ' 13' ' ' PRO 0.254 5.3 p90 -60.61 -32.8 71.91 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -177.27 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 m -59.92 -31.26 69.67 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 123.742 0.817 . . . . 0.0 110.462 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.27 -35.37 41.49 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -73.33 -28.6 62.16 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.513 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -78.1 -36.97 47.42 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.49 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.6 t -78.52 -10.5 59.74 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.946 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.21 64.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.198 0.523 . . . . 0.0 110.453 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.56 -15.88 62.33 Favored Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.833 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 7.0 pt -93.76 154.04 41.01 Favored Pre-proline 0 C--N 1.301 -1.537 0 C-N-CA 123.026 0.53 . . . . 0.0 110.249 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HG2' HG12 ' A' ' 55' ' ' ILE . 15.0 Cg_endo -54.22 145.36 55.19 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 124.115 3.21 . . . . 0.0 114.663 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tt -108.69 127.02 53.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -97.94 107.65 20.18 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -88.46 120.68 30.06 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.283 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.631 HG12 HD13 ' A' ' 44' ' ' LEU . 3.4 mp -110.74 89.11 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.824 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.043 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.567 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 48.6 m-85 -78.6 109.96 13.29 Favored 'General case' 0 CA--C 1.452 -2.791 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -120.98 119.2 31.87 Favored 'General case' 1 C--N 1.238 -4.266 0 CA-C-O 121.197 0.522 . . . . 0.0 109.816 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -70.22 -28.77 65.54 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.651 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 18.0 p -75.16 119.12 18.87 Favored 'General case' 0 N--CA 1.379 -3.988 0 CA-C-N 113.296 -1.775 . . . . 0.0 108.436 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.434 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . . . -99.05 -17.62 18.16 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.595 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -99.01 -53.16 3.34 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.701 0.763 . . . . 0.0 109.623 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -86.71 7.44 26.71 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.109 -175.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.651 ' HB3' ' O ' ' A' ' 33' ' ' THR . 6.7 ptp180 -71.71 -16.78 62.24 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.372 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -69.42 -45.03 70.17 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 1.6 mp0 -65.72 -35.12 79.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.393 0.616 . . . . 0.0 109.771 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.513 HD21 ' HB ' ' A' ' 101' ' ' ILE . 1.2 tm? -60.81 -49.08 78.93 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.466 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 14.5 m -75.36 -10.6 59.61 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.056 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.601 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 19.0 t70 -78.09 -37.4 46.54 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 123.163 0.585 . . . . 0.0 110.32 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.623 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -72.23 -33.26 67.42 Favored 'General case' 0 C--O 1.285 2.944 0 CA-C-O 123.166 1.46 . . . . 0.0 108.136 173.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.631 HD13 HG12 ' A' ' 29' ' ' ILE . 85.6 mt -73.67 -21.94 60.11 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.19 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -66.35 -50.09 50.35 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 6.9 Cg_exo -78.2 -34.14 1.72 Allowed 'Trans proline' 0 CA--C 1.491 -1.655 0 C-N-CA 121.923 1.749 . . . . 0.0 110.034 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -62.33 -28.86 45.44 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.94 -20.06 21.0 Favored 'General case' 0 C--O 1.186 -2.25 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.794 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.22 -19.11 63.17 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.2 -14.01 54.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.54 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 10.1 pt20 -146.64 36.28 0.96 Allowed 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.061 0.934 . . . . 0.0 111.128 -173.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -74.46 -19.47 60.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.701 -1.59 . . . . 0.0 111.065 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.32 20.91 18.24 Favored Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.41 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.8 p -139.77 -33.73 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.657 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 25' ' ' PRO . 88.4 mt -124.75 134.62 66.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.109 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -91.44 97.44 11.08 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.422 ' O ' ' HB ' ' A' ' 8' ' ' ILE . 15.0 m-85 -76.79 131.68 38.82 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.399 0.619 . . . . 0.0 111.278 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.556 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -144.06 123.55 2.04 Favored Glycine 0 N--CA 1.396 -3.974 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.388 176.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.42 HG21 ' OG ' ' A' ' 41' ' ' SER . 38.9 p -86.45 136.41 33.11 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 7.5 tt -141.04 145.48 25.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -177.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.02 126.97 31.22 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.518 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -85.75 0.09 53.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -102.28 -42.31 6.06 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.99 -51.44 6.35 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.919 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -112.16 18.36 18.73 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.754 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.38 -22.86 67.89 Favored Glycine 0 CA--C 1.497 -1.089 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.38 -35.18 60.04 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 122.991 0.516 . . . . 0.0 110.796 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -63.57 -22.22 66.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.291 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.627 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -65.54 -39.18 91.46 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.999 0.904 . . . . 0.0 109.227 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.486 ' HA2' ' N ' ' A' ' 74' ' ' LEU . . . -103.61 6.12 48.61 Favored Glycine 0 C--N 1.283 -2.387 0 C-N-CA 118.114 -1.993 . . . . 0.0 114.904 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -32.68 72.6 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 166.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 3.2 pp -89.67 -37.58 14.5 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.433 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.457 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 21.2 t-20 -171.48 -60.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.486 ' N ' ' HA2' ' A' ' 70' ' ' GLY . 2.4 mm? -56.55 167.97 0.64 Allowed 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -166.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -82.61 -16.54 48.01 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.762 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 p 61.36 21.81 12.3 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 126.357 1.863 . . . . 0.0 112.803 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -107.66 -23.77 11.99 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -172.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.567 ' HG2' ' HB3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -106.42 -162.01 0.83 Allowed 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.104 -169.152 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.731 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 67.2 m-85 -72.9 -172.42 0.23 Allowed Pre-proline 0 CA--C 1.571 1.76 0 C-N-CA 125.036 1.334 . . . . 0.0 108.998 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.731 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 5.6 Cg_endo -47.48 133.59 20.67 Favored 'Trans proline' 0 C--N 1.408 3.708 0 CA-C-N 122.583 1.958 . . . . 0.0 115.61 -175.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.06 122.4 37.11 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.252 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.531 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 75.9 t80 -96.47 117.44 30.91 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.381 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -119.46 122.35 41.52 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 122.046 -0.409 . . . . 0.0 111.998 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 49.3 mt -95.13 116.28 36.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 45.6 tt0 -106.69 122.38 46.24 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 19.8 mt-10 -80.58 148.96 30.1 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.956 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.513 HG11 ' O ' ' A' ' 20' ' ' MET . 19.9 t -113.0 -0.42 9.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.1 -57.15 3.21 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.819 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -111.33 -9.98 14.25 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.628 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 49.7 t-20 65.88 86.72 0.13 Allowed 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.225 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 29.8 tp60 -139.69 164.15 30.71 Favored 'General case' 0 CA--C 1.464 -2.339 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.639 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 11.3 mptt -119.88 95.05 4.61 Favored 'General case' 1 N--CA 1.376 -4.174 0 O-C-N 125.056 1.473 . . . . 0.0 108.572 -174.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 28.9 m-85 -101.28 83.13 0.41 Allowed Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 172.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 5.8 Cg_endo -101.58 144.92 0.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.396 2.064 . . . . 0.0 114.572 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -85.3 173.56 10.25 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 126.37 1.868 . . . . 0.0 109.088 -174.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.5 m-20 -66.3 148.79 51.33 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -95.47 2.47 54.45 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.567 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 9.8 pt-20 -149.31 23.66 0.92 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.009 -172.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.577 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 18.0 ttmm -90.76 -81.79 0.3 Allowed 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.001 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 172.45 123.63 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.513 ' HB ' HD21 ' A' ' 40' ' ' LEU . 3.4 mp -99.88 94.57 3.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -122.68 167.74 13.07 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.435 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.454 ' HE2' ' HB2' ' A' ' 46' ' ' PRO . 39.5 t80 -51.73 -61.06 2.49 Favored 'General case' 0 CA--C 1.483 -1.618 0 O-C-N 124.061 0.851 . . . . 0.0 110.107 -176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -69.17 -27.01 65.14 Favored 'General case' 1 N--CA 1.372 -4.361 0 C-N-CA 125.784 1.634 . . . . 0.0 112.778 -172.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.7 -44.44 42.16 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.543 0.687 . . . . 0.0 109.354 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.412 ' CG1' HG23 ' A' ' 101' ' ' ILE . 32.8 mm -68.88 -40.34 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.575 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -56.43 -51.55 68.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.672 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.02 -43.36 70.06 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.164 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.01 -59.3 3.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.52 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 84' ' ' ILE . 33.9 m -60.83 -33.19 54.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 O-C-N 121.777 -0.577 . . . . 0.0 111.508 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.86 -50.42 73.87 Favored 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 124.067 0.947 . . . . 0.0 109.258 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.633 ' HB3' HG13 ' A' ' 118' ' ' ILE . 1.9 t70 -58.77 -47.74 83.63 Favored 'General case' 0 C--O 1.2 -1.513 0 CA-C-N 113.16 -1.836 . . . . 0.0 107.441 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.514 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.1 t80 -57.53 -65.55 0.61 Allowed 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.473 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 110' ' ' VAL . 8.8 p -62.07 -24.57 34.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.79 -34.86 52.03 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.75 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.99 30.89 2.62 Favored Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.577 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 22.2 mtmt -99.88 -44.31 6.1 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 113.202 -1.499 . . . . 0.0 108.422 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.633 HG13 ' HB3' ' A' ' 112' ' ' ASP . 33.4 mt -83.0 146.74 6.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 170.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.478 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 10.4 pt-20 -134.72 168.53 17.33 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 119' ' ' GLU . 65.8 Cg_exo -43.93 126.27 5.88 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.4 2.733 . . . . 0.0 113.179 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.4 m -92.81 -28.1 16.77 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.945 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 123' ' ' LYS . 16.3 pt -126.83 -54.42 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.141 0.496 . . . . 0.0 112.275 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.414 ' H ' HG13 ' A' ' 122' ' ' ILE . 31.2 mmmt -90.27 71.44 7.17 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.6 m -86.55 73.76 10.02 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.952 0.882 . . . . 0.0 108.75 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -143.6 89.7 7.36 Favored Pre-proline 0 N--CA 1.42 -1.926 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.15 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.37 168.24 14.92 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 121.556 1.504 . . . . 0.0 110.775 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.0 mt -111.32 89.4 10.2 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.71 153.56 11.67 Favored 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 122.179 1.92 . . . . 0.0 112.759 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 69.53 151.94 0.09 Allowed 'General case' 0 C--O 1.243 0.752 0 C-N-CA 125.752 1.621 . . . . 0.0 112.787 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . 0.271 58.8 pttt -88.89 74.58 8.21 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 122.599 1.19 . . . . 0.0 112.937 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -158.34 149.36 20.73 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 112.886 -1.961 . . . . 0.0 106.31 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.75 135.24 45.61 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.897 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.102 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.302 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.1 129.72 35.88 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 123.27 2.647 . . . . 0.0 112.063 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.14 -59.75 2.46 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.37 -53.71 2.1 Favored Glycine 0 C--N 1.31 -0.897 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.653 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m -138.4 155.92 73.69 Favored Pre-proline 0 C--N 1.291 -1.97 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.07 136.77 61.99 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 122.729 2.286 . . . . 0.0 110.015 175.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.2 -54.12 10.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.81 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.407 ' HB ' ' N ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -90.04 152.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.09 -70.43 0.26 Allowed Glycine 0 CA--C 1.474 -2.498 0 C-N-CA 119.373 -1.394 . . . . 0.0 111.718 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -125.92 147.71 49.42 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.517 HG13 ' HB ' ' A' ' 60' ' ' ILE . 2.2 pt -120.44 154.88 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-O 121.482 0.658 . . . . 0.0 111.777 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.55 176.59 30.7 Favored Glycine 0 N--CA 1.403 -3.501 0 N-CA-C 107.751 -2.139 . . . . 0.0 107.751 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.5 -27.44 68.82 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.167 2.578 . . . . 0.0 113.648 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -89.23 -20.52 24.04 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.0 p -97.91 -36.36 10.19 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.534 -169.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -62.71 -29.42 70.65 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.976 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -24.77 67.07 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.2 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.29 -37.67 44.27 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.88 0.848 . . . . 0.0 109.882 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -76.06 -27.44 57.25 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.493 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.04 -35.31 71.91 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.358 175.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 t -74.7 -19.51 60.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.933 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.28 -30.12 57.68 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 120.95 0.405 . . . . 0.0 110.2 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.39 -23.67 26.45 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.947 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 6.6 pt -81.15 152.87 71.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.479 -0.361 . . . . 0.0 111.68 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.452 ' HG2' HG12 ' A' ' 55' ' ' ILE . 10.6 Cg_endo -52.42 137.25 56.93 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.063 3.175 . . . . 0.0 114.442 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 tt -106.8 125.96 51.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.507 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -97.56 104.86 16.92 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -86.96 120.71 28.52 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.446 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.653 HG12 HD13 ' A' ' 44' ' ' LEU . 3.4 mp -110.69 94.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.361 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.691 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 34.7 m-85 -80.34 126.64 31.42 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -142.15 122.1 13.64 Favored 'General case' 0 C--N 1.252 -3.639 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.493 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.446 ' HG2' ' C ' ' A' ' 62' ' ' ALA . 32.2 mt-10 -73.15 -20.82 60.83 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.445 ' HB ' ' CG ' ' A' ' 36' ' ' GLU . 1.5 p -86.66 83.86 7.51 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.997 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 37' ' ' ARG . . . -87.31 -25.21 24.03 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.154 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.5 mp0 -63.23 -34.13 76.99 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.179 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.445 ' CG ' ' HB ' ' A' ' 33' ' ' THR . 11.1 pt-20 -116.48 13.55 15.42 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.412 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.443 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 7.5 ptp180 -57.73 -27.93 63.44 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.812 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -50.4 -49.46 54.5 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 123.608 0.763 . . . . 0.0 111.517 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.627 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 12.1 pt-20 -86.97 -24.4 24.73 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.435 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.496 HD21 ' HB ' ' A' ' 101' ' ' ILE . 1.7 tm? -63.98 -44.92 91.24 Favored 'General case' 0 C--O 1.261 1.701 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.578 ' OG ' HG21 ' A' ' 59' ' ' THR . 15.7 m -73.01 -17.33 61.46 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.456 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.455 ' CB ' ' HA ' ' A' ' 39' ' ' GLU . 23.4 t70 -70.99 -40.87 71.61 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.677 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.632 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -65.24 -38.11 89.33 Favored 'General case' 0 C--O 1.27 2.177 0 CA-C-O 123.426 1.584 . . . . 0.0 106.848 173.308 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.653 HD13 HG12 ' A' ' 29' ' ' ILE . 94.0 mt -71.12 -19.06 62.49 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 112.884 -1.962 . . . . 0.0 113.065 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.573 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 24.3 ttpp -66.56 -55.42 18.72 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.68 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 81.6 Cg_exo -65.59 -38.94 22.92 Favored 'Trans proline' 0 CA--C 1.489 -1.733 0 C-N-CA 123.174 2.582 . . . . 0.0 110.508 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.549 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 93.7 mt -53.68 -38.47 34.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 O-C-N 124.052 0.845 . . . . 0.0 109.695 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.92 -16.84 23.61 Favored 'General case' 0 C--O 1.19 -2.053 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.217 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 3.6 tt0 -74.42 -17.73 60.75 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.57 -20.79 30.92 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.933 177.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 9.9 pt20 -137.66 37.84 2.43 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.495 1.14 . . . . 0.0 110.609 -171.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -65.92 -24.83 66.91 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.542 -2.117 . . . . 0.0 112.846 -172.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.54 9.22 17.08 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.314 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.415 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 13.0 p -122.86 -33.0 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.452 HG12 ' HG2' ' A' ' 25' ' ' PRO . 88.1 mt -122.86 134.64 65.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.211 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -94.46 102.89 14.87 Favored 'General case' 0 C--O 1.207 -1.159 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' N ' ' HB ' ' A' ' 8' ' ' ILE . 7.8 m-85 -80.19 139.47 36.74 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.795 0.807 . . . . 0.0 111.851 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 11' ' ' ILE . . . -151.54 113.27 0.57 Allowed Glycine 0 C--N 1.275 -2.811 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.649 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.578 HG21 ' OG ' ' A' ' 41' ' ' SER . 40.3 p -84.64 132.19 34.51 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.517 ' HB ' HG13 ' A' ' 11' ' ' ILE . 7.6 tt -131.73 145.24 35.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 63' ' ' LYS . 7.7 t0 -73.33 123.9 24.68 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.042 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.691 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -92.54 1.99 56.94 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.042 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HB3' ' OD1' ' A' ' 61' ' ' ASP . 39.4 ttmt -100.33 -31.17 11.47 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.68 -44.53 7.07 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.217 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -120.42 26.67 9.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.476 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -70.44 -15.92 73.23 Favored Glycine 0 CA--C 1.489 -1.565 0 N-CA-C 116.206 1.242 . . . . 0.0 116.206 -170.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.16 -35.55 71.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.374 0.607 . . . . 0.0 110.007 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 71' ' ' ASN . 63.7 m-70 -60.49 -21.79 62.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.146 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.413 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -62.11 -31.87 72.37 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 121.506 0.67 . . . . 0.0 110.283 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -122.77 9.99 9.07 Favored Glycine 0 CA--C 1.479 -2.205 0 C-N-CA 118.26 -1.924 . . . . 0.0 115.089 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 7.9 m-20 -73.95 -16.42 61.08 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 166.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.436 ' O ' ' HE3' ' A' ' 92' ' ' LYS . 3.9 pp -99.13 -26.25 14.27 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.928 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.415 ' CB ' HD12 ' A' ' 72' ' ' LEU . 3.3 t-20 177.78 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.599 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 89.8 mt -53.04 159.23 1.24 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.793 2.145 . . . . 0.0 116.793 -171.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -71.15 -17.91 62.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.235 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.413 HG22 ' HB3' ' A' ' 69' ' ' ALA . 13.8 p 50.13 57.83 6.14 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -135.25 -17.98 1.78 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -119.54 -159.92 0.79 Allowed 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.867 -167.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.637 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 57.7 m-85 -61.47 -176.37 0.12 Allowed Pre-proline 0 N--CA 1.499 1.993 0 C-N-CA 126.485 1.914 . . . . 0.0 111.262 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 3.7 Cg_endo -45.92 135.87 13.8 Favored 'Trans proline' 1 C--N 1.422 4.444 0 CA-C-N 121.75 1.661 . . . . 0.0 113.079 177.338 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -116.52 136.67 52.79 Favored 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.927 -171.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.507 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 77.6 t80 -120.11 120.09 35.23 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.12 123.46 39.73 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.359 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.486 HD11 HG12 ' A' ' 110' ' ' VAL . 56.3 mt -93.87 109.15 21.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 25' ' ' PRO . 41.3 tt0 -95.25 127.38 41.25 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -86.0 132.28 34.1 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.493 HG11 ' O ' ' A' ' 20' ' ' MET . 12.0 t -94.49 -0.42 10.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-O 122.139 0.971 . . . . 0.0 108.727 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.95 -44.68 3.94 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.699 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.431 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 58.1 mttp -93.85 -12.36 29.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.54 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 2.3 p-10 56.28 33.43 22.23 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 123.258 1.504 . . . . 0.0 109.894 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.506 ' C ' ' HD3' ' A' ' 92' ' ' LYS . 8.1 tp60 -98.12 167.04 11.12 Favored 'General case' 0 CA--C 1.464 -2.354 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.957 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.634 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 3.6 mppt? -132.76 102.88 5.84 Favored 'General case' 1 N--CA 1.373 -4.317 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -176.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 50.6 m-85 -98.91 83.83 0.33 Allowed Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 173.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 24.1 Cg_endo -100.18 149.42 0.45 Allowed 'Trans proline' 0 N--CA 1.42 -2.809 0 C-N-CA 121.935 1.757 . . . . 0.0 113.411 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 83.2 t80 -84.34 168.16 15.86 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.789 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.648 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 18.6 m-20 -70.65 143.3 51.47 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.471 ' NE2' ' HB3' ' A' ' 74' ' ' LEU . 31.4 mt-30 -84.75 2.38 42.34 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.012 -171.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 7.7 pt-20 -152.22 22.02 0.65 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 14.9 tppt? -90.65 -3.22 57.67 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 70.49 133.02 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.911 2.085 . . . . 0.0 112.716 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.549 HG23 HG13 ' A' ' 106' ' ' ILE . 2.4 mp -91.24 97.91 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.943 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.4 p -110.25 -165.93 1.04 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.148 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.9 t80 -84.46 -55.0 4.38 Favored 'General case' 0 CA--C 1.485 -1.558 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -58.85 -43.86 90.89 Favored 'General case' 0 N--CA 1.387 -3.607 0 CA-C-N 113.096 -1.865 . . . . 0.0 113.731 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.62 -49.94 73.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.067 0.46 . . . . 0.0 111.328 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 101' ' ' ILE . 44.2 mm -72.11 -40.54 66.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.599 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 30.7 ttpt -57.71 -48.84 78.43 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 111' ' ' ASP . . . -61.4 -42.6 98.99 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 123.914 0.759 . . . . 0.0 110.922 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.426 ' HA ' ' OD1' ' A' ' 112' ' ' ASP . 63.4 t80 -61.56 -60.73 3.25 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.209 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.486 HG12 HD11 ' A' ' 84' ' ' ILE . 35.9 m -59.48 -30.67 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.642 -0.661 . . . . 0.0 110.468 -177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 23.9 t70 -64.27 -53.18 52.96 Favored 'General case' 0 CA--C 1.479 -1.756 0 C-N-CA 124.629 1.171 . . . . 0.0 108.96 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.586 ' OD2' HG12 ' A' ' 118' ' ' ILE 0.265 0.1 OUTLIER -68.2 -25.12 65.06 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.959 -177.167 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.541 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.4 t80 -68.97 -62.01 1.56 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.772 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.79 -25.42 38.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.335 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.64 -30.72 67.43 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 121.175 0.512 . . . . 0.0 109.934 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.71 7.06 10.95 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.77 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.583 ' HE2' ' OD2' ' A' ' 112' ' ' ASP . 25.1 ttpt -89.42 -37.07 15.09 Favored 'General case' 0 N--CA 1.393 -3.311 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.591 -172.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.586 HG12 ' OD2' ' A' ' 112' ' ' ASP . 4.2 mt -74.02 135.45 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 118.446 -1.302 . . . . 0.0 109.851 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -127.53 168.44 15.06 Favored Pre-proline 0 C--N 1.267 -3.015 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.58 122.04 9.58 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.931 1.754 . . . . 0.0 111.003 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.1 t -66.9 -52.91 37.54 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 35.0 pt -147.46 169.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -139.88 105.6 5.14 Favored 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.2 m -154.57 89.07 1.23 Allowed 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.033 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -126.93 103.3 23.88 Favored Pre-proline 0 CA--C 1.484 -1.595 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -84.88 179.85 4.04 Favored 'Trans proline' 0 N--CA 1.431 -2.156 0 C-N-CA 122.117 1.878 . . . . 0.0 112.951 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 pt -51.2 112.32 2.95 Favored Pre-proline 0 C--O 1.248 1.016 0 O-C-N 124.695 1.247 . . . . 0.0 112.52 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -47.37 139.28 16.99 Favored 'Trans proline' 0 C--O 1.251 1.167 0 C-N-CA 123.672 2.915 . . . . 0.0 110.83 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.07 103.63 0.12 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 124.447 1.092 . . . . 0.0 110.787 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -83.77 125.25 31.73 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.92 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -102.49 140.96 36.09 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -60.37 131.16 49.9 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 124.152 0.908 . . . . 0.0 111.471 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.433 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -177.229 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.709 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.59 123.01 10.81 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.506 2.137 . . . . 0.0 112.488 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.7 tp -102.4 166.61 10.45 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.51 73.54 0.6 Allowed Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 m -89.84 133.27 34.31 Favored Pre-proline 0 N--CA 1.416 -2.171 0 C-N-CA 123.801 0.84 . . . . 0.0 109.113 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.25 103.86 0.56 Allowed 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.225 1.95 . . . . 0.0 111.494 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.5 mt -124.1 -44.54 2.03 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' A' ' 57' ' ' PHE . 5.4 mp -121.0 90.79 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 169.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.81 -130.58 2.84 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.994 -173.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -122.67 143.56 49.7 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.437 0.636 . . . . 0.0 110.669 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.632 HG13 ' HA3' ' A' ' 58' ' ' GLY . 62.9 mt -103.71 118.11 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.957 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.25 178.32 17.87 Favored Glycine 0 N--CA 1.408 -3.218 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.42 -29.49 84.64 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.264 2.643 . . . . 0.0 112.939 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.96 -8.94 23.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.2 p -102.21 -35.88 8.71 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.466 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -62.5 -32.04 72.89 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.217 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.8 t -63.19 -27.9 69.68 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.571 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.61 -38.19 59.22 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.599 0.714 . . . . 0.0 109.73 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.404 ' HB3' ' CG ' ' A' ' 56' ' ' ASN . 18.4 m-85 -76.94 -23.39 52.42 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.582 ' SD ' HG22 ' A' ' 87' ' ' VAL . 8.7 tpp -80.67 -21.92 40.91 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.214 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -92.18 -13.05 31.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.07 -31.1 68.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.05 11.48 73.0 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.526 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 9.5 pt -123.98 151.06 64.46 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HG2' HG12 ' A' ' 55' ' ' ILE . 11.6 Cg_endo -53.34 144.84 47.77 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 124.125 3.217 . . . . 0.0 114.067 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 tt -116.14 126.34 53.57 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.74 110.54 22.98 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -90.73 120.18 31.57 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.176 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.532 HG12 HD13 ' A' ' 44' ' ' LEU . 3.2 mp -111.37 90.84 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.07 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.699 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 44.1 m-85 -79.41 133.37 36.55 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.546 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -142.99 120.32 11.59 Favored 'General case' 0 C--N 1.273 -2.719 0 O-C-N 123.314 0.384 . . . . 0.0 111.884 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.18 -32.01 66.44 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 3.1 p -83.08 109.59 17.27 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.202 -171.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.89 -16.95 45.5 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.424 0.63 . . . . 0.0 109.708 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -70.8 -59.6 2.71 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.425 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -97.93 8.59 44.49 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.693 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 33' ' ' THR . 53.6 ttt180 -55.69 -36.94 67.69 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -59.31 -48.48 81.45 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.096 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.661 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 12.4 pt-20 -79.37 -27.23 41.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.671 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.513 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.1 tm? -59.41 -50.01 75.6 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.545 ' HA ' HD12 ' A' ' 44' ' ' LEU . 9.2 m -74.88 -19.57 60.1 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.975 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.577 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 33.8 t70 -70.1 -39.97 75.2 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 122.866 0.466 . . . . 0.0 111.334 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.661 ' HE2' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -70.51 -35.43 73.2 Favored 'General case' 0 C--O 1.297 3.554 0 CA-C-O 123.177 1.465 . . . . 0.0 108.509 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 41' ' ' SER . 68.6 mt -70.79 -23.64 62.43 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 113.102 -1.863 . . . . 0.0 111.814 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.526 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 36.4 ttpt -63.61 -52.1 61.51 Favored Pre-proline 0 C--N 1.289 -2.03 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.182 -173.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 51.5 Cg_exo -71.83 -44.28 1.01 Allowed 'Trans proline' 0 CA--C 1.492 -1.598 0 C-N-CA 122.803 2.335 . . . . 0.0 111.095 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.484 HG13 ' HA ' ' A' ' 44' ' ' LEU . 2.4 pp -61.95 -22.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.375 1.68 0 C-N-CA 117.777 -1.569 . . . . 0.0 111.735 -176.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.23 -21.0 16.3 Favored 'General case' 0 C--O 1.202 -1.416 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.31 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 22.4 tt0 -69.82 -23.07 63.25 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.76 -16.63 60.1 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.228 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.484 HE22 HG21 ' A' ' 110' ' ' VAL . 9.8 pt20 -142.34 31.8 1.52 Allowed 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.522 -172.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.81 -14.27 59.63 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.977 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.89 5.52 50.64 Favored Glycine 0 C--N 1.296 -1.684 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.853 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 11.8 p -130.05 -37.47 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.534 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.438 HG12 ' HG2' ' A' ' 25' ' ' PRO . 92.3 mt -117.87 145.39 23.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.404 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 8.2 m120 -92.94 121.76 34.62 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.572 ' HB2' HG13 ' A' ' 8' ' ' ILE . 6.4 m-85 -103.87 128.71 51.33 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.174 0.988 . . . . 0.0 112.825 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.632 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -145.9 131.9 4.32 Favored Glycine 0 N--CA 1.415 -2.734 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.252 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 44.9 p -96.08 143.59 27.08 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 8.2 tt -148.01 154.99 10.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.53 132.02 34.57 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.336 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -87.48 -3.63 59.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.135 0.493 . . . . 0.0 111.776 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -103.77 -32.05 9.53 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.002 0.429 . . . . 0.0 110.153 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.69 -46.59 7.5 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -117.24 19.29 14.21 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.502 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -66.95 -14.61 63.61 Favored Glycine 0 C--N 1.307 -1.036 0 N-CA-C 116.382 1.313 . . . . 0.0 116.382 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.29 -24.64 67.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.085 0.942 . . . . 0.0 109.993 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -74.77 -22.3 58.85 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.946 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.475 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -61.07 -44.22 97.71 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 121.835 0.826 . . . . 0.0 109.408 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -112.56 24.0 14.36 Favored Glycine 0 C--N 1.272 -3.019 0 C-N-CA 117.987 -2.054 . . . . 0.0 115.381 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -14.36 59.46 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 169.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 73' ' ' ASN . 4.1 pp -100.37 -29.37 12.45 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.568 177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.506 ' N ' HD12 ' A' ' 72' ' ' LEU . 1.8 t30 -175.8 -60.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.627 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.4 mm? -53.62 155.49 3.07 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -169.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -78.37 -12.96 60.04 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.012 -1.449 . . . . 0.0 112.49 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.475 HG22 ' HB3' ' A' ' 69' ' ' ALA . 75.7 p 58.61 28.52 17.23 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 126.56 1.944 . . . . 0.0 113.635 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.07 -28.44 6.98 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -170.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.717 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -124.9 106.07 9.72 Favored 'General case' 0 C--O 1.197 -1.676 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.418 -167.177 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.683 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 12.9 m-85 60.07 -171.06 0.02 OUTLIER Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.838 168.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.683 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 10.2 Cg_endo -58.72 149.91 73.92 Favored 'Trans proline' 0 C--N 1.379 2.148 0 CA-C-N 120.79 1.318 . . . . 0.0 113.8 171.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.58 126.21 34.21 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.783 -176.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 77.5 t80 -105.45 119.01 38.03 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -126.96 117.34 22.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.541 HD11 HG12 ' A' ' 110' ' ' VAL . 51.4 mt -91.02 110.18 22.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -92.04 135.0 34.31 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.575 ' OE2' ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -90.61 132.94 35.45 Favored 'General case' 0 CA--C 1.461 -2.462 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.371 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.582 HG22 ' SD ' ' A' ' 20' ' ' MET . 22.0 t -101.05 -6.7 9.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.98 -46.15 5.45 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 119.771 -0.771 . . . . 0.0 109.575 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.575 ' HG2' ' OE2' ' A' ' 86' ' ' GLU . 43.6 mmtm -92.62 -25.45 18.29 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.505 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 63.0 t30 66.65 59.16 0.61 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 123.646 1.688 . . . . 0.0 106.799 -171.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.552 ' HB2' ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -130.24 176.34 8.19 Favored 'General case' 0 CA--C 1.468 -2.183 0 CA-C-N 113.098 -1.864 . . . . 0.0 107.4 -172.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 91' ' ' GLN . 60.3 mmtt -142.52 111.04 6.15 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -106.63 87.96 3.12 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HB2' HD21 ' A' ' 74' ' ' LEU . 2.9 Cg_endo -104.48 150.89 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 122.689 2.259 . . . . 0.0 114.675 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 57.2 t80 -98.51 149.88 22.26 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.437 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 3.4 m-20 -58.72 139.51 56.07 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-O 121.702 0.763 . . . . 0.0 111.196 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.717 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 45.3 mt-30 -77.71 -8.54 58.09 Favored 'General case' 0 C--N 1.265 -3.103 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.181 -176.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 6.4 pt-20 -130.29 16.58 5.52 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.528 0.68 . . . . 0.0 111.42 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 34.8 ttmt -107.21 9.07 30.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.374 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 66.68 117.31 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.666 1.587 . . . . 0.0 114.6 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.543 HG23 HG13 ' A' ' 106' ' ' ILE . 3.4 mp -83.06 106.35 13.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.498 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.7 p -129.83 175.69 8.64 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.649 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 31.2 t80 -51.45 -63.79 1.02 Allowed 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 124.147 0.904 . . . . 0.0 110.047 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -67.38 -42.06 84.01 Favored 'General case' 1 N--CA 1.373 -4.299 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.195 -172.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.05 92.46 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 123.646 0.591 . . . . 0.0 110.296 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.543 HG13 HG23 ' A' ' 101' ' ' ILE . 32.6 mm -75.3 -42.26 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.101 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 27.0 ttpp -55.28 -50.33 69.8 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 123.759 0.662 . . . . 0.0 109.996 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.0 -33.54 75.78 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.043 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.462 ' CD1' ' HD1' ' A' ' 95' ' ' PHE . 68.8 t80 -66.21 -60.76 2.48 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.855 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.541 HG12 HD11 ' A' ' 84' ' ' ILE . 27.8 m -58.67 -31.3 43.86 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 122.033 -0.417 . . . . 0.0 110.411 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 23.0 t70 -61.48 -50.97 70.59 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.789 1.236 . . . . 0.0 109.69 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.696 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 4.4 t70 -61.65 -46.29 90.38 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-N 113.941 -1.482 . . . . 0.0 107.247 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.498 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.1 t80 -55.4 -65.14 0.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.01 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.88 -15.29 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 C-N-CA 123.661 0.785 . . . . 0.0 111.909 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.35 -25.39 25.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 0.0 110.17 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.56 26.67 6.74 Favored Glycine 0 CA--C 1.485 -1.782 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.696 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -98.09 -47.12 5.62 Favored 'General case' 0 N--CA 1.411 -2.414 0 CA-C-N 114.055 -1.073 . . . . 0.0 109.113 -176.226 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.556 HG13 ' HB3' ' A' ' 112' ' ' ASP . 20.5 mt -74.5 145.66 10.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.03 151.41 78.26 Favored Pre-proline 0 C--N 1.283 -2.296 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.121 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.59 106.85 2.35 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.609 1.539 . . . . 0.0 112.792 -175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 122' ' ' ILE . 17.0 t -85.04 75.54 10.36 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 123' ' ' LYS . 3.0 pt 179.67 -45.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 C-N-CA 128.355 2.662 . . . . 0.0 107.292 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.413 ' N ' HG13 ' A' ' 122' ' ' ILE . 16.5 tppt? -90.39 97.93 11.47 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.768 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.45 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.8 m -135.29 105.83 6.45 Favored 'General case' 0 C--N 1.273 -2.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -111.62 94.02 21.94 Favored Pre-proline 0 N--CA 1.42 -1.936 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 124' ' ' SER . 44.4 Cg_endo -95.24 173.22 1.22 Allowed 'Trans proline' 0 N--CA 1.413 -3.246 0 C-N-CA 121.513 1.475 . . . . 0.0 112.635 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.4 pt -114.83 94.57 38.19 Favored Pre-proline 0 C--N 1.301 -1.542 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.558 175.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.85 132.85 50.09 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.471 2.114 . . . . 0.0 109.7 174.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -85.43 95.91 9.41 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.178 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 68.75 108.63 0.05 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.317 1.447 . . . . 0.0 111.968 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.431 ' HG2' ' N ' ' A' ' 132' ' ' GLU . 13.8 tt0 -141.17 168.6 19.38 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.431 ' N ' ' HG2' ' A' ' 131' ' ' GLN . 5.0 mp0 -77.95 154.75 31.32 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.579 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.718 -177.936 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.754 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -65.72 -43.01 10.65 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.346 2.031 . . . . 0.0 109.067 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt -141.22 165.29 27.94 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.12 -12.29 75.68 Favored Glycine 0 C--N 1.316 -0.545 0 O-C-N 123.503 0.502 . . . . 0.0 112.512 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.4 t -148.28 139.11 13.38 Favored Pre-proline 0 N--CA 1.416 -2.152 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.28 -49.56 3.49 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.0 1.8 . . . . 0.0 110.757 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.7 tp -169.73 -61.21 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 79.9 mt -99.03 117.65 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.736 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.4 -99.44 0.15 Allowed Glycine 0 N--CA 1.418 -2.565 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HA ' ' H ' ' A' ' 59' ' ' THR . 10.6 pt-20 -118.09 167.68 11.25 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.041 0.448 . . . . 0.0 109.957 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.509 HG13 ' HA3' ' A' ' 58' ' ' GLY . 69.2 mt -110.79 128.96 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 172.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.06 170.68 19.43 Favored Glycine 0 N--CA 1.416 -2.679 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.74 -18.23 54.54 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.278 2.652 . . . . 0.0 112.642 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.83 6.39 31.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.837 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -114.95 -25.98 7.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.374 -1.33 . . . . 0.0 111.981 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -41.75 -59.49 1.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.751 0.821 . . . . 0.0 112.248 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.6 m -54.3 -33.04 57.89 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.011 -1.449 . . . . 0.0 112.738 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.58 -26.99 31.82 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -74.68 -29.26 61.17 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.418 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -76.76 -35.79 57.48 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.731 178.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -70.87 -21.72 62.37 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.394 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.07 -24.23 59.48 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 120.831 0.348 . . . . 0.0 111.307 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.61 -15.49 30.29 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-O 121.443 0.468 . . . . 0.0 112.309 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.612 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 19.8 pt -90.07 153.35 46.91 Favored Pre-proline 0 C--N 1.293 -1.888 0 CA-C-N 115.175 -0.513 . . . . 0.0 109.98 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 21.4 Cg_exo -52.42 140.47 53.53 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.313 2.675 . . . . 0.0 113.879 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.435 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 2.7 tt -102.31 125.2 48.95 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.91 106.29 18.58 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.435 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 57.1 m-85 -87.88 113.92 23.99 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.12 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.607 HG12 HD13 ' A' ' 44' ' ' LEU . 3.1 mp -103.71 86.96 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.815 0 C-N-CA 118.379 -1.328 . . . . 0.0 108.958 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.63 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 41.5 m-85 -75.87 125.82 29.82 Favored 'General case' 0 CA--C 1.457 -2.609 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . . . -140.58 119.5 12.65 Favored 'General case' 0 C--N 1.258 -3.381 0 O-C-N 123.567 0.542 . . . . 0.0 111.489 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.99 -26.44 67.55 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.57 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 1.2 p -81.39 120.42 24.94 Favored 'General case' 0 N--CA 1.393 -3.287 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.914 -176.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.04 -16.75 12.58 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 173.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.0 mp0 -72.74 -45.49 58.45 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.764 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -116.28 12.99 15.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.137 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.574 ' HA ' HD23 ' A' ' 40' ' ' LEU . 44.1 ttm180 -51.79 -41.25 61.55 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 13.2 ptmm? -54.75 -32.0 59.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 124.147 0.904 . . . . 0.0 111.751 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -73.81 -43.78 57.8 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.674 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.8 mm? -58.14 -48.42 80.29 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.518 ' HA ' HD12 ' A' ' 44' ' ' LEU . 1.8 m -72.4 -21.48 61.26 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.817 -173.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 18.4 t70 -72.43 -39.19 68.06 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.743 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.62 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -73.02 -32.13 64.91 Favored 'General case' 0 C--O 1.287 3.035 0 CA-C-O 123.015 1.388 . . . . 0.0 108.69 175.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 52.5 mt -70.53 -26.51 63.61 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.434 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 4.0 tppp? -65.51 -51.8 48.81 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.304 -174.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 89.2 Cg_exo -67.14 -43.62 6.12 Favored 'Trans proline' 0 C--O 1.27 2.098 0 C-N-CA 122.901 2.4 . . . . 0.0 111.571 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.506 HG13 ' HA ' ' A' ' 44' ' ' LEU . 2.2 pp -63.13 -21.75 29.02 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 118.457 -1.297 . . . . 0.0 111.099 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.39 -24.26 16.79 Favored 'General case' 0 C--O 1.197 -1.681 0 O-C-N 123.677 0.611 . . . . 0.0 111.085 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.506 ' OE1' ' HD2' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -66.26 -21.39 66.28 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.41 -19.46 56.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.73 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 8.7 pt20 -139.04 35.73 2.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.267 1.032 . . . . 0.0 110.883 -171.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.506 ' HD2' ' OE1' ' A' ' 49' ' ' GLU . 14.3 ptm180 -73.05 -18.84 61.28 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.614 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.83 15.34 31.51 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.612 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.2 p -137.85 -29.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.866 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.6 mt -128.65 136.15 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 O-C-N 121.546 -0.721 . . . . 0.0 111.361 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.454 HD21 HG13 ' A' ' 24' ' ' ILE . 17.9 m-80 -88.88 109.35 20.14 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.509 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 5.0 m-85 -93.31 114.98 27.56 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -136.97 128.62 4.46 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.353 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.471 ' H ' ' HA ' ' A' ' 10' ' ' GLU . 55.3 p -87.84 132.36 34.21 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 6.8 tt -132.79 145.25 34.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 63' ' ' LYS . 11.2 t70 -75.56 127.83 33.95 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.263 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -90.98 -1.3 57.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.624 0.725 . . . . 0.0 111.285 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HB3' ' OD1' ' A' ' 61' ' ' ASP . 39.1 ttmt -99.35 -34.19 10.41 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.38 -54.5 3.25 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.766 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.29 20.25 19.25 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 121.767 -0.583 . . . . 0.0 111.007 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -63.3 -20.4 63.08 Favored Glycine 0 C--N 1.309 -0.919 0 N-CA-C 116.246 1.258 . . . . 0.0 116.246 -172.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.04 -25.03 66.63 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.021 0.911 . . . . 0.0 110.591 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -73.09 -17.83 61.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.458 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.438 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -64.18 -33.58 76.11 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.623 1.202 . . . . 0.0 108.837 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.571 ' HA2' ' H ' ' A' ' 73' ' ' ASN . . . -116.22 24.08 10.17 Favored Glycine 0 C--N 1.27 -3.111 0 C-N-CA 118.564 -1.779 . . . . 0.0 114.226 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -8.4 58.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 166.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.483 HD12 ' CB ' ' A' ' 73' ' ' ASN . 4.1 pp -112.71 -38.55 4.55 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 112.867 -1.97 . . . . 0.0 109.18 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.571 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 11.5 t-20 -169.23 -56.95 0.02 OUTLIER 'General case' 0 C--N 1.367 1.356 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.5 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.3 mm? -60.49 173.37 0.71 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -167.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.605 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 53.1 tttm -90.54 -9.75 46.05 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.588 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.2 p 74.7 -13.13 0.85 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 128.358 2.663 . . . . 0.0 115.714 168.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.605 ' OD1' ' HG2' ' A' ' 75' ' ' LYS . 17.7 p-10 -108.1 5.04 25.6 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -166.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 36.2 ttmt -129.23 103.98 7.26 Favored 'General case' 0 C--N 1.258 -3.395 0 C-N-CA 119.527 -0.869 . . . . 0.0 113.256 -173.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.547 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 31.6 m-85 56.52 -175.57 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 124.417 1.073 . . . . 0.0 113.195 167.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 9.2 Cg_endo -65.12 134.07 38.01 Favored 'Trans proline' 0 N--CA 1.424 -2.596 0 CA-C-N 119.978 1.028 . . . . 0.0 113.113 167.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.95 116.64 20.39 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 113.903 -1.498 . . . . 0.0 107.878 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 61.5 t80 -91.34 109.32 20.6 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.381 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -111.0 115.85 30.18 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 39.2 mt -90.93 109.38 20.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 25.4 tt0 -106.74 120.54 42.27 Favored 'General case' 0 N--CA 1.395 -3.203 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.436 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 13.1 mt-10 -75.38 148.23 39.37 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.885 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 20' ' ' MET . 16.4 t -113.72 -1.87 10.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.88 -55.9 3.63 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -97.36 -19.78 18.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.212 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.759 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 47.2 t-20 59.85 80.43 0.2 Allowed 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 125.119 1.368 . . . . 0.0 108.277 -170.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.558 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 5.3 tp60 -133.59 165.26 25.33 Favored 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 113.789 -1.55 . . . . 0.0 107.519 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.504 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 1.2 mptp? -125.25 99.85 6.26 Favored 'General case' 0 N--CA 1.4 -2.964 0 O-C-N 123.82 0.7 . . . . 0.0 109.242 -175.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 44.6 m-85 -104.57 83.45 0.77 Allowed Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.999 174.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 4.6 Cg_endo -100.74 148.42 0.37 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 C-N-CA 122.879 2.386 . . . . 0.0 114.354 -177.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -88.8 158.75 18.03 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.844 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.5 m-20 -65.99 145.79 55.46 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 121.514 0.673 . . . . 0.0 111.426 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 13.2 mt-30 -84.25 5.2 27.53 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.299 -174.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.3 22.63 2.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.037 0.923 . . . . 0.0 110.108 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 14.6 tppt? -104.03 170.23 8.04 Favored 'General case' 0 N--CA 1.401 -2.898 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -94.26 110.29 22.05 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 118.647 0.658 . . . . 0.0 111.503 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.71 101.59 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.637 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.3 p -125.29 -170.59 2.2 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.019 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.3 t80 -75.28 -54.24 7.42 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -174.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -55.18 -54.0 48.87 Favored 'General case' 0 N--CA 1.384 -3.767 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.777 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.68 -48.82 78.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 123.742 0.651 . . . . 0.0 112.265 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 47.7 mm -73.65 -40.55 54.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -59.13 -46.6 87.94 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.48 94.78 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.829 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -65.38 -58.67 5.3 Favored 'General case' 0 C--O 1.21 -0.987 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.276 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.402 HG12 HD11 ' A' ' 84' ' ' ILE . 35.0 m -59.92 -33.25 52.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 O-C-N 121.689 -0.632 . . . . 0.0 110.7 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.18 -51.91 67.97 Favored 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 124.241 1.016 . . . . 0.0 109.673 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.667 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 3.6 t70 -58.89 -47.12 86.08 Favored 'General case' 0 C--O 1.206 -1.197 0 CA-C-N 113.699 -1.591 . . . . 0.0 107.383 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.47 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.1 t80 -55.44 -64.48 0.83 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.059 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.99 -11.95 14.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.224 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.77 -30.14 23.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.435 0.636 . . . . 0.0 109.744 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.41 26.74 5.54 Favored Glycine 0 CA--C 1.481 -2.051 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.667 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -96.68 -52.32 3.97 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-N 114.131 -1.035 . . . . 0.0 109.157 -176.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 112' ' ' ASP . 18.5 mt -71.15 145.1 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.56 150.94 74.29 Favored Pre-proline 0 C--N 1.277 -2.57 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -46.33 122.23 5.38 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.569 2.846 . . . . 0.0 112.845 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.9 t -82.88 40.0 0.66 Allowed 'General case' 0 CA--C 1.56 1.338 0 CA-C-O 122.33 1.062 . . . . 0.0 110.425 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.431 HG13 ' H ' ' A' ' 123' ' ' LYS . 1.1 pt -156.89 -82.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 125.32 1.448 . . . . 0.0 109.193 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.431 ' H ' HG13 ' A' ' 122' ' ' ILE . 49.9 mmtm -80.96 79.18 7.68 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.545 0.688 . . . . 0.0 110.775 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -156.26 102.84 2.13 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -114.2 92.94 28.81 Favored Pre-proline 0 N--CA 1.415 -2.182 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.548 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 40.2 Cg_endo -85.53 -173.15 1.29 Allowed 'Trans proline' 0 N--CA 1.436 -1.897 0 C-N-CA 122.268 1.979 . . . . 0.0 112.747 -173.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.4 pt -110.39 95.74 23.78 Favored Pre-proline 0 N--CA 1.431 -1.421 0 CA-C-O 121.662 0.744 . . . . 0.0 113.004 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 126' ' ' PRO . 2.4 Cg_endo -82.66 -172.02 1.3 Allowed 'Trans proline' 0 N--CA 1.428 -2.366 0 C-N-CA 122.078 1.852 . . . . 0.0 107.466 169.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -130.67 168.18 17.56 Favored 'General case' 0 C--N 1.274 -2.707 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.514 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.71 129.54 41.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.828 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -74.86 146.17 42.16 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -73.64 -27.84 61.47 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.061 0.458 . . . . 0.0 111.391 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.0 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.523 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.693 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.44 -34.29 54.47 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.763 2.309 . . . . 0.0 112.924 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -122.3 80.8 1.76 Allowed 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.47 170.06 46.11 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.759 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.572 ' OG ' ' HD3' ' A' ' 6' ' ' PRO 0.271 2.9 p -134.26 -65.27 0.02 OUTLIER Pre-proline 0 CA--C 1.566 1.593 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 178.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.572 ' HD3' ' OG ' ' A' ' 5' ' ' SER . 51.7 Cg_endo -107.63 50.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.902 2.401 . . . . 0.0 111.537 -176.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.425 HD22 ' H ' ' A' ' 7' ' ' LEU . 3.3 mm? -45.02 -48.23 11.62 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.627 1.171 . . . . 0.0 113.808 -174.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 92.4 mt -126.04 128.68 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.63 -117.92 0.81 Allowed Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -119.81 136.0 54.64 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.573 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 57.1 mt -92.48 139.05 18.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.54 -179.65 18.87 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.79 -31.68 42.98 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.45 3.433 . . . . 0.0 114.582 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.24 -7.59 24.47 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.0 p -93.83 -27.26 16.54 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.985 -169.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -45.93 -51.43 13.29 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.884 0.85 . . . . 0.0 111.012 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -55.5 -34.4 64.57 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.387 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -71.04 -41.64 70.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.456 0.646 . . . . 0.0 110.096 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 41.9 m-85 -72.48 -28.94 63.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.35 1.071 . . . . 0.0 108.271 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.464 ' SD ' HG22 ' A' ' 87' ' ' VAL . 5.8 tpp -78.39 -19.96 52.2 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.315 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -87.79 -17.11 32.31 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.355 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.37 -41.7 72.75 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.025 0.441 . . . . 0.0 110.794 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.22 0.28 65.66 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.662 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 13.7 pt -107.8 152.48 41.59 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HG2' HG12 ' A' ' 55' ' ' ILE . 9.9 Cg_endo -53.25 138.91 64.18 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.923 3.082 . . . . 0.0 113.759 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.488 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 2.5 tt -105.33 125.85 51.45 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.591 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -98.76 105.55 17.71 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.488 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 65.5 m-85 -86.72 112.43 21.66 Favored 'General case' 0 CA--C 1.467 -2.234 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.429 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.9 mt -101.09 85.08 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.596 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 43.6 m-85 -76.35 124.52 27.65 Favored 'General case' 0 CA--C 1.46 -2.515 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.64 121.17 21.62 Favored 'General case' 0 C--N 1.257 -3.447 0 O-C-N 123.456 0.473 . . . . 0.0 110.66 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -81.99 -16.69 49.49 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 17.6 p -97.11 100.55 12.03 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.722 -174.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.64 -16.93 60.14 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.94 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -71.57 -56.67 5.43 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.164 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.565 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 15.0 pt-20 -91.0 8.49 35.04 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.561 -175.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 33' ' ' THR 0.275 0.1 OUTLIER -59.71 -32.85 70.91 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.159 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -77.46 -33.63 54.61 Favored 'General case' 0 C--O 1.2 -1.543 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.782 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.565 ' OE2' ' HA ' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -65.77 -43.92 87.38 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.323 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.492 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -56.92 -49.51 75.39 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.552 ' OG ' HG21 ' A' ' 59' ' ' THR . 15.0 m -73.63 -13.41 61.0 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.061 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 24.4 t70 -77.49 -38.32 49.36 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 123.138 0.575 . . . . 0.0 111.074 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.597 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -69.37 -36.34 76.74 Favored 'General case' 0 C--O 1.276 2.495 0 CA-C-O 123.271 1.51 . . . . 0.0 107.952 172.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 75.5 mt -73.22 -18.52 61.23 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 113.527 -1.67 . . . . 0.0 111.94 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.622 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 36.9 ttpt -62.37 -55.03 43.6 Favored Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 123.646 0.778 . . . . 0.0 111.382 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.622 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 51.6 Cg_exo -72.22 -36.97 4.99 Favored 'Trans proline' 0 CA--C 1.485 -1.926 0 C-N-CA 122.593 2.195 . . . . 0.0 109.795 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.611 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 27.3 mm -54.38 -36.64 34.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.383 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.33 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.05 -20.47 22.04 Favored 'General case' 0 C--O 1.195 -1.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.249 -174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -69.9 -22.72 63.19 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.32 -9.62 59.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.757 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 9.3 pt20 -148.57 35.37 0.79 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.298 1.046 . . . . 0.0 110.644 -173.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HA ' HD11 ' A' ' 8' ' ' ILE . 38.8 ptt180 -73.2 -19.23 61.14 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.805 -173.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.13 21.68 11.9 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.679 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.496 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.7 p -138.84 -32.65 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.504 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.475 HG12 ' HG2' ' A' ' 25' ' ' PRO . 95.2 mt -122.85 137.6 55.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.812 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 13.1 m120 -84.16 111.75 19.63 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 1.6 m-85 -97.67 105.82 18.03 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.573 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -130.62 130.46 6.16 Favored Glycine 0 N--CA 1.415 -2.747 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.867 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.567 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 35.6 p -92.38 136.97 32.76 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 tt -137.31 156.92 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD2' ' HD1' ' A' ' 65' ' ' PHE . 3.4 p30 -75.28 149.71 38.73 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.347 0.594 . . . . 0.0 110.172 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.6 14.03 26.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.904 0.859 . . . . 0.0 108.764 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -84.43 -53.71 5.25 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.045 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.56 -48.6 3.21 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.3 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.482 ' HD1' ' OD2' ' A' ' 61' ' ' ASP . 96.0 m-85 -97.97 10.49 40.2 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.987 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.11 -24.63 61.1 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 115.881 1.113 . . . . 0.0 115.881 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.92 -20.83 65.98 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.399 1.099 . . . . 0.0 110.333 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -70.82 -20.72 62.54 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.552 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -61.19 -39.39 89.99 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-O 122.343 1.068 . . . . 0.0 109.652 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -113.21 31.44 6.71 Favored Glycine 0 C--N 1.27 -3.101 0 C-N-CA 119.275 -1.441 . . . . 0.0 113.825 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.59 -17.46 38.71 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 168.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.457 HD12 ' N ' ' A' ' 73' ' ' ASN . 4.0 pp -102.82 -24.95 13.67 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.041 -1.891 . . . . 0.0 110.998 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.457 ' N ' HD12 ' A' ' 72' ' ' LEU . 1.9 t30 -179.96 -59.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.604 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.6 mm? -54.41 158.71 2.29 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -168.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -75.42 -17.69 60.1 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.829 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.428 HG22 ' HB3' ' A' ' 69' ' ' ALA . 48.6 p 55.17 40.33 31.72 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.182 1.393 . . . . 0.0 113.42 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' OD2' ' HE2' ' A' ' 78' ' ' LYS . 20.6 p-10 -125.18 -23.13 4.25 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.164 0.507 . . . . 0.0 111.224 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HE2' ' OD2' ' A' ' 77' ' ' ASP . 33.6 mtmt -108.13 -174.69 2.58 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -170.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.729 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 95.7 m-85 -69.16 -172.45 0.17 Allowed Pre-proline 0 CA--C 1.572 1.822 0 C-N-CA 125.791 1.637 . . . . 0.0 109.967 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.729 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 1.3 Cg_endo -43.67 131.09 7.52 Favored 'Trans proline' 1 C--N 1.429 4.788 0 CA-C-N 122.415 1.898 . . . . 0.0 116.42 -170.476 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.423 ' HB1' ' HG ' ' A' ' 74' ' ' LEU . . . -126.85 116.05 20.27 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 113.101 -1.863 . . . . 0.0 107.93 -175.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.591 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 71.5 t80 -95.14 109.85 21.88 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.971 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -112.07 117.1 31.72 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.478 HD11 HG12 ' A' ' 110' ' ' VAL . 56.2 mt -91.45 105.22 16.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.666 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -90.13 126.37 35.77 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 2.8 mm-40 -87.88 125.59 34.57 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.549 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.464 HG22 ' SD ' ' A' ' 20' ' ' MET . 15.1 t -98.12 1.22 10.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.39 -35.07 3.66 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.177 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 89' ' ' LYS . 5.9 tmtm? -95.83 -20.16 19.03 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.3 m120 67.52 36.72 3.66 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-O 122.847 1.308 . . . . 0.0 110.337 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.505 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 2.0 tp60 -121.14 -179.69 4.12 Favored 'General case' 0 CA--C 1.472 -2.048 0 CA-C-N 112.803 -1.999 . . . . 0.0 107.681 -172.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.541 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 57.3 mmtt -138.12 106.17 5.71 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -102.47 87.2 1.08 Allowed Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 10.8 Cg_endo -102.33 142.25 0.19 Allowed 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 122.572 2.182 . . . . 0.0 114.638 -176.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.451 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 86.4 t80 -84.58 170.49 13.35 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.34 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 9.3 m-20 -72.42 159.49 33.89 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.122 0.969 . . . . 0.0 110.295 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -100.75 -11.67 19.72 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-O 121.83 0.824 . . . . 0.0 108.909 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -123.42 -0.18 8.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.347 -173.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 33.3 ttmt -87.58 -3.18 58.99 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.869 -172.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 72.95 134.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.145 0.978 . . . . 0.0 111.703 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.567 HG23 HG13 ' A' ' 106' ' ' ILE . 2.8 mp -90.04 101.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 122.009 0.909 . . . . 0.0 109.846 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.7 p -109.33 -174.02 2.4 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 18.9 t80 -77.2 -51.14 11.45 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -59.95 -52.39 65.61 Favored 'General case' 0 N--CA 1.379 -3.985 0 CA-C-N 112.493 -2.14 . . . . 0.0 113.397 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.57 83.46 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.121 0.486 . . . . 0.0 111.39 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.567 HG13 HG23 ' A' ' 101' ' ' ILE . 40.2 mm -73.05 -42.0 59.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.0 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 47' ' ' ILE . 33.8 ttpt -56.46 -50.56 71.38 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.34 92.63 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.143 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.496 ' O ' HD11 ' A' ' 118' ' ' ILE . 57.8 t80 -63.69 -59.92 3.98 Favored 'General case' 0 C--O 1.204 -1.305 0 O-C-N 124.02 0.825 . . . . 0.0 111.074 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 106' ' ' ILE . 31.4 m -58.87 -35.72 57.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 O-C-N 121.998 -0.438 . . . . 0.0 111.535 -176.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.88 -51.93 66.18 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.719 0.771 . . . . 0.0 109.036 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.69 ' OD1' ' HB3' ' A' ' 117' ' ' LYS . 5.6 t0 -57.35 -36.08 70.75 Favored 'General case' 0 C--O 1.196 -1.711 0 CA-C-N 113.45 -1.704 . . . . 0.0 109.731 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.693 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -71.25 -61.22 1.85 Allowed 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.89 177.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.09 -23.44 33.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.542 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.52 -22.19 44.26 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.605 0.717 . . . . 0.0 109.622 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.4 18.22 15.31 Favored Glycine 0 CA--C 1.466 -2.994 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.487 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.69 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 12.7 ttpp -93.04 -38.31 11.7 Favored 'General case' 0 N--CA 1.384 -3.753 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.609 -172.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.693 HD12 ' HB2' ' A' ' 113' ' ' PHE . 9.9 mt -67.57 141.92 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.407 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -118.55 135.67 23.75 Favored Pre-proline 0 C--N 1.256 -3.471 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.14 124.13 15.22 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.982 2.455 . . . . 0.0 112.368 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.1 m -57.52 -29.92 64.74 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.553 0.741 . . . . 0.0 112.605 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 19.5 pt -121.35 -39.71 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 O-C-N 122.004 -0.435 . . . . 0.0 111.656 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.468 ' HG2' ' H ' ' A' ' 124' ' ' SER . 72.6 tttt 74.14 -157.79 0.07 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.468 ' H ' ' HG2' ' A' ' 123' ' ' LYS . 24.3 m 69.26 126.91 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.023 0.916 . . . . 0.0 112.022 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -117.08 95.91 48.04 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.76 140.86 16.75 Favored 'Trans proline' 0 N--CA 1.425 -2.508 0 C-N-CA 121.702 1.601 . . . . 0.0 114.097 -170.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.422 HD11 ' HE3' ' A' ' 130' ' ' LYS . 8.1 tp -147.0 83.55 7.89 Favored Pre-proline 0 C--N 1.282 -2.352 0 CA-C-N 114.051 -1.432 . . . . 0.0 109.231 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.96 -175.47 2.69 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.101 1.867 . . . . 0.0 110.733 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -71.84 132.69 44.78 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.422 ' HE3' HD11 ' A' ' 127' ' ' ILE . 11.8 mptt -69.39 95.22 0.78 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.251 0.548 . . . . 0.0 111.727 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -82.5 152.6 25.98 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -88.07 152.91 21.68 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.195 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.553 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -175.498 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.838 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.97 -26.11 9.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.035 1.823 . . . . 0.0 112.878 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 57.1 72.29 0.52 Allowed 'General case' 0 C--O 1.249 1.037 0 CA-C-O 122.067 0.936 . . . . 0.0 109.56 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.39 128.5 3.28 Favored Glycine 0 N--CA 1.411 -2.975 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.888 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 p -156.88 116.42 2.05 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.44 -12.45 27.74 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 123.095 2.53 . . . . 0.0 113.591 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.74 -11.51 21.84 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.488 HG12 ' HB2' ' A' ' 57' ' ' PHE . 85.4 mt -126.1 142.22 43.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.976 -0.452 . . . . 0.0 111.061 -174.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.16 -125.99 1.73 Allowed Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.91 176.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -118.56 144.56 46.0 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.46 0.648 . . . . 0.0 110.272 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.533 HG13 ' HA3' ' A' ' 58' ' ' GLY . 62.1 mt -95.72 114.04 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -127.77 -178.92 15.56 Favored Glycine 0 N--CA 1.408 -3.199 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.29 -8.28 8.23 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.036 3.157 . . . . 0.0 115.67 -173.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -123.98 -18.36 5.98 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.018 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.8 p -85.23 -27.62 25.94 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.573 -172.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -62.09 -36.74 82.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.293 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 m -66.66 -27.31 67.57 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.867 0.867 . . . . 0.0 110.574 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.95 -39.07 61.55 Favored 'General case' 0 C--O 1.258 1.549 0 CA-C-O 121.704 0.764 . . . . 0.0 109.095 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -75.12 -26.15 58.98 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.463 ' SD ' HG22 ' A' ' 87' ' ' VAL . 8.8 tpp -77.76 -25.3 49.03 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.661 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -88.82 -10.75 46.98 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.405 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.27 -35.19 73.6 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 122.086 -0.384 . . . . 0.0 111.543 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.48 65.55 Favored Glycine 0 N--CA 1.461 0.304 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.366 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 9.1 pt -126.1 151.62 72.07 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HG2' HG12 ' A' ' 55' ' ' ILE . 8.0 Cg_endo -50.14 141.56 30.32 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.068 3.179 . . . . 0.0 114.037 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.448 HD13 ' CE1' ' A' ' 28' ' ' TYR . 2.5 tt -110.4 124.81 52.42 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.548 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -94.1 105.46 17.46 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.448 ' CE1' HD13 ' A' ' 26' ' ' LEU . 48.3 m-85 -87.59 110.7 20.57 Favored 'General case' 0 CA--C 1.471 -2.058 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.363 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.7 mt -100.23 85.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.319 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.546 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 31.5 m-85 -77.53 109.91 11.88 Favored 'General case' 0 CA--C 1.468 -2.181 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -124.06 119.75 30.39 Favored 'General case' 1 C--N 1.238 -4.245 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.701 177.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -74.54 -27.2 60.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 11.4 p -93.49 106.6 18.55 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.61 -173.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . -78.78 -21.28 48.1 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.909 -175.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -80.1 -48.51 13.12 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.042 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.489 ' HG2' ' HB ' ' A' ' 33' ' ' THR . 12.5 pt-20 -90.7 1.18 57.07 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.553 -0.859 . . . . 0.0 112.158 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 12.2 ptm180 -60.19 -24.31 64.68 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -58.48 -57.9 10.92 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.53 -25.79 54.51 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.166 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.654 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -60.24 -50.98 71.5 Favored 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.416 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.457 ' HA ' HD12 ' A' ' 44' ' ' LEU . 9.9 m -75.11 -19.4 59.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.73 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.43 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 15.9 t70 -67.79 -43.39 79.84 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.836 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.626 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.6 OUTLIER -70.37 -34.05 72.14 Favored 'General case' 0 C--O 1.278 2.597 0 CA-C-O 122.772 1.272 . . . . 0.0 108.463 176.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 56.9 mt -69.94 -20.51 63.33 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.716 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.599 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 17.4 tppt? -61.97 -57.29 24.8 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.843 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 72.8 Cg_exo -66.82 -39.42 14.84 Favored 'Trans proline' 0 CA--C 1.49 -1.696 0 C-N-CA 122.917 2.411 . . . . 0.0 110.351 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.579 HD11 ' HA ' ' A' ' 103' ' ' PHE . 93.8 mt -52.67 -40.36 34.02 Favored 'Isoleucine or valine' 0 C--N 1.368 1.388 0 O-C-N 124.086 0.866 . . . . 0.0 109.208 176.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -94.26 -13.79 26.16 Favored 'General case' 0 C--O 1.177 -2.718 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.603 -173.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -71.94 -22.36 61.48 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.92 -23.45 33.51 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.906 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.524 ' OE1' HD12 ' A' ' 55' ' ' ILE . 5.4 pt20 -130.85 34.37 4.09 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.19 0.995 . . . . 0.0 112.373 -174.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -73.25 -18.58 61.21 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.393 -1.73 . . . . 0.0 111.858 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.38 4.4 28.17 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.418 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.8 p -124.15 -33.5 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.325 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.524 HD12 ' OE1' ' A' ' 51' ' ' GLN . 95.0 mt -124.39 136.81 59.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.034 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.43 HD21 HG13 ' A' ' 24' ' ' ILE . 20.3 m-80 -84.83 104.65 14.97 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.488 ' HB2' HG12 ' A' ' 8' ' ' ILE . 5.2 m-85 -90.16 102.67 15.39 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.573 0.701 . . . . 0.0 112.564 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.533 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -124.21 131.74 8.05 Favored Glycine 0 N--CA 1.415 -2.762 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.424 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 27.4 p -92.27 134.67 34.68 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 120.896 0.379 . . . . 0.0 110.515 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 8.7 tt -137.15 165.58 27.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -89.13 153.88 20.6 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-O 121.458 0.647 . . . . 0.0 110.922 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -110.48 19.83 18.36 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 173.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -102.82 -46.02 4.82 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 113.382 -1.735 . . . . 0.0 109.844 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.47 -43.58 3.48 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.139 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.421 ' O ' ' HE2' ' A' ' 30' ' ' PHE . 96.4 m-85 -99.21 10.12 42.07 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 122.124 -0.36 . . . . 0.0 110.68 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 62' ' ' ALA . . . -58.97 -30.04 66.0 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.01 -30.08 46.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.413 0.625 . . . . 0.0 111.303 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -69.15 -23.81 64.0 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.285 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.461 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -63.02 -34.41 77.5 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-O 121.978 0.894 . . . . 0.0 109.861 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.45 ' HA2' ' N ' ' A' ' 74' ' ' LEU . . . -109.28 5.34 31.7 Favored Glycine 0 C--N 1.279 -2.591 0 C-N-CA 117.403 -2.332 . . . . 0.0 115.502 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -76.57 -16.97 59.46 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 73' ' ' ASN . 4.2 pp -97.68 -31.38 12.3 Favored 'General case' 0 N--CA 1.399 -2.987 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.349 174.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.432 ' HB2' HD12 ' A' ' 72' ' ' LEU . 2.2 t-20 179.51 -56.74 0.01 OUTLIER 'General case' 0 C--N 1.38 1.906 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' A' ' 94' ' ' PRO . 2.3 mm? -61.4 179.9 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -169.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.25 -0.68 20.72 Favored 'General case' 0 CA--C 1.486 -1.515 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.99 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.467 ' N ' HE22 ' A' ' 97' ' ' GLN . 19.2 p 59.3 5.78 0.64 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 125.205 1.402 . . . . 0.0 112.401 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.92 -25.09 28.12 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -170.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 11.4 tptm -119.21 -158.68 0.74 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.672 -166.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.529 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 89.5 m-85 -54.99 168.32 0.53 Allowed Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 125.054 1.341 . . . . 0.0 110.506 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 2.5 Cg_endo -40.63 130.44 2.64 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.998 2.465 . . . . 0.0 114.431 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -103.75 104.82 14.88 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.608 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.548 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 74.3 t80 -87.13 111.5 21.0 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.908 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.88 119.39 32.51 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.518 HD11 HG12 ' A' ' 110' ' ' VAL . 55.2 mt -89.41 104.84 15.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -86.18 132.77 33.94 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.626 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.15 141.89 29.87 Favored 'General case' 0 C--N 1.265 -3.098 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.017 175.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.463 HG22 ' SD ' ' A' ' 20' ' ' MET . 25.8 t -107.79 -2.06 10.0 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.38 -48.19 3.75 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.42 ' HD3' ' OE2' ' A' ' 86' ' ' GLU . 4.7 mptp? -89.38 -25.15 21.73 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.981 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 16.2 t-20 66.17 20.72 11.15 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.36 1.464 . . . . 0.0 108.465 -173.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.539 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 4.4 tp60 -85.95 178.7 7.19 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.617 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 56.7 mmtt -138.46 105.04 5.31 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -96.88 87.84 0.49 Allowed Pre-proline 0 N--CA 1.481 1.084 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 6.0 Cg_endo -104.82 145.7 0.12 Allowed 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.516 2.144 . . . . 0.0 115.01 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.4 ' HD1' ' CD1' ' A' ' 109' ' ' PHE . 77.2 t80 -86.0 158.78 19.78 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.595 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.619 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.3 m-20 -71.48 134.49 46.59 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.109 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.467 HE22 ' N ' ' A' ' 76' ' ' THR . 48.1 mt-30 -75.74 9.62 2.21 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.722 -175.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -154.92 20.96 0.45 Allowed 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.177 0.513 . . . . 0.0 111.443 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.619 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 39.1 ttmt -97.86 9.89 41.57 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 74.09 120.46 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 113.562 -1.654 . . . . 0.0 112.025 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.2 mp -92.82 98.54 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.03 -164.47 1.32 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.923 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.579 ' HA ' HD11 ' A' ' 47' ' ' ILE . 16.0 t80 -77.79 -58.62 3.17 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -174.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -52.84 -53.75 44.18 Favored 'General case' 0 N--CA 1.386 -3.638 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.527 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.83 -49.31 77.1 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 123.596 0.56 . . . . 0.0 112.371 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 110' ' ' VAL . 41.8 mm -72.96 -42.45 59.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.024 -177.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.414 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 28.6 ttpt -54.52 -50.96 66.61 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.996 0.81 . . . . 0.0 109.241 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 112' ' ' ASP . . . -63.11 -39.11 93.73 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.559 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.4 ' CD1' ' HD1' ' A' ' 95' ' ' PHE . 66.7 t80 -65.32 -60.13 3.31 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.62 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.518 HG12 HD11 ' A' ' 84' ' ' ILE . 27.6 m -57.62 -36.62 54.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 O-C-N 121.83 -0.544 . . . . 0.0 111.422 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.29 -46.37 87.07 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.216 0.531 . . . . 0.0 109.681 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.69 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 3.4 t70 -57.27 -48.98 77.5 Favored 'General case' 0 C--O 1.203 -1.39 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.523 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.7 t80 -57.02 -63.59 1.16 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.622 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 110' ' ' VAL . 90.6 t -52.48 -30.8 14.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 C-N-CA 124.311 1.044 . . . . 0.0 112.37 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.59 -38.95 58.7 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.676 0.751 . . . . 0.0 110.026 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.16 23.87 5.64 Favored Glycine 0 CA--C 1.473 -2.534 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.69 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 3.3 ttmm -92.39 -42.52 9.73 Favored 'General case' 0 N--CA 1.387 -3.579 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.605 HG13 ' HB3' ' A' ' 112' ' ' ASP . 23.5 mt -81.37 143.35 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.05 175.44 3.68 Favored Pre-proline 0 C--N 1.272 -2.772 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.9 108.67 0.26 Allowed 'Trans proline' 0 CA--C 1.544 1.018 0 CA-C-N 121.174 1.455 . . . . 0.0 110.305 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.5 m -49.37 -54.66 16.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.938 1.295 . . . . 0.0 113.85 -172.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.9 pt -138.55 -50.75 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.928 0.394 . . . . 0.0 109.986 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -66.01 110.3 2.87 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.759 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -149.67 135.19 18.39 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -143.13 88.03 8.38 Favored Pre-proline 0 N--CA 1.428 -1.559 0 CA-C-O 122.0 0.905 . . . . 0.0 110.472 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -99.83 169.43 0.46 Allowed 'Trans proline' 0 N--CA 1.427 -2.4 0 C-N-CA 122.128 1.885 . . . . 0.0 112.563 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.7 pt -125.16 80.26 64.77 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.73 147.82 86.06 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 123.419 2.746 . . . . 0.0 113.854 -174.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.36 -168.33 0.2 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.445 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -147.33 169.52 19.25 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -107.47 142.72 36.91 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -80.47 -54.19 5.91 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.466 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.612 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -175.877 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.684 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.08 -70.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 123.244 2.629 . . . . 0.0 113.029 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.584 HD23 ' H ' ' A' ' 3' ' ' LEU . 2.1 pt? -83.68 131.38 34.95 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.27 -161.03 34.1 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.9 m -143.46 93.4 6.37 Favored Pre-proline 0 C--N 1.291 -1.973 0 CA-C-N 117.585 0.693 . . . . 0.0 110.923 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -85.33 -31.56 0.36 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.104 1.869 . . . . 0.0 112.099 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.7 mt -138.93 -59.04 0.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 49.0 mt -110.12 138.35 38.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.399 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.32 -121.34 1.12 Allowed Glycine 0 N--CA 1.425 -2.053 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.413 ' HG2' ' OG1' ' A' ' 59' ' ' THR . 42.4 mt-10 -118.23 155.12 31.1 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.565 HG13 ' HA3' ' A' ' 58' ' ' GLY . 67.7 mt -105.69 120.9 57.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.56 179.75 18.57 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.54 5.36 4.3 Favored 'Trans proline' 0 C--O 1.221 -0.367 0 C-N-CA 123.029 2.486 . . . . 0.0 112.752 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -128.64 -6.18 5.18 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.869 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -100.27 -28.31 13.05 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.736 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -59.09 -38.38 79.38 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.9 0.381 . . . . 0.0 111.693 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 m -65.22 -27.09 68.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.717 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.81 -33.4 40.41 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.034 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.402 ' HB3' ' CG ' ' A' ' 56' ' ' ASN . 21.1 m-85 -75.8 -27.21 57.88 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.558 ' SD ' HG22 ' A' ' 87' ' ' VAL . 8.7 tpp -77.07 -21.53 54.28 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 113.554 -1.657 . . . . 0.0 108.757 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.4 t -90.0 -12.77 37.66 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.8 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.26 60.39 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.226 0.536 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.63 2.85 78.46 Favored Glycine 0 C--N 1.32 -0.35 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.25 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 13.6 pt -112.04 148.64 39.47 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.481 ' HG2' HG12 ' A' ' 55' ' ' ILE . 6.6 Cg_endo -51.29 142.21 37.63 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.834 3.022 . . . . 0.0 113.846 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.51 HD13 ' CE1' ' A' ' 28' ' ' TYR . 2.6 tt -108.98 126.91 53.6 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -101.02 109.07 20.93 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE1' HD13 ' A' ' 26' ' ' LEU . 47.1 m-85 -89.58 109.61 20.54 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.365 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.532 HD11 ' CD2' ' A' ' 57' ' ' PHE . 2.5 mp -101.04 87.92 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.337 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.586 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 42.9 m-85 -73.02 133.73 44.36 Favored 'General case' 0 CA--C 1.467 -2.226 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . . . -148.19 117.08 6.73 Favored 'General case' 0 C--N 1.274 -2.693 0 O-C-N 123.593 0.558 . . . . 0.0 111.665 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.01 -22.8 59.44 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.852 0.834 . . . . 0.0 108.911 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.452 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 17.0 p -76.52 115.88 16.68 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.882 -173.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.33 -15.26 19.82 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.395 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -85.69 -63.72 1.27 Allowed 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.452 ' HG2' ' HB ' ' A' ' 33' ' ' THR . 1.3 pm0 -78.91 12.5 2.14 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.462 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.6 tpp85 -52.7 -39.07 61.64 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 169.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -67.03 -48.49 68.17 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.607 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 45.6 mt-10 -59.61 -50.52 73.55 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.217 0.532 . . . . 0.0 110.307 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -53.23 -54.42 36.43 Favored 'General case' 0 C--O 1.255 1.354 0 C-N-CA 124.653 1.181 . . . . 0.0 108.849 -176.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.468 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 12.3 m -73.6 -15.18 61.28 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.62 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 33.8 t70 -75.09 -35.59 61.79 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 122.954 0.501 . . . . 0.0 111.458 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -77.49 -30.17 52.94 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 122.865 1.317 . . . . 0.0 108.81 173.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 45.8 mt -73.16 -30.97 63.95 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 113.626 -1.624 . . . . 0.0 113.713 -177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 24.8 ttpp -68.2 -46.4 39.84 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.694 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 73.5 Cg_endo -70.88 -42.56 2.18 Favored 'Trans proline' 0 C--O 1.26 1.593 0 C-N-CA 122.485 2.123 . . . . 0.0 110.996 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 107' ' ' LYS . 2.6 pp -63.15 -24.89 37.15 Favored 'Isoleucine or valine' 0 C--N 1.385 2.128 0 C-N-CA 118.11 -1.436 . . . . 0.0 109.99 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.85 -22.23 19.4 Favored 'General case' 0 C--O 1.194 -1.841 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.201 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 6.2 tt0 -69.84 -18.44 63.44 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.72 -21.56 51.71 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.971 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 9.3 pt20 -138.51 36.54 2.25 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.2 1.0 . . . . 0.0 111.108 -170.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 49' ' ' GLU . 9.1 ptm180 -76.85 -14.02 59.94 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.645 -172.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.6 6.68 22.54 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.632 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.567 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.6 p -125.6 -32.51 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.515 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.481 HG12 ' HG2' ' A' ' 25' ' ' PRO . 94.6 mt -122.2 136.31 59.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.412 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.402 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 11.3 m120 -84.65 104.04 14.28 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.532 ' CD2' HD11 ' A' ' 29' ' ' ILE . 3.7 m-85 -90.75 103.61 16.29 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.565 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -124.34 130.88 7.69 Favored Glycine 0 N--CA 1.408 -3.22 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.412 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.413 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 20.7 p -92.01 127.82 37.62 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 9.3 tt -126.57 143.17 40.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 63' ' ' LYS . 20.3 t70 -76.27 131.13 39.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.122 -175.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -92.48 -1.08 57.23 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.343 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HB3' ' OD2' ' A' ' 61' ' ' ASP . 81.8 tttt -92.4 -43.61 9.13 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.52 -40.09 9.63 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.769 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -115.48 20.8 14.52 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.736 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.437 ' CA ' ' HA ' ' A' ' 62' ' ' ALA . . . -69.31 -23.29 76.41 Favored Glycine 0 C--N 1.305 -1.181 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 -169.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.0 -21.69 63.81 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.254 0.55 . . . . 0.0 111.4 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -69.13 -25.35 64.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.666 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -59.56 -35.28 73.94 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.073 0.939 . . . . 0.0 111.362 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -109.54 13.49 32.88 Favored Glycine 0 C--N 1.27 -3.114 0 C-N-CA 117.596 -2.24 . . . . 0.0 115.895 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -24.25 58.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 169.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 4.0 pp -92.45 -37.53 12.49 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.385 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.502 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 20.9 t-20 -172.94 -57.88 0.02 OUTLIER 'General case' 0 C--N 1.369 1.452 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.536 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.5 mm? -54.58 164.79 0.67 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -167.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -81.06 -14.87 57.42 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.757 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.475 HG22 ' HB3' ' A' ' 69' ' ' ALA . 28.9 p 59.6 21.44 10.05 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.655 1.982 . . . . 0.0 114.076 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -105.39 -25.27 12.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -135.41 115.05 12.76 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -166.05 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.677 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 14.8 t80 60.39 179.74 0.04 OUTLIER Pre-proline 0 CA--C 1.581 2.16 0 O-C-N 125.126 1.516 . . . . 0.0 111.546 158.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.677 ' HD2' ' CG ' ' A' ' 79' ' ' PHE . 3.7 Cg_endo -55.81 134.52 64.54 Favored 'Trans proline' 0 C--N 1.378 2.095 0 CA-C-N 120.805 1.323 . . . . 0.0 113.837 167.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.421 ' HB1' ' HG ' ' A' ' 74' ' ' LEU . . . -125.8 113.17 16.91 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.45 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.454 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 62.5 t80 -90.25 111.3 22.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -116.27 118.05 31.71 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 58.7 mt -93.7 114.09 29.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.547 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -102.53 126.77 49.7 Favored 'General case' 0 N--CA 1.405 -2.717 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 0.7 OUTLIER -78.98 136.65 37.28 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.95 177.291 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.558 HG22 ' SD ' ' A' ' 20' ' ' MET . 23.6 t -104.3 -5.18 9.56 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.62 -38.17 6.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.368 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 23.1 ttmm -101.88 -17.83 15.99 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 44.8 t-20 56.44 75.43 0.35 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 124.55 1.14 . . . . 0.0 108.507 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -144.17 174.34 10.97 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.087 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -126.97 102.35 6.95 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -177.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.408 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 60.8 m-85 -107.93 80.7 1.07 Allowed Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 15.4 Cg_endo -101.17 144.84 0.28 Allowed 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.907 2.405 . . . . 0.0 114.077 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -85.01 165.55 17.45 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 125.247 1.419 . . . . 0.0 108.259 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.742 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 9.0 m-20 -73.78 145.39 45.08 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.446 ' O ' ' HB3' ' A' ' 79' ' ' PHE . 13.0 mt-30 -83.02 -5.47 59.11 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.233 -170.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -148.09 32.36 0.83 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.337 1.065 . . . . 0.0 110.685 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 17.2 tppt? -95.95 -6.76 38.29 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.206 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 74.24 127.69 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.967 1.307 . . . . 0.0 111.734 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.472 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.0 mp -93.65 116.89 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.369 -176.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 p -122.49 -174.69 2.97 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.411 ' HA ' ' HB3' ' A' ' 43' ' ' LYS . 20.2 t80 -76.73 -48.7 17.98 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.6 -55.8 30.21 Favored 'General case' 0 N--CA 1.387 -3.618 0 CA-C-N 112.099 -2.319 . . . . 0.0 112.38 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.44 74.51 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.654 0.596 . . . . 0.0 111.996 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.472 ' CG1' HG23 ' A' ' 101' ' ' ILE . 42.1 mm -74.08 -43.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.68 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.41 ' HB2' HG21 ' A' ' 47' ' ' ILE . 36.5 ttpt -56.85 -48.24 78.54 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 124.118 0.886 . . . . 0.0 109.683 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.55 99.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.733 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.605 ' HA ' ' OD1' ' A' ' 112' ' ' ASP . 38.5 t80 -64.44 -58.13 7.31 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.495 1.118 . . . . 0.0 111.273 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 106' ' ' ILE . 26.8 m -58.95 -31.94 46.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 O-C-N 121.531 -0.731 . . . . 0.0 110.614 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.32 -52.93 50.7 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 123.828 0.851 . . . . 0.0 109.358 177.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.605 ' OD1' ' HA ' ' A' ' 109' ' ' PHE 0.281 0.4 OUTLIER -67.48 -22.1 65.49 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.329 -177.027 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.53 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.6 OUTLIER -72.75 -63.7 1.11 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.524 172.501 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.05 -20.95 27.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.09 -174.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.1 -30.43 60.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.22 40.24 1.83 Allowed Glycine 0 CA--C 1.479 -2.211 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.665 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -117.58 -41.73 2.92 Favored 'General case' 0 N--CA 1.391 -3.391 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.739 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 113' ' ' PHE . 6.6 mt -65.09 141.27 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.723 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -124.26 160.14 53.93 Favored Pre-proline 0 C--N 1.265 -3.091 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.467 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -74.54 147.4 36.03 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 121.374 1.383 . . . . 0.0 110.978 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.4 p -98.94 27.52 4.94 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.663 0.744 . . . . 0.0 110.51 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.9 pt -147.8 -41.11 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.121 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -124.08 -175.79 3.33 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.9 t -157.08 178.16 10.67 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -124.16 89.01 52.29 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -88.54 159.25 6.53 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 121.887 1.724 . . . . 0.0 111.046 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.3 mt -114.11 93.13 29.1 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -69.72 166.95 25.81 Favored 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.952 1.768 . . . . 0.0 109.964 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 68.19 115.97 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 O-C-N 124.336 1.022 . . . . 0.0 110.118 -173.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -74.05 104.37 4.86 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.524 -174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -159.84 169.3 23.87 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -123.72 138.45 54.52 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.66 0 CA-C-O 117.96 -1.466 . . . . 0.0 109.971 178.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 N--CA 1.431 -1.398 0 CA-C-O 122.09 0.947 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.569 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 62.7 mt -88.22 127.96 40.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.476 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.2 -176.42 20.04 Favored Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.06 -18.45 50.87 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.769 2.979 . . . . 0.0 113.792 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -94.8 -40.77 9.57 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.995 0.426 . . . . 0.0 110.818 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.2 p -86.18 -29.58 23.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -167.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -60.66 -37.5 81.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.654 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.5 m -67.9 -26.31 65.93 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.598 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -79.01 -34.57 43.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.414 0.626 . . . . 0.0 110.015 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -74.95 -28.37 60.56 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.489 ' SD ' HG22 ' A' ' 87' ' ' VAL . 7.4 tpp -79.67 -20.73 45.94 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.709 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 t -96.57 -5.51 39.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.862 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.27 -34.83 66.02 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.946 0.403 . . . . 0.0 110.202 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.21 -13.32 64.8 Favored Glycine 0 CA--C 1.51 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.27 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 16.5 pt -98.73 153.73 37.76 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 123.66 0.784 . . . . 0.0 109.475 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HG2' HG12 ' A' ' 55' ' ' ILE . 18.3 Cg_endo -58.69 145.77 94.51 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 123.53 2.82 . . . . 0.0 113.534 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.607 HD13 ' CE1' ' A' ' 28' ' ' TYR . 1.8 tt -110.98 127.25 55.45 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -176.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.453 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.8 108.97 21.73 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CE1' HD13 ' A' ' 26' ' ' LEU . 23.0 m-85 -90.19 110.5 21.53 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 124.387 1.075 . . . . 0.0 109.462 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.531 HD11 ' CD2' ' A' ' 57' ' ' PHE . 3.5 mp -101.25 91.05 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 C-N-CA 118.811 -1.156 . . . . 0.0 109.521 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.625 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 46.6 m-85 -76.43 128.24 34.43 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -143.48 119.42 10.63 Favored 'General case' 0 C--N 1.27 -2.862 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.576 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.44 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 49.1 mt-10 -84.99 -2.05 57.5 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.252 0.549 . . . . 0.0 109.747 173.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 7.3 p -91.61 123.54 35.09 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.877 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.99 -21.05 18.86 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.26 0.552 . . . . 0.0 110.655 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 37.1 mt-10 -86.07 -66.43 0.9 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.82 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 12.5 pt-20 -73.7 1.59 9.98 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 33' ' ' THR . 15.7 ttt180 -54.46 -43.03 71.34 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 124.223 1.009 . . . . 0.0 108.705 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 45.5 mtmt -60.6 -49.45 77.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.896 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -64.82 -43.82 91.87 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 123.609 0.568 . . . . 0.0 111.434 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -54.24 -52.68 60.56 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -178.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.625 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 7.9 m -76.21 -18.85 58.86 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.891 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 25.1 t70 -74.66 -31.34 61.91 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.45 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.625 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 46.2 mmtt -79.8 -29.35 40.26 Favored 'General case' 0 C--O 1.277 2.508 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 64.3 mt -70.02 -25.62 63.67 Favored 'General case' 0 N--CA 1.408 -2.573 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.373 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 41' ' ' SER . 87.9 mttt -61.14 -54.79 50.39 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 119.712 -0.185 . . . . 0.0 111.251 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 73.8 Cg_exo -69.16 -43.92 2.84 Favored 'Trans proline' 0 C--O 1.263 1.765 0 C-N-CA 122.856 2.371 . . . . 0.0 111.801 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.456 HG13 ' HA ' ' A' ' 44' ' ' LEU . 2.3 pp -63.89 -24.12 35.0 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.063 0 C-N-CA 118.405 -1.318 . . . . 0.0 110.981 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.21 -20.99 18.76 Favored 'General case' 0 C--O 1.204 -1.316 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.724 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -66.3 -25.11 66.7 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.4 -11.83 59.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.794 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 2.8 pt20 -145.32 33.96 1.08 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.405 1.098 . . . . 0.0 110.488 -172.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -74.38 -7.97 54.7 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.287 -173.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.96 0.6 14.94 Favored Glycine 0 C--N 1.289 -2.074 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.76 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.522 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 13.2 p -121.85 -31.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.845 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.431 HG12 ' HG2' ' A' ' 25' ' ' PRO . 84.2 mt -123.17 140.45 46.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.594 -0.843 . . . . 0.0 110.47 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -86.17 117.17 24.82 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.531 ' CD2' HD11 ' A' ' 29' ' ' ILE . 1.8 m-85 -103.89 103.03 12.84 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.977 0.894 . . . . 0.0 112.874 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.569 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -123.65 128.43 6.92 Favored Glycine 0 N--CA 1.406 -3.345 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.72 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.3 p -92.36 127.69 37.93 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 7.8 tt -124.26 142.64 40.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.47 125.96 28.28 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.579 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -92.9 7.34 44.3 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.221 -0.991 . . . . 0.0 111.507 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -104.78 -38.0 6.84 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.11 -42.48 9.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.611 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.73 26.99 8.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.454 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -70.82 -24.21 77.22 Favored Glycine 0 CA--C 1.488 -1.617 0 C-N-CA 120.779 -0.724 . . . . 0.0 114.683 -173.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.54 -28.6 46.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.436 0.636 . . . . 0.0 110.847 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -64.93 -23.09 67.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.234 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.604 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -64.08 -36.22 83.29 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.984 0.897 . . . . 0.0 110.4 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.468 ' HA2' ' H ' ' A' ' 73' ' ' ASN . . . -105.09 7.47 44.21 Favored Glycine 0 C--N 1.281 -2.518 0 C-N-CA 117.568 -2.253 . . . . 0.0 114.835 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -74.76 -16.89 60.71 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 166.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 4.2 pp -104.22 -37.56 7.23 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.065 174.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.468 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 5.2 t-20 -176.35 -52.19 0.01 OUTLIER 'General case' 0 C--N 1.384 2.107 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.485 HD22 ' H ' ' A' ' 74' ' ' LEU . 2.0 mm? -65.44 159.59 23.96 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -167.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -81.1 -4.28 54.77 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 69' ' ' ALA . 80.3 p 56.43 17.41 2.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.268 1.027 . . . . 0.0 112.226 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.408 ' OD1' ' HG3' ' A' ' 75' ' ' LYS . 14.3 p-10 -94.39 -14.98 24.74 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -172.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 98' ' ' GLU . 22.7 tptt -123.49 -165.29 1.31 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 118.503 -1.279 . . . . 0.0 113.273 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.64 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 96.5 m-85 -61.47 173.14 0.82 Allowed Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 125.925 1.69 . . . . 0.0 110.35 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 5.5 Cg_endo -40.15 131.21 2.24 Favored 'Trans proline' 0 C--N 1.414 3.993 0 C-N-CA 122.444 2.096 . . . . 0.0 115.557 -171.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -109.68 110.11 21.04 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.808 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.453 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 53.5 t80 -88.84 112.45 23.25 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.723 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -121.0 120.35 35.16 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.409 HD11 HG12 ' A' ' 110' ' ' VAL . 59.2 mt -92.66 113.35 27.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.852 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.18 134.33 35.46 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 89' ' ' LYS . 2.5 mm-40 -87.5 126.97 35.22 Favored 'General case' 0 C--N 1.266 -3.058 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.227 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.489 HG22 ' SD ' ' A' ' 20' ' ' MET . 41.2 t -95.31 -2.77 10.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.77 -44.12 3.52 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.438 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 36.3 mtmm -97.83 -11.06 23.69 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.344 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 66.89 10.55 7.7 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 125.011 1.324 . . . . 0.0 110.247 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.444 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 1.5 tp60 -80.08 172.35 13.89 Favored 'General case' 0 CA--C 1.477 -1.856 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.356 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.615 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 65.4 mmtt -139.36 105.09 5.13 Favored 'General case' 0 N--CA 1.404 -2.733 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 62.4 m-85 -100.28 86.4 0.63 Allowed Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 7.8 Cg_endo -101.96 152.63 0.32 Allowed 'Trans proline' 0 N--CA 1.429 -2.294 0 C-N-CA 122.477 2.118 . . . . 0.0 114.065 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.438 ' HD1' ' CD1' ' A' ' 109' ' ' PHE . 49.8 t80 -94.67 162.97 13.56 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 124.858 1.263 . . . . 0.0 107.746 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 10.7 m-20 -66.22 153.19 43.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.067 0.461 . . . . 0.0 110.32 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -102.22 0.96 35.31 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.432 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 8.6 pt-20 -132.38 28.45 4.36 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.146 -171.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 3.7 tppp? -113.63 -89.53 0.53 Allowed 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.739 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 176.39 127.33 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 124.062 0.945 . . . . 0.0 109.032 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.484 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.9 mp -102.62 105.37 18.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.42 -169.04 1.87 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.596 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.8 t80 -77.57 -53.23 7.84 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -60.39 -46.82 88.6 Favored 'General case' 0 N--CA 1.391 -3.393 0 CA-C-N 112.267 -2.242 . . . . 0.0 112.894 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.82 83.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.991 0.424 . . . . 0.0 111.149 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.484 ' CG1' HG23 ' A' ' 101' ' ' ILE . 36.9 mm -70.95 -44.37 75.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.863 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -51.32 -52.64 43.46 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 124.044 0.84 . . . . 0.0 109.973 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.36 -43.87 92.77 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.947 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.507 ' HA ' ' OD1' ' A' ' 112' ' ' ASP . 46.1 t80 -63.43 -59.9 4.07 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 124.411 1.084 . . . . 0.0 110.984 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 106' ' ' ILE . 27.5 m -58.59 -31.82 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 121.519 -0.738 . . . . 0.0 110.901 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.65 -47.74 68.69 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 123.886 0.874 . . . . 0.0 109.033 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.507 ' OD1' ' HA ' ' A' ' 109' ' ' PHE 0.299 0.1 OUTLIER -70.83 -23.77 62.41 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.545 -179.0 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.523 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.6 OUTLIER -71.18 -61.25 1.83 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.892 173.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -61.98 -25.25 36.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.163 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.35 -33.79 55.29 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.246 0.546 . . . . 0.0 109.777 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.17 25.86 2.87 Favored Glycine 0 CA--C 1.485 -1.794 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.953 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -101.17 -32.67 10.44 Favored 'General case' 0 N--CA 1.396 -3.15 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.19 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 113' ' ' PHE . 4.9 mt -74.45 142.26 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.31 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 . . . . . 0 C--N 1.285 -2.231 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.678 -172.855 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.518 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 51.6 mt -119.14 143.24 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.15 162.37 25.03 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -47.52 -34.05 19.08 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 124.14 3.227 . . . . 0.0 114.044 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -89.43 -26.91 20.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.953 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.1 p -78.85 -19.97 50.7 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.018 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' A' ' 20' ' ' MET . 69.3 m-85 -50.19 -49.93 50.93 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 123.934 0.771 . . . . 0.0 109.685 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -62.37 -33.41 74.69 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.107 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -70.9 -44.64 65.82 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 120.937 0.398 . . . . 0.0 110.535 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -72.8 -30.45 64.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.445 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.41 -39.89 62.35 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.05 -178.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -81.58 -9.02 59.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.649 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.09 -19.06 60.72 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.202 0.525 . . . . 0.0 110.619 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.21 -4.16 63.76 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.823 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.562 HG13 HD21 ' A' ' 56' ' ' ASN . 11.1 pt -103.2 152.5 38.65 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HG2' HG12 ' A' ' 55' ' ' ILE . 17.5 Cg_endo -54.58 142.18 72.35 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 124.194 3.263 . . . . 0.0 114.064 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.408 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 3.6 tt -108.13 125.18 51.3 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.615 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -95.67 103.06 14.92 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.408 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 53.5 m-85 -83.83 114.84 21.92 Favored 'General case' 0 CA--C 1.47 -2.126 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.303 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.584 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 8.1 mt -102.6 84.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.252 -3.67 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.614 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 48.7 m-85 -76.81 123.84 26.82 Favored 'General case' 0 CA--C 1.465 -2.324 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.98 123.61 19.77 Favored 'General case' 0 C--N 1.254 -3.584 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.445 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -79.64 -14.64 58.66 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.553 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 13.1 p -83.73 113.49 20.92 Favored 'General case' 0 N--CA 1.403 -2.78 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.107 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.71 -21.06 16.6 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.389 0.431 . . . . 0.0 110.918 -175.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -88.37 -54.2 4.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.742 0.782 . . . . 0.0 110.354 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.453 ' OE1' ' HB ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -84.84 3.13 39.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.823 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 33' ' ' THR . 52.2 ttt180 -49.27 -46.1 45.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.573 1.149 . . . . 0.0 110.018 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -65.31 -35.76 81.98 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.251 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -82.05 -31.27 30.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.894 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.528 HD21 ' HB ' ' A' ' 101' ' ' ILE . 1.7 tm? -61.48 -44.09 97.7 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.417 ' HA ' HD12 ' A' ' 44' ' ' LEU . 11.9 m -77.52 -17.0 58.36 Favored 'General case' 0 C--O 1.2 -1.542 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.576 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 20.5 t70 -76.67 -31.07 57.05 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.703 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.627 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -73.69 -36.59 65.3 Favored 'General case' 0 C--O 1.281 2.761 0 CA-C-O 123.109 1.433 . . . . 0.0 107.861 171.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 67.8 mt -72.63 -18.16 61.61 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.8 -1.545 . . . . 0.0 111.404 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.609 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 38.6 ttmt -63.74 -53.83 47.14 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 123.793 0.837 . . . . 0.0 111.759 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 52.4 Cg_exo -71.19 -37.22 6.19 Favored 'Trans proline' 0 CA--C 1.493 -1.553 0 C-N-CA 122.471 2.114 . . . . 0.0 109.784 175.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.669 HD11 ' HA ' ' A' ' 103' ' ' PHE . 86.0 mt -53.12 -38.41 29.99 Favored 'Isoleucine or valine' 0 C--N 1.37 1.461 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.856 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.35 -21.64 19.43 Favored 'General case' 0 C--O 1.195 -1.767 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.627 -172.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.497 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -68.45 -22.4 64.59 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 176.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.27 -11.3 57.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.977 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 2.8 pt20 -147.13 36.1 0.91 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.562 1.172 . . . . 0.0 110.749 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HD3' ' OE1' ' A' ' 49' ' ' GLU . 13.9 ptt180 -74.14 -18.6 60.77 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.988 -1.915 . . . . 0.0 110.778 -174.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.69 17.74 22.87 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.582 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.6 p -138.71 -33.26 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.551 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.431 HG12 ' HG2' ' A' ' 25' ' ' PRO . 88.7 mt -122.95 136.84 58.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.287 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.562 HD21 HG13 ' A' ' 24' ' ' ILE . 9.9 m-80 -94.48 96.39 9.45 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.74 141.94 40.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.521 0.677 . . . . 0.0 111.123 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.518 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -159.76 129.48 2.21 Favored Glycine 0 N--CA 1.412 -2.944 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.061 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.584 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 44.6 p -83.78 144.91 28.99 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.202 0.525 . . . . 0.0 111.445 174.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 4.8 tt -145.8 142.48 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.336 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 63' ' ' LYS . 19.9 t70 -70.9 124.35 24.14 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -175.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -86.85 4.04 42.9 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.218 -0.593 . . . . 0.0 112.277 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HB3' ' OD2' ' A' ' 61' ' ' ASP . 3.7 ttpm? -100.91 -44.72 5.66 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.45 -45.6 9.82 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.664 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -115.5 20.34 14.81 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.242 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -69.69 -20.48 75.8 Favored Glycine 0 CA--C 1.493 -1.308 0 N-CA-C 116.479 1.352 . . . . 0.0 116.479 -171.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.57 -27.74 64.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.982 0.891 . . . . 0.0 110.305 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -62.2 -24.74 67.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.601 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.625 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -65.75 -37.86 87.52 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 122.633 1.206 . . . . 0.0 109.024 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.94 11.02 66.16 Favored Glycine 0 C--N 1.284 -2.32 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.54 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.18 -8.29 59.64 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.729 HD12 ' HB2' ' A' ' 73' ' ' ASN . 3.1 pp -118.69 -34.97 3.82 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.729 ' HB2' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -168.07 -64.89 0.03 OUTLIER 'General case' 0 C--N 1.366 1.326 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.561 HD21 ' HB2' ' A' ' 94' ' ' PRO . 2.2 mm? -53.23 166.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -163.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -89.14 -12.3 41.43 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.578 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 69' ' ' ALA . 64.0 p 54.86 35.4 24.19 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.387 1.475 . . . . 0.0 112.992 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -117.44 -15.94 10.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -160.44 0.78 Allowed 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.944 -169.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.531 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 83.5 m-85 -59.99 170.66 1.11 Allowed Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.582 1.553 . . . . 0.0 109.635 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 2.4 Cg_endo -39.35 133.43 1.38 Allowed 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 122.765 2.31 . . . . 0.0 114.852 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.497 ' HB1' ' HG ' ' A' ' 74' ' ' LEU . . . -113.0 104.3 12.25 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.86 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.615 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 65.1 t80 -85.39 108.17 17.72 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.6 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -114.88 115.28 26.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.537 HD11 HG12 ' A' ' 110' ' ' VAL . 42.4 mt -90.7 110.59 22.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -88.14 129.58 35.28 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HB3' ' H ' ' A' ' 89' ' ' LYS . 4.2 mm-40 -87.62 121.03 29.54 Favored 'General case' 0 C--N 1.28 -2.444 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.412 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 20' ' ' MET . 3.8 t -96.82 4.19 9.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.95 -36.24 3.89 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.824 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 29.5 mmmt -99.08 -15.08 19.14 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.248 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 74.1 19.42 2.97 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 124.769 2.224 . . . . 0.0 108.414 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.506 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -96.0 170.09 9.52 Favored 'General case' 0 CA--C 1.464 -2.331 0 CA-C-N 111.828 -2.442 . . . . 0.0 110.851 -174.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.6 ' HB3' HD13 ' A' ' 72' ' ' LEU . 70.1 mmtt -141.25 109.46 5.84 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 72.2 m-85 -109.02 88.65 5.79 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.561 ' HB2' HD21 ' A' ' 74' ' ' LEU . 2.6 Cg_endo -101.15 147.78 0.33 Allowed 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 122.43 2.086 . . . . 0.0 114.384 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -85.09 158.98 20.27 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.077 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.625 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 5.9 m-20 -64.72 143.91 57.6 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 123.827 0.851 . . . . 0.0 108.883 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -85.7 -1.24 56.97 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.644 -172.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.16 18.69 1.4 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.24 0.543 . . . . 0.0 112.109 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.625 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 4.3 tppp? -93.17 -3.74 53.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 68.84 126.55 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.472 1.509 . . . . 0.0 112.321 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.534 HG23 HG13 ' A' ' 106' ' ' ILE . 3.5 mp -89.77 102.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.065 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 p -122.43 170.52 9.88 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.669 ' HA ' HD11 ' A' ' 47' ' ' ILE . 23.0 t80 -56.42 -59.37 5.07 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.554 0.692 . . . . 0.0 109.991 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -57.44 -45.44 84.68 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.232 -1.349 . . . . 0.0 113.526 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.43 -49.09 79.14 Favored 'General case' 0 C--N 1.254 -3.559 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.371 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.534 HG13 HG23 ' A' ' 101' ' ' ILE . 42.5 mm -75.0 -39.49 44.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.654 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 26.7 ttpp -58.22 -46.19 86.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.732 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.39 90.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.581 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.473 ' O ' HD11 ' A' ' 118' ' ' ILE . 70.6 t80 -64.49 -62.6 1.49 Allowed 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.537 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.537 HG12 HD11 ' A' ' 84' ' ' ILE . 34.7 m -58.67 -30.98 43.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 O-C-N 122.182 -0.324 . . . . 0.0 111.202 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 12.5 t70 -62.6 -50.47 71.14 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.333 1.053 . . . . 0.0 108.937 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.671 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 9.3 t70 -61.25 -43.11 99.42 Favored 'General case' 0 C--O 1.198 -1.649 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.21 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.577 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.5 t80 -59.22 -63.96 1.12 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.465 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.6 -17.04 20.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.838 -175.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.96 -33.84 30.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.509 0.671 . . . . 0.0 109.395 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.5 21.5 6.13 Favored Glycine 0 CA--C 1.482 -1.993 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.671 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 7.0 ttmm -94.38 -43.09 8.55 Favored 'General case' 0 N--CA 1.395 -3.185 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.046 -174.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.577 HD12 ' HB2' ' A' ' 113' ' ' PHE . 10.8 mt -72.14 146.04 11.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 C--N 1.283 -2.292 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.058 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.245 0.856 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.6 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 61.0 mt -96.71 120.76 46.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.096 0.474 . . . . 0.0 110.284 -177.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.17 167.75 12.98 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.635 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 14.8 Cg_endo -59.2 -25.69 79.05 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 122.812 2.341 . . . . 0.0 111.717 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -87.5 -12.11 46.89 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.816 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.6 p -105.03 -37.0 7.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.535 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' HA ' ' A' ' 13' ' ' PRO 0.293 10.0 p90 -62.18 -26.92 68.61 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 m -59.56 -32.41 70.32 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.206 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -78.08 -34.83 50.06 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.535 ' CD2' ' HA ' ' A' ' 16' ' ' TYR . 14.8 m-85 -73.13 -29.59 62.99 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.517 ' SD ' HG22 ' A' ' 87' ' ' VAL . 5.5 tpp -79.14 -24.05 43.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.01 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 t -92.1 -10.0 40.57 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.03 -21.03 43.97 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 121.955 -0.465 . . . . 0.0 111.43 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.18 8.98 87.31 Favored Glycine 0 C--O 1.235 0.189 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.956 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 12.2 pt -117.18 149.06 43.74 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 122.879 -0.189 . . . . 0.0 111.133 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HG2' HG12 ' A' ' 55' ' ' ILE . 9.2 Cg_endo -51.81 136.13 50.78 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 124.115 3.21 . . . . 0.0 113.82 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.17 125.53 51.11 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.534 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -98.66 109.29 22.07 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-O 121.185 0.517 . . . . 0.0 109.731 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -89.28 117.82 28.51 Favored 'General case' 0 CA--C 1.468 -2.182 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.729 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.6 mt -106.87 84.4 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.54 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 33.5 m-85 -75.54 134.9 40.63 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -149.76 120.04 7.32 Favored 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.578 176.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.405 ' N ' ' HB3' ' A' ' 62' ' ' ALA . 29.3 mt-10 -72.23 -28.79 63.39 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-O 121.663 0.744 . . . . 0.0 109.365 173.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.644 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 2.3 p -89.31 103.78 16.38 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.622 -170.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.73 -25.16 41.2 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.791 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.06 -62.31 1.43 Allowed 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.538 ' OE1' ' HB ' ' A' ' 33' ' ' THR . 1.2 pm0 -83.2 4.07 28.31 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 33' ' ' THR . 3.9 tmm_? -60.47 -32.73 71.69 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -60.83 -49.38 77.7 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.182 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 14.3 pt-20 -81.83 -22.36 37.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.38 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.657 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -61.53 -52.58 63.87 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 21.8 m -71.59 -20.8 61.95 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.587 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 22.0 t70 -61.98 -41.4 97.99 Favored 'General case' 0 CA--C 1.486 -1.506 0 C-N-CA 123.553 0.741 . . . . 0.0 111.206 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.64 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 51.7 mmtt -77.53 -29.43 52.35 Favored 'General case' 0 C--O 1.27 2.132 0 CA-C-O 122.511 1.148 . . . . 0.0 108.606 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 67.0 mt -70.97 -23.6 62.24 Favored 'General case' 0 N--CA 1.406 -2.667 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.951 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.483 ' HB2' ' HD3' ' A' ' 46' ' ' PRO . 56.1 mtpt -63.41 -53.34 53.43 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 86.3 Cg_exo -67.63 -45.18 3.6 Favored 'Trans proline' 0 C--O 1.263 1.731 0 C-N-CA 123.169 2.579 . . . . 0.0 111.803 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.617 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 6.5 tp -61.22 -30.55 48.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.402 0 C-N-CA 117.934 -1.506 . . . . 0.0 109.706 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.81 -18.69 27.17 Favored 'General case' 0 C--O 1.182 -2.496 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.761 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.05 -24.77 65.12 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.32 -19.45 50.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.567 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 2.3 pt20 -139.96 35.19 1.95 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.249 1.023 . . . . 0.0 110.948 -171.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -69.49 -19.21 63.74 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.137 -1.847 . . . . 0.0 112.375 -173.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.21 14.58 11.01 Favored Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.526 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.582 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.7 p -129.31 -32.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.214 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.472 HG12 ' HG2' ' A' ' 25' ' ' PRO . 79.0 mt -122.55 134.45 65.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.838 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.489 HD21 HG13 ' A' ' 24' ' ' ILE . 10.5 m-80 -88.56 109.86 20.42 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -93.48 108.3 20.0 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.6 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -131.49 132.26 6.7 Favored Glycine 0 C--N 1.29 -2.005 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.693 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.567 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 42.2 p -91.65 150.17 21.28 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 122.686 0.394 . . . . 0.0 111.131 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 6.7 tt -151.6 147.27 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -68.39 130.45 42.92 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.69 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -93.26 -3.72 53.15 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.819 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -86.1 -49.51 7.72 Favored 'General case' 0 N--CA 1.42 -1.943 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.771 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.54 -37.69 9.07 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -104.37 14.36 30.32 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.791 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -71.55 -19.9 78.09 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 -172.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.54 68.8 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 117.69 0.745 . . . . 0.0 110.008 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -64.91 -24.95 67.68 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.009 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.494 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -63.16 -34.76 78.31 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 122.303 1.049 . . . . 0.0 109.82 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.527 ' HA2' ' H ' ' A' ' 73' ' ' ASN . . . -104.49 18.57 44.34 Favored Glycine 0 C--N 1.28 -2.576 0 C-N-CA 118.348 -1.882 . . . . 0.0 114.15 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.21 -22.26 55.47 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.495 HD12 ' CB ' ' A' ' 73' ' ' ASN . 4.3 pp -104.68 -33.33 8.51 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.396 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 12.9 t-20 -174.5 -56.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.477 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.0 mm? -59.51 162.84 4.57 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -165.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -83.03 -9.85 59.05 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.239 -174.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p 61.53 18.4 9.41 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.954 2.102 . . . . 0.0 114.744 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -113.39 -17.56 12.23 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -170.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 19.4 ttmt -117.84 -160.84 0.8 Allowed 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.31 -167.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.497 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 88.9 m-85 -54.9 164.2 1.26 Allowed Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.974 1.31 . . . . 0.0 111.481 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.505 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -39.74 129.65 1.92 Allowed 'Trans proline' 0 C--N 1.403 3.44 0 C-N-CA 122.793 2.328 . . . . 0.0 114.886 -174.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -108.17 104.44 13.85 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.084 -172.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.534 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 69.0 t80 -87.47 113.28 23.03 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.79 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -118.88 121.61 40.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.523 HD11 HG12 ' A' ' 110' ' ' VAL . 43.4 mt -95.67 110.99 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.205 0.526 . . . . 0.0 109.858 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -100.03 126.35 46.22 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.494 ' HB3' ' H ' ' A' ' 89' ' ' LYS . 1.9 mm-40 -88.6 140.48 29.41 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 120.897 0.38 . . . . 0.0 111.31 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.517 HG22 ' SD ' ' A' ' 20' ' ' MET . 22.1 t -99.89 -4.85 9.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.035 0.922 . . . . 0.0 108.633 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.52 -38.62 4.59 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.606 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.494 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 75.4 mmtt -91.06 -16.35 28.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.505 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 59.25 30.46 20.21 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 122.303 1.049 . . . . 0.0 109.715 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.546 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 5.5 tp-100 -109.85 167.85 9.86 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.727 -171.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 10.5 mptt -122.71 98.68 6.02 Favored 'General case' 1 N--CA 1.373 -4.324 0 CA-C-N 113.216 -1.811 . . . . 0.0 106.548 -176.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.546 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 38.0 m-85 -100.39 82.64 0.33 Allowed Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 5.6 Cg_endo -100.33 148.96 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.639 2.226 . . . . 0.0 113.573 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -82.78 162.29 21.74 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.444 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.742 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 6.4 m-20 -71.37 139.02 49.65 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -84.61 1.72 44.77 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.954 -173.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 8.9 pt-20 -137.86 13.33 2.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.392 0.615 . . . . 0.0 111.594 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 15.4 tppt? -90.73 -8.91 48.54 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.58 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 69.64 117.97 0.04 OUTLIER 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.45 1.1 . . . . 0.0 111.105 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.482 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.4 mp -85.05 125.78 40.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.409 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.7 p -139.34 175.37 9.62 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.553 ' HE1' ' HB2' ' A' ' 46' ' ' PRO . 54.0 t80 -55.18 -61.11 2.54 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 122.081 0.943 . . . . 0.0 110.064 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . 0.255 23.5 tp10 -60.76 -39.64 89.54 Favored 'General case' 1 N--CA 1.37 -4.435 0 C-N-CA 126.811 2.044 . . . . 0.0 111.968 -171.997 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.26 93.5 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 123.816 0.698 . . . . 0.0 110.528 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.482 ' CG1' HG23 ' A' ' 101' ' ' ILE . 34.9 mm -72.36 -41.74 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.237 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.434 ' HG3' HD13 ' A' ' 47' ' ' ILE . 12.4 ttpt -55.33 -52.06 64.73 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 124.179 0.924 . . . . 0.0 108.895 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.03 83.63 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.507 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -68.59 -58.16 4.69 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.828 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.523 HG12 HD11 ' A' ' 84' ' ' ILE . 35.5 m -60.23 -32.61 51.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.889 0 O-C-N 121.841 -0.537 . . . . 0.0 110.71 -177.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.33 -53.8 54.21 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 124.958 1.303 . . . . 0.0 109.153 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.654 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 7.2 t70 -60.62 -43.63 97.25 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 113.687 -1.597 . . . . 0.0 108.002 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.532 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.7 t80 -59.51 -64.02 1.09 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.173 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.8 -21.03 27.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.068 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.48 -35.19 53.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.23 0.538 . . . . 0.0 109.86 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.54 30.4 3.31 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.654 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 5.5 mtmt -102.26 -45.19 5.19 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.504 -1.348 . . . . 0.0 109.283 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 113' ' ' PHE . 31.8 mt -76.14 142.45 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 171.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 C--N 1.273 -2.747 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.734 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 . . . . . 0 C--O 1.24 0.592 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.556 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 51.7 mt -102.18 119.98 51.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.67 174.7 20.33 Favored Glycine 0 N--CA 1.41 -3.067 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.508 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 28.4 Cg_endo -61.4 -17.03 51.07 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.091 2.527 . . . . 0.0 112.793 -177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.8 -13.4 16.44 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 119.37 -0.347 . . . . 0.0 111.747 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.8 p -102.03 -32.47 10.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 119.489 -0.884 . . . . 0.0 112.641 -173.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CE2' ' HA ' ' A' ' 13' ' ' PRO 0.254 5.3 p90 -60.61 -32.8 71.91 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -177.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 m -59.92 -31.26 69.67 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 123.742 0.817 . . . . 0.0 110.462 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.27 -35.37 41.49 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -73.33 -28.6 62.16 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.513 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -78.1 -36.97 47.42 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.49 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.6 t -78.52 -10.5 59.74 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.946 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.21 64.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.198 0.523 . . . . 0.0 110.453 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.56 -15.88 62.33 Favored Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.833 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.523 HG13 HD21 ' A' ' 56' ' ' ASN . 7.0 pt -93.76 154.04 41.01 Favored Pre-proline 0 C--N 1.301 -1.537 0 C-N-CA 123.026 0.53 . . . . 0.0 110.249 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HG2' HG12 ' A' ' 55' ' ' ILE . 15.0 Cg_endo -54.22 145.36 55.19 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 124.115 3.21 . . . . 0.0 114.663 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tt -108.69 127.02 53.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -97.94 107.65 20.18 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -88.46 120.68 30.06 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.283 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.631 HG12 HD13 ' A' ' 44' ' ' LEU . 3.4 mp -110.74 89.11 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.824 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.043 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.567 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 48.6 m-85 -78.6 109.96 13.29 Favored 'General case' 0 CA--C 1.452 -2.791 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -120.98 119.2 31.87 Favored 'General case' 1 C--N 1.238 -4.266 0 CA-C-O 121.197 0.522 . . . . 0.0 109.816 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -70.22 -28.77 65.54 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.651 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 18.0 p -75.16 119.12 18.87 Favored 'General case' 0 N--CA 1.379 -3.988 0 CA-C-N 113.296 -1.775 . . . . 0.0 108.436 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.434 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . . . -99.05 -17.62 18.16 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.595 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -99.01 -53.16 3.34 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.701 0.763 . . . . 0.0 109.623 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -86.71 7.44 26.71 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.109 -175.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.651 ' HB3' ' O ' ' A' ' 33' ' ' THR . 6.7 ptp180 -71.71 -16.78 62.24 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.372 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -69.42 -45.03 70.17 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 1.6 mp0 -65.72 -35.12 79.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.393 0.616 . . . . 0.0 109.771 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.513 HD21 ' HB ' ' A' ' 101' ' ' ILE . 1.2 tm? -60.81 -49.08 78.93 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.466 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 14.5 m -75.36 -10.6 59.61 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.056 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.601 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 19.0 t70 -78.09 -37.4 46.54 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 123.163 0.585 . . . . 0.0 110.32 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.623 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -72.23 -33.26 67.42 Favored 'General case' 0 C--O 1.285 2.944 0 CA-C-O 123.166 1.46 . . . . 0.0 108.136 173.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.631 HD13 HG12 ' A' ' 29' ' ' ILE . 85.6 mt -73.67 -21.94 60.11 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.19 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -66.35 -50.09 50.35 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 6.9 Cg_exo -78.2 -34.14 1.72 Allowed 'Trans proline' 0 CA--C 1.491 -1.655 0 C-N-CA 121.923 1.749 . . . . 0.0 110.034 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -62.33 -28.86 45.44 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.94 -20.06 21.0 Favored 'General case' 0 C--O 1.186 -2.25 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.794 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.22 -19.11 63.17 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.2 -14.01 54.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.54 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 3.1 pt20 -146.64 36.28 0.96 Allowed 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.061 0.934 . . . . 0.0 111.128 -173.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -74.46 -19.47 60.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.701 -1.59 . . . . 0.0 111.065 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.32 20.91 18.24 Favored Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.41 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.8 p -139.77 -33.73 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.657 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 25' ' ' PRO . 88.4 mt -124.75 134.62 66.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.109 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.523 HD21 HG13 ' A' ' 24' ' ' ILE . 21.4 m-80 -91.44 97.44 11.08 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -76.79 131.68 38.82 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.399 0.619 . . . . 0.0 111.278 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.556 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -144.06 123.55 2.04 Favored Glycine 0 N--CA 1.396 -3.974 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.388 176.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.42 HG21 ' OG ' ' A' ' 41' ' ' SER . 38.9 p -86.45 136.41 33.11 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 7.5 tt -141.04 145.48 25.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -177.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.02 126.97 31.22 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.518 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -85.75 0.09 53.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -102.28 -42.31 6.06 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.99 -51.44 6.35 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.919 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -112.16 18.36 18.73 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.754 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.38 -22.86 67.89 Favored Glycine 0 CA--C 1.497 -1.089 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.38 -35.18 60.04 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 122.991 0.516 . . . . 0.0 110.796 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -63.57 -22.22 66.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.291 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.627 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -65.54 -39.18 91.46 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.999 0.904 . . . . 0.0 109.227 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.486 ' HA2' ' N ' ' A' ' 74' ' ' LEU . . . -103.61 6.12 48.61 Favored Glycine 0 C--N 1.283 -2.387 0 C-N-CA 118.114 -1.993 . . . . 0.0 114.904 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -32.68 72.6 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 166.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 3.2 pp -89.67 -37.58 14.5 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.433 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.457 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 21.2 t-20 -171.48 -60.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.486 ' N ' ' HA2' ' A' ' 70' ' ' GLY . 2.4 mm? -56.55 167.97 0.64 Allowed 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -166.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -82.61 -16.54 48.01 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.762 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 p 61.36 21.81 12.3 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 126.357 1.863 . . . . 0.0 112.803 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -107.66 -23.77 11.99 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -172.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.567 ' HG2' ' HB3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -106.42 -162.01 0.83 Allowed 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.104 -169.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.731 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 67.2 m-85 -72.9 -172.42 0.23 Allowed Pre-proline 0 CA--C 1.571 1.76 0 C-N-CA 125.036 1.334 . . . . 0.0 108.998 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.731 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 5.6 Cg_endo -47.48 133.59 20.67 Favored 'Trans proline' 0 C--N 1.408 3.708 0 CA-C-N 122.583 1.958 . . . . 0.0 115.61 -175.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.06 122.4 37.11 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.252 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.531 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 75.9 t80 -96.47 117.44 30.91 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.381 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -119.46 122.35 41.52 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 122.046 -0.409 . . . . 0.0 111.998 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 49.3 mt -95.13 116.28 36.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 45.6 tt0 -106.69 122.38 46.24 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 19.8 mt-10 -80.58 148.96 30.1 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.956 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.513 HG11 ' O ' ' A' ' 20' ' ' MET . 19.9 t -113.0 -0.42 9.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.1 -57.15 3.21 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.819 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -111.33 -9.98 14.25 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.628 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 49.7 t-20 65.88 86.72 0.13 Allowed 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.225 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 85' ' ' GLN . 5.9 tp-100 -139.69 164.15 30.71 Favored 'General case' 0 CA--C 1.464 -2.339 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.639 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 11.3 mptt -119.88 95.05 4.61 Favored 'General case' 1 N--CA 1.376 -4.174 0 O-C-N 125.056 1.473 . . . . 0.0 108.572 -174.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 28.9 m-85 -101.28 83.13 0.41 Allowed Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 172.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 5.8 Cg_endo -101.58 144.92 0.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.396 2.064 . . . . 0.0 114.572 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -85.3 173.56 10.25 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 126.37 1.868 . . . . 0.0 109.088 -174.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.5 m-20 -66.3 148.79 51.33 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -95.47 2.47 54.45 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.567 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 9.8 pt-20 -149.31 23.66 0.92 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.009 -172.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.577 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 18.0 ttmm -90.76 -81.79 0.3 Allowed 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.001 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 172.45 123.63 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.513 ' HB ' HD21 ' A' ' 40' ' ' LEU . 3.4 mp -99.88 94.57 3.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -122.68 167.74 13.07 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.435 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.454 ' HE2' ' HB2' ' A' ' 46' ' ' PRO . 39.5 t80 -51.73 -61.06 2.49 Favored 'General case' 0 CA--C 1.483 -1.618 0 O-C-N 124.061 0.851 . . . . 0.0 110.107 -176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -69.17 -27.01 65.14 Favored 'General case' 1 N--CA 1.372 -4.361 0 C-N-CA 125.784 1.634 . . . . 0.0 112.778 -172.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.7 -44.44 42.16 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.543 0.687 . . . . 0.0 109.354 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.412 ' CG1' HG23 ' A' ' 101' ' ' ILE . 32.8 mm -68.88 -40.34 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.575 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -56.43 -51.55 68.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.672 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.02 -43.36 70.06 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.164 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.01 -59.3 3.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.52 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 84' ' ' ILE . 33.9 m -60.83 -33.19 54.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 O-C-N 121.777 -0.577 . . . . 0.0 111.508 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.86 -50.42 73.87 Favored 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 124.067 0.947 . . . . 0.0 109.258 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.633 ' HB3' HG13 ' A' ' 118' ' ' ILE . 1.9 t70 -58.77 -47.74 83.63 Favored 'General case' 0 C--O 1.2 -1.513 0 CA-C-N 113.16 -1.836 . . . . 0.0 107.441 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.514 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.1 t80 -57.53 -65.55 0.61 Allowed 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.473 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 110' ' ' VAL . 8.8 p -62.07 -24.57 34.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.79 -34.86 52.03 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.75 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.99 30.89 2.62 Favored Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.577 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 22.2 mtmt -99.88 -44.31 6.1 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 113.202 -1.499 . . . . 0.0 108.422 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.633 HG13 ' HB3' ' A' ' 112' ' ' ASP . 33.4 mt -83.0 146.74 6.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 170.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 C--N 1.291 -1.955 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -178.726 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.517 HG13 ' HB ' ' A' ' 60' ' ' ILE . 2.2 pt -120.44 154.88 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-O 121.482 0.658 . . . . 0.0 111.777 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.55 176.59 30.7 Favored Glycine 0 N--CA 1.403 -3.501 0 N-CA-C 107.751 -2.139 . . . . 0.0 107.751 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.5 -27.44 68.82 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.167 2.578 . . . . 0.0 113.648 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -89.23 -20.52 24.04 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.0 p -97.91 -36.36 10.19 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.534 -169.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -62.71 -29.42 70.65 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.976 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -24.77 67.07 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.2 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.29 -37.67 44.27 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.88 0.848 . . . . 0.0 109.882 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -76.06 -27.44 57.25 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.493 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.04 -35.31 71.91 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.358 175.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 t -74.7 -19.51 60.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.933 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.28 -30.12 57.68 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 120.95 0.405 . . . . 0.0 110.2 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.39 -23.67 26.45 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.947 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.524 HG13 HD21 ' A' ' 56' ' ' ASN . 6.6 pt -81.15 152.87 71.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.479 -0.361 . . . . 0.0 111.68 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.452 ' HG2' HG12 ' A' ' 55' ' ' ILE . 10.6 Cg_endo -52.42 137.25 56.93 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.063 3.175 . . . . 0.0 114.442 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 tt -106.8 125.96 51.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.507 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -97.56 104.86 16.92 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -86.96 120.71 28.52 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.446 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.653 HG12 HD13 ' A' ' 44' ' ' LEU . 3.4 mp -110.69 94.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.361 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.691 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 34.7 m-85 -80.34 126.64 31.42 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -142.15 122.1 13.64 Favored 'General case' 0 C--N 1.252 -3.639 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.493 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.446 ' HG2' ' C ' ' A' ' 62' ' ' ALA . 32.2 mt-10 -73.15 -20.82 60.83 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.445 ' HB ' ' CG ' ' A' ' 36' ' ' GLU . 1.5 p -86.66 83.86 7.51 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.997 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 37' ' ' ARG . . . -87.31 -25.21 24.03 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.154 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.5 mp0 -63.23 -34.13 76.99 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.179 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.445 ' CG ' ' HB ' ' A' ' 33' ' ' THR . 11.1 pt-20 -116.48 13.55 15.42 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.412 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.443 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 7.5 ptp180 -57.73 -27.93 63.44 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.812 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -50.4 -49.46 54.5 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 123.608 0.763 . . . . 0.0 111.517 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.627 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 12.1 pt-20 -86.97 -24.4 24.73 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.435 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.496 HD21 ' HB ' ' A' ' 101' ' ' ILE . 1.7 tm? -63.98 -44.92 91.24 Favored 'General case' 0 C--O 1.261 1.701 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.578 ' OG ' HG21 ' A' ' 59' ' ' THR . 15.7 m -73.01 -17.33 61.46 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.456 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.455 ' CB ' ' HA ' ' A' ' 39' ' ' GLU . 23.4 t70 -70.99 -40.87 71.61 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.677 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.632 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -65.24 -38.11 89.33 Favored 'General case' 0 C--O 1.27 2.177 0 CA-C-O 123.426 1.584 . . . . 0.0 106.848 173.308 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.653 HD13 HG12 ' A' ' 29' ' ' ILE . 94.0 mt -71.12 -19.06 62.49 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 112.884 -1.962 . . . . 0.0 113.065 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.573 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 24.3 ttpp -66.56 -55.42 18.72 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.68 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 81.6 Cg_exo -65.59 -38.94 22.92 Favored 'Trans proline' 0 CA--C 1.489 -1.733 0 C-N-CA 123.174 2.582 . . . . 0.0 110.508 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.549 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 93.7 mt -53.68 -38.47 34.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 O-C-N 124.052 0.845 . . . . 0.0 109.695 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.92 -16.84 23.61 Favored 'General case' 0 C--O 1.19 -2.053 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.217 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 3.6 tt0 -74.42 -17.73 60.75 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.57 -20.79 30.92 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.933 177.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 2.8 pt20 -137.66 37.84 2.43 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.495 1.14 . . . . 0.0 110.609 -171.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -65.92 -24.83 66.91 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.542 -2.117 . . . . 0.0 112.846 -172.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.54 9.22 17.08 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.314 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.415 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 13.0 p -122.86 -33.0 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.452 HG12 ' HG2' ' A' ' 25' ' ' PRO . 88.1 mt -122.86 134.64 65.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.211 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.524 HD21 HG13 ' A' ' 24' ' ' ILE . 9.2 m-80 -94.46 102.89 14.87 Favored 'General case' 0 C--O 1.207 -1.159 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -80.19 139.47 36.74 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.795 0.807 . . . . 0.0 111.851 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 11' ' ' ILE . . . -151.54 113.27 0.57 Allowed Glycine 0 C--N 1.275 -2.811 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.649 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.578 HG21 ' OG ' ' A' ' 41' ' ' SER . 40.3 p -84.64 132.19 34.51 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.517 ' HB ' HG13 ' A' ' 11' ' ' ILE . 7.6 tt -131.73 145.24 35.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 63' ' ' LYS . 7.7 t0 -73.33 123.9 24.68 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.042 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.691 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -92.54 1.99 56.94 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.042 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HB3' ' OD1' ' A' ' 61' ' ' ASP . 39.4 ttmt -100.33 -31.17 11.47 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.68 -44.53 7.07 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.217 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -120.42 26.67 9.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.476 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -70.44 -15.92 73.23 Favored Glycine 0 CA--C 1.489 -1.565 0 N-CA-C 116.206 1.242 . . . . 0.0 116.206 -170.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.16 -35.55 71.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.374 0.607 . . . . 0.0 110.007 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 71' ' ' ASN . 63.7 m-70 -60.49 -21.79 62.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.146 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.413 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -62.11 -31.87 72.37 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 121.506 0.67 . . . . 0.0 110.283 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -122.77 9.99 9.07 Favored Glycine 0 CA--C 1.479 -2.205 0 C-N-CA 118.26 -1.924 . . . . 0.0 115.089 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -73.95 -16.42 61.08 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 166.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.436 ' O ' ' HE3' ' A' ' 92' ' ' LYS . 3.9 pp -99.13 -26.25 14.27 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.928 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.415 ' CB ' HD12 ' A' ' 72' ' ' LEU . 3.3 t-20 177.78 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.599 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 89.8 mt -53.04 159.23 1.24 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.793 2.145 . . . . 0.0 116.793 -171.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -71.15 -17.91 62.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.235 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.413 HG22 ' HB3' ' A' ' 69' ' ' ALA . 13.8 p 50.13 57.83 6.14 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -135.25 -17.98 1.78 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -119.54 -159.92 0.79 Allowed 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.867 -167.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.637 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 57.7 m-85 -61.47 -176.37 0.12 Allowed Pre-proline 0 N--CA 1.499 1.993 0 C-N-CA 126.485 1.914 . . . . 0.0 111.262 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 3.7 Cg_endo -45.92 135.87 13.8 Favored 'Trans proline' 1 C--N 1.422 4.444 0 CA-C-N 121.75 1.661 . . . . 0.0 113.079 177.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -116.52 136.67 52.79 Favored 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.927 -171.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.507 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 77.6 t80 -120.11 120.09 35.23 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.12 123.46 39.73 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.359 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.486 HD11 HG12 ' A' ' 110' ' ' VAL . 56.3 mt -93.87 109.15 21.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 25' ' ' PRO . 41.3 tt0 -95.25 127.38 41.25 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -86.0 132.28 34.1 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.493 HG11 ' O ' ' A' ' 20' ' ' MET . 12.0 t -94.49 -0.42 10.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-O 122.139 0.971 . . . . 0.0 108.727 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.95 -44.68 3.94 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.699 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.431 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 58.1 mttp -93.85 -12.36 29.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.54 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 2.3 p-10 56.28 33.43 22.23 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 123.258 1.504 . . . . 0.0 109.894 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.506 ' C ' ' HD3' ' A' ' 92' ' ' LYS . 8.1 tp60 -98.12 167.04 11.12 Favored 'General case' 0 CA--C 1.464 -2.354 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.957 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.634 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 3.6 mppt? -132.76 102.88 5.84 Favored 'General case' 1 N--CA 1.373 -4.317 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -176.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 50.6 m-85 -98.91 83.83 0.33 Allowed Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 173.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 24.1 Cg_endo -100.18 149.42 0.45 Allowed 'Trans proline' 0 N--CA 1.42 -2.809 0 C-N-CA 121.935 1.757 . . . . 0.0 113.411 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 83.2 t80 -84.34 168.16 15.86 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.789 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.648 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 18.6 m-20 -70.65 143.3 51.47 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.471 ' NE2' ' HB3' ' A' ' 74' ' ' LEU . 31.4 mt-30 -84.75 2.38 42.34 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.012 -171.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 7.7 pt-20 -152.22 22.02 0.65 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 14.9 tppt? -90.65 -3.22 57.67 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 70.49 133.02 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.911 2.085 . . . . 0.0 112.716 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.549 HG23 HG13 ' A' ' 106' ' ' ILE . 2.4 mp -91.24 97.91 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.943 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.4 p -110.25 -165.93 1.04 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.148 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.9 t80 -84.46 -55.0 4.38 Favored 'General case' 0 CA--C 1.485 -1.558 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -58.85 -43.86 90.89 Favored 'General case' 0 N--CA 1.387 -3.607 0 CA-C-N 113.096 -1.865 . . . . 0.0 113.731 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.62 -49.94 73.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.067 0.46 . . . . 0.0 111.328 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 101' ' ' ILE . 44.2 mm -72.11 -40.54 66.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.599 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 30.7 ttpt -57.71 -48.84 78.43 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 111' ' ' ASP . . . -61.4 -42.6 98.99 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 123.914 0.759 . . . . 0.0 110.922 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.426 ' HA ' ' OD1' ' A' ' 112' ' ' ASP . 63.4 t80 -61.56 -60.73 3.25 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.209 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.486 HG12 HD11 ' A' ' 84' ' ' ILE . 35.9 m -59.48 -30.67 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.642 -0.661 . . . . 0.0 110.468 -177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 23.9 t70 -64.27 -53.18 52.96 Favored 'General case' 0 CA--C 1.479 -1.756 0 C-N-CA 124.629 1.171 . . . . 0.0 108.96 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.586 ' OD2' HG12 ' A' ' 118' ' ' ILE 0.265 0.1 OUTLIER -68.2 -25.12 65.06 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.959 -177.167 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.541 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.4 t80 -68.97 -62.01 1.56 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.772 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.79 -25.42 38.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.335 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.64 -30.72 67.43 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 121.175 0.512 . . . . 0.0 109.934 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.71 7.06 10.95 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.77 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.583 ' HE2' ' OD2' ' A' ' 112' ' ' ASP . 25.1 ttpt -89.42 -37.07 15.09 Favored 'General case' 0 N--CA 1.393 -3.311 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.591 -172.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.586 HG12 ' OD2' ' A' ' 112' ' ' ASP . 4.2 mt -74.02 135.45 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 118.446 -1.302 . . . . 0.0 109.851 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--N 1.267 -3.015 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -178.89 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.437 -1.085 0 CA-C-O 121.437 0.636 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.632 HG13 ' HA3' ' A' ' 58' ' ' GLY . 62.9 mt -103.71 118.11 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.957 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.25 178.32 17.87 Favored Glycine 0 N--CA 1.408 -3.218 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.42 -29.49 84.64 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.264 2.643 . . . . 0.0 112.939 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.96 -8.94 23.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.2 p -102.21 -35.88 8.71 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.466 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -62.5 -32.04 72.89 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.217 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.8 t -63.19 -27.9 69.68 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.571 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.61 -38.19 59.22 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.599 0.714 . . . . 0.0 109.73 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.404 ' HB3' ' CG ' ' A' ' 56' ' ' ASN . 18.4 m-85 -76.94 -23.39 52.42 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.582 ' SD ' HG22 ' A' ' 87' ' ' VAL . 8.7 tpp -80.67 -21.92 40.91 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.214 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -92.18 -13.05 31.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.07 -31.1 68.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.05 11.48 73.0 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.526 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.496 HG13 HD21 ' A' ' 56' ' ' ASN . 9.5 pt -123.98 151.06 64.46 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HG2' HG12 ' A' ' 55' ' ' ILE . 11.6 Cg_endo -53.34 144.84 47.77 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 124.125 3.217 . . . . 0.0 114.067 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 tt -116.14 126.34 53.57 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.74 110.54 22.98 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -90.73 120.18 31.57 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.176 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.532 HG12 HD13 ' A' ' 44' ' ' LEU . 3.2 mp -111.37 90.84 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.07 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.699 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 44.1 m-85 -79.41 133.37 36.55 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.546 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -142.99 120.32 11.59 Favored 'General case' 0 C--N 1.273 -2.719 0 O-C-N 123.314 0.384 . . . . 0.0 111.884 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.18 -32.01 66.44 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 3.1 p -83.08 109.59 17.27 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.202 -171.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.89 -16.95 45.5 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.424 0.63 . . . . 0.0 109.708 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -70.8 -59.6 2.71 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.425 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -97.93 8.59 44.49 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.693 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 33' ' ' THR . 53.6 ttt180 -55.69 -36.94 67.69 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -59.31 -48.48 81.45 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.096 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.661 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 12.4 pt-20 -79.37 -27.23 41.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.671 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.513 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.1 tm? -59.41 -50.01 75.6 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.545 ' HA ' HD12 ' A' ' 44' ' ' LEU . 9.2 m -74.88 -19.57 60.1 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.975 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.577 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 33.8 t70 -70.1 -39.97 75.2 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 122.866 0.466 . . . . 0.0 111.334 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.661 ' HE2' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -70.51 -35.43 73.2 Favored 'General case' 0 C--O 1.297 3.554 0 CA-C-O 123.177 1.465 . . . . 0.0 108.509 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 41' ' ' SER . 68.6 mt -70.79 -23.64 62.43 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 113.102 -1.863 . . . . 0.0 111.814 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.526 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 36.4 ttpt -63.61 -52.1 61.51 Favored Pre-proline 0 C--N 1.289 -2.03 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.182 -173.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 51.5 Cg_exo -71.83 -44.28 1.01 Allowed 'Trans proline' 0 CA--C 1.492 -1.598 0 C-N-CA 122.803 2.335 . . . . 0.0 111.095 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.484 HG13 ' HA ' ' A' ' 44' ' ' LEU . 2.4 pp -61.95 -22.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.375 1.68 0 C-N-CA 117.777 -1.569 . . . . 0.0 111.735 -176.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.23 -21.0 16.3 Favored 'General case' 0 C--O 1.202 -1.416 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.31 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 22.4 tt0 -69.82 -23.07 63.25 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.76 -16.63 60.1 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.228 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 3.1 pt20 -142.34 31.8 1.52 Allowed 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.522 -172.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.81 -14.27 59.63 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.977 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.89 5.52 50.64 Favored Glycine 0 C--N 1.296 -1.684 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.853 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 11.8 p -130.05 -37.47 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.534 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.438 HG12 ' HG2' ' A' ' 25' ' ' PRO . 92.3 mt -117.87 145.39 23.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.496 HD21 HG13 ' A' ' 24' ' ' ILE . 10.4 m-80 -92.94 121.76 34.62 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.446 ' CD2' HD11 ' A' ' 29' ' ' ILE . 6.4 m-85 -103.87 128.71 51.33 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.174 0.988 . . . . 0.0 112.825 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.632 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -145.9 131.9 4.32 Favored Glycine 0 N--CA 1.415 -2.734 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.252 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 44.9 p -96.08 143.59 27.08 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 8.2 tt -148.01 154.99 10.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.53 132.02 34.57 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.336 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -87.48 -3.63 59.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.135 0.493 . . . . 0.0 111.776 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -103.77 -32.05 9.53 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.002 0.429 . . . . 0.0 110.153 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.69 -46.59 7.5 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -117.24 19.29 14.21 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.502 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -66.95 -14.61 63.61 Favored Glycine 0 C--N 1.307 -1.036 0 N-CA-C 116.382 1.313 . . . . 0.0 116.382 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.29 -24.64 67.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.085 0.942 . . . . 0.0 109.993 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -74.77 -22.3 58.85 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.946 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.475 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -61.07 -44.22 97.71 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 121.835 0.826 . . . . 0.0 109.408 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -112.56 24.0 14.36 Favored Glycine 0 C--N 1.272 -3.019 0 C-N-CA 117.987 -2.054 . . . . 0.0 115.381 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -14.36 59.46 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 169.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 73' ' ' ASN . 4.1 pp -100.37 -29.37 12.45 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.568 177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.506 ' N ' HD12 ' A' ' 72' ' ' LEU . 3.2 t-20 -175.8 -60.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.627 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.4 mm? -53.62 155.49 3.07 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -169.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -78.37 -12.96 60.04 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.012 -1.449 . . . . 0.0 112.49 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.475 HG22 ' HB3' ' A' ' 69' ' ' ALA . 75.7 p 58.61 28.52 17.23 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 126.56 1.944 . . . . 0.0 113.635 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.07 -28.44 6.98 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -170.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.717 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -124.9 106.07 9.72 Favored 'General case' 0 C--O 1.197 -1.676 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.418 -167.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.683 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 12.9 m-85 60.07 -171.06 0.02 OUTLIER Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.838 168.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.683 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 10.2 Cg_endo -58.72 149.91 73.92 Favored 'Trans proline' 0 C--N 1.379 2.148 0 CA-C-N 120.79 1.318 . . . . 0.0 113.8 171.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.58 126.21 34.21 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.783 -176.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 77.5 t80 -105.45 119.01 38.03 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -126.96 117.34 22.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.541 HD11 HG12 ' A' ' 110' ' ' VAL . 51.4 mt -91.02 110.18 22.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -92.04 135.0 34.31 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.575 ' OE2' ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -90.61 132.94 35.45 Favored 'General case' 0 CA--C 1.461 -2.462 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.371 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.582 HG22 ' SD ' ' A' ' 20' ' ' MET . 22.0 t -101.05 -6.7 9.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.98 -46.15 5.45 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 119.771 -0.771 . . . . 0.0 109.575 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.575 ' HG2' ' OE2' ' A' ' 86' ' ' GLU . 43.6 mmtm -92.62 -25.45 18.29 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.505 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 63.0 t30 66.65 59.16 0.61 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 123.646 1.688 . . . . 0.0 106.799 -171.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.552 ' HB2' ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -130.24 176.34 8.19 Favored 'General case' 0 CA--C 1.468 -2.183 0 CA-C-N 113.098 -1.864 . . . . 0.0 107.4 -172.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 91' ' ' GLN . 60.3 mmtt -142.52 111.04 6.15 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -106.63 87.96 3.12 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HB2' HD21 ' A' ' 74' ' ' LEU . 2.9 Cg_endo -104.48 150.89 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 122.689 2.259 . . . . 0.0 114.675 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 57.2 t80 -98.51 149.88 22.26 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.437 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 3.4 m-20 -58.72 139.51 56.07 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-O 121.702 0.763 . . . . 0.0 111.196 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.717 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 45.3 mt-30 -77.71 -8.54 58.09 Favored 'General case' 0 C--N 1.265 -3.103 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.181 -176.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 6.4 pt-20 -130.29 16.58 5.52 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.528 0.68 . . . . 0.0 111.42 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 34.8 ttmt -107.21 9.07 30.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.374 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 66.68 117.31 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.666 1.587 . . . . 0.0 114.6 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.543 HG23 HG13 ' A' ' 106' ' ' ILE . 3.4 mp -83.06 106.35 13.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.498 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.7 p -129.83 175.69 8.64 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.649 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 31.2 t80 -51.45 -63.79 1.02 Allowed 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 124.147 0.904 . . . . 0.0 110.047 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -67.38 -42.06 84.01 Favored 'General case' 1 N--CA 1.373 -4.299 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.195 -172.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.05 92.46 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 123.646 0.591 . . . . 0.0 110.296 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.543 HG13 HG23 ' A' ' 101' ' ' ILE . 32.6 mm -75.3 -42.26 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.101 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 27.0 ttpp -55.28 -50.33 69.8 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 123.759 0.662 . . . . 0.0 109.996 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.0 -33.54 75.78 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.043 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.462 ' CD1' ' HD1' ' A' ' 95' ' ' PHE . 68.8 t80 -66.21 -60.76 2.48 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.855 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.541 HG12 HD11 ' A' ' 84' ' ' ILE . 27.8 m -58.67 -31.3 43.86 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 122.033 -0.417 . . . . 0.0 110.411 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 23.0 t70 -61.48 -50.97 70.59 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.789 1.236 . . . . 0.0 109.69 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.696 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 4.4 t70 -61.65 -46.29 90.38 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-N 113.941 -1.482 . . . . 0.0 107.247 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.498 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.1 t80 -55.4 -65.14 0.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.01 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.88 -15.29 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 C-N-CA 123.661 0.785 . . . . 0.0 111.909 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.35 -25.39 25.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 0.0 110.17 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.56 26.67 6.74 Favored Glycine 0 CA--C 1.485 -1.782 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.696 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -98.09 -47.12 5.62 Favored 'General case' 0 N--CA 1.411 -2.414 0 CA-C-N 114.055 -1.073 . . . . 0.0 109.113 -176.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.556 HG13 ' HB3' ' A' ' 112' ' ' ASP . 20.5 mt -74.5 145.66 10.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--N 1.283 -2.296 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.121 -179.417 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HA ' ' H ' ' A' ' 59' ' ' THR . 10.6 pt-20 . . . . . 0 N--CA 1.429 -1.497 0 CA-C-O 121.041 0.448 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.509 HG13 ' HA3' ' A' ' 58' ' ' GLY . 69.2 mt -110.79 128.96 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 172.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.06 170.68 19.43 Favored Glycine 0 N--CA 1.416 -2.679 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.74 -18.23 54.54 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.278 2.652 . . . . 0.0 112.642 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.83 6.39 31.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.837 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -114.95 -25.98 7.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.374 -1.33 . . . . 0.0 111.981 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -41.75 -59.49 1.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.751 0.821 . . . . 0.0 112.248 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.6 m -54.3 -33.04 57.89 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.011 -1.449 . . . . 0.0 112.738 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.58 -26.99 31.82 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -74.68 -29.26 61.17 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.418 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -76.76 -35.79 57.48 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.731 178.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -70.87 -21.72 62.37 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.394 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.07 -24.23 59.48 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 120.831 0.348 . . . . 0.0 111.307 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.61 -15.49 30.29 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-O 121.443 0.468 . . . . 0.0 112.309 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.612 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 19.8 pt -90.07 153.35 46.91 Favored Pre-proline 0 C--N 1.293 -1.888 0 CA-C-N 115.175 -0.513 . . . . 0.0 109.98 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 21.4 Cg_exo -52.42 140.47 53.53 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.313 2.675 . . . . 0.0 113.879 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.435 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 2.7 tt -102.31 125.2 48.95 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.91 106.29 18.58 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.435 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 57.1 m-85 -87.88 113.92 23.99 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.12 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.607 HG12 HD13 ' A' ' 44' ' ' LEU . 3.1 mp -103.71 86.96 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.815 0 C-N-CA 118.379 -1.328 . . . . 0.0 108.958 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.63 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 41.5 m-85 -75.87 125.82 29.82 Favored 'General case' 0 CA--C 1.457 -2.609 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . . . -140.58 119.5 12.65 Favored 'General case' 0 C--N 1.258 -3.381 0 O-C-N 123.567 0.542 . . . . 0.0 111.489 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.99 -26.44 67.55 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.57 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 1.2 p -81.39 120.42 24.94 Favored 'General case' 0 N--CA 1.393 -3.287 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.914 -176.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.04 -16.75 12.58 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 173.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.0 mp0 -72.74 -45.49 58.45 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.764 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -116.28 12.99 15.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.137 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.574 ' HA ' HD23 ' A' ' 40' ' ' LEU . 44.1 ttm180 -51.79 -41.25 61.55 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 13.2 ptmm? -54.75 -32.0 59.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 124.147 0.904 . . . . 0.0 111.751 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -73.81 -43.78 57.8 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.674 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.8 mm? -58.14 -48.42 80.29 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.518 ' HA ' HD12 ' A' ' 44' ' ' LEU . 1.8 m -72.4 -21.48 61.26 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.817 -173.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 18.4 t70 -72.43 -39.19 68.06 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.743 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.62 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -73.02 -32.13 64.91 Favored 'General case' 0 C--O 1.287 3.035 0 CA-C-O 123.015 1.388 . . . . 0.0 108.69 175.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 52.5 mt -70.53 -26.51 63.61 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.434 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 4.0 tppp? -65.51 -51.8 48.81 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.304 -174.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 89.2 Cg_exo -67.14 -43.62 6.12 Favored 'Trans proline' 0 C--O 1.27 2.098 0 C-N-CA 122.901 2.4 . . . . 0.0 111.571 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.506 HG13 ' HA ' ' A' ' 44' ' ' LEU . 2.2 pp -63.13 -21.75 29.02 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 118.457 -1.297 . . . . 0.0 111.099 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.39 -24.26 16.79 Favored 'General case' 0 C--O 1.197 -1.681 0 O-C-N 123.677 0.611 . . . . 0.0 111.085 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.506 ' OE1' ' HD2' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -66.26 -21.39 66.28 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.41 -19.46 56.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.73 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 3.0 pt20 -139.04 35.73 2.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.267 1.032 . . . . 0.0 110.883 -171.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.506 ' HD2' ' OE1' ' A' ' 49' ' ' GLU . 14.3 ptm180 -73.05 -18.84 61.28 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.614 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.83 15.34 31.51 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.612 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.2 p -137.85 -29.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.866 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.6 mt -128.65 136.15 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 O-C-N 121.546 -0.721 . . . . 0.0 111.361 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.454 HD21 HG13 ' A' ' 24' ' ' ILE . 17.9 m-80 -88.88 109.35 20.14 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.485 ' CD2' HD11 ' A' ' 29' ' ' ILE . 5.0 m-85 -93.31 114.98 27.56 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.509 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -136.97 128.62 4.46 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.353 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.471 ' H ' ' HA ' ' A' ' 10' ' ' GLU . 55.3 p -87.84 132.36 34.21 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 6.8 tt -132.79 145.25 34.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 63' ' ' LYS . 11.2 t70 -75.56 127.83 33.95 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.263 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -90.98 -1.3 57.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.624 0.725 . . . . 0.0 111.285 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HB3' ' OD1' ' A' ' 61' ' ' ASP . 39.1 ttmt -99.35 -34.19 10.41 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.38 -54.5 3.25 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.766 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.29 20.25 19.25 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 121.767 -0.583 . . . . 0.0 111.007 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -63.3 -20.4 63.08 Favored Glycine 0 C--N 1.309 -0.919 0 N-CA-C 116.246 1.258 . . . . 0.0 116.246 -172.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.04 -25.03 66.63 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.021 0.911 . . . . 0.0 110.591 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -73.09 -17.83 61.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.458 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.438 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -64.18 -33.58 76.11 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.623 1.202 . . . . 0.0 108.837 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.571 ' HA2' ' H ' ' A' ' 73' ' ' ASN . . . -116.22 24.08 10.17 Favored Glycine 0 C--N 1.27 -3.111 0 C-N-CA 118.564 -1.779 . . . . 0.0 114.226 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -8.4 58.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 166.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.483 HD12 ' CB ' ' A' ' 73' ' ' ASN . 4.1 pp -112.71 -38.55 4.55 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 112.867 -1.97 . . . . 0.0 109.18 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.571 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 11.5 t-20 -169.23 -56.95 0.02 OUTLIER 'General case' 0 C--N 1.367 1.356 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.5 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.3 mm? -60.49 173.37 0.71 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -167.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.605 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 53.1 tttm -90.54 -9.75 46.05 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.588 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.2 p 74.7 -13.13 0.85 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 128.358 2.663 . . . . 0.0 115.714 168.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.605 ' OD1' ' HG2' ' A' ' 75' ' ' LYS . 17.7 p-10 -108.1 5.04 25.6 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -166.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 36.2 ttmt -129.23 103.98 7.26 Favored 'General case' 0 C--N 1.258 -3.395 0 C-N-CA 119.527 -0.869 . . . . 0.0 113.256 -173.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.547 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 31.6 m-85 56.52 -175.57 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 124.417 1.073 . . . . 0.0 113.195 167.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 9.2 Cg_endo -65.12 134.07 38.01 Favored 'Trans proline' 0 N--CA 1.424 -2.596 0 CA-C-N 119.978 1.028 . . . . 0.0 113.113 167.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.95 116.64 20.39 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 113.903 -1.498 . . . . 0.0 107.878 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 61.5 t80 -91.34 109.32 20.6 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.381 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -111.0 115.85 30.18 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 39.2 mt -90.93 109.38 20.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 25.4 tt0 -106.74 120.54 42.27 Favored 'General case' 0 N--CA 1.395 -3.203 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.436 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 13.1 mt-10 -75.38 148.23 39.37 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.885 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 20' ' ' MET . 16.4 t -113.72 -1.87 10.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.88 -55.9 3.63 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -97.36 -19.78 18.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.212 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.759 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 47.2 t-20 59.85 80.43 0.2 Allowed 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 125.119 1.368 . . . . 0.0 108.277 -170.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.558 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 5.3 tp60 -133.59 165.26 25.33 Favored 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 113.789 -1.55 . . . . 0.0 107.519 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.504 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 1.2 mptp? -125.25 99.85 6.26 Favored 'General case' 0 N--CA 1.4 -2.964 0 O-C-N 123.82 0.7 . . . . 0.0 109.242 -175.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 44.6 m-85 -104.57 83.45 0.77 Allowed Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.999 174.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 4.6 Cg_endo -100.74 148.42 0.37 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 C-N-CA 122.879 2.386 . . . . 0.0 114.354 -177.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -88.8 158.75 18.03 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.844 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.5 m-20 -65.99 145.79 55.46 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 121.514 0.673 . . . . 0.0 111.426 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 13.2 mt-30 -84.25 5.2 27.53 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.299 -174.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.3 22.63 2.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.037 0.923 . . . . 0.0 110.108 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 14.6 tppt? -104.03 170.23 8.04 Favored 'General case' 0 N--CA 1.401 -2.898 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -94.26 110.29 22.05 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 118.647 0.658 . . . . 0.0 111.503 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.71 101.59 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.637 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.3 p -125.29 -170.59 2.2 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.019 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.3 t80 -75.28 -54.24 7.42 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -174.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -55.18 -54.0 48.87 Favored 'General case' 0 N--CA 1.384 -3.767 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.777 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.68 -48.82 78.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 123.742 0.651 . . . . 0.0 112.265 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 47.7 mm -73.65 -40.55 54.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -59.13 -46.6 87.94 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.48 94.78 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.829 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -65.38 -58.67 5.3 Favored 'General case' 0 C--O 1.21 -0.987 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.276 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.402 HG12 HD11 ' A' ' 84' ' ' ILE . 35.0 m -59.92 -33.25 52.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 O-C-N 121.689 -0.632 . . . . 0.0 110.7 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.18 -51.91 67.97 Favored 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 124.241 1.016 . . . . 0.0 109.673 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.667 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 3.6 t70 -58.89 -47.12 86.08 Favored 'General case' 0 C--O 1.206 -1.197 0 CA-C-N 113.699 -1.591 . . . . 0.0 107.383 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.47 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.1 t80 -55.44 -64.48 0.83 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.059 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.99 -11.95 14.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.224 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.77 -30.14 23.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.435 0.636 . . . . 0.0 109.744 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.41 26.74 5.54 Favored Glycine 0 CA--C 1.481 -2.051 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.667 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -96.68 -52.32 3.97 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-N 114.131 -1.035 . . . . 0.0 109.157 -176.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 112' ' ' ASP . 18.5 mt -71.15 145.1 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--N 1.277 -2.57 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.75 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 N--CA 1.442 -0.873 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.573 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 57.1 mt -92.48 139.05 18.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.54 -179.65 18.87 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.79 -31.68 42.98 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.45 3.433 . . . . 0.0 114.582 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.24 -7.59 24.47 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.0 p -93.83 -27.26 16.54 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.985 -169.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -45.93 -51.43 13.29 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.884 0.85 . . . . 0.0 111.012 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -55.5 -34.4 64.57 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.387 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -71.04 -41.64 70.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.456 0.646 . . . . 0.0 110.096 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 41.9 m-85 -72.48 -28.94 63.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.35 1.071 . . . . 0.0 108.271 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.464 ' SD ' HG22 ' A' ' 87' ' ' VAL . 5.8 tpp -78.39 -19.96 52.2 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.315 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -87.79 -17.11 32.31 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.355 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.37 -41.7 72.75 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.025 0.441 . . . . 0.0 110.794 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.22 0.28 65.66 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.662 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 13.7 pt -107.8 152.48 41.59 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HG2' HG12 ' A' ' 55' ' ' ILE . 9.9 Cg_endo -53.25 138.91 64.18 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.923 3.082 . . . . 0.0 113.759 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.488 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 2.5 tt -105.33 125.85 51.45 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.591 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -98.76 105.55 17.71 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.488 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 65.5 m-85 -86.72 112.43 21.66 Favored 'General case' 0 CA--C 1.467 -2.234 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.429 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.9 mt -101.09 85.08 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.596 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 43.6 m-85 -76.35 124.52 27.65 Favored 'General case' 0 CA--C 1.46 -2.515 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.64 121.17 21.62 Favored 'General case' 0 C--N 1.257 -3.447 0 O-C-N 123.456 0.473 . . . . 0.0 110.66 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -81.99 -16.69 49.49 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 17.6 p -97.11 100.55 12.03 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.722 -174.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.64 -16.93 60.14 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.94 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -71.57 -56.67 5.43 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.164 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.565 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 15.0 pt-20 -91.0 8.49 35.04 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.561 -175.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 33' ' ' THR 0.275 0.1 OUTLIER -59.71 -32.85 70.91 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.159 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -77.46 -33.63 54.61 Favored 'General case' 0 C--O 1.2 -1.543 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.782 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.565 ' OE2' ' HA ' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -65.77 -43.92 87.38 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.492 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -56.92 -49.51 75.39 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.552 ' OG ' HG21 ' A' ' 59' ' ' THR . 15.0 m -73.63 -13.41 61.0 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.061 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 24.4 t70 -77.49 -38.32 49.36 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 123.138 0.575 . . . . 0.0 111.074 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.597 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -69.37 -36.34 76.74 Favored 'General case' 0 C--O 1.276 2.495 0 CA-C-O 123.271 1.51 . . . . 0.0 107.952 172.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 75.5 mt -73.22 -18.52 61.23 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 113.527 -1.67 . . . . 0.0 111.94 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.622 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 36.9 ttpt -62.37 -55.03 43.6 Favored Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 123.646 0.778 . . . . 0.0 111.382 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.622 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 51.6 Cg_exo -72.22 -36.97 4.99 Favored 'Trans proline' 0 CA--C 1.485 -1.926 0 C-N-CA 122.593 2.195 . . . . 0.0 109.795 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.611 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 27.3 mm -54.38 -36.64 34.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.383 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.33 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.05 -20.47 22.04 Favored 'General case' 0 C--O 1.195 -1.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.249 -174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -69.9 -22.72 63.19 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.32 -9.62 59.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.757 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 3.0 pt20 -148.57 35.37 0.79 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.298 1.046 . . . . 0.0 110.644 -173.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -73.2 -19.23 61.14 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.805 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.13 21.68 11.9 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.679 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.496 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.7 p -138.84 -32.65 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.504 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.475 HG12 ' HG2' ' A' ' 25' ' ' PRO . 95.2 mt -122.85 137.6 55.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.812 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 20.9 m-80 -84.16 111.75 19.63 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 29' ' ' ILE . 1.6 m-85 -97.67 105.82 18.03 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.573 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -130.62 130.46 6.16 Favored Glycine 0 N--CA 1.415 -2.747 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.867 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.567 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 35.6 p -92.38 136.97 32.76 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 tt -137.31 156.92 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD2' ' HD1' ' A' ' 65' ' ' PHE . 3.4 p30 -75.28 149.71 38.73 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.347 0.594 . . . . 0.0 110.172 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.6 14.03 26.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.904 0.859 . . . . 0.0 108.764 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -84.43 -53.71 5.25 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.045 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.56 -48.6 3.21 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.3 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.482 ' HD1' ' OD2' ' A' ' 61' ' ' ASP . 96.0 m-85 -97.97 10.49 40.2 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.987 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.11 -24.63 61.1 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 115.881 1.113 . . . . 0.0 115.881 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.92 -20.83 65.98 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.399 1.099 . . . . 0.0 110.333 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -70.82 -20.72 62.54 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.552 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -61.19 -39.39 89.99 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-O 122.343 1.068 . . . . 0.0 109.652 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -113.21 31.44 6.71 Favored Glycine 0 C--N 1.27 -3.101 0 C-N-CA 119.275 -1.441 . . . . 0.0 113.825 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.59 -17.46 38.71 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 168.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.457 HD12 ' N ' ' A' ' 73' ' ' ASN . 4.0 pp -102.82 -24.95 13.67 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.041 -1.891 . . . . 0.0 110.998 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.457 ' N ' HD12 ' A' ' 72' ' ' LEU . 2.2 t-20 -179.96 -59.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.604 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.6 mm? -54.41 158.71 2.29 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -168.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -75.42 -17.69 60.1 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.829 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.428 HG22 ' HB3' ' A' ' 69' ' ' ALA . 48.6 p 55.17 40.33 31.72 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.182 1.393 . . . . 0.0 113.42 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' OD2' ' HE2' ' A' ' 78' ' ' LYS . 20.6 p-10 -125.18 -23.13 4.25 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.164 0.507 . . . . 0.0 111.224 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HE2' ' OD2' ' A' ' 77' ' ' ASP . 33.6 mtmt -108.13 -174.69 2.58 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -170.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.729 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 95.7 m-85 -69.16 -172.45 0.17 Allowed Pre-proline 0 CA--C 1.572 1.822 0 C-N-CA 125.791 1.637 . . . . 0.0 109.967 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.729 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 1.3 Cg_endo -43.67 131.09 7.52 Favored 'Trans proline' 1 C--N 1.429 4.788 0 CA-C-N 122.415 1.898 . . . . 0.0 116.42 -170.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.423 ' HB1' ' HG ' ' A' ' 74' ' ' LEU . . . -126.85 116.05 20.27 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 113.101 -1.863 . . . . 0.0 107.93 -175.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.591 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 71.5 t80 -95.14 109.85 21.88 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.971 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -112.07 117.1 31.72 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.478 HD11 HG12 ' A' ' 110' ' ' VAL . 56.2 mt -91.45 105.22 16.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.666 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -90.13 126.37 35.77 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 2.8 mm-40 -87.88 125.59 34.57 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.549 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.464 HG22 ' SD ' ' A' ' 20' ' ' MET . 15.1 t -98.12 1.22 10.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.39 -35.07 3.66 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.177 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 89' ' ' LYS . 5.9 tmtm? -95.83 -20.16 19.03 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.3 m120 67.52 36.72 3.66 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-O 122.847 1.308 . . . . 0.0 110.337 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.505 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 2.0 tp60 -121.14 -179.69 4.12 Favored 'General case' 0 CA--C 1.472 -2.048 0 CA-C-N 112.803 -1.999 . . . . 0.0 107.681 -172.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.541 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 57.3 mmtt -138.12 106.17 5.71 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -102.47 87.2 1.08 Allowed Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 10.8 Cg_endo -102.33 142.25 0.19 Allowed 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 122.572 2.182 . . . . 0.0 114.638 -176.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.451 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 86.4 t80 -84.58 170.49 13.35 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.34 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 9.3 m-20 -72.42 159.49 33.89 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.122 0.969 . . . . 0.0 110.295 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -100.75 -11.67 19.72 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-O 121.83 0.824 . . . . 0.0 108.909 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -123.42 -0.18 8.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.347 -173.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 33.3 ttmt -87.58 -3.18 58.99 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.869 -172.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 72.95 134.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.145 0.978 . . . . 0.0 111.703 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.567 HG23 HG13 ' A' ' 106' ' ' ILE . 2.8 mp -90.04 101.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 122.009 0.909 . . . . 0.0 109.846 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.7 p -109.33 -174.02 2.4 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 18.9 t80 -77.2 -51.14 11.45 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -59.95 -52.39 65.61 Favored 'General case' 0 N--CA 1.379 -3.985 0 CA-C-N 112.493 -2.14 . . . . 0.0 113.397 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.57 83.46 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.121 0.486 . . . . 0.0 111.39 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.567 HG13 HG23 ' A' ' 101' ' ' ILE . 40.2 mm -73.05 -42.0 59.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.0 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 47' ' ' ILE . 33.8 ttpt -56.46 -50.56 71.38 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.34 92.63 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.143 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.496 ' O ' HD11 ' A' ' 118' ' ' ILE . 57.8 t80 -63.69 -59.92 3.98 Favored 'General case' 0 C--O 1.204 -1.305 0 O-C-N 124.02 0.825 . . . . 0.0 111.074 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 106' ' ' ILE . 31.4 m -58.87 -35.72 57.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 O-C-N 121.998 -0.438 . . . . 0.0 111.535 -176.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.88 -51.93 66.18 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.719 0.771 . . . . 0.0 109.036 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.69 ' OD1' ' HB3' ' A' ' 117' ' ' LYS . 5.6 t0 -57.35 -36.08 70.75 Favored 'General case' 0 C--O 1.196 -1.711 0 CA-C-N 113.45 -1.704 . . . . 0.0 109.731 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.693 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -71.25 -61.22 1.85 Allowed 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.89 177.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.09 -23.44 33.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.542 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.52 -22.19 44.26 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.605 0.717 . . . . 0.0 109.622 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.4 18.22 15.31 Favored Glycine 0 CA--C 1.466 -2.994 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.487 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.69 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 12.7 ttpp -93.04 -38.31 11.7 Favored 'General case' 0 N--CA 1.384 -3.753 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.609 -172.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.693 HD12 ' HB2' ' A' ' 113' ' ' PHE . 9.9 mt -67.57 141.92 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.407 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--N 1.256 -3.471 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.23 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.423 -1.777 0 CA-C-O 121.46 0.648 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.533 HG13 ' HA3' ' A' ' 58' ' ' GLY . 62.1 mt -95.72 114.04 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -127.77 -178.92 15.56 Favored Glycine 0 N--CA 1.408 -3.199 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.29 -8.28 8.23 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.036 3.157 . . . . 0.0 115.67 -173.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -123.98 -18.36 5.98 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.018 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.8 p -85.23 -27.62 25.94 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.573 -172.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -62.09 -36.74 82.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.293 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 m -66.66 -27.31 67.57 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.867 0.867 . . . . 0.0 110.574 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.95 -39.07 61.55 Favored 'General case' 0 C--O 1.258 1.549 0 CA-C-O 121.704 0.764 . . . . 0.0 109.095 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -75.12 -26.15 58.98 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.463 ' SD ' HG22 ' A' ' 87' ' ' VAL . 8.8 tpp -77.76 -25.3 49.03 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.661 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -88.82 -10.75 46.98 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.405 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.27 -35.19 73.6 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 122.086 -0.384 . . . . 0.0 111.543 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.48 65.55 Favored Glycine 0 N--CA 1.461 0.304 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.366 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 9.1 pt -126.1 151.62 72.07 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HG2' HG12 ' A' ' 55' ' ' ILE . 8.0 Cg_endo -50.14 141.56 30.32 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.068 3.179 . . . . 0.0 114.037 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.448 HD13 ' CE1' ' A' ' 28' ' ' TYR . 2.5 tt -110.4 124.81 52.42 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.548 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -94.1 105.46 17.46 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.448 ' CE1' HD13 ' A' ' 26' ' ' LEU . 48.3 m-85 -87.59 110.7 20.57 Favored 'General case' 0 CA--C 1.471 -2.058 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.363 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.7 mt -100.23 85.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.319 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.546 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 31.5 m-85 -77.53 109.91 11.88 Favored 'General case' 0 CA--C 1.468 -2.181 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -124.06 119.75 30.39 Favored 'General case' 1 C--N 1.238 -4.245 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.701 177.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -74.54 -27.2 60.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 11.4 p -93.49 106.6 18.55 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.61 -173.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . -78.78 -21.28 48.1 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.909 -175.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -80.1 -48.51 13.12 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.042 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.489 ' HG2' ' HB ' ' A' ' 33' ' ' THR . 12.5 pt-20 -90.7 1.18 57.07 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.553 -0.859 . . . . 0.0 112.158 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 12.2 ptm180 -60.19 -24.31 64.68 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -58.48 -57.9 10.92 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.53 -25.79 54.51 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.166 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.654 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -60.24 -50.98 71.5 Favored 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.457 ' HA ' HD12 ' A' ' 44' ' ' LEU . 9.9 m -75.11 -19.4 59.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.73 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.43 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 15.9 t70 -67.79 -43.39 79.84 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.836 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.626 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.6 OUTLIER -70.37 -34.05 72.14 Favored 'General case' 0 C--O 1.278 2.597 0 CA-C-O 122.772 1.272 . . . . 0.0 108.463 176.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 56.9 mt -69.94 -20.51 63.33 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.716 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.599 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 17.4 tppt? -61.97 -57.29 24.8 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.843 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 72.8 Cg_exo -66.82 -39.42 14.84 Favored 'Trans proline' 0 CA--C 1.49 -1.696 0 C-N-CA 122.917 2.411 . . . . 0.0 110.351 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.579 HD11 ' HA ' ' A' ' 103' ' ' PHE . 93.8 mt -52.67 -40.36 34.02 Favored 'Isoleucine or valine' 0 C--N 1.368 1.388 0 O-C-N 124.086 0.866 . . . . 0.0 109.208 176.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -94.26 -13.79 26.16 Favored 'General case' 0 C--O 1.177 -2.718 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.603 -173.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -71.94 -22.36 61.48 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.92 -23.45 33.51 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.906 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.524 ' OE1' HD12 ' A' ' 55' ' ' ILE . 5.4 pt20 -130.85 34.37 4.09 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.19 0.995 . . . . 0.0 112.373 -174.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -73.25 -18.58 61.21 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.393 -1.73 . . . . 0.0 111.858 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.38 4.4 28.17 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.418 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.8 p -124.15 -33.5 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.325 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.524 HD12 ' OE1' ' A' ' 51' ' ' GLN . 95.0 mt -124.39 136.81 59.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.034 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.43 HD21 HG13 ' A' ' 24' ' ' ILE . 20.3 m-80 -84.83 104.65 14.97 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -90.16 102.67 15.39 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.573 0.701 . . . . 0.0 112.564 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.533 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -124.21 131.74 8.05 Favored Glycine 0 N--CA 1.415 -2.762 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.424 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 27.4 p -92.27 134.67 34.68 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 120.896 0.379 . . . . 0.0 110.515 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 8.7 tt -137.15 165.58 27.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -89.13 153.88 20.6 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-O 121.458 0.647 . . . . 0.0 110.922 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -110.48 19.83 18.36 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 173.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -102.82 -46.02 4.82 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 113.382 -1.735 . . . . 0.0 109.844 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.47 -43.58 3.48 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.139 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.421 ' O ' ' HE2' ' A' ' 30' ' ' PHE . 96.4 m-85 -99.21 10.12 42.07 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 122.124 -0.36 . . . . 0.0 110.68 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 62' ' ' ALA . . . -58.97 -30.04 66.0 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.01 -30.08 46.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.413 0.625 . . . . 0.0 111.303 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -69.15 -23.81 64.0 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.285 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.461 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -63.02 -34.41 77.5 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-O 121.978 0.894 . . . . 0.0 109.861 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.45 ' HA2' ' N ' ' A' ' 74' ' ' LEU . . . -109.28 5.34 31.7 Favored Glycine 0 C--N 1.279 -2.591 0 C-N-CA 117.403 -2.332 . . . . 0.0 115.502 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -76.57 -16.97 59.46 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 73' ' ' ASN . 4.2 pp -97.68 -31.38 12.3 Favored 'General case' 0 N--CA 1.399 -2.987 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.349 174.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.432 ' HB2' HD12 ' A' ' 72' ' ' LEU . 2.2 t-20 179.51 -56.74 0.01 OUTLIER 'General case' 0 C--N 1.38 1.906 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' A' ' 94' ' ' PRO . 2.3 mm? -61.4 179.9 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -169.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.25 -0.68 20.72 Favored 'General case' 0 CA--C 1.486 -1.515 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.99 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.467 ' N ' HE22 ' A' ' 97' ' ' GLN . 19.2 p 59.3 5.78 0.64 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 125.205 1.402 . . . . 0.0 112.401 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.92 -25.09 28.12 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -170.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 11.4 tptm -119.21 -158.68 0.74 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.672 -166.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.529 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 89.5 m-85 -54.99 168.32 0.53 Allowed Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 125.054 1.341 . . . . 0.0 110.506 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 2.5 Cg_endo -40.63 130.44 2.64 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.998 2.465 . . . . 0.0 114.431 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -103.75 104.82 14.88 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.608 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.548 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 74.3 t80 -87.13 111.5 21.0 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.908 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.88 119.39 32.51 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.518 HD11 HG12 ' A' ' 110' ' ' VAL . 55.2 mt -89.41 104.84 15.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -86.18 132.77 33.94 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.626 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.15 141.89 29.87 Favored 'General case' 0 C--N 1.265 -3.098 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.017 175.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.463 HG22 ' SD ' ' A' ' 20' ' ' MET . 25.8 t -107.79 -2.06 10.0 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.38 -48.19 3.75 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.42 ' HD3' ' OE2' ' A' ' 86' ' ' GLU . 4.7 mptp? -89.38 -25.15 21.73 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.981 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 16.2 t-20 66.17 20.72 11.15 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.36 1.464 . . . . 0.0 108.465 -173.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.539 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 4.4 tp60 -85.95 178.7 7.19 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.617 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 56.7 mmtt -138.46 105.04 5.31 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -96.88 87.84 0.49 Allowed Pre-proline 0 N--CA 1.481 1.084 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 6.0 Cg_endo -104.82 145.7 0.12 Allowed 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.516 2.144 . . . . 0.0 115.01 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.4 ' HD1' ' CD1' ' A' ' 109' ' ' PHE . 77.2 t80 -86.0 158.78 19.78 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.595 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.619 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.3 m-20 -71.48 134.49 46.59 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.109 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.467 HE22 ' N ' ' A' ' 76' ' ' THR . 48.1 mt-30 -75.74 9.62 2.21 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.722 -175.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -154.92 20.96 0.45 Allowed 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.177 0.513 . . . . 0.0 111.443 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.619 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 39.1 ttmt -97.86 9.89 41.57 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 74.09 120.46 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 113.562 -1.654 . . . . 0.0 112.025 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.2 mp -92.82 98.54 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.03 -164.47 1.32 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.923 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.579 ' HA ' HD11 ' A' ' 47' ' ' ILE . 16.0 t80 -77.79 -58.62 3.17 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -174.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -52.84 -53.75 44.18 Favored 'General case' 0 N--CA 1.386 -3.638 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.527 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.83 -49.31 77.1 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 123.596 0.56 . . . . 0.0 112.371 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 110' ' ' VAL . 41.8 mm -72.96 -42.45 59.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.024 -177.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.414 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 28.6 ttpt -54.52 -50.96 66.61 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.996 0.81 . . . . 0.0 109.241 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 112' ' ' ASP . . . -63.11 -39.11 93.73 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.559 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.4 ' CD1' ' HD1' ' A' ' 95' ' ' PHE . 66.7 t80 -65.32 -60.13 3.31 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.62 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.518 HG12 HD11 ' A' ' 84' ' ' ILE . 27.6 m -57.62 -36.62 54.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 O-C-N 121.83 -0.544 . . . . 0.0 111.422 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.29 -46.37 87.07 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.216 0.531 . . . . 0.0 109.681 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.69 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 3.4 t70 -57.27 -48.98 77.5 Favored 'General case' 0 C--O 1.203 -1.39 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.523 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.7 t80 -57.02 -63.59 1.16 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.622 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 110' ' ' VAL . 90.6 t -52.48 -30.8 14.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 C-N-CA 124.311 1.044 . . . . 0.0 112.37 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.59 -38.95 58.7 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.676 0.751 . . . . 0.0 110.026 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.16 23.87 5.64 Favored Glycine 0 CA--C 1.473 -2.534 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.69 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 3.3 ttmm -92.39 -42.52 9.73 Favored 'General case' 0 N--CA 1.387 -3.579 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.605 HG13 ' HB3' ' A' ' 112' ' ' ASP . 23.5 mt -81.37 143.35 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--N 1.272 -2.772 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 179.373 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.413 ' HG2' ' OG1' ' A' ' 59' ' ' THR . 42.4 mt-10 . . . . . 0 N--CA 1.426 -1.652 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.565 HG13 ' HA3' ' A' ' 58' ' ' GLY . 67.7 mt -105.69 120.9 57.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.56 179.75 18.57 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.54 5.36 4.3 Favored 'Trans proline' 0 C--O 1.221 -0.367 0 C-N-CA 123.029 2.486 . . . . 0.0 112.752 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -128.64 -6.18 5.18 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.869 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -100.27 -28.31 13.05 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.736 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -59.09 -38.38 79.38 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.9 0.381 . . . . 0.0 111.693 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 m -65.22 -27.09 68.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.717 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.81 -33.4 40.41 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.034 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.402 ' HB3' ' CG ' ' A' ' 56' ' ' ASN . 21.1 m-85 -75.8 -27.21 57.88 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.558 ' SD ' HG22 ' A' ' 87' ' ' VAL . 8.7 tpp -77.07 -21.53 54.28 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 113.554 -1.657 . . . . 0.0 108.757 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.4 t -90.0 -12.77 37.66 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.8 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.26 60.39 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.226 0.536 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.63 2.85 78.46 Favored Glycine 0 C--N 1.32 -0.35 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.25 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 13.6 pt -112.04 148.64 39.47 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.481 ' HG2' HG12 ' A' ' 55' ' ' ILE . 6.6 Cg_endo -51.29 142.21 37.63 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.834 3.022 . . . . 0.0 113.846 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.51 HD13 ' CE1' ' A' ' 28' ' ' TYR . 2.6 tt -108.98 126.91 53.6 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -101.02 109.07 20.93 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE1' HD13 ' A' ' 26' ' ' LEU . 47.1 m-85 -89.58 109.61 20.54 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.365 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.532 HD11 ' CD2' ' A' ' 57' ' ' PHE . 2.5 mp -101.04 87.92 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.337 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.586 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 42.9 m-85 -73.02 133.73 44.36 Favored 'General case' 0 CA--C 1.467 -2.226 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . . . -148.19 117.08 6.73 Favored 'General case' 0 C--N 1.274 -2.693 0 O-C-N 123.593 0.558 . . . . 0.0 111.665 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.01 -22.8 59.44 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.852 0.834 . . . . 0.0 108.911 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.452 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 17.0 p -76.52 115.88 16.68 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.882 -173.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.33 -15.26 19.82 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.395 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -85.69 -63.72 1.27 Allowed 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.452 ' HG2' ' HB ' ' A' ' 33' ' ' THR . 1.3 pm0 -78.91 12.5 2.14 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.462 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.6 tpp85 -52.7 -39.07 61.64 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 169.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -67.03 -48.49 68.17 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.607 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 45.6 mt-10 -59.61 -50.52 73.55 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.217 0.532 . . . . 0.0 110.307 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -53.23 -54.42 36.43 Favored 'General case' 0 C--O 1.255 1.354 0 C-N-CA 124.653 1.181 . . . . 0.0 108.849 -176.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.468 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 12.3 m -73.6 -15.18 61.28 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.62 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 33.8 t70 -75.09 -35.59 61.79 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 122.954 0.501 . . . . 0.0 111.458 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -77.49 -30.17 52.94 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 122.865 1.317 . . . . 0.0 108.81 173.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 45.8 mt -73.16 -30.97 63.95 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 113.626 -1.624 . . . . 0.0 113.713 -177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 24.8 ttpp -68.2 -46.4 39.84 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.694 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 73.5 Cg_endo -70.88 -42.56 2.18 Favored 'Trans proline' 0 C--O 1.26 1.593 0 C-N-CA 122.485 2.123 . . . . 0.0 110.996 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 107' ' ' LYS . 2.6 pp -63.15 -24.89 37.15 Favored 'Isoleucine or valine' 0 C--N 1.385 2.128 0 C-N-CA 118.11 -1.436 . . . . 0.0 109.99 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.85 -22.23 19.4 Favored 'General case' 0 C--O 1.194 -1.841 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.201 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 6.2 tt0 -69.84 -18.44 63.44 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.72 -21.56 51.71 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.971 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 51' ' ' GLN . 2.7 pt20 -138.51 36.54 2.25 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.2 1.0 . . . . 0.0 111.108 -170.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 49' ' ' GLU . 9.1 ptm180 -76.85 -14.02 59.94 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.645 -172.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.6 6.68 22.54 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.632 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.567 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.6 p -125.6 -32.51 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.515 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.481 HG12 ' HG2' ' A' ' 25' ' ' PRO . 94.6 mt -122.2 136.31 59.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.412 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.461 HD21 HG13 ' A' ' 24' ' ' ILE . 16.7 m-80 -84.65 104.04 14.28 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.532 ' CD2' HD11 ' A' ' 29' ' ' ILE . 3.7 m-85 -90.75 103.61 16.29 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.565 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -124.34 130.88 7.69 Favored Glycine 0 N--CA 1.408 -3.22 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.412 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.413 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 20.7 p -92.01 127.82 37.62 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 9.3 tt -126.57 143.17 40.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 63' ' ' LYS . 20.3 t70 -76.27 131.13 39.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.122 -175.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -92.48 -1.08 57.23 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.343 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HB3' ' OD2' ' A' ' 61' ' ' ASP . 81.8 tttt -92.4 -43.61 9.13 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.52 -40.09 9.63 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.769 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -115.48 20.8 14.52 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.736 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.437 ' CA ' ' HA ' ' A' ' 62' ' ' ALA . . . -69.31 -23.29 76.41 Favored Glycine 0 C--N 1.305 -1.181 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 -169.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.0 -21.69 63.81 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.254 0.55 . . . . 0.0 111.4 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -69.13 -25.35 64.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.666 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -59.56 -35.28 73.94 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.073 0.939 . . . . 0.0 111.362 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -109.54 13.49 32.88 Favored Glycine 0 C--N 1.27 -3.114 0 C-N-CA 117.596 -2.24 . . . . 0.0 115.895 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -24.25 58.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 169.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 4.0 pp -92.45 -37.53 12.49 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.385 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.502 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 20.9 t-20 -172.94 -57.88 0.02 OUTLIER 'General case' 0 C--N 1.369 1.452 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.536 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.5 mm? -54.58 164.79 0.67 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -167.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -81.06 -14.87 57.42 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.757 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.475 HG22 ' HB3' ' A' ' 69' ' ' ALA . 28.9 p 59.6 21.44 10.05 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.655 1.982 . . . . 0.0 114.076 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -105.39 -25.27 12.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -135.41 115.05 12.76 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -166.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.677 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 14.8 t80 60.39 179.74 0.04 OUTLIER Pre-proline 0 CA--C 1.581 2.16 0 O-C-N 125.126 1.516 . . . . 0.0 111.546 158.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.677 ' HD2' ' CG ' ' A' ' 79' ' ' PHE . 3.7 Cg_endo -55.81 134.52 64.54 Favored 'Trans proline' 0 C--N 1.378 2.095 0 CA-C-N 120.805 1.323 . . . . 0.0 113.837 167.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.421 ' HB1' ' HG ' ' A' ' 74' ' ' LEU . . . -125.8 113.17 16.91 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.45 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.454 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 62.5 t80 -90.25 111.3 22.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -116.27 118.05 31.71 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 58.7 mt -93.7 114.09 29.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.547 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -102.53 126.77 49.7 Favored 'General case' 0 N--CA 1.405 -2.717 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 0.7 OUTLIER -78.98 136.65 37.28 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.95 177.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.558 HG22 ' SD ' ' A' ' 20' ' ' MET . 23.6 t -104.3 -5.18 9.56 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.62 -38.17 6.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.368 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 23.1 ttmm -101.88 -17.83 15.99 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 44.8 t-20 56.44 75.43 0.35 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 124.55 1.14 . . . . 0.0 108.507 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -144.17 174.34 10.97 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.087 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -126.97 102.35 6.95 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -177.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.408 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 60.8 m-85 -107.93 80.7 1.07 Allowed Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 15.4 Cg_endo -101.17 144.84 0.28 Allowed 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.907 2.405 . . . . 0.0 114.077 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -85.01 165.55 17.45 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 125.247 1.419 . . . . 0.0 108.259 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.742 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 9.0 m-20 -73.78 145.39 45.08 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.446 ' O ' ' HB3' ' A' ' 79' ' ' PHE . 13.0 mt-30 -83.02 -5.47 59.11 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.233 -170.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -148.09 32.36 0.83 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.337 1.065 . . . . 0.0 110.685 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 17.2 tppt? -95.95 -6.76 38.29 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.206 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 74.24 127.69 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.967 1.307 . . . . 0.0 111.734 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.472 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.0 mp -93.65 116.89 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.369 -176.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 p -122.49 -174.69 2.97 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.411 ' HA ' ' HB3' ' A' ' 43' ' ' LYS . 20.2 t80 -76.73 -48.7 17.98 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.6 -55.8 30.21 Favored 'General case' 0 N--CA 1.387 -3.618 0 CA-C-N 112.099 -2.319 . . . . 0.0 112.38 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.44 74.51 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.654 0.596 . . . . 0.0 111.996 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.472 ' CG1' HG23 ' A' ' 101' ' ' ILE . 42.1 mm -74.08 -43.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.68 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.41 ' HB2' HG21 ' A' ' 47' ' ' ILE . 36.5 ttpt -56.85 -48.24 78.54 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 124.118 0.886 . . . . 0.0 109.683 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.55 99.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.733 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.605 ' HA ' ' OD1' ' A' ' 112' ' ' ASP . 38.5 t80 -64.44 -58.13 7.31 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.495 1.118 . . . . 0.0 111.273 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 106' ' ' ILE . 26.8 m -58.95 -31.94 46.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 O-C-N 121.531 -0.731 . . . . 0.0 110.614 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.32 -52.93 50.7 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 123.828 0.851 . . . . 0.0 109.358 177.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.605 ' OD1' ' HA ' ' A' ' 109' ' ' PHE 0.281 0.4 OUTLIER -67.48 -22.1 65.49 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.329 -177.027 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.53 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.6 OUTLIER -72.75 -63.7 1.11 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.524 172.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.05 -20.95 27.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.09 -174.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.1 -30.43 60.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.22 40.24 1.83 Allowed Glycine 0 CA--C 1.479 -2.211 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.665 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -117.58 -41.73 2.92 Favored 'General case' 0 N--CA 1.391 -3.391 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.739 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 113' ' ' PHE . 6.6 mt -65.09 141.27 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.723 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--N 1.265 -3.091 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.467 -176.776 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.407 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -91.95 16.8 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.042 2.495 . . . . 0.0 112.592 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.3 mt -87.35 152.12 22.53 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.28 63.83 1.91 Allowed Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 m -66.99 152.98 95.39 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 122.924 0.489 . . . . 0.0 110.41 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.98 117.91 4.73 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 107.228 -1.874 . . . . 0.0 107.228 171.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 52' ' ' ARG . 15.1 tp -75.97 -24.1 55.38 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.235 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 5.2 mp -113.07 106.03 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 170.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.37 -144.3 4.14 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -107.79 138.69 43.58 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 122.09 0.947 . . . . 0.0 111.813 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.569 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 62.7 mt -88.22 127.96 40.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.476 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.2 -176.42 20.04 Favored Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.06 -18.45 50.87 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.769 2.979 . . . . 0.0 113.792 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -94.8 -40.77 9.57 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.995 0.426 . . . . 0.0 110.818 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.2 p -86.18 -29.58 23.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -167.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -60.66 -37.5 81.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.654 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.5 m -67.9 -26.31 65.93 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.598 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -79.01 -34.57 43.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.414 0.626 . . . . 0.0 110.015 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -74.95 -28.37 60.56 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.489 ' SD ' HG22 ' A' ' 87' ' ' VAL . 7.4 tpp -79.67 -20.73 45.94 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.709 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.4 t -96.57 -5.51 39.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.862 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.27 -34.83 66.02 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.946 0.403 . . . . 0.0 110.202 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.21 -13.32 64.8 Favored Glycine 0 CA--C 1.51 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.27 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 16.5 pt -98.73 153.73 37.76 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 123.66 0.784 . . . . 0.0 109.475 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HG2' HG12 ' A' ' 55' ' ' ILE . 18.3 Cg_endo -58.69 145.77 94.51 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 123.53 2.82 . . . . 0.0 113.534 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.607 HD13 ' CE1' ' A' ' 28' ' ' TYR . 1.8 tt -110.98 127.25 55.45 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -176.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.453 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.8 108.97 21.73 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CE1' HD13 ' A' ' 26' ' ' LEU . 23.0 m-85 -90.19 110.5 21.53 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 124.387 1.075 . . . . 0.0 109.462 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.531 HD11 ' CD2' ' A' ' 57' ' ' PHE . 3.5 mp -101.25 91.05 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.608 0 C-N-CA 118.811 -1.156 . . . . 0.0 109.521 177.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.625 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 46.6 m-85 -76.43 128.24 34.43 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -143.48 119.42 10.63 Favored 'General case' 0 C--N 1.27 -2.862 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.576 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.44 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 49.1 mt-10 -84.99 -2.05 57.5 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.252 0.549 . . . . 0.0 109.747 173.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 7.3 p -91.61 123.54 35.09 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.877 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.99 -21.05 18.86 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.26 0.552 . . . . 0.0 110.655 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.453 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 37.1 mt-10 -86.07 -66.43 0.9 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.82 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 12.5 pt-20 -73.7 1.59 9.98 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.208 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 33' ' ' THR . 15.7 ttt180 -54.46 -43.03 71.34 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 124.223 1.009 . . . . 0.0 108.705 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 45.5 mtmt -60.6 -49.45 77.5 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.802 -1.545 . . . . 0.0 109.896 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -64.82 -43.82 91.87 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 123.609 0.568 . . . . 0.0 111.434 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -54.24 -52.68 60.56 Favored 'General case' 0 C--O 1.258 1.522 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -178.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.625 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 7.9 m -76.21 -18.85 58.86 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.891 -176.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 25.1 t70 -74.66 -31.34 61.91 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.45 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.625 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 46.2 mmtt -79.8 -29.35 40.26 Favored 'General case' 0 C--O 1.277 2.508 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 64.3 mt -70.02 -25.62 63.67 Favored 'General case' 0 N--CA 1.408 -2.573 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.373 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 41' ' ' SER . 87.9 mttt -61.14 -54.79 50.39 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 119.712 -0.185 . . . . 0.0 111.251 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 73.8 Cg_exo -69.16 -43.92 2.84 Favored 'Trans proline' 0 C--O 1.263 1.765 0 C-N-CA 122.856 2.371 . . . . 0.0 111.801 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.456 HG13 ' HA ' ' A' ' 44' ' ' LEU . 2.3 pp -63.89 -24.12 35.0 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.063 0 C-N-CA 118.405 -1.318 . . . . 0.0 110.981 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.21 -20.99 18.76 Favored 'General case' 0 C--O 1.204 -1.316 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.724 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -66.3 -25.11 66.7 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.4 -11.83 59.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.794 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 2.8 pt20 -145.32 33.96 1.08 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.405 1.098 . . . . 0.0 110.488 -172.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.528 ' O ' HD23 ' A' ' 7' ' ' LEU . 15.1 ptt180 -74.38 -7.97 54.7 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.287 -173.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.96 0.6 14.94 Favored Glycine 0 C--N 1.289 -2.074 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.76 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.522 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 13.2 p -121.85 -31.13 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.845 -176.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.431 HG12 ' HG2' ' A' ' 25' ' ' PRO . 84.2 mt -123.17 140.45 46.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.594 -0.843 . . . . 0.0 110.47 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.444 ' OD1' HD11 ' A' ' 7' ' ' LEU . 13.8 m-80 -86.17 117.17 24.82 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 1.8 m-85 -103.89 103.03 12.84 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.977 0.894 . . . . 0.0 112.874 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.569 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -123.65 128.43 6.92 Favored Glycine 0 N--CA 1.406 -3.345 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.72 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.3 p -92.36 127.69 37.93 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 7.8 tt -124.26 142.64 40.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -70.47 125.96 28.28 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.579 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -92.9 7.34 44.3 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.221 -0.991 . . . . 0.0 111.507 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -104.78 -38.0 6.84 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.11 -42.48 9.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.611 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.73 26.99 8.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.454 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -70.82 -24.21 77.22 Favored Glycine 0 CA--C 1.488 -1.617 0 C-N-CA 120.779 -0.724 . . . . 0.0 114.683 -173.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.54 -28.6 46.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.436 0.636 . . . . 0.0 110.847 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -64.93 -23.09 67.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.234 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.604 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -64.08 -36.22 83.29 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.984 0.897 . . . . 0.0 110.4 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.468 ' HA2' ' H ' ' A' ' 73' ' ' ASN . . . -105.09 7.47 44.21 Favored Glycine 0 C--N 1.281 -2.518 0 C-N-CA 117.568 -2.253 . . . . 0.0 114.835 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -74.76 -16.89 60.71 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 166.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 4.2 pp -104.22 -37.56 7.23 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.065 174.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.468 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 5.2 t-20 -176.35 -52.19 0.01 OUTLIER 'General case' 0 C--N 1.384 2.107 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.485 HD22 ' H ' ' A' ' 74' ' ' LEU . 2.0 mm? -65.44 159.59 23.96 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -167.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -81.1 -4.28 54.77 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 69' ' ' ALA . 80.3 p 56.43 17.41 2.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.268 1.027 . . . . 0.0 112.226 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.408 ' OD1' ' HG3' ' A' ' 75' ' ' LYS . 14.3 p-10 -94.39 -14.98 24.74 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -172.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 98' ' ' GLU . 22.7 tptt -123.49 -165.29 1.31 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 118.503 -1.279 . . . . 0.0 113.273 -171.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.64 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 96.5 m-85 -61.47 173.14 0.82 Allowed Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 125.925 1.69 . . . . 0.0 110.35 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 5.5 Cg_endo -40.15 131.21 2.24 Favored 'Trans proline' 0 C--N 1.414 3.993 0 C-N-CA 122.444 2.096 . . . . 0.0 115.557 -171.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -109.68 110.11 21.04 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.808 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.453 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 53.5 t80 -88.84 112.45 23.25 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.723 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -121.0 120.35 35.16 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.409 HD11 HG12 ' A' ' 110' ' ' VAL . 59.2 mt -92.66 113.35 27.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.852 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.18 134.33 35.46 Favored 'General case' 0 N--CA 1.408 -2.569 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 89' ' ' LYS . 2.5 mm-40 -87.5 126.97 35.22 Favored 'General case' 0 C--N 1.266 -3.058 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.227 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.489 HG22 ' SD ' ' A' ' 20' ' ' MET . 41.2 t -95.31 -2.77 10.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.77 -44.12 3.52 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.438 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 36.3 mtmm -97.83 -11.06 23.69 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.344 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 66.89 10.55 7.7 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 125.011 1.324 . . . . 0.0 110.247 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.444 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 1.5 tp60 -80.08 172.35 13.89 Favored 'General case' 0 CA--C 1.477 -1.856 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.356 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.615 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 65.4 mmtt -139.36 105.09 5.13 Favored 'General case' 0 N--CA 1.404 -2.733 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 62.4 m-85 -100.28 86.4 0.63 Allowed Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 7.8 Cg_endo -101.96 152.63 0.32 Allowed 'Trans proline' 0 N--CA 1.429 -2.294 0 C-N-CA 122.477 2.118 . . . . 0.0 114.065 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' HD1' ' CD1' ' A' ' 109' ' ' PHE . 49.8 t80 -94.67 162.97 13.56 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 124.858 1.263 . . . . 0.0 107.746 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 10.7 m-20 -66.22 153.19 43.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.067 0.461 . . . . 0.0 110.32 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -102.22 0.96 35.31 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 8.6 pt-20 -132.38 28.45 4.36 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.146 -171.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 3.7 tppp? -113.63 -89.53 0.53 Allowed 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.739 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 176.39 127.33 0.04 OUTLIER 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 124.062 0.945 . . . . 0.0 109.032 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.484 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.9 mp -102.62 105.37 18.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.42 -169.04 1.87 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.596 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.8 t80 -77.57 -53.23 7.84 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -60.39 -46.82 88.6 Favored 'General case' 0 N--CA 1.391 -3.393 0 CA-C-N 112.267 -2.242 . . . . 0.0 112.894 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.82 83.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.991 0.424 . . . . 0.0 111.149 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.484 ' CG1' HG23 ' A' ' 101' ' ' ILE . 36.9 mm -70.95 -44.37 75.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.863 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -51.32 -52.64 43.46 Favored 'General case' 0 CA--C 1.502 -0.898 0 O-C-N 124.044 0.84 . . . . 0.0 109.973 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.36 -43.87 92.77 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.947 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.507 ' HA ' ' OD1' ' A' ' 112' ' ' ASP . 46.1 t80 -63.43 -59.9 4.07 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 124.411 1.084 . . . . 0.0 110.984 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 106' ' ' ILE . 27.5 m -58.59 -31.82 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 121.519 -0.738 . . . . 0.0 110.901 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.65 -47.74 68.69 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 123.886 0.874 . . . . 0.0 109.033 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.507 ' OD1' ' HA ' ' A' ' 109' ' ' PHE 0.299 0.1 OUTLIER -70.83 -23.77 62.41 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.545 -179.0 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.523 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.6 OUTLIER -71.18 -61.25 1.83 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.892 173.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -61.98 -25.25 36.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.163 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.35 -33.79 55.29 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 121.246 0.546 . . . . 0.0 109.777 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.17 25.86 2.87 Favored Glycine 0 CA--C 1.485 -1.794 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.953 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -101.17 -32.67 10.44 Favored 'General case' 0 N--CA 1.396 -3.15 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.19 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 113' ' ' PHE . 4.9 mt -74.45 142.26 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.31 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -124.41 168.82 12.01 Favored Pre-proline 0 C--N 1.285 -2.231 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.678 -172.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.06 111.5 1.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.506 1.471 . . . . 0.0 110.138 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.5 m -56.58 -36.84 69.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.187 0.595 . . . . 0.0 112.415 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.7 pt -146.86 -110.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 118.978 -0.534 . . . . 0.0 109.947 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.7 tttp 66.22 109.81 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.597 0.759 . . . . 0.0 111.659 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.9 m -61.94 107.14 0.8 Allowed 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.807 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -135.63 98.73 12.01 Favored Pre-proline 0 N--CA 1.415 -2.223 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.43 151.04 22.54 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.054 1.836 . . . . 0.0 114.243 -170.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.08 94.58 13.2 Favored Pre-proline 0 N--CA 1.43 -1.432 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -86.06 164.61 10.06 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 122.302 2.001 . . . . 0.0 111.435 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.84 117.39 11.37 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.307 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -101.1 170.47 8.24 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -106.81 175.99 5.32 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -66.42 -34.39 77.85 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.967 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -178.754 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.715 0 CA-C-O 119.032 -0.871 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.37 -30.24 51.78 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.403 2.735 . . . . 0.0 113.035 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.4 mt -123.73 149.91 44.99 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.68 -40.41 2.58 Favored Glycine 0 C--N 1.315 -0.63 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.5 p -133.01 173.84 5.41 Favored Pre-proline 0 C--N 1.286 -2.191 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -71.38 168.75 22.58 Favored 'Trans proline' 0 C--O 1.253 1.231 0 CA-C-N 120.696 1.284 . . . . 0.0 109.163 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.53 -43.16 99.49 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.468 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -91.34 132.98 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 173.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.51 -19.57 0.91 Allowed Glycine 0 N--CA 1.42 -2.402 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.568 -175.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -135.79 148.57 48.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 122.297 -0.531 . . . . 0.0 109.575 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.518 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 51.6 mt -119.14 143.24 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.15 162.37 25.03 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -47.52 -34.05 19.08 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 124.14 3.227 . . . . 0.0 114.044 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -89.43 -26.91 20.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.953 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.1 p -78.85 -19.97 50.7 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.018 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' A' ' 20' ' ' MET . 69.3 m-85 -50.19 -49.93 50.93 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 123.934 0.771 . . . . 0.0 109.685 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.2 t -62.37 -33.41 74.69 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.107 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -70.9 -44.64 65.82 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 120.937 0.398 . . . . 0.0 110.535 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -72.8 -30.45 64.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.445 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.41 -39.89 62.35 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.05 -178.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -81.58 -9.02 59.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.649 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.09 -19.06 60.72 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.202 0.525 . . . . 0.0 110.619 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.21 -4.16 63.76 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.823 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.562 HG13 HD21 ' A' ' 56' ' ' ASN . 11.1 pt -103.2 152.5 38.65 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.431 ' HG2' HG12 ' A' ' 55' ' ' ILE . 17.5 Cg_endo -54.58 142.18 72.35 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 124.194 3.263 . . . . 0.0 114.064 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.408 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 3.6 tt -108.13 125.18 51.3 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.615 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -95.67 103.06 14.92 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.408 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 53.5 m-85 -83.83 114.84 21.92 Favored 'General case' 0 CA--C 1.47 -2.126 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.303 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.584 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 8.1 mt -102.6 84.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.252 -3.67 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.614 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 48.7 m-85 -76.81 123.84 26.82 Favored 'General case' 0 CA--C 1.465 -2.324 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.98 123.61 19.77 Favored 'General case' 0 C--N 1.254 -3.584 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.445 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -79.64 -14.64 58.66 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.553 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 13.1 p -83.73 113.49 20.92 Favored 'General case' 0 N--CA 1.403 -2.78 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.107 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.71 -21.06 16.6 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.389 0.431 . . . . 0.0 110.918 -175.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -88.37 -54.2 4.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.742 0.782 . . . . 0.0 110.354 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' OE1' ' HB ' ' A' ' 33' ' ' THR . 0.8 OUTLIER -84.84 3.13 39.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.823 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 33' ' ' THR . 52.2 ttt180 -49.27 -46.1 45.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.573 1.149 . . . . 0.0 110.018 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -65.31 -35.76 81.98 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.251 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -82.05 -31.27 30.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.894 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.528 HD21 ' HB ' ' A' ' 101' ' ' ILE . 1.7 tm? -61.48 -44.09 97.7 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.417 ' HA ' HD12 ' A' ' 44' ' ' LEU . 11.9 m -77.52 -17.0 58.36 Favored 'General case' 0 C--O 1.2 -1.542 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.576 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 20.5 t70 -76.67 -31.07 57.05 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.703 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.627 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -73.69 -36.59 65.3 Favored 'General case' 0 C--O 1.281 2.761 0 CA-C-O 123.109 1.433 . . . . 0.0 107.861 171.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 67.8 mt -72.63 -18.16 61.61 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.8 -1.545 . . . . 0.0 111.404 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.609 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 38.6 ttmt -63.74 -53.83 47.14 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 123.793 0.837 . . . . 0.0 111.759 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 52.4 Cg_exo -71.19 -37.22 6.19 Favored 'Trans proline' 0 CA--C 1.493 -1.553 0 C-N-CA 122.471 2.114 . . . . 0.0 109.784 175.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.669 HD11 ' HA ' ' A' ' 103' ' ' PHE . 86.0 mt -53.12 -38.41 29.99 Favored 'Isoleucine or valine' 0 C--N 1.37 1.461 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.856 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.35 -21.64 19.43 Favored 'General case' 0 C--O 1.195 -1.767 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.627 -172.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.497 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -68.45 -22.4 64.59 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 176.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.27 -11.3 57.91 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.977 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 2.8 pt20 -147.13 36.1 0.91 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.562 1.172 . . . . 0.0 110.749 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HD3' ' OE1' ' A' ' 49' ' ' GLU . 13.9 ptt180 -74.14 -18.6 60.77 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 112.988 -1.915 . . . . 0.0 110.778 -174.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.69 17.74 22.87 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.582 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.6 p -138.71 -33.26 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.551 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.431 HG12 ' HG2' ' A' ' 25' ' ' PRO . 88.7 mt -122.95 136.84 58.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.287 176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.562 HD21 HG13 ' A' ' 24' ' ' ILE . 9.9 m-80 -94.48 96.39 9.45 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.456 ' N ' ' HB ' ' A' ' 8' ' ' ILE . 8.8 m-85 -76.74 141.94 40.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.521 0.677 . . . . 0.0 111.123 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.518 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -159.76 129.48 2.21 Favored Glycine 0 N--CA 1.412 -2.944 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.061 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.584 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 44.6 p -83.78 144.91 28.99 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.202 0.525 . . . . 0.0 111.445 174.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 4.8 tt -145.8 142.48 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.336 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 63' ' ' LYS . 19.9 t70 -70.9 124.35 24.14 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -175.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -86.85 4.04 42.9 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.218 -0.593 . . . . 0.0 112.277 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HB3' ' OD2' ' A' ' 61' ' ' ASP . 3.7 ttpm? -100.91 -44.72 5.66 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.45 -45.6 9.82 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.664 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -115.5 20.34 14.81 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.242 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -69.69 -20.48 75.8 Favored Glycine 0 CA--C 1.493 -1.308 0 N-CA-C 116.479 1.352 . . . . 0.0 116.479 -171.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.57 -27.74 64.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.982 0.891 . . . . 0.0 110.305 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -62.2 -24.74 67.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.601 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.625 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -65.75 -37.86 87.52 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 122.633 1.206 . . . . 0.0 109.024 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -96.94 11.02 66.16 Favored Glycine 0 C--N 1.284 -2.32 0 C-N-CA 119.086 -1.53 . . . . 0.0 113.54 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.18 -8.29 59.64 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.729 HD12 ' HB2' ' A' ' 73' ' ' ASN . 3.1 pp -118.69 -34.97 3.82 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.729 ' HB2' HD12 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -168.07 -64.89 0.03 OUTLIER 'General case' 0 C--N 1.366 1.326 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.561 HD21 ' HB2' ' A' ' 94' ' ' PRO . 2.2 mm? -53.23 166.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -163.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -89.14 -12.3 41.43 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.578 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 69' ' ' ALA . 64.0 p 54.86 35.4 24.19 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.387 1.475 . . . . 0.0 112.992 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -117.44 -15.94 10.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -160.44 0.78 Allowed 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.944 -169.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.531 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 83.5 m-85 -59.99 170.66 1.11 Allowed Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.582 1.553 . . . . 0.0 109.635 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 2.4 Cg_endo -39.35 133.43 1.38 Allowed 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 122.765 2.31 . . . . 0.0 114.852 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.497 ' HB1' ' HG ' ' A' ' 74' ' ' LEU . . . -113.0 104.3 12.25 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.86 -174.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.615 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 65.1 t80 -85.39 108.17 17.72 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.6 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -114.88 115.28 26.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.537 HD11 HG12 ' A' ' 110' ' ' VAL . 42.4 mt -90.7 110.59 22.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -88.14 129.58 35.28 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HB3' ' H ' ' A' ' 89' ' ' LYS . 4.2 mm-40 -87.62 121.03 29.54 Favored 'General case' 0 C--N 1.28 -2.444 0 C-N-CA 119.879 -0.728 . . . . 0.0 109.412 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 20' ' ' MET . 3.8 t -96.82 4.19 9.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.95 -36.24 3.89 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.824 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 29.5 mmmt -99.08 -15.08 19.14 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.248 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 74.1 19.42 2.97 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 124.769 2.224 . . . . 0.0 108.414 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.506 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -96.0 170.09 9.52 Favored 'General case' 0 CA--C 1.464 -2.331 0 CA-C-N 111.828 -2.442 . . . . 0.0 110.851 -174.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.6 ' HB3' HD13 ' A' ' 72' ' ' LEU . 70.1 mmtt -141.25 109.46 5.84 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 72.2 m-85 -109.02 88.65 5.79 Favored Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.561 ' HB2' HD21 ' A' ' 74' ' ' LEU . 2.6 Cg_endo -101.15 147.78 0.33 Allowed 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 122.43 2.086 . . . . 0.0 114.384 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -85.09 158.98 20.27 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.077 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.625 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 5.9 m-20 -64.72 143.91 57.6 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 123.827 0.851 . . . . 0.0 108.883 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -85.7 -1.24 56.97 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.644 -172.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.16 18.69 1.4 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.24 0.543 . . . . 0.0 112.109 -175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.625 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 4.3 tppp? -93.17 -3.74 53.38 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 68.84 126.55 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.472 1.509 . . . . 0.0 112.321 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.534 HG23 HG13 ' A' ' 106' ' ' ILE . 3.5 mp -89.77 102.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.065 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 p -122.43 170.52 9.88 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.669 ' HA ' HD11 ' A' ' 47' ' ' ILE . 23.0 t80 -56.42 -59.37 5.07 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 121.554 0.692 . . . . 0.0 109.991 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -57.44 -45.44 84.68 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.232 -1.349 . . . . 0.0 113.526 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.43 -49.09 79.14 Favored 'General case' 0 C--N 1.254 -3.559 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.371 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.534 HG13 HG23 ' A' ' 101' ' ' ILE . 42.5 mm -75.0 -39.49 44.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.654 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 26.7 ttpp -58.22 -46.19 86.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.732 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.39 90.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.581 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.473 ' O ' HD11 ' A' ' 118' ' ' ILE . 70.6 t80 -64.49 -62.6 1.49 Allowed 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.537 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.537 HG12 HD11 ' A' ' 84' ' ' ILE . 34.7 m -58.67 -30.98 43.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 O-C-N 122.182 -0.324 . . . . 0.0 111.202 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 12.5 t70 -62.6 -50.47 71.14 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.333 1.053 . . . . 0.0 108.937 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.671 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 9.3 t70 -61.25 -43.11 99.42 Favored 'General case' 0 C--O 1.198 -1.649 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.21 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.577 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.5 t80 -59.22 -63.96 1.12 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.465 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.6 -17.04 20.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.838 -175.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.96 -33.84 30.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.509 0.671 . . . . 0.0 109.395 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.5 21.5 6.13 Favored Glycine 0 CA--C 1.482 -1.993 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.671 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 7.0 ttmm -94.38 -43.09 8.55 Favored 'General case' 0 N--CA 1.395 -3.185 0 CA-C-N 115.052 -0.574 . . . . 0.0 110.046 -174.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.577 HD12 ' HB2' ' A' ' 113' ' ' PHE . 10.8 mt -72.14 146.04 11.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -127.58 160.38 60.92 Favored Pre-proline 0 C--N 1.283 -2.292 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -61.07 112.36 1.35 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 121.197 1.264 . . . . 0.0 109.73 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.8 t -61.41 -49.78 75.47 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.5 pt -147.21 151.23 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.863 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.0 tptm 161.62 135.37 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 O-C-N 125.142 1.526 . . . . 0.0 106.993 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.1 m -77.77 107.48 10.31 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-O 121.412 0.625 . . . . 0.0 109.491 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -125.44 91.68 48.37 Favored Pre-proline 0 C--N 1.297 -1.696 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.468 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 89.0 Cg_endo -80.07 140.69 14.3 Favored 'Trans proline' 0 N--CA 1.418 -2.914 0 C-N-CA 121.0 1.133 . . . . 0.0 111.525 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.0 mm -112.45 98.27 43.12 Favored Pre-proline 0 C--N 1.291 -1.943 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.331 -175.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 126' ' ' PRO . 20.2 Cg_exo -67.15 133.62 31.35 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.718 2.279 . . . . 0.0 111.656 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -91.39 178.53 5.93 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.997 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -92.51 73.45 5.15 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.469 1.128 . . . . 0.0 109.564 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -85.85 137.8 32.5 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.633 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -101.1 132.01 46.76 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.893 0 CA-C-O 118.25 -1.306 . . . . 0.0 110.504 -177.205 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.544 0 N-CA-C 111.609 -0.597 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -86.51 157.3 9.28 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.741 2.294 . . . . 0.0 112.318 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.06 114.03 10.76 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.37 51.12 0.2 Allowed Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.3 m -102.17 138.03 19.62 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.73 86.55 1.04 Allowed 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.016 1.811 . . . . 0.0 112.164 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.2 mt -99.65 -26.12 14.18 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 94.0 mt -127.75 133.54 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 114.049 -1.432 . . . . 0.0 107.886 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.13 -116.57 0.73 Allowed Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.72 144.65 48.13 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.6 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 61.0 mt -96.71 120.76 46.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.096 0.474 . . . . 0.0 110.284 -177.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.17 167.75 12.98 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.635 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 14.8 Cg_endo -59.2 -25.69 79.05 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 122.812 2.341 . . . . 0.0 111.717 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -87.5 -12.11 46.89 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.816 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.6 p -105.03 -37.0 7.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.535 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' HA ' ' A' ' 13' ' ' PRO 0.293 10.0 p90 -62.18 -26.92 68.61 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 m -59.56 -32.41 70.32 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.206 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -78.08 -34.83 50.06 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.535 ' CD2' ' HA ' ' A' ' 16' ' ' TYR . 14.8 m-85 -73.13 -29.59 62.99 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.517 ' SD ' HG22 ' A' ' 87' ' ' VAL . 5.5 tpp -79.14 -24.05 43.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.01 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.7 t -92.1 -10.0 40.57 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.03 -21.03 43.97 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 121.955 -0.465 . . . . 0.0 111.43 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.18 8.98 87.31 Favored Glycine 0 C--O 1.235 0.189 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.956 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 12.2 pt -117.18 149.06 43.74 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 122.879 -0.189 . . . . 0.0 111.133 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.472 ' HG2' HG12 ' A' ' 55' ' ' ILE . 9.2 Cg_endo -51.81 136.13 50.78 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 124.115 3.21 . . . . 0.0 113.82 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.17 125.53 51.11 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -98.66 109.29 22.07 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-O 121.185 0.517 . . . . 0.0 109.731 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -89.28 117.82 28.51 Favored 'General case' 0 CA--C 1.468 -2.182 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.729 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.6 mt -106.87 84.4 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.54 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 33.5 m-85 -75.54 134.9 40.63 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -149.76 120.04 7.32 Favored 'General case' 0 C--N 1.277 -2.565 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.578 176.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.405 ' N ' ' HB3' ' A' ' 62' ' ' ALA . 29.3 mt-10 -72.23 -28.79 63.39 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-O 121.663 0.744 . . . . 0.0 109.365 173.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.644 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 2.3 p -89.31 103.78 16.38 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.622 -170.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.73 -25.16 41.2 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.791 -176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -69.06 -62.31 1.43 Allowed 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.538 ' OE1' ' HB ' ' A' ' 33' ' ' THR . 1.2 pm0 -83.2 4.07 28.31 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 33' ' ' THR . 3.9 tmm_? -60.47 -32.73 71.69 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -60.83 -49.38 77.7 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.182 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 14.3 pt-20 -81.83 -22.36 37.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.38 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.657 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -61.53 -52.58 63.87 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 21.8 m -71.59 -20.8 61.95 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.587 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 22.0 t70 -61.98 -41.4 97.99 Favored 'General case' 0 CA--C 1.486 -1.506 0 C-N-CA 123.553 0.741 . . . . 0.0 111.206 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.64 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 51.7 mmtt -77.53 -29.43 52.35 Favored 'General case' 0 C--O 1.27 2.132 0 CA-C-O 122.511 1.148 . . . . 0.0 108.606 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 67.0 mt -70.97 -23.6 62.24 Favored 'General case' 0 N--CA 1.406 -2.667 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.951 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.483 ' HB2' ' HD3' ' A' ' 46' ' ' PRO . 56.1 mtpt -63.41 -53.34 53.43 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 86.3 Cg_exo -67.63 -45.18 3.6 Favored 'Trans proline' 0 C--O 1.263 1.731 0 C-N-CA 123.169 2.579 . . . . 0.0 111.803 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.617 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 6.5 tp -61.22 -30.55 48.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.402 0 C-N-CA 117.934 -1.506 . . . . 0.0 109.706 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.81 -18.69 27.17 Favored 'General case' 0 C--O 1.182 -2.496 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.761 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.05 -24.77 65.12 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.32 -19.45 50.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.567 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 2.3 pt20 -139.96 35.19 1.95 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.249 1.023 . . . . 0.0 110.948 -171.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -69.49 -19.21 63.74 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.137 -1.847 . . . . 0.0 112.375 -173.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.21 14.58 11.01 Favored Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.526 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.582 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.7 p -129.31 -32.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.214 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.472 HG12 ' HG2' ' A' ' 25' ' ' PRO . 79.0 mt -122.55 134.45 65.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.838 176.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.489 HD21 HG13 ' A' ' 24' ' ' ILE . 10.5 m-80 -88.56 109.86 20.42 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 7.9 m-85 -93.48 108.3 20.0 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.6 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -131.49 132.26 6.7 Favored Glycine 0 C--N 1.29 -2.005 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.693 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.567 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 42.2 p -91.65 150.17 21.28 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 122.686 0.394 . . . . 0.0 111.131 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 6.7 tt -151.6 147.27 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -68.39 130.45 42.92 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.69 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -93.26 -3.72 53.15 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.819 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -86.1 -49.51 7.72 Favored 'General case' 0 N--CA 1.42 -1.943 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.771 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.54 -37.69 9.07 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -104.37 14.36 30.32 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.791 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -71.55 -19.9 78.09 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 -172.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.54 68.8 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 117.69 0.745 . . . . 0.0 110.008 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -64.91 -24.95 67.68 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.009 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.494 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -63.16 -34.76 78.31 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 122.303 1.049 . . . . 0.0 109.82 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.527 ' HA2' ' H ' ' A' ' 73' ' ' ASN . . . -104.49 18.57 44.34 Favored Glycine 0 C--N 1.28 -2.576 0 C-N-CA 118.348 -1.882 . . . . 0.0 114.15 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.21 -22.26 55.47 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.495 HD12 ' CB ' ' A' ' 73' ' ' ASN . 4.3 pp -104.68 -33.33 8.51 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.396 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 12.9 t-20 -174.5 -56.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.477 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.0 mm? -59.51 162.84 4.57 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -165.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -83.03 -9.85 59.05 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.239 -174.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 44.0 p 61.53 18.4 9.41 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.954 2.102 . . . . 0.0 114.744 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -113.39 -17.56 12.23 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -170.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 19.4 ttmt -117.84 -160.84 0.8 Allowed 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.31 -167.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.497 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 88.9 m-85 -54.9 164.2 1.26 Allowed Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 124.974 1.31 . . . . 0.0 111.481 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.505 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -39.74 129.65 1.92 Allowed 'Trans proline' 0 C--N 1.403 3.44 0 C-N-CA 122.793 2.328 . . . . 0.0 114.886 -174.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -108.17 104.44 13.85 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.084 -172.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.534 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 69.0 t80 -87.47 113.28 23.03 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.79 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -118.88 121.61 40.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.523 HD11 HG12 ' A' ' 110' ' ' VAL . 43.4 mt -95.67 110.99 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.205 0.526 . . . . 0.0 109.858 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -100.03 126.35 46.22 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.494 ' HB3' ' H ' ' A' ' 89' ' ' LYS . 1.9 mm-40 -88.6 140.48 29.41 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 120.897 0.38 . . . . 0.0 111.31 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.517 HG22 ' SD ' ' A' ' 20' ' ' MET . 22.1 t -99.89 -4.85 9.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.035 0.922 . . . . 0.0 108.633 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.52 -38.62 4.59 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.606 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.494 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 75.4 mmtt -91.06 -16.35 28.02 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.505 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 59.25 30.46 20.21 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 122.303 1.049 . . . . 0.0 109.715 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.546 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 5.5 tp-100 -109.85 167.85 9.86 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.727 -171.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 10.5 mptt -122.71 98.68 6.02 Favored 'General case' 1 N--CA 1.373 -4.324 0 CA-C-N 113.216 -1.811 . . . . 0.0 106.548 -176.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.546 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 38.0 m-85 -100.39 82.64 0.33 Allowed Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 5.6 Cg_endo -100.33 148.96 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.639 2.226 . . . . 0.0 113.573 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -82.78 162.29 21.74 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.444 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.742 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 6.4 m-20 -71.37 139.02 49.65 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -84.61 1.72 44.77 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.954 -173.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 8.9 pt-20 -137.86 13.33 2.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.392 0.615 . . . . 0.0 111.594 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 15.4 tppt? -90.73 -8.91 48.54 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.58 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 69.64 117.97 0.04 OUTLIER 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.45 1.1 . . . . 0.0 111.105 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.482 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.4 mp -85.05 125.78 40.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.409 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.7 p -139.34 175.37 9.62 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.553 ' HE1' ' HB2' ' A' ' 46' ' ' PRO . 54.0 t80 -55.18 -61.11 2.54 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 122.081 0.943 . . . . 0.0 110.064 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . 0.255 23.5 tp10 -60.76 -39.64 89.54 Favored 'General case' 1 N--CA 1.37 -4.435 0 C-N-CA 126.811 2.044 . . . . 0.0 111.968 -171.997 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.26 93.5 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 123.816 0.698 . . . . 0.0 110.528 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.482 ' CG1' HG23 ' A' ' 101' ' ' ILE . 34.9 mm -72.36 -41.74 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.237 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.434 ' HG3' HD13 ' A' ' 47' ' ' ILE . 12.4 ttpt -55.33 -52.06 64.73 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 124.179 0.924 . . . . 0.0 108.895 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.03 83.63 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.507 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -68.59 -58.16 4.69 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.828 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.523 HG12 HD11 ' A' ' 84' ' ' ILE . 35.5 m -60.23 -32.61 51.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.889 0 O-C-N 121.841 -0.537 . . . . 0.0 110.71 -177.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -58.33 -53.8 54.21 Favored 'General case' 0 CA--C 1.488 -1.415 0 C-N-CA 124.958 1.303 . . . . 0.0 109.153 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.654 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 7.2 t70 -60.62 -43.63 97.25 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 113.687 -1.597 . . . . 0.0 108.002 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.532 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.7 t80 -59.51 -64.02 1.09 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.173 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.8 -21.03 27.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.068 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.48 -35.19 53.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.23 0.538 . . . . 0.0 109.86 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 110.54 30.4 3.31 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.654 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 5.5 mtmt -102.26 -45.19 5.19 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.504 -1.348 . . . . 0.0 109.283 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 113' ' ' PHE . 31.8 mt -76.14 142.45 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 171.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.432 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 11.7 pt-20 -124.29 166.87 17.37 Favored Pre-proline 0 C--N 1.273 -2.747 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 119' ' ' GLU . 28.2 Cg_exo -38.98 118.51 0.38 Allowed 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 123.621 2.881 . . . . 0.0 113.216 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.8 t -61.35 -47.18 87.07 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.683 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.77 -54.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.43 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.7 tttp 58.11 72.58 0.51 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.457 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.9 m -80.61 88.01 5.74 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.719 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -142.03 94.21 7.17 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.72 175.91 10.78 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.154 1.902 . . . . 0.0 112.128 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 11.3 tt -118.0 86.95 26.86 Favored Pre-proline 0 C--N 1.297 -1.688 0 CA-C-O 121.75 0.786 . . . . 0.0 110.486 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.434 ' HG3' ' OE2' ' A' ' 132' ' ' GLU . 66.4 Cg_endo -95.26 164.28 1.57 Allowed 'Trans proline' 0 N--CA 1.424 -2.567 0 C-N-CA 122.249 1.966 . . . . 0.0 112.477 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -122.68 127.44 49.29 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.111 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 62.38 20.17 11.64 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.025 0.93 . . . . 0.0 112.949 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -125.69 164.68 20.09 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.434 ' OE2' ' HG3' ' A' ' 128' ' ' PRO . 44.8 mt-10 68.89 115.77 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.736 1.272 . . . . 0.0 112.282 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.027 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -176.141 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 CA--C 1.511 -0.205 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 1' ' ' GLY . 18.1 Cg_exo -68.8 109.99 2.25 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.941 2.427 . . . . 0.0 111.945 178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.3 tp -148.21 87.05 1.58 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.117 0.961 . . . . 0.0 109.55 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.31 47.99 0.04 OUTLIER Glycine 0 C--N 1.28 -2.557 0 N-CA-C 105.583 -3.007 . . . . 0.0 105.583 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 9.7 m -85.23 114.56 56.85 Favored Pre-proline 0 N--CA 1.422 -1.841 0 CA-C-N 113.296 -1.452 . . . . 0.0 111.979 -169.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 10.4 Cg_endo -91.35 105.27 0.26 Allowed 'Trans proline' 0 N--CA 1.426 -2.461 0 C-N-CA 122.207 1.938 . . . . 0.0 108.965 172.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.9 mt -74.63 -30.32 61.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.731 0.777 . . . . 0.0 109.102 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -101.36 160.44 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.81 -83.98 0.1 Allowed Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.347 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -126.83 147.17 50.04 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -175.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.556 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 51.7 mt -102.18 119.98 51.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.67 174.7 20.33 Favored Glycine 0 N--CA 1.41 -3.067 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.508 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 28.4 Cg_endo -61.4 -17.03 51.07 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.091 2.527 . . . . 0.0 112.793 -177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.8 -13.4 16.44 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 119.37 -0.347 . . . . 0.0 111.747 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.8 p -102.03 -32.47 10.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 119.489 -0.884 . . . . 0.0 112.641 -173.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CE2' ' HA ' ' A' ' 13' ' ' PRO 0.254 5.3 p90 -60.61 -32.8 71.91 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -177.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 m -59.92 -31.26 69.67 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 123.742 0.817 . . . . 0.0 110.462 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.27 -35.37 41.49 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -73.33 -28.6 62.16 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.513 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -78.1 -36.97 47.42 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.49 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.6 t -78.52 -10.5 59.74 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.946 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.19 -36.21 64.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.198 0.523 . . . . 0.0 110.453 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.56 -15.88 62.33 Favored Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.833 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.523 HG13 HD21 ' A' ' 56' ' ' ASN . 7.0 pt -93.76 154.04 41.01 Favored Pre-proline 0 C--N 1.301 -1.537 0 C-N-CA 123.026 0.53 . . . . 0.0 110.249 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HG2' HG12 ' A' ' 55' ' ' ILE . 15.0 Cg_endo -54.22 145.36 55.19 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 124.115 3.21 . . . . 0.0 114.663 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tt -108.69 127.02 53.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -97.94 107.65 20.18 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -88.46 120.68 30.06 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.283 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.631 HG12 HD13 ' A' ' 44' ' ' LEU . 3.4 mp -110.74 89.11 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.824 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.043 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.567 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 48.6 m-85 -78.6 109.96 13.29 Favored 'General case' 0 CA--C 1.452 -2.791 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -120.98 119.2 31.87 Favored 'General case' 1 C--N 1.238 -4.266 0 CA-C-O 121.197 0.522 . . . . 0.0 109.816 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -70.22 -28.77 65.54 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.651 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 18.0 p -75.16 119.12 18.87 Favored 'General case' 0 N--CA 1.379 -3.988 0 CA-C-N 113.296 -1.775 . . . . 0.0 108.436 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.434 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . . . -99.05 -17.62 18.16 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.595 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -99.01 -53.16 3.34 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.701 0.763 . . . . 0.0 109.623 -174.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -86.71 7.44 26.71 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.109 -175.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.651 ' HB3' ' O ' ' A' ' 33' ' ' THR . 6.7 ptp180 -71.71 -16.78 62.24 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.372 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -69.42 -45.03 70.17 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 1.6 mp0 -65.72 -35.12 79.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.393 0.616 . . . . 0.0 109.771 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.513 HD21 ' HB ' ' A' ' 101' ' ' ILE . 1.2 tm? -60.81 -49.08 78.93 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.466 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 14.5 m -75.36 -10.6 59.61 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.056 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.601 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 19.0 t70 -78.09 -37.4 46.54 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 123.163 0.585 . . . . 0.0 110.32 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.623 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -72.23 -33.26 67.42 Favored 'General case' 0 C--O 1.285 2.944 0 CA-C-O 123.166 1.46 . . . . 0.0 108.136 173.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.631 HD13 HG12 ' A' ' 29' ' ' ILE . 85.6 mt -73.67 -21.94 60.11 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 113.301 -1.772 . . . . 0.0 112.19 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -66.35 -50.09 50.35 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 6.9 Cg_exo -78.2 -34.14 1.72 Allowed 'Trans proline' 0 CA--C 1.491 -1.655 0 C-N-CA 121.923 1.749 . . . . 0.0 110.034 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 0.3 OUTLIER -62.33 -28.86 45.44 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.94 -20.06 21.0 Favored 'General case' 0 C--O 1.186 -2.25 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.794 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.22 -19.11 63.17 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.2 -14.01 54.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.54 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 3.1 pt20 -146.64 36.28 0.96 Allowed 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.061 0.934 . . . . 0.0 111.128 -173.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -74.46 -19.47 60.38 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.701 -1.59 . . . . 0.0 111.065 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.32 20.91 18.24 Favored Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.41 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.8 p -139.77 -33.73 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.657 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 25' ' ' PRO . 88.4 mt -124.75 134.62 66.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.109 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.523 HD21 HG13 ' A' ' 24' ' ' ILE . 21.4 m-80 -91.44 97.44 11.08 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.422 ' O ' ' HB ' ' A' ' 8' ' ' ILE . 15.0 m-85 -76.79 131.68 38.82 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.399 0.619 . . . . 0.0 111.278 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.556 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -144.06 123.55 2.04 Favored Glycine 0 N--CA 1.396 -3.974 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.388 176.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.42 HG21 ' OG ' ' A' ' 41' ' ' SER . 38.9 p -86.45 136.41 33.11 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 7.5 tt -141.04 145.48 25.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -177.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -73.02 126.97 31.22 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.518 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -85.75 0.09 53.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -102.28 -42.31 6.06 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.99 -51.44 6.35 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.919 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -112.16 18.36 18.73 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.754 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.38 -22.86 67.89 Favored Glycine 0 CA--C 1.497 -1.089 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.38 -35.18 60.04 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 122.991 0.516 . . . . 0.0 110.796 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -63.57 -22.22 66.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.291 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.627 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -65.54 -39.18 91.46 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.999 0.904 . . . . 0.0 109.227 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.486 ' HA2' ' N ' ' A' ' 74' ' ' LEU . . . -103.61 6.12 48.61 Favored Glycine 0 C--N 1.283 -2.387 0 C-N-CA 118.114 -1.993 . . . . 0.0 114.904 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -32.68 72.6 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 166.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 69' ' ' ALA . 3.2 pp -89.67 -37.58 14.5 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.433 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.457 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 21.2 t-20 -171.48 -60.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.486 ' N ' ' HA2' ' A' ' 70' ' ' GLY . 2.4 mm? -56.55 167.97 0.64 Allowed 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -166.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -82.61 -16.54 48.01 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.762 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 p 61.36 21.81 12.3 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 126.357 1.863 . . . . 0.0 112.803 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -107.66 -23.77 11.99 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -172.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.567 ' HG2' ' HB3' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -106.42 -162.01 0.83 Allowed 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.104 -169.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.731 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 67.2 m-85 -72.9 -172.42 0.23 Allowed Pre-proline 0 CA--C 1.571 1.76 0 C-N-CA 125.036 1.334 . . . . 0.0 108.998 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.731 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 5.6 Cg_endo -47.48 133.59 20.67 Favored 'Trans proline' 0 C--N 1.408 3.708 0 CA-C-N 122.583 1.958 . . . . 0.0 115.61 -175.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.06 122.4 37.11 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.252 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.531 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 75.9 t80 -96.47 117.44 30.91 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.381 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -119.46 122.35 41.52 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 122.046 -0.409 . . . . 0.0 111.998 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 49.3 mt -95.13 116.28 36.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 45.6 tt0 -106.69 122.38 46.24 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 19.8 mt-10 -80.58 148.96 30.1 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.956 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.513 HG11 ' O ' ' A' ' 20' ' ' MET . 19.9 t -113.0 -0.42 9.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.1 -57.15 3.21 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.819 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -111.33 -9.98 14.25 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.628 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 49.7 t-20 65.88 86.72 0.13 Allowed 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.225 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.628 HE22 ' HB2' ' A' ' 123' ' ' LYS . 5.9 tp-100 -139.69 164.15 30.71 Favored 'General case' 0 CA--C 1.464 -2.339 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.639 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 11.3 mptt -119.88 95.05 4.61 Favored 'General case' 1 N--CA 1.376 -4.174 0 O-C-N 125.056 1.473 . . . . 0.0 108.572 -174.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 28.9 m-85 -101.28 83.13 0.41 Allowed Pre-proline 0 C--N 1.298 -1.662 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 172.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 5.8 Cg_endo -101.58 144.92 0.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.396 2.064 . . . . 0.0 114.572 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -85.3 173.56 10.25 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 126.37 1.868 . . . . 0.0 109.088 -174.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.5 m-20 -66.3 148.79 51.33 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -95.47 2.47 54.45 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.567 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 9.8 pt-20 -149.31 23.66 0.92 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.009 -172.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.577 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 18.0 ttmm -90.76 -81.79 0.3 Allowed 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.001 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 172.45 123.63 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.513 ' HB ' HD21 ' A' ' 40' ' ' LEU . 3.4 mp -99.88 94.57 3.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -122.68 167.74 13.07 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.435 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.454 ' HE2' ' HB2' ' A' ' 46' ' ' PRO . 39.5 t80 -51.73 -61.06 2.49 Favored 'General case' 0 CA--C 1.483 -1.618 0 O-C-N 124.061 0.851 . . . . 0.0 110.107 -176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -69.17 -27.01 65.14 Favored 'General case' 1 N--CA 1.372 -4.361 0 C-N-CA 125.784 1.634 . . . . 0.0 112.778 -172.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.7 -44.44 42.16 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.543 0.687 . . . . 0.0 109.354 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.412 ' CG1' HG23 ' A' ' 101' ' ' ILE . 32.8 mm -68.88 -40.34 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.575 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -56.43 -51.55 68.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.672 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.02 -43.36 70.06 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.164 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.01 -59.3 3.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.52 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 84' ' ' ILE . 33.9 m -60.83 -33.19 54.37 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 O-C-N 121.777 -0.577 . . . . 0.0 111.508 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.86 -50.42 73.87 Favored 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 124.067 0.947 . . . . 0.0 109.258 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.633 ' HB3' HG13 ' A' ' 118' ' ' ILE . 1.9 t70 -58.77 -47.74 83.63 Favored 'General case' 0 C--O 1.2 -1.513 0 CA-C-N 113.16 -1.836 . . . . 0.0 107.441 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.514 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.1 t80 -57.53 -65.55 0.61 Allowed 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.473 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 110' ' ' VAL . 8.8 p -62.07 -24.57 34.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.79 -34.86 52.03 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.75 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.99 30.89 2.62 Favored Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.577 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 22.2 mtmt -99.88 -44.31 6.1 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 113.202 -1.499 . . . . 0.0 108.422 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.633 HG13 ' HB3' ' A' ' 112' ' ' ASP . 33.4 mt -83.0 146.74 6.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 170.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.478 ' HB2' ' HD2' ' A' ' 120' ' ' PRO . 10.4 pt-20 -134.72 168.53 17.33 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 119' ' ' GLU . 65.8 Cg_exo -43.93 126.27 5.88 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.4 2.733 . . . . 0.0 113.179 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.4 m -92.81 -28.1 16.77 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.945 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.414 HG13 ' H ' ' A' ' 123' ' ' LYS . 16.3 pt -126.83 -54.42 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.141 0.496 . . . . 0.0 112.275 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.628 ' HB2' HE22 ' A' ' 91' ' ' GLN . 31.2 mmmt -90.27 71.44 7.17 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.6 m -86.55 73.76 10.02 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.952 0.882 . . . . 0.0 108.75 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -143.6 89.7 7.36 Favored Pre-proline 0 N--CA 1.42 -1.926 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.15 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.37 168.24 14.92 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 121.556 1.504 . . . . 0.0 110.775 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.0 mt -111.32 89.4 10.2 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.71 153.56 11.67 Favored 'Trans proline' 0 N--CA 1.437 -1.811 0 C-N-CA 122.179 1.92 . . . . 0.0 112.759 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 69.53 151.94 0.09 Allowed 'General case' 0 C--O 1.243 0.752 0 C-N-CA 125.752 1.621 . . . . 0.0 112.787 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . 0.271 58.8 pttt -88.89 74.58 8.21 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 122.599 1.19 . . . . 0.0 112.937 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -158.34 149.36 20.73 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 112.886 -1.961 . . . . 0.0 106.31 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.75 135.24 45.61 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.897 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.102 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.302 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.1 129.72 35.88 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 123.27 2.647 . . . . 0.0 112.063 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.14 -59.75 2.46 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.37 -53.71 2.1 Favored Glycine 0 C--N 1.31 -0.897 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.653 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m -138.4 155.92 73.69 Favored Pre-proline 0 C--N 1.291 -1.97 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.07 136.77 61.99 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 122.729 2.286 . . . . 0.0 110.015 175.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.2 -54.12 10.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.81 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.407 ' HB ' ' N ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -90.04 152.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.09 -70.43 0.26 Allowed Glycine 0 CA--C 1.474 -2.498 0 C-N-CA 119.373 -1.394 . . . . 0.0 111.718 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -125.92 147.71 49.42 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.517 HG13 ' HB ' ' A' ' 60' ' ' ILE . 2.2 pt -120.44 154.88 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-O 121.482 0.658 . . . . 0.0 111.777 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.55 176.59 30.7 Favored Glycine 0 N--CA 1.403 -3.501 0 N-CA-C 107.751 -2.139 . . . . 0.0 107.751 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.5 -27.44 68.82 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.167 2.578 . . . . 0.0 113.648 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -89.23 -20.52 24.04 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.0 p -97.91 -36.36 10.19 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.534 -169.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -62.71 -29.42 70.65 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.976 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -24.77 67.07 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.2 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.29 -37.67 44.27 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.88 0.848 . . . . 0.0 109.882 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -76.06 -27.44 57.25 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.493 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.04 -35.31 71.91 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.358 175.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 t -74.7 -19.51 60.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.933 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.28 -30.12 57.68 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 120.95 0.405 . . . . 0.0 110.2 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.39 -23.67 26.45 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.947 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.524 HG13 HD21 ' A' ' 56' ' ' ASN . 6.6 pt -81.15 152.87 71.63 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.479 -0.361 . . . . 0.0 111.68 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.452 ' HG2' HG12 ' A' ' 55' ' ' ILE . 10.6 Cg_endo -52.42 137.25 56.93 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.063 3.175 . . . . 0.0 114.442 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 tt -106.8 125.96 51.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.507 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -97.56 104.86 16.92 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -86.96 120.71 28.52 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.446 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.653 HG12 HD13 ' A' ' 44' ' ' LEU . 3.4 mp -110.69 94.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.361 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.691 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 34.7 m-85 -80.34 126.64 31.42 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -142.15 122.1 13.64 Favored 'General case' 0 C--N 1.252 -3.639 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.493 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.446 ' HG2' ' C ' ' A' ' 62' ' ' ALA . 32.2 mt-10 -73.15 -20.82 60.83 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.445 ' HB ' ' CG ' ' A' ' 36' ' ' GLU . 1.5 p -86.66 83.86 7.51 Favored 'General case' 0 N--CA 1.398 -3.066 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.997 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 37' ' ' ARG . . . -87.31 -25.21 24.03 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.154 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.5 mp0 -63.23 -34.13 76.99 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.179 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.445 ' CG ' ' HB ' ' A' ' 33' ' ' THR . 11.1 pt-20 -116.48 13.55 15.42 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.412 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.443 ' HB3' ' HA ' ' A' ' 34' ' ' ALA . 7.5 ptp180 -57.73 -27.93 63.44 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.812 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -50.4 -49.46 54.5 Favored 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 123.608 0.763 . . . . 0.0 111.517 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.627 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 12.1 pt-20 -86.97 -24.4 24.73 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.435 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.496 HD21 ' HB ' ' A' ' 101' ' ' ILE . 1.7 tm? -63.98 -44.92 91.24 Favored 'General case' 0 C--O 1.261 1.701 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.578 ' OG ' HG21 ' A' ' 59' ' ' THR . 15.7 m -73.01 -17.33 61.46 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.456 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.455 ' CB ' ' HA ' ' A' ' 39' ' ' GLU . 23.4 t70 -70.99 -40.87 71.61 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.677 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.632 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -65.24 -38.11 89.33 Favored 'General case' 0 C--O 1.27 2.177 0 CA-C-O 123.426 1.584 . . . . 0.0 106.848 173.308 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.653 HD13 HG12 ' A' ' 29' ' ' ILE . 94.0 mt -71.12 -19.06 62.49 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 112.884 -1.962 . . . . 0.0 113.065 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.573 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 24.3 ttpp -66.56 -55.42 18.72 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.68 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 81.6 Cg_exo -65.59 -38.94 22.92 Favored 'Trans proline' 0 CA--C 1.489 -1.733 0 C-N-CA 123.174 2.582 . . . . 0.0 110.508 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.549 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 93.7 mt -53.68 -38.47 34.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 O-C-N 124.052 0.845 . . . . 0.0 109.695 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.92 -16.84 23.61 Favored 'General case' 0 C--O 1.19 -2.053 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.217 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 3.6 tt0 -74.42 -17.73 60.75 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.57 -20.79 30.92 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.933 177.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 2.8 pt20 -137.66 37.84 2.43 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.495 1.14 . . . . 0.0 110.609 -171.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -65.92 -24.83 66.91 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.542 -2.117 . . . . 0.0 112.846 -172.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.54 9.22 17.08 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.314 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.415 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 13.0 p -122.86 -33.0 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.452 HG12 ' HG2' ' A' ' 25' ' ' PRO . 88.1 mt -122.86 134.64 65.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.211 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.524 HD21 HG13 ' A' ' 24' ' ' ILE . 9.2 m-80 -94.46 102.89 14.87 Favored 'General case' 0 C--O 1.207 -1.159 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' N ' ' HB ' ' A' ' 8' ' ' ILE . 7.8 m-85 -80.19 139.47 36.74 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.795 0.807 . . . . 0.0 111.851 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 11' ' ' ILE . . . -151.54 113.27 0.57 Allowed Glycine 0 C--N 1.275 -2.811 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.649 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.578 HG21 ' OG ' ' A' ' 41' ' ' SER . 40.3 p -84.64 132.19 34.51 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.517 ' HB ' HG13 ' A' ' 11' ' ' ILE . 7.6 tt -131.73 145.24 35.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 63' ' ' LYS . 7.7 t0 -73.33 123.9 24.68 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.042 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.691 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -92.54 1.99 56.94 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.042 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HB3' ' OD1' ' A' ' 61' ' ' ASP . 39.4 ttmt -100.33 -31.17 11.47 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.68 -44.53 7.07 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.217 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -120.42 26.67 9.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.476 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -70.44 -15.92 73.23 Favored Glycine 0 CA--C 1.489 -1.565 0 N-CA-C 116.206 1.242 . . . . 0.0 116.206 -170.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.16 -35.55 71.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.374 0.607 . . . . 0.0 110.007 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 71' ' ' ASN . 63.7 m-70 -60.49 -21.79 62.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.146 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.413 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -62.11 -31.87 72.37 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 121.506 0.67 . . . . 0.0 110.283 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -122.77 9.99 9.07 Favored Glycine 0 CA--C 1.479 -2.205 0 C-N-CA 118.26 -1.924 . . . . 0.0 115.089 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -73.95 -16.42 61.08 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 166.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.436 ' O ' ' HE3' ' A' ' 92' ' ' LYS . 3.9 pp -99.13 -26.25 14.27 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.928 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.415 ' CB ' HD12 ' A' ' 72' ' ' LEU . 3.3 t-20 177.78 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.599 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 89.8 mt -53.04 159.23 1.24 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.793 2.145 . . . . 0.0 116.793 -171.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -71.15 -17.91 62.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.676 -1.602 . . . . 0.0 113.235 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.413 HG22 ' HB3' ' A' ' 69' ' ' ALA . 13.8 p 50.13 57.83 6.14 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -135.25 -17.98 1.78 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -119.54 -159.92 0.79 Allowed 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.867 -167.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.637 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 57.7 m-85 -61.47 -176.37 0.12 Allowed Pre-proline 0 N--CA 1.499 1.993 0 C-N-CA 126.485 1.914 . . . . 0.0 111.262 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 3.7 Cg_endo -45.92 135.87 13.8 Favored 'Trans proline' 1 C--N 1.422 4.444 0 CA-C-N 121.75 1.661 . . . . 0.0 113.079 177.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -116.52 136.67 52.79 Favored 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.927 -171.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.507 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 77.6 t80 -120.11 120.09 35.23 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.12 123.46 39.73 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.359 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.486 HD11 HG12 ' A' ' 110' ' ' VAL . 56.3 mt -93.87 109.15 21.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 25' ' ' PRO . 41.3 tt0 -95.25 127.38 41.25 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -86.0 132.28 34.1 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.493 HG11 ' O ' ' A' ' 20' ' ' MET . 12.0 t -94.49 -0.42 10.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-O 122.139 0.971 . . . . 0.0 108.727 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.95 -44.68 3.94 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.699 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.431 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 58.1 mttp -93.85 -12.36 29.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.54 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 2.3 p-10 56.28 33.43 22.23 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 123.258 1.504 . . . . 0.0 109.894 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.506 ' C ' ' HD3' ' A' ' 92' ' ' LYS . 8.1 tp60 -98.12 167.04 11.12 Favored 'General case' 0 CA--C 1.464 -2.354 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.957 -177.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.634 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 3.6 mppt? -132.76 102.88 5.84 Favored 'General case' 1 N--CA 1.373 -4.317 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -176.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 91' ' ' GLN . 50.6 m-85 -98.91 83.83 0.33 Allowed Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 173.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 24.1 Cg_endo -100.18 149.42 0.45 Allowed 'Trans proline' 0 N--CA 1.42 -2.809 0 C-N-CA 121.935 1.757 . . . . 0.0 113.411 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 83.2 t80 -84.34 168.16 15.86 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.789 -174.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.648 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 18.6 m-20 -70.65 143.3 51.47 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.471 ' NE2' ' HB3' ' A' ' 74' ' ' LEU . 31.4 mt-30 -84.75 2.38 42.34 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.012 -171.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 7.7 pt-20 -152.22 22.02 0.65 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 14.9 tppt? -90.65 -3.22 57.67 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 70.49 133.02 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.911 2.085 . . . . 0.0 112.716 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.549 HG23 HG13 ' A' ' 106' ' ' ILE . 2.4 mp -91.24 97.91 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.841 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.943 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.4 p -110.25 -165.93 1.04 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.148 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.9 t80 -84.46 -55.0 4.38 Favored 'General case' 0 CA--C 1.485 -1.558 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -58.85 -43.86 90.89 Favored 'General case' 0 N--CA 1.387 -3.607 0 CA-C-N 113.096 -1.865 . . . . 0.0 113.731 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.62 -49.94 73.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.067 0.46 . . . . 0.0 111.328 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 101' ' ' ILE . 44.2 mm -72.11 -40.54 66.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.599 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 30.7 ttpt -57.71 -48.84 78.43 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 111' ' ' ASP . . . -61.4 -42.6 98.99 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 123.914 0.759 . . . . 0.0 110.922 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.426 ' HA ' ' OD1' ' A' ' 112' ' ' ASP . 63.4 t80 -61.56 -60.73 3.25 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.209 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.486 HG12 HD11 ' A' ' 84' ' ' ILE . 35.9 m -59.48 -30.67 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.642 -0.661 . . . . 0.0 110.468 -177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 23.9 t70 -64.27 -53.18 52.96 Favored 'General case' 0 CA--C 1.479 -1.756 0 C-N-CA 124.629 1.171 . . . . 0.0 108.96 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.586 ' OD2' HG12 ' A' ' 118' ' ' ILE 0.265 0.1 OUTLIER -68.2 -25.12 65.06 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.959 -177.167 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.541 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.4 t80 -68.97 -62.01 1.56 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.772 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.79 -25.42 38.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.335 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.64 -30.72 67.43 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 121.175 0.512 . . . . 0.0 109.934 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.71 7.06 10.95 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.77 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.583 ' HE2' ' OD2' ' A' ' 112' ' ' ASP . 25.1 ttpt -89.42 -37.07 15.09 Favored 'General case' 0 N--CA 1.393 -3.311 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.591 -172.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.586 HG12 ' OD2' ' A' ' 112' ' ' ASP . 4.2 mt -74.02 135.45 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 118.446 -1.302 . . . . 0.0 109.851 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -127.53 168.44 15.06 Favored Pre-proline 0 C--N 1.267 -3.015 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.58 122.04 9.58 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.931 1.754 . . . . 0.0 111.003 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.1 t -66.9 -52.91 37.54 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 35.0 pt -147.46 169.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.052 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -139.88 105.6 5.14 Favored 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.2 m -154.57 89.07 1.23 Allowed 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.033 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -126.93 103.3 23.88 Favored Pre-proline 0 CA--C 1.484 -1.595 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -84.88 179.85 4.04 Favored 'Trans proline' 0 N--CA 1.431 -2.156 0 C-N-CA 122.117 1.878 . . . . 0.0 112.951 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 pt -51.2 112.32 2.95 Favored Pre-proline 0 C--O 1.248 1.016 0 O-C-N 124.695 1.247 . . . . 0.0 112.52 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -47.37 139.28 16.99 Favored 'Trans proline' 0 C--O 1.251 1.167 0 C-N-CA 123.672 2.915 . . . . 0.0 110.83 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -57.07 103.63 0.12 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 124.447 1.092 . . . . 0.0 110.787 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -83.77 125.25 31.73 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.92 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -102.49 140.96 36.09 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -60.37 131.16 49.9 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 124.152 0.908 . . . . 0.0 111.471 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.433 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -177.229 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.709 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.59 123.01 10.81 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.506 2.137 . . . . 0.0 112.488 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.7 tp -102.4 166.61 10.45 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.51 73.54 0.6 Allowed Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 m -89.84 133.27 34.31 Favored Pre-proline 0 N--CA 1.416 -2.171 0 C-N-CA 123.801 0.84 . . . . 0.0 109.113 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.25 103.86 0.56 Allowed 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.225 1.95 . . . . 0.0 111.494 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.5 mt -124.1 -44.54 2.03 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' A' ' 57' ' ' PHE . 5.4 mp -121.0 90.79 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 169.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.81 -130.58 2.84 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.994 -173.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -122.67 143.56 49.7 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.437 0.636 . . . . 0.0 110.669 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.632 HG13 ' HA3' ' A' ' 58' ' ' GLY . 62.9 mt -103.71 118.11 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.957 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.25 178.32 17.87 Favored Glycine 0 N--CA 1.408 -3.218 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.42 -29.49 84.64 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.264 2.643 . . . . 0.0 112.939 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.96 -8.94 23.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.2 p -102.21 -35.88 8.71 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.466 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -62.5 -32.04 72.89 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.217 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.8 t -63.19 -27.9 69.68 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.571 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.61 -38.19 59.22 Favored 'General case' 0 C--O 1.249 1.079 0 CA-C-O 121.599 0.714 . . . . 0.0 109.73 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.404 ' HB3' ' CG ' ' A' ' 56' ' ' ASN . 18.4 m-85 -76.94 -23.39 52.42 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.582 ' SD ' HG22 ' A' ' 87' ' ' VAL . 8.7 tpp -80.67 -21.92 40.91 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.214 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 t -92.18 -13.05 31.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.07 -31.1 68.53 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.05 11.48 73.0 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.526 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.496 HG13 HD21 ' A' ' 56' ' ' ASN . 9.5 pt -123.98 151.06 64.46 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HG2' HG12 ' A' ' 55' ' ' ILE . 11.6 Cg_endo -53.34 144.84 47.77 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 124.125 3.217 . . . . 0.0 114.067 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 tt -116.14 126.34 53.57 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.74 110.54 22.98 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -90.73 120.18 31.57 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.176 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.532 HG12 HD13 ' A' ' 44' ' ' LEU . 3.2 mp -111.37 90.84 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.07 177.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.699 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 44.1 m-85 -79.41 133.37 36.55 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.546 ' CB ' ' HB3' ' A' ' 80' ' ' PRO . . . -142.99 120.32 11.59 Favored 'General case' 0 C--N 1.273 -2.719 0 O-C-N 123.314 0.384 . . . . 0.0 111.884 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.18 -32.01 66.44 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 3.1 p -83.08 109.59 17.27 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.202 -171.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.89 -16.95 45.5 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.424 0.63 . . . . 0.0 109.708 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -70.8 -59.6 2.71 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.425 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -97.93 8.59 44.49 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.693 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 33' ' ' THR . 53.6 ttt180 -55.69 -36.94 67.69 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -59.31 -48.48 81.45 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.096 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.661 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 12.4 pt-20 -79.37 -27.23 41.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.671 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.513 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.1 tm? -59.41 -50.01 75.6 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.545 ' HA ' HD12 ' A' ' 44' ' ' LEU . 9.2 m -74.88 -19.57 60.1 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.975 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.577 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 33.8 t70 -70.1 -39.97 75.2 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 122.866 0.466 . . . . 0.0 111.334 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.661 ' HE2' ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -70.51 -35.43 73.2 Favored 'General case' 0 C--O 1.297 3.554 0 CA-C-O 123.177 1.465 . . . . 0.0 108.509 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 41' ' ' SER . 68.6 mt -70.79 -23.64 62.43 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 113.102 -1.863 . . . . 0.0 111.814 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.526 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 36.4 ttpt -63.61 -52.1 61.51 Favored Pre-proline 0 C--N 1.289 -2.03 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.182 -173.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 42' ' ' ASP . 51.5 Cg_exo -71.83 -44.28 1.01 Allowed 'Trans proline' 0 CA--C 1.492 -1.598 0 C-N-CA 122.803 2.335 . . . . 0.0 111.095 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.484 HG13 ' HA ' ' A' ' 44' ' ' LEU . 2.4 pp -61.95 -22.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.375 1.68 0 C-N-CA 117.777 -1.569 . . . . 0.0 111.735 -176.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.23 -21.0 16.3 Favored 'General case' 0 C--O 1.202 -1.416 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.31 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 22.4 tt0 -69.82 -23.07 63.25 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.76 -16.63 60.1 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.123 -1.399 . . . . 0.0 110.228 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 3.1 pt20 -142.34 31.8 1.52 Allowed 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.522 -172.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.81 -14.27 59.63 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.977 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.89 5.52 50.64 Favored Glycine 0 C--N 1.296 -1.684 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.853 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 11.8 p -130.05 -37.47 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.534 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.438 HG12 ' HG2' ' A' ' 25' ' ' PRO . 92.3 mt -117.87 145.39 23.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.496 HD21 HG13 ' A' ' 24' ' ' ILE . 10.4 m-80 -92.94 121.76 34.62 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.572 ' HB2' HG13 ' A' ' 8' ' ' ILE . 6.4 m-85 -103.87 128.71 51.33 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.174 0.988 . . . . 0.0 112.825 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.632 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -145.9 131.9 4.32 Favored Glycine 0 N--CA 1.415 -2.734 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.252 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 44.9 p -96.08 143.59 27.08 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 8.2 tt -148.01 154.99 10.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -84.53 132.02 34.57 Favored 'General case' 0 C--N 1.283 -2.283 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.336 -175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -87.48 -3.63 59.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.135 0.493 . . . . 0.0 111.776 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -103.77 -32.05 9.53 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.002 0.429 . . . . 0.0 110.153 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.69 -46.59 7.5 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.694 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -117.24 19.29 14.21 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.502 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -66.95 -14.61 63.61 Favored Glycine 0 C--N 1.307 -1.036 0 N-CA-C 116.382 1.313 . . . . 0.0 116.382 -172.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.29 -24.64 67.95 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.085 0.942 . . . . 0.0 109.993 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -74.77 -22.3 58.85 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.946 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.475 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -61.07 -44.22 97.71 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 121.835 0.826 . . . . 0.0 109.408 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -112.56 24.0 14.36 Favored Glycine 0 C--N 1.272 -3.019 0 C-N-CA 117.987 -2.054 . . . . 0.0 115.381 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -14.36 59.46 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 169.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 73' ' ' ASN . 4.1 pp -100.37 -29.37 12.45 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.568 177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.506 ' N ' HD12 ' A' ' 72' ' ' LEU . 3.2 t-20 -175.8 -60.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -175.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.627 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.4 mm? -53.62 155.49 3.07 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -169.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -78.37 -12.96 60.04 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.012 -1.449 . . . . 0.0 112.49 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.475 HG22 ' HB3' ' A' ' 69' ' ' ALA . 75.7 p 58.61 28.52 17.23 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 126.56 1.944 . . . . 0.0 113.635 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.07 -28.44 6.98 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -170.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.717 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -124.9 106.07 9.72 Favored 'General case' 0 C--O 1.197 -1.676 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.418 -167.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.683 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 12.9 m-85 60.07 -171.06 0.02 OUTLIER Pre-proline 0 CA--C 1.571 1.753 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.838 168.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.683 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 10.2 Cg_endo -58.72 149.91 73.92 Favored 'Trans proline' 0 C--N 1.379 2.148 0 CA-C-N 120.79 1.318 . . . . 0.0 113.8 171.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.58 126.21 34.21 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.783 -176.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 77.5 t80 -105.45 119.01 38.03 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -126.96 117.34 22.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.541 HD11 HG12 ' A' ' 110' ' ' VAL . 51.4 mt -91.02 110.18 22.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -92.04 135.0 34.31 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.575 ' OE2' ' HG2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -90.61 132.94 35.45 Favored 'General case' 0 CA--C 1.461 -2.462 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.371 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.582 HG22 ' SD ' ' A' ' 20' ' ' MET . 22.0 t -101.05 -6.7 9.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.98 -46.15 5.45 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 119.771 -0.771 . . . . 0.0 109.575 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.575 ' HG2' ' OE2' ' A' ' 86' ' ' GLU . 43.6 mmtm -92.62 -25.45 18.29 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.505 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 63.0 t30 66.65 59.16 0.61 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 123.646 1.688 . . . . 0.0 106.799 -171.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.552 ' HB2' ' HB2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -130.24 176.34 8.19 Favored 'General case' 0 CA--C 1.468 -2.183 0 CA-C-N 113.098 -1.864 . . . . 0.0 107.4 -172.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 91' ' ' GLN . 60.3 mmtt -142.52 111.04 6.15 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -106.63 87.96 3.12 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HB2' HD21 ' A' ' 74' ' ' LEU . 2.9 Cg_endo -104.48 150.89 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.649 0 C-N-CA 122.689 2.259 . . . . 0.0 114.675 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 57.2 t80 -98.51 149.88 22.26 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.437 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 3.4 m-20 -58.72 139.51 56.07 Favored 'General case' 0 CA--C 1.478 -1.818 0 CA-C-O 121.702 0.763 . . . . 0.0 111.196 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.717 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 45.3 mt-30 -77.71 -8.54 58.09 Favored 'General case' 0 C--N 1.265 -3.103 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.181 -176.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 6.4 pt-20 -130.29 16.58 5.52 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.528 0.68 . . . . 0.0 111.42 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 34.8 ttmt -107.21 9.07 30.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.374 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 66.68 117.31 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.666 1.587 . . . . 0.0 114.6 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.543 HG23 HG13 ' A' ' 106' ' ' ILE . 3.4 mp -83.06 106.35 13.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.498 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.7 p -129.83 175.69 8.64 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.649 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 31.2 t80 -51.45 -63.79 1.02 Allowed 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 124.147 0.904 . . . . 0.0 110.047 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -67.38 -42.06 84.01 Favored 'General case' 1 N--CA 1.373 -4.299 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.195 -172.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.05 92.46 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 123.646 0.591 . . . . 0.0 110.296 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.543 HG13 HG23 ' A' ' 101' ' ' ILE . 32.6 mm -75.3 -42.26 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.101 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 27.0 ttpp -55.28 -50.33 69.8 Favored 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 123.759 0.662 . . . . 0.0 109.996 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.0 -33.54 75.78 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.043 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.462 ' CD1' ' HD1' ' A' ' 95' ' ' PHE . 68.8 t80 -66.21 -60.76 2.48 Favored 'General case' 0 C--O 1.205 -1.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.855 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.541 HG12 HD11 ' A' ' 84' ' ' ILE . 27.8 m -58.67 -31.3 43.86 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 122.033 -0.417 . . . . 0.0 110.411 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 107' ' ' LYS . 23.0 t70 -61.48 -50.97 70.59 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.789 1.236 . . . . 0.0 109.69 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.696 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 4.4 t70 -61.65 -46.29 90.38 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-N 113.941 -1.482 . . . . 0.0 107.247 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.498 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.1 t80 -55.4 -65.14 0.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.01 177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.88 -15.29 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 C-N-CA 123.661 0.785 . . . . 0.0 111.909 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.35 -25.39 25.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 0.0 110.17 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.56 26.67 6.74 Favored Glycine 0 CA--C 1.485 -1.782 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.696 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -98.09 -47.12 5.62 Favored 'General case' 0 N--CA 1.411 -2.414 0 CA-C-N 114.055 -1.073 . . . . 0.0 109.113 -176.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.556 HG13 ' HB3' ' A' ' 112' ' ' ASP . 20.5 mt -74.5 145.66 10.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.03 151.41 78.26 Favored Pre-proline 0 C--N 1.283 -2.296 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.121 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.59 106.85 2.35 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.609 1.539 . . . . 0.0 112.792 -175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 122' ' ' ILE . 17.0 t -85.04 75.54 10.36 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 123' ' ' LYS . 3.0 pt 179.67 -45.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 C-N-CA 128.355 2.662 . . . . 0.0 107.292 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.413 ' N ' HG13 ' A' ' 122' ' ' ILE . 16.5 tppt? -90.39 97.93 11.47 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.768 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.45 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 22.8 m -135.29 105.83 6.45 Favored 'General case' 0 C--N 1.273 -2.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -111.62 94.02 21.94 Favored Pre-proline 0 N--CA 1.42 -1.936 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 124' ' ' SER . 44.4 Cg_endo -95.24 173.22 1.22 Allowed 'Trans proline' 0 N--CA 1.413 -3.246 0 C-N-CA 121.513 1.475 . . . . 0.0 112.635 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.4 pt -114.83 94.57 38.19 Favored Pre-proline 0 C--N 1.301 -1.542 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.558 175.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.85 132.85 50.09 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.471 2.114 . . . . 0.0 109.7 174.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -85.43 95.91 9.41 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.178 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 68.75 108.63 0.05 Allowed 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.317 1.447 . . . . 0.0 111.968 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.431 ' HG2' ' N ' ' A' ' 132' ' ' GLU . 13.8 tt0 -141.17 168.6 19.38 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.431 ' N ' ' HG2' ' A' ' 131' ' ' GLN . 5.0 mp0 -77.95 154.75 31.32 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.579 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.718 -177.936 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.754 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -65.72 -43.01 10.65 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.346 2.031 . . . . 0.0 109.067 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.0 mt -141.22 165.29 27.94 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.12 -12.29 75.68 Favored Glycine 0 C--N 1.316 -0.545 0 O-C-N 123.503 0.502 . . . . 0.0 112.512 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.4 t -148.28 139.11 13.38 Favored Pre-proline 0 N--CA 1.416 -2.152 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.28 -49.56 3.49 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.0 1.8 . . . . 0.0 110.757 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.7 tp -169.73 -61.21 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 79.9 mt -99.03 117.65 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.736 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.4 -99.44 0.15 Allowed Glycine 0 N--CA 1.418 -2.565 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HA ' ' H ' ' A' ' 59' ' ' THR . 10.6 pt-20 -118.09 167.68 11.25 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.041 0.448 . . . . 0.0 109.957 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.509 HG13 ' HA3' ' A' ' 58' ' ' GLY . 69.2 mt -110.79 128.96 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 172.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.06 170.68 19.43 Favored Glycine 0 N--CA 1.416 -2.679 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.74 -18.23 54.54 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.278 2.652 . . . . 0.0 112.642 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.83 6.39 31.58 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.837 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 p -114.95 -25.98 7.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.374 -1.33 . . . . 0.0 111.981 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -41.75 -59.49 1.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.751 0.821 . . . . 0.0 112.248 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.6 m -54.3 -33.04 57.89 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.011 -1.449 . . . . 0.0 112.738 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.58 -26.99 31.82 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -74.68 -29.26 61.17 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.418 ' O ' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -76.76 -35.79 57.48 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.731 178.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -70.87 -21.72 62.37 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.394 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.07 -24.23 59.48 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 120.831 0.348 . . . . 0.0 111.307 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.61 -15.49 30.29 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-O 121.443 0.468 . . . . 0.0 112.309 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.612 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 19.8 pt -90.07 153.35 46.91 Favored Pre-proline 0 C--N 1.293 -1.888 0 CA-C-N 115.175 -0.513 . . . . 0.0 109.98 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 54' ' ' VAL . 21.4 Cg_exo -52.42 140.47 53.53 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.313 2.675 . . . . 0.0 113.879 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.435 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 2.7 tt -102.31 125.2 48.95 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -96.91 106.29 18.58 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.435 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 57.1 m-85 -87.88 113.92 23.99 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.12 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.607 HG12 HD13 ' A' ' 44' ' ' LEU . 3.1 mp -103.71 86.96 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.815 0 C-N-CA 118.379 -1.328 . . . . 0.0 108.958 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.63 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 41.5 m-85 -75.87 125.82 29.82 Favored 'General case' 0 CA--C 1.457 -2.609 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . . . -140.58 119.5 12.65 Favored 'General case' 0 C--N 1.258 -3.381 0 O-C-N 123.567 0.542 . . . . 0.0 111.489 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.99 -26.44 67.55 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.57 ' O ' ' HB2' ' A' ' 37' ' ' ARG . 1.2 p -81.39 120.42 24.94 Favored 'General case' 0 N--CA 1.393 -3.287 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.914 -176.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.04 -16.75 12.58 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 173.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.0 mp0 -72.74 -45.49 58.45 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.764 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -116.28 12.99 15.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.137 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.574 ' HA ' HD23 ' A' ' 40' ' ' LEU . 44.1 ttm180 -51.79 -41.25 61.55 Favored 'General case' 0 C--O 1.255 1.365 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 13.2 ptmm? -54.75 -32.0 59.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 124.147 0.904 . . . . 0.0 111.751 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -73.81 -43.78 57.8 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.674 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.8 mm? -58.14 -48.42 80.29 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.518 ' HA ' HD12 ' A' ' 44' ' ' LEU . 1.8 m -72.4 -21.48 61.26 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.817 -173.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 18.4 t70 -72.43 -39.19 68.06 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.743 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.62 ' HE2' ' N ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -73.02 -32.13 64.91 Favored 'General case' 0 C--O 1.287 3.035 0 CA-C-O 123.015 1.388 . . . . 0.0 108.69 175.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 52.5 mt -70.53 -26.51 63.61 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.434 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 4.0 tppp? -65.51 -51.8 48.81 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.304 -174.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 89.2 Cg_exo -67.14 -43.62 6.12 Favored 'Trans proline' 0 C--O 1.27 2.098 0 C-N-CA 122.901 2.4 . . . . 0.0 111.571 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.506 HG13 ' HA ' ' A' ' 44' ' ' LEU . 2.2 pp -63.13 -21.75 29.02 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 118.457 -1.297 . . . . 0.0 111.099 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.39 -24.26 16.79 Favored 'General case' 0 C--O 1.197 -1.681 0 O-C-N 123.677 0.611 . . . . 0.0 111.085 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.506 ' OE1' ' HD2' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -66.26 -21.39 66.28 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.41 -19.46 56.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.73 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 3.0 pt20 -139.04 35.73 2.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.267 1.032 . . . . 0.0 110.883 -171.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.506 ' HD2' ' OE1' ' A' ' 49' ' ' GLU . 14.3 ptm180 -73.05 -18.84 61.28 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.614 -174.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.83 15.34 31.51 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.612 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.2 p -137.85 -29.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.866 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.6 mt -128.65 136.15 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 O-C-N 121.546 -0.721 . . . . 0.0 111.361 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.454 HD21 HG13 ' A' ' 24' ' ' ILE . 17.9 m-80 -88.88 109.35 20.14 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.509 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 5.0 m-85 -93.31 114.98 27.56 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -136.97 128.62 4.46 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.353 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.471 ' H ' ' HA ' ' A' ' 10' ' ' GLU . 55.3 p -87.84 132.36 34.21 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' PHE . 6.8 tt -132.79 145.25 34.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 63' ' ' LYS . 11.2 t70 -75.56 127.83 33.95 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.263 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -90.98 -1.3 57.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.624 0.725 . . . . 0.0 111.285 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HB3' ' OD1' ' A' ' 61' ' ' ASP . 39.1 ttmt -99.35 -34.19 10.41 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -96.38 -54.5 3.25 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.766 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.29 20.25 19.25 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 121.767 -0.583 . . . . 0.0 111.007 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 62' ' ' ALA . . . -63.3 -20.4 63.08 Favored Glycine 0 C--N 1.309 -0.919 0 N-CA-C 116.246 1.258 . . . . 0.0 116.246 -172.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.04 -25.03 66.63 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.021 0.911 . . . . 0.0 110.591 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -73.09 -17.83 61.37 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.458 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.438 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -64.18 -33.58 76.11 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.623 1.202 . . . . 0.0 108.837 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.571 ' HA2' ' H ' ' A' ' 73' ' ' ASN . . . -116.22 24.08 10.17 Favored Glycine 0 C--N 1.27 -3.111 0 C-N-CA 118.564 -1.779 . . . . 0.0 114.226 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -8.4 58.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 166.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.483 HD12 ' CB ' ' A' ' 73' ' ' ASN . 4.1 pp -112.71 -38.55 4.55 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 112.867 -1.97 . . . . 0.0 109.18 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.571 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 11.5 t-20 -169.23 -56.95 0.02 OUTLIER 'General case' 0 C--N 1.367 1.356 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.5 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.3 mm? -60.49 173.37 0.71 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -167.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.605 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 53.1 tttm -90.54 -9.75 46.05 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.588 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.2 p 74.7 -13.13 0.85 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 128.358 2.663 . . . . 0.0 115.714 168.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.605 ' OD1' ' HG2' ' A' ' 75' ' ' LYS . 17.7 p-10 -108.1 5.04 25.6 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -166.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 36.2 ttmt -129.23 103.98 7.26 Favored 'General case' 0 C--N 1.258 -3.395 0 C-N-CA 119.527 -0.869 . . . . 0.0 113.256 -173.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.547 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 31.6 m-85 56.52 -175.57 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 124.417 1.073 . . . . 0.0 113.195 167.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 9.2 Cg_endo -65.12 134.07 38.01 Favored 'Trans proline' 0 N--CA 1.424 -2.596 0 CA-C-N 119.978 1.028 . . . . 0.0 113.113 167.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.95 116.64 20.39 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 113.903 -1.498 . . . . 0.0 107.878 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 61.5 t80 -91.34 109.32 20.6 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.381 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -111.0 115.85 30.18 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 39.2 mt -90.93 109.38 20.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 25.4 tt0 -106.74 120.54 42.27 Favored 'General case' 0 N--CA 1.395 -3.203 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.436 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 13.1 mt-10 -75.38 148.23 39.37 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.885 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 20' ' ' MET . 16.4 t -113.72 -1.87 10.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.88 -55.9 3.63 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -97.36 -19.78 18.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.212 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.759 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 47.2 t-20 59.85 80.43 0.2 Allowed 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 125.119 1.368 . . . . 0.0 108.277 -170.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.558 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 5.3 tp60 -133.59 165.26 25.33 Favored 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 113.789 -1.55 . . . . 0.0 107.519 -174.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.504 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 1.2 mptp? -125.25 99.85 6.26 Favored 'General case' 0 N--CA 1.4 -2.964 0 O-C-N 123.82 0.7 . . . . 0.0 109.242 -175.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 91' ' ' GLN . 44.6 m-85 -104.57 83.45 0.77 Allowed Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.999 174.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 4.6 Cg_endo -100.74 148.42 0.37 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 C-N-CA 122.879 2.386 . . . . 0.0 114.354 -177.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -88.8 158.75 18.03 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.844 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.5 m-20 -65.99 145.79 55.46 Favored 'General case' 0 CA--C 1.484 -1.571 0 CA-C-O 121.514 0.673 . . . . 0.0 111.426 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 13.2 mt-30 -84.25 5.2 27.53 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.299 -174.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.3 22.63 2.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.037 0.923 . . . . 0.0 110.108 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 14.6 tppt? -104.03 170.23 8.04 Favored 'General case' 0 N--CA 1.401 -2.898 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -94.26 110.29 22.05 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 118.647 0.658 . . . . 0.0 111.503 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.71 101.59 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.637 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.3 p -125.29 -170.59 2.2 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.019 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 17.3 t80 -75.28 -54.24 7.42 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 -174.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -55.18 -54.0 48.87 Favored 'General case' 0 N--CA 1.384 -3.767 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.777 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.68 -48.82 78.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 123.742 0.651 . . . . 0.0 112.265 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 47.7 mm -73.65 -40.55 54.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -59.13 -46.6 87.94 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.48 94.78 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.829 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -65.38 -58.67 5.3 Favored 'General case' 0 C--O 1.21 -0.987 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.276 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.402 HG12 HD11 ' A' ' 84' ' ' ILE . 35.0 m -59.92 -33.25 52.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 O-C-N 121.689 -0.632 . . . . 0.0 110.7 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.18 -51.91 67.97 Favored 'General case' 0 CA--C 1.486 -1.487 0 C-N-CA 124.241 1.016 . . . . 0.0 109.673 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.667 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 3.6 t70 -58.89 -47.12 86.08 Favored 'General case' 0 C--O 1.206 -1.197 0 CA-C-N 113.699 -1.591 . . . . 0.0 107.383 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.47 ' HB2' HD12 ' A' ' 118' ' ' ILE . 1.1 t80 -55.44 -64.48 0.83 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.059 177.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.99 -11.95 14.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.224 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.77 -30.14 23.28 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.435 0.636 . . . . 0.0 109.744 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.41 26.74 5.54 Favored Glycine 0 CA--C 1.481 -2.051 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.667 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -96.68 -52.32 3.97 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-N 114.131 -1.035 . . . . 0.0 109.157 -176.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 112' ' ' ASP . 18.5 mt -71.15 145.1 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.56 150.94 74.29 Favored Pre-proline 0 C--N 1.277 -2.57 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -46.33 122.23 5.38 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.569 2.846 . . . . 0.0 112.845 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.9 t -82.88 40.0 0.66 Allowed 'General case' 0 CA--C 1.56 1.338 0 CA-C-O 122.33 1.062 . . . . 0.0 110.425 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.431 HG13 ' H ' ' A' ' 123' ' ' LYS . 1.1 pt -156.89 -82.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 125.32 1.448 . . . . 0.0 109.193 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.431 ' H ' HG13 ' A' ' 122' ' ' ILE . 49.9 mmtm -80.96 79.18 7.68 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.545 0.688 . . . . 0.0 110.775 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -156.26 102.84 2.13 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 175.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -114.2 92.94 28.81 Favored Pre-proline 0 N--CA 1.415 -2.182 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.548 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 40.2 Cg_endo -85.53 -173.15 1.29 Allowed 'Trans proline' 0 N--CA 1.436 -1.897 0 C-N-CA 122.268 1.979 . . . . 0.0 112.747 -173.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.4 pt -110.39 95.74 23.78 Favored Pre-proline 0 N--CA 1.431 -1.421 0 CA-C-O 121.662 0.744 . . . . 0.0 113.004 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 126' ' ' PRO . 2.4 Cg_endo -82.66 -172.02 1.3 Allowed 'Trans proline' 0 N--CA 1.428 -2.366 0 C-N-CA 122.078 1.852 . . . . 0.0 107.466 169.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -130.67 168.18 17.56 Favored 'General case' 0 C--N 1.274 -2.707 0 C-N-CA 118.935 -1.106 . . . . 0.0 112.514 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.71 129.54 41.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.828 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -74.86 146.17 42.16 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -73.64 -27.84 61.47 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 121.061 0.458 . . . . 0.0 111.391 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.0 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.523 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.693 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.44 -34.29 54.47 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.763 2.309 . . . . 0.0 112.924 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -122.3 80.8 1.76 Allowed 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.47 170.06 46.11 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.759 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.572 ' OG ' ' HD3' ' A' ' 6' ' ' PRO 0.271 2.9 p -134.26 -65.27 0.02 OUTLIER Pre-proline 0 CA--C 1.566 1.593 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 178.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.572 ' HD3' ' OG ' ' A' ' 5' ' ' SER . 51.7 Cg_endo -107.63 50.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.902 2.401 . . . . 0.0 111.537 -176.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.425 HD22 ' H ' ' A' ' 7' ' ' LEU . 3.3 mm? -45.02 -48.23 11.62 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.627 1.171 . . . . 0.0 113.808 -174.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 92.4 mt -126.04 128.68 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.63 -117.92 0.81 Allowed Glycine 0 N--CA 1.42 -2.389 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -119.81 136.0 54.64 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.573 ' CG1' ' HA3' ' A' ' 58' ' ' GLY . 57.1 mt -92.48 139.05 18.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -141.54 -179.65 18.87 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -51.79 -31.68 42.98 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.45 3.433 . . . . 0.0 114.582 -177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.24 -7.59 24.47 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.0 p -93.83 -27.26 16.54 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.985 -169.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -45.93 -51.43 13.29 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.884 0.85 . . . . 0.0 111.012 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -55.5 -34.4 64.57 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.387 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -71.04 -41.64 70.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.456 0.646 . . . . 0.0 110.096 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CD1' ' HB3' ' A' ' 56' ' ' ASN . 41.9 m-85 -72.48 -28.94 63.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.35 1.071 . . . . 0.0 108.271 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.464 ' SD ' HG22 ' A' ' 87' ' ' VAL . 5.8 tpp -78.39 -19.96 52.2 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.315 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -87.79 -17.11 32.31 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.355 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.37 -41.7 72.75 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.025 0.441 . . . . 0.0 110.794 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.22 0.28 65.66 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.662 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 13.7 pt -107.8 152.48 41.59 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HG2' HG12 ' A' ' 55' ' ' ILE . 9.9 Cg_endo -53.25 138.91 64.18 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.923 3.082 . . . . 0.0 113.759 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.488 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 2.5 tt -105.33 125.85 51.45 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.591 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -98.76 105.55 17.71 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.488 ' CZ ' HD13 ' A' ' 26' ' ' LEU . 65.5 m-85 -86.72 112.43 21.66 Favored 'General case' 0 CA--C 1.467 -2.234 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.429 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.9 mt -101.09 85.08 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.596 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 80' ' ' PRO . 43.6 m-85 -76.35 124.52 27.65 Favored 'General case' 0 CA--C 1.46 -2.515 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.64 121.17 21.62 Favored 'General case' 0 C--N 1.257 -3.447 0 O-C-N 123.456 0.473 . . . . 0.0 110.66 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -81.99 -16.69 49.49 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 17.6 p -97.11 100.55 12.03 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.722 -174.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.64 -16.93 60.14 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.94 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -71.57 -56.67 5.43 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.164 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.565 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 15.0 pt-20 -91.0 8.49 35.04 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.561 -175.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 33' ' ' THR 0.275 0.1 OUTLIER -59.71 -32.85 70.91 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.159 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -77.46 -33.63 54.61 Favored 'General case' 0 C--O 1.2 -1.543 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.782 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.565 ' OE2' ' HA ' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -65.77 -43.92 87.38 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.492 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -56.92 -49.51 75.39 Favored 'General case' 0 C--O 1.259 1.555 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.552 ' OG ' HG21 ' A' ' 59' ' ' THR . 15.0 m -73.63 -13.41 61.0 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.061 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 24.4 t70 -77.49 -38.32 49.36 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 123.138 0.575 . . . . 0.0 111.074 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.597 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -69.37 -36.34 76.74 Favored 'General case' 0 C--O 1.276 2.495 0 CA-C-O 123.271 1.51 . . . . 0.0 107.952 172.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 75.5 mt -73.22 -18.52 61.23 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 113.527 -1.67 . . . . 0.0 111.94 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.622 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 36.9 ttpt -62.37 -55.03 43.6 Favored Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 123.646 0.778 . . . . 0.0 111.382 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.622 ' HD3' ' HB3' ' A' ' 45' ' ' LYS . 51.6 Cg_exo -72.22 -36.97 4.99 Favored 'Trans proline' 0 CA--C 1.485 -1.926 0 C-N-CA 122.593 2.195 . . . . 0.0 109.795 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.611 ' O ' ' HG2' ' A' ' 51' ' ' GLN . 27.3 mm -54.38 -36.64 34.67 Favored 'Isoleucine or valine' 0 C--N 1.368 1.383 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.33 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.05 -20.47 22.04 Favored 'General case' 0 C--O 1.195 -1.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.249 -174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -69.9 -22.72 63.19 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.32 -9.62 59.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.757 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 47' ' ' ILE . 3.0 pt20 -148.57 35.37 0.79 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.298 1.046 . . . . 0.0 110.644 -173.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HA ' HD11 ' A' ' 8' ' ' ILE . 38.8 ptt180 -73.2 -19.23 61.14 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.805 -173.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.13 21.68 11.9 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.679 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.496 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.7 p -138.84 -32.65 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.504 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.475 HG12 ' HG2' ' A' ' 25' ' ' PRO . 95.2 mt -122.85 137.6 55.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.812 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 20.9 m-80 -84.16 111.75 19.63 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 1.6 m-85 -97.67 105.82 18.03 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.573 ' HA3' ' CG1' ' A' ' 11' ' ' ILE . . . -130.62 130.46 6.16 Favored Glycine 0 N--CA 1.415 -2.747 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.867 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.567 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 35.6 p -92.38 136.97 32.76 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 tt -137.31 156.92 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD2' ' HD1' ' A' ' 65' ' ' PHE . 3.4 p30 -75.28 149.71 38.73 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.347 0.594 . . . . 0.0 110.172 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.6 14.03 26.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.904 0.859 . . . . 0.0 108.764 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -84.43 -53.71 5.25 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.045 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -109.56 -48.6 3.21 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.3 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.482 ' HD1' ' OD2' ' A' ' 61' ' ' ASP . 96.0 m-85 -97.97 10.49 40.2 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.987 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.11 -24.63 61.1 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 115.881 1.113 . . . . 0.0 115.881 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.92 -20.83 65.98 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.399 1.099 . . . . 0.0 110.333 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -70.82 -20.72 62.54 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.552 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -61.19 -39.39 89.99 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-O 122.343 1.068 . . . . 0.0 109.652 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -113.21 31.44 6.71 Favored Glycine 0 C--N 1.27 -3.101 0 C-N-CA 119.275 -1.441 . . . . 0.0 113.825 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.59 -17.46 38.71 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 168.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.457 HD12 ' N ' ' A' ' 73' ' ' ASN . 4.0 pp -102.82 -24.95 13.67 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.041 -1.891 . . . . 0.0 110.998 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.517 ' ND2' HG12 ' A' ' 122' ' ' ILE . 2.2 t-20 -179.96 -59.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.604 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.6 mm? -54.41 158.71 2.29 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -168.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -75.42 -17.69 60.1 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.829 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.428 HG22 ' HB3' ' A' ' 69' ' ' ALA . 48.6 p 55.17 40.33 31.72 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.182 1.393 . . . . 0.0 113.42 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' OD2' ' HE2' ' A' ' 78' ' ' LYS . 20.6 p-10 -125.18 -23.13 4.25 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.164 0.507 . . . . 0.0 111.224 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HE2' ' OD2' ' A' ' 77' ' ' ASP . 33.6 mtmt -108.13 -174.69 2.58 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -170.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.729 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 95.7 m-85 -69.16 -172.45 0.17 Allowed Pre-proline 0 CA--C 1.572 1.822 0 C-N-CA 125.791 1.637 . . . . 0.0 109.967 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.729 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 1.3 Cg_endo -43.67 131.09 7.52 Favored 'Trans proline' 1 C--N 1.429 4.788 0 CA-C-N 122.415 1.898 . . . . 0.0 116.42 -170.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.423 ' HB1' ' HG ' ' A' ' 74' ' ' LEU . . . -126.85 116.05 20.27 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 113.101 -1.863 . . . . 0.0 107.93 -175.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.591 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 71.5 t80 -95.14 109.85 21.88 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.971 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -112.07 117.1 31.72 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.478 HD11 HG12 ' A' ' 110' ' ' VAL . 56.2 mt -91.45 105.22 16.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.666 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -90.13 126.37 35.77 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 91' ' ' GLN . 2.8 mm-40 -87.88 125.59 34.57 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.549 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.464 HG22 ' SD ' ' A' ' 20' ' ' MET . 15.1 t -98.12 1.22 10.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.39 -35.07 3.66 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.177 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 89' ' ' LYS . 5.9 tmtm? -95.83 -20.16 19.03 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.3 m120 67.52 36.72 3.66 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-O 122.847 1.308 . . . . 0.0 110.337 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.505 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 2.0 tp60 -121.14 -179.69 4.12 Favored 'General case' 0 CA--C 1.472 -2.048 0 CA-C-N 112.803 -1.999 . . . . 0.0 107.681 -172.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.541 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 57.3 mmtt -138.12 106.17 5.71 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -102.47 87.2 1.08 Allowed Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 10.8 Cg_endo -102.33 142.25 0.19 Allowed 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 122.572 2.182 . . . . 0.0 114.638 -176.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.451 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 86.4 t80 -84.58 170.49 13.35 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.34 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 99' ' ' LYS . 9.3 m-20 -72.42 159.49 33.89 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.122 0.969 . . . . 0.0 110.295 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -100.75 -11.67 19.72 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-O 121.83 0.824 . . . . 0.0 108.909 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -123.42 -0.18 8.78 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.347 -173.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . 33.3 ttmt -87.58 -3.18 58.99 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.869 -172.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 72.95 134.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.145 0.978 . . . . 0.0 111.703 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.567 HG23 HG13 ' A' ' 106' ' ' ILE . 2.8 mp -90.04 101.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 122.009 0.909 . . . . 0.0 109.846 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.7 p -109.33 -174.02 2.4 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 46' ' ' PRO . 18.9 t80 -77.2 -51.14 11.45 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -59.95 -52.39 65.61 Favored 'General case' 0 N--CA 1.379 -3.985 0 CA-C-N 112.493 -2.14 . . . . 0.0 113.397 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.45 -46.57 83.46 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.121 0.486 . . . . 0.0 111.39 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.567 HG13 HG23 ' A' ' 101' ' ' ILE . 40.2 mm -73.05 -42.0 59.33 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.0 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 47' ' ' ILE . 33.8 ttpt -56.46 -50.56 71.38 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.34 92.63 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.143 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.496 ' O ' HD11 ' A' ' 118' ' ' ILE . 57.8 t80 -63.69 -59.92 3.98 Favored 'General case' 0 C--O 1.204 -1.305 0 O-C-N 124.02 0.825 . . . . 0.0 111.074 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 106' ' ' ILE . 31.4 m -58.87 -35.72 57.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 O-C-N 121.998 -0.438 . . . . 0.0 111.535 -176.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.88 -51.93 66.18 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.719 0.771 . . . . 0.0 109.036 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.69 ' OD1' ' HB3' ' A' ' 117' ' ' LYS . 5.6 t0 -57.35 -36.08 70.75 Favored 'General case' 0 C--O 1.196 -1.711 0 CA-C-N 113.45 -1.704 . . . . 0.0 109.731 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.693 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -71.25 -61.22 1.85 Allowed 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.89 177.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.09 -23.44 33.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.542 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.52 -22.19 44.26 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.605 0.717 . . . . 0.0 109.622 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.4 18.22 15.31 Favored Glycine 0 CA--C 1.466 -2.994 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.487 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.69 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 12.7 ttpp -93.04 -38.31 11.7 Favored 'General case' 0 N--CA 1.384 -3.753 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.609 -172.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.693 HD12 ' HB2' ' A' ' 113' ' ' PHE . 9.9 mt -67.57 141.92 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.407 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -118.55 135.67 23.75 Favored Pre-proline 0 C--N 1.256 -3.471 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.14 124.13 15.22 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.982 2.455 . . . . 0.0 112.368 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.1 m -57.52 -29.92 64.74 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.553 0.741 . . . . 0.0 112.605 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.517 HG12 ' ND2' ' A' ' 73' ' ' ASN . 19.5 pt -121.35 -39.71 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 O-C-N 122.004 -0.435 . . . . 0.0 111.656 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.468 ' HG2' ' H ' ' A' ' 124' ' ' SER . 72.6 tttt 74.14 -157.79 0.07 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.468 ' H ' ' HG2' ' A' ' 123' ' ' LYS . 24.3 m 69.26 126.91 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.023 0.916 . . . . 0.0 112.022 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -117.08 95.91 48.04 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.76 140.86 16.75 Favored 'Trans proline' 0 N--CA 1.425 -2.508 0 C-N-CA 121.702 1.601 . . . . 0.0 114.097 -170.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.422 HD11 ' HE3' ' A' ' 130' ' ' LYS . 8.1 tp -147.0 83.55 7.89 Favored Pre-proline 0 C--N 1.282 -2.352 0 CA-C-N 114.051 -1.432 . . . . 0.0 109.231 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.96 -175.47 2.69 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.101 1.867 . . . . 0.0 110.733 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -71.84 132.69 44.78 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.422 ' HE3' HD11 ' A' ' 127' ' ' ILE . 11.8 mptt -69.39 95.22 0.78 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.251 0.548 . . . . 0.0 111.727 -176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -82.5 152.6 25.98 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -88.07 152.91 21.68 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.195 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.553 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -175.498 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.838 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.97 -26.11 9.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.035 1.823 . . . . 0.0 112.878 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 57.1 72.29 0.52 Allowed 'General case' 0 C--O 1.249 1.037 0 CA-C-O 122.067 0.936 . . . . 0.0 109.56 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.39 128.5 3.28 Favored Glycine 0 N--CA 1.411 -2.975 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.888 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 p -156.88 116.42 2.05 Favored Pre-proline 0 C--N 1.289 -2.031 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.44 -12.45 27.74 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 123.095 2.53 . . . . 0.0 113.591 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.74 -11.51 21.84 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.488 HG12 ' HB2' ' A' ' 57' ' ' PHE . 85.4 mt -126.1 142.22 43.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.976 -0.452 . . . . 0.0 111.061 -174.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.16 -125.99 1.73 Allowed Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.91 176.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -118.56 144.56 46.0 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.46 0.648 . . . . 0.0 110.272 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.533 HG13 ' HA3' ' A' ' 58' ' ' GLY . 62.1 mt -95.72 114.04 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -127.77 -178.92 15.56 Favored Glycine 0 N--CA 1.408 -3.199 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.29 -8.28 8.23 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.036 3.157 . . . . 0.0 115.67 -173.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -123.98 -18.36 5.98 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.018 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.8 p -85.23 -27.62 25.94 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.573 -172.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -62.09 -36.74 82.6 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.293 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 m -66.66 -27.31 67.57 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.867 0.867 . . . . 0.0 110.574 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.95 -39.07 61.55 Favored 'General case' 0 C--O 1.258 1.549 0 CA-C-O 121.704 0.764 . . . . 0.0 109.095 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -75.12 -26.15 58.98 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.463 ' SD ' HG22 ' A' ' 87' ' ' VAL . 8.8 tpp -77.76 -25.3 49.03 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.661 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -88.82 -10.75 46.98 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.405 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.27 -35.19 73.6 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 122.086 -0.384 . . . . 0.0 111.543 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.48 65.55 Favored Glycine 0 N--CA 1.461 0.304 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.366 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 9.1 pt -126.1 151.62 72.07 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HG2' HG12 ' A' ' 55' ' ' ILE . 8.0 Cg_endo -50.14 141.56 30.32 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.068 3.179 . . . . 0.0 114.037 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.448 HD13 ' CE1' ' A' ' 28' ' ' TYR . 2.5 tt -110.4 124.81 52.42 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.548 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -94.1 105.46 17.46 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.448 ' CE1' HD13 ' A' ' 26' ' ' LEU . 48.3 m-85 -87.59 110.7 20.57 Favored 'General case' 0 CA--C 1.471 -2.058 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.363 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 59' ' ' THR . 6.7 mt -100.23 85.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.319 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.546 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 31.5 m-85 -77.53 109.91 11.88 Favored 'General case' 0 CA--C 1.468 -2.181 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . . . -124.06 119.75 30.39 Favored 'General case' 1 C--N 1.238 -4.245 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.701 177.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -74.54 -27.2 60.42 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 11.4 p -93.49 106.6 18.55 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.61 -173.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . -78.78 -21.28 48.1 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.909 -175.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -80.1 -48.51 13.12 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.042 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.489 ' HG2' ' HB ' ' A' ' 33' ' ' THR . 12.5 pt-20 -90.7 1.18 57.07 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.553 -0.859 . . . . 0.0 112.158 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 34' ' ' ALA . 12.2 ptm180 -60.19 -24.31 64.68 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -58.48 -57.9 10.92 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.53 -25.79 54.51 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.166 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.654 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -60.24 -50.98 71.5 Favored 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.457 ' HA ' HD12 ' A' ' 44' ' ' LEU . 9.9 m -75.11 -19.4 59.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.73 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.43 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 15.9 t70 -67.79 -43.39 79.84 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.836 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.626 ' O ' ' HD2' ' A' ' 46' ' ' PRO . 0.6 OUTLIER -70.37 -34.05 72.14 Favored 'General case' 0 C--O 1.278 2.597 0 CA-C-O 122.772 1.272 . . . . 0.0 108.463 176.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 56.9 mt -69.94 -20.51 63.33 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.716 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.599 ' HB3' ' HD3' ' A' ' 46' ' ' PRO . 17.4 tppt? -61.97 -57.29 24.8 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.843 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 72.8 Cg_exo -66.82 -39.42 14.84 Favored 'Trans proline' 0 CA--C 1.49 -1.696 0 C-N-CA 122.917 2.411 . . . . 0.0 110.351 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.579 HD11 ' HA ' ' A' ' 103' ' ' PHE . 93.8 mt -52.67 -40.36 34.02 Favored 'Isoleucine or valine' 0 C--N 1.368 1.388 0 O-C-N 124.086 0.866 . . . . 0.0 109.208 176.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HA ' ' HG3' ' A' ' 51' ' ' GLN . . . -94.26 -13.79 26.16 Favored 'General case' 0 C--O 1.177 -2.718 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.603 -173.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -71.94 -22.36 61.48 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.92 -23.45 33.51 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.906 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.524 ' OE1' HD12 ' A' ' 55' ' ' ILE . 5.4 pt20 -130.85 34.37 4.09 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.19 0.995 . . . . 0.0 112.373 -174.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -73.25 -18.58 61.21 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.393 -1.73 . . . . 0.0 111.858 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.38 4.4 28.17 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.418 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.8 p -124.15 -33.5 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.325 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.524 HD12 ' OE1' ' A' ' 51' ' ' GLN . 95.0 mt -124.39 136.81 59.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.034 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.43 HD21 HG13 ' A' ' 24' ' ' ILE . 20.3 m-80 -84.83 104.65 14.97 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.488 ' HB2' HG12 ' A' ' 8' ' ' ILE . 5.2 m-85 -90.16 102.67 15.39 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.573 0.701 . . . . 0.0 112.564 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.533 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -124.21 131.74 8.05 Favored Glycine 0 N--CA 1.415 -2.762 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.424 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . 27.4 p -92.27 134.67 34.68 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 120.896 0.379 . . . . 0.0 110.515 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.524 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 8.7 tt -137.15 165.58 27.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -89.13 153.88 20.6 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-O 121.458 0.647 . . . . 0.0 110.922 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -110.48 19.83 18.36 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 173.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -102.82 -46.02 4.82 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 113.382 -1.735 . . . . 0.0 109.844 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.47 -43.58 3.48 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.139 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.421 ' O ' ' HE2' ' A' ' 30' ' ' PHE . 96.4 m-85 -99.21 10.12 42.07 Favored 'General case' 0 CA--C 1.504 -0.814 0 O-C-N 122.124 -0.36 . . . . 0.0 110.68 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 62' ' ' ALA . . . -58.97 -30.04 66.0 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.01 -30.08 46.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.413 0.625 . . . . 0.0 111.303 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -69.15 -23.81 64.0 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.285 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.461 ' HB3' HG22 ' A' ' 76' ' ' THR . . . -63.02 -34.41 77.5 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-O 121.978 0.894 . . . . 0.0 109.861 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.45 ' HA2' ' N ' ' A' ' 74' ' ' LEU . . . -109.28 5.34 31.7 Favored Glycine 0 C--N 1.279 -2.591 0 C-N-CA 117.403 -2.332 . . . . 0.0 115.502 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -76.57 -16.97 59.46 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 73' ' ' ASN . 4.2 pp -97.68 -31.38 12.3 Favored 'General case' 0 N--CA 1.399 -2.987 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.349 174.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.432 ' HB2' HD12 ' A' ' 72' ' ' LEU . 2.2 t-20 179.51 -56.74 0.01 OUTLIER 'General case' 0 C--N 1.38 1.906 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' A' ' 94' ' ' PRO . 2.3 mm? -61.4 179.9 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -169.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.25 -0.68 20.72 Favored 'General case' 0 CA--C 1.486 -1.515 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.99 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.467 ' N ' HE22 ' A' ' 97' ' ' GLN . 19.2 p 59.3 5.78 0.64 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 125.205 1.402 . . . . 0.0 112.401 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.92 -25.09 28.12 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -170.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HG3' ' H ' ' A' ' 79' ' ' PHE . 11.4 tptm -119.21 -158.68 0.74 Allowed 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.672 -166.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.529 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 89.5 m-85 -54.99 168.32 0.53 Allowed Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 125.054 1.341 . . . . 0.0 110.506 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 79' ' ' PHE . 2.5 Cg_endo -40.63 130.44 2.64 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.998 2.465 . . . . 0.0 114.431 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -103.75 104.82 14.88 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.608 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.548 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 74.3 t80 -87.13 111.5 21.0 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.908 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.88 119.39 32.51 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.518 HD11 HG12 ' A' ' 110' ' ' VAL . 55.2 mt -89.41 104.84 15.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -86.18 132.77 33.94 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.626 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.15 141.89 29.87 Favored 'General case' 0 C--N 1.265 -3.098 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.017 175.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.463 HG22 ' SD ' ' A' ' 20' ' ' MET . 25.8 t -107.79 -2.06 10.0 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.38 -48.19 3.75 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.42 ' HD3' ' OE2' ' A' ' 86' ' ' GLU . 4.7 mptp? -89.38 -25.15 21.73 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.981 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 16.2 t-20 66.17 20.72 11.15 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.36 1.464 . . . . 0.0 108.465 -173.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.539 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 4.4 tp60 -85.95 178.7 7.19 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.617 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 56.7 mmtt -138.46 105.04 5.31 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -96.88 87.84 0.49 Allowed Pre-proline 0 N--CA 1.481 1.084 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 6.0 Cg_endo -104.82 145.7 0.12 Allowed 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.516 2.144 . . . . 0.0 115.01 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.4 ' HD1' ' CD1' ' A' ' 109' ' ' PHE . 77.2 t80 -86.0 158.78 19.78 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.595 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.619 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 1.3 m-20 -71.48 134.49 46.59 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.109 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.467 HE22 ' N ' ' A' ' 76' ' ' THR . 48.1 mt-30 -75.74 9.62 2.21 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.722 -175.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -154.92 20.96 0.45 Allowed 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.177 0.513 . . . . 0.0 111.443 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.619 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 39.1 ttmt -97.86 9.89 41.57 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 74.09 120.46 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 113.562 -1.654 . . . . 0.0 112.025 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.2 mp -92.82 98.54 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.03 -164.47 1.32 Allowed 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.923 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.579 ' HA ' HD11 ' A' ' 47' ' ' ILE . 16.0 t80 -77.79 -58.62 3.17 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -174.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -52.84 -53.75 44.18 Favored 'General case' 0 N--CA 1.386 -3.638 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.527 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.83 -49.31 77.1 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 123.596 0.56 . . . . 0.0 112.371 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 110' ' ' VAL . 41.8 mm -72.96 -42.45 59.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.024 -177.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.414 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 28.6 ttpt -54.52 -50.96 66.61 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.996 0.81 . . . . 0.0 109.241 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 112' ' ' ASP . . . -63.11 -39.11 93.73 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.559 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.4 ' CD1' ' HD1' ' A' ' 95' ' ' PHE . 66.7 t80 -65.32 -60.13 3.31 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.62 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.518 HG12 HD11 ' A' ' 84' ' ' ILE . 27.6 m -57.62 -36.62 54.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 O-C-N 121.83 -0.544 . . . . 0.0 111.422 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.29 -46.37 87.07 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-O 121.216 0.531 . . . . 0.0 109.681 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.69 ' CG ' ' HB3' ' A' ' 117' ' ' LYS . 3.4 t70 -57.27 -48.98 77.5 Favored 'General case' 0 C--O 1.203 -1.39 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.523 ' HB2' HD12 ' A' ' 118' ' ' ILE . 2.7 t80 -57.02 -63.59 1.16 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.622 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 110' ' ' VAL . 90.6 t -52.48 -30.8 14.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 C-N-CA 124.311 1.044 . . . . 0.0 112.37 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.59 -38.95 58.7 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.676 0.751 . . . . 0.0 110.026 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 111.16 23.87 5.64 Favored Glycine 0 CA--C 1.473 -2.534 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.69 ' HB3' ' CG ' ' A' ' 112' ' ' ASP . 3.3 ttmm -92.39 -42.52 9.73 Favored 'General case' 0 N--CA 1.387 -3.579 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.605 HG13 ' HB3' ' A' ' 112' ' ' ASP . 23.5 mt -81.37 143.35 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.05 175.44 3.68 Favored Pre-proline 0 C--N 1.272 -2.772 0 N-CA-C 104.132 -2.544 . . . . 0.0 104.132 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.9 108.67 0.26 Allowed 'Trans proline' 0 CA--C 1.544 1.018 0 CA-C-N 121.174 1.455 . . . . 0.0 110.305 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.5 m -49.37 -54.66 16.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.938 1.295 . . . . 0.0 113.85 -172.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.9 pt -138.55 -50.75 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-O 120.928 0.394 . . . . 0.0 109.986 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -66.01 110.3 2.87 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.759 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -149.67 135.19 18.39 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -143.13 88.03 8.38 Favored Pre-proline 0 N--CA 1.428 -1.559 0 CA-C-O 122.0 0.905 . . . . 0.0 110.472 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -99.83 169.43 0.46 Allowed 'Trans proline' 0 N--CA 1.427 -2.4 0 C-N-CA 122.128 1.885 . . . . 0.0 112.563 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.7 pt -125.16 80.26 64.77 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.73 147.82 86.06 Favored 'Trans proline' 0 CA--C 1.508 -0.817 0 C-N-CA 123.419 2.746 . . . . 0.0 113.854 -174.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.36 -168.33 0.2 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.568 -1.651 . . . . 0.0 112.445 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -147.33 169.52 19.25 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -107.47 142.72 36.91 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -80.47 -54.19 5.91 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.466 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.612 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -175.877 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.684 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.08 -70.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 123.244 2.629 . . . . 0.0 113.029 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.584 HD23 ' H ' ' A' ' 3' ' ' LEU . 2.1 pt? -83.68 131.38 34.95 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.27 -161.03 34.1 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.9 m -143.46 93.4 6.37 Favored Pre-proline 0 C--N 1.291 -1.973 0 CA-C-N 117.585 0.693 . . . . 0.0 110.923 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -85.33 -31.56 0.36 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.104 1.869 . . . . 0.0 112.099 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.7 mt -138.93 -59.04 0.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 49.0 mt -110.12 138.35 38.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.399 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.32 -121.34 1.12 Allowed Glycine 0 N--CA 1.425 -2.053 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.413 ' HG2' ' OG1' ' A' ' 59' ' ' THR . 42.4 mt-10 -118.23 155.12 31.1 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.565 HG13 ' HA3' ' A' ' 58' ' ' GLY . 67.7 mt -105.69 120.9 57.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -114.56 179.75 18.57 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.54 5.36 4.3 Favored 'Trans proline' 0 C--O 1.221 -0.367 0 C-N-CA 123.029 2.486 . . . . 0.0 112.752 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -128.64 -6.18 5.18 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.869 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -100.27 -28.31 13.05 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.736 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -59.09 -38.38 79.38 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.9 0.381 . . . . 0.0 111.693 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 m -65.22 -27.09 68.43 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.717 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.81 -33.4 40.41 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.034 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.402 ' HB3' ' CG ' ' A' ' 56' ' ' ASN . 21.1 m-85 -75.8 -27.21 57.88 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.558 ' SD ' HG22 ' A' ' 87' ' ' VAL . 8.7 tpp -77.07 -21.53 54.28 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 113.554 -1.657 . . . . 0.0 108.757 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.4 t -90.0 -12.77 37.66 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.8 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.54 -32.26 60.39 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.226 0.536 . . . . 0.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.63 2.85 78.46 Favored Glycine 0 C--N 1.32 -0.35 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.25 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 54' ' ' VAL . 13.6 pt -112.04 148.64 39.47 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.481 ' HG2' HG12 ' A' ' 55' ' ' ILE . 6.6 Cg_endo -51.29 142.21 37.63 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 123.834 3.022 . . . . 0.0 113.846 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.51 HD13 ' CE1' ' A' ' 28' ' ' TYR . 2.6 tt -108.98 126.91 53.6 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HB1' ' CE1' ' A' ' 82' ' ' PHE . . . -101.02 109.07 20.93 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE1' HD13 ' A' ' 26' ' ' LEU . 47.1 m-85 -89.58 109.61 20.54 Favored 'General case' 0 CA--C 1.478 -1.809 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.365 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.532 HD11 ' CD2' ' A' ' 57' ' ' PHE . 2.5 mp -101.04 87.92 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.337 176.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.586 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 42.9 m-85 -73.02 133.73 44.36 Favored 'General case' 0 CA--C 1.467 -2.226 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . . . -148.19 117.08 6.73 Favored 'General case' 0 C--N 1.274 -2.693 0 O-C-N 123.593 0.558 . . . . 0.0 111.665 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.01 -22.8 59.44 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.852 0.834 . . . . 0.0 108.911 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.452 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 17.0 p -76.52 115.88 16.68 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.882 -173.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.33 -15.26 19.82 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.395 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -85.69 -63.72 1.27 Allowed 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.452 ' HG2' ' HB ' ' A' ' 33' ' ' THR . 1.3 pm0 -78.91 12.5 2.14 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.462 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.6 tpp85 -52.7 -39.07 61.64 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 169.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -67.03 -48.49 68.17 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.607 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 42' ' ' ASP . 45.6 mt-10 -59.61 -50.52 73.55 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.217 0.532 . . . . 0.0 110.307 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -53.23 -54.42 36.43 Favored 'General case' 0 C--O 1.255 1.354 0 C-N-CA 124.653 1.181 . . . . 0.0 108.849 -176.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.468 ' HA ' ' HB2' ' A' ' 44' ' ' LEU . 12.3 m -73.6 -15.18 61.28 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.62 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 39' ' ' GLU . 33.8 t70 -75.09 -35.59 61.79 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 122.954 0.501 . . . . 0.0 111.458 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -77.49 -30.17 52.94 Favored 'General case' 0 C--O 1.281 2.749 0 CA-C-O 122.865 1.317 . . . . 0.0 108.81 173.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 45.8 mt -73.16 -30.97 63.95 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 113.626 -1.624 . . . . 0.0 113.713 -177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 24.8 ttpp -68.2 -46.4 39.84 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.694 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 73.5 Cg_endo -70.88 -42.56 2.18 Favored 'Trans proline' 0 C--O 1.26 1.593 0 C-N-CA 122.485 2.123 . . . . 0.0 110.996 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 107' ' ' LYS . 2.6 pp -63.15 -24.89 37.15 Favored 'Isoleucine or valine' 0 C--N 1.385 2.128 0 C-N-CA 118.11 -1.436 . . . . 0.0 109.99 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.85 -22.23 19.4 Favored 'General case' 0 C--O 1.194 -1.841 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.201 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 6.2 tt0 -69.84 -18.44 63.44 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.72 -21.56 51.71 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.971 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 51' ' ' GLN . 2.7 pt20 -138.51 36.54 2.25 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.2 1.0 . . . . 0.0 111.108 -170.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 49' ' ' GLU . 9.1 ptm180 -76.85 -14.02 59.94 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.645 -172.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.6 6.68 22.54 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.632 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.567 ' O ' ' HB ' ' A' ' 24' ' ' ILE . 14.6 p -125.6 -32.51 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.515 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.481 HG12 ' HG2' ' A' ' 25' ' ' PRO . 94.6 mt -122.2 136.31 59.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.412 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.461 HD21 HG13 ' A' ' 24' ' ' ILE . 16.7 m-80 -84.65 104.04 14.28 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.532 ' CD2' HD11 ' A' ' 29' ' ' ILE . 3.7 m-85 -90.75 103.61 16.29 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.565 ' HA3' HG13 ' A' ' 11' ' ' ILE . . . -124.34 130.88 7.69 Favored Glycine 0 N--CA 1.408 -3.22 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.412 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.413 ' OG1' ' HG2' ' A' ' 10' ' ' GLU . 20.7 p -92.01 127.82 37.62 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 9.3 tt -126.57 143.17 40.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 63' ' ' LYS . 20.3 t70 -76.27 131.13 39.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.122 -175.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 30' ' ' PHE . . . -92.48 -1.08 57.23 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.343 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HB3' ' OD2' ' A' ' 61' ' ' ASP . 81.8 tttt -92.4 -43.61 9.13 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.52 -40.09 9.63 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.769 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -115.48 20.8 14.52 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.736 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.437 ' CA ' ' HA ' ' A' ' 62' ' ' ALA . . . -69.31 -23.29 76.41 Favored Glycine 0 C--N 1.305 -1.181 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 -169.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.0 -21.69 63.81 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.254 0.55 . . . . 0.0 111.4 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -69.13 -25.35 64.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.666 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -59.56 -35.28 73.94 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.073 0.939 . . . . 0.0 111.362 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 74' ' ' LEU . . . -109.54 13.49 32.88 Favored Glycine 0 C--N 1.27 -3.114 0 C-N-CA 117.596 -2.24 . . . . 0.0 115.895 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -24.25 58.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 169.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 4.0 pp -92.45 -37.53 12.49 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.385 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.502 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 20.9 t-20 -172.94 -57.88 0.02 OUTLIER 'General case' 0 C--N 1.369 1.452 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.536 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 2.5 mm? -54.58 164.79 0.67 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -167.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -81.06 -14.87 57.42 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.757 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.475 HG22 ' HB3' ' A' ' 69' ' ' ALA . 28.9 p 59.6 21.44 10.05 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.655 1.982 . . . . 0.0 114.076 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -105.39 -25.27 12.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -135.41 115.05 12.76 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -166.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.677 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 14.8 t80 60.39 179.74 0.04 OUTLIER Pre-proline 0 CA--C 1.581 2.16 0 O-C-N 125.126 1.516 . . . . 0.0 111.546 158.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.677 ' HD2' ' CG ' ' A' ' 79' ' ' PHE . 3.7 Cg_endo -55.81 134.52 64.54 Favored 'Trans proline' 0 C--N 1.378 2.095 0 CA-C-N 120.805 1.323 . . . . 0.0 113.837 167.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.421 ' HB1' ' HG ' ' A' ' 74' ' ' LEU . . . -125.8 113.17 16.91 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.45 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.454 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 62.5 t80 -90.25 111.3 22.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . . . -116.27 118.05 31.71 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 93' ' ' PHE . 58.7 mt -93.7 114.09 29.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.547 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -102.53 126.77 49.7 Favored 'General case' 0 N--CA 1.405 -2.717 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 90' ' ' ASN . 0.7 OUTLIER -78.98 136.65 37.28 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.95 177.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.558 HG22 ' SD ' ' A' ' 20' ' ' MET . 23.6 t -104.3 -5.18 9.56 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.62 -38.17 6.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.368 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 86' ' ' GLU . 23.1 ttmm -101.88 -17.83 15.99 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 44.8 t-20 56.44 75.43 0.35 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 124.55 1.14 . . . . 0.0 108.507 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -144.17 174.34 10.97 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.087 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -126.97 102.35 6.95 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -177.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.408 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 60.8 m-85 -107.93 80.7 1.07 Allowed Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 15.4 Cg_endo -101.17 144.84 0.28 Allowed 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.907 2.405 . . . . 0.0 114.077 -176.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -85.01 165.55 17.45 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 125.247 1.419 . . . . 0.0 108.259 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.742 ' HB2' ' HB2' ' A' ' 99' ' ' LYS . 9.0 m-20 -73.78 145.39 45.08 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.446 ' O ' ' HB3' ' A' ' 79' ' ' PHE . 13.0 mt-30 -83.02 -5.47 59.11 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.233 -170.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -148.09 32.36 0.83 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.337 1.065 . . . . 0.0 110.685 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 96' ' ' ASP . 17.2 tppt? -95.95 -6.76 38.29 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.206 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 74.24 127.69 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.967 1.307 . . . . 0.0 111.734 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.472 HG23 ' CG1' ' A' ' 106' ' ' ILE . 3.0 mp -93.65 116.89 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.369 -176.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 p -122.49 -174.69 2.97 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.411 ' HA ' ' HB3' ' A' ' 43' ' ' LYS . 20.2 t80 -76.73 -48.7 17.98 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.6 -55.8 30.21 Favored 'General case' 0 N--CA 1.387 -3.618 0 CA-C-N 112.099 -2.319 . . . . 0.0 112.38 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.44 74.51 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.654 0.596 . . . . 0.0 111.996 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.472 ' CG1' HG23 ' A' ' 101' ' ' ILE . 42.1 mm -74.08 -43.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.68 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.41 ' HB2' HG21 ' A' ' 47' ' ' ILE . 36.5 ttpt -56.85 -48.24 78.54 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 124.118 0.886 . . . . 0.0 109.683 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.55 99.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.733 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.605 ' HA ' ' OD1' ' A' ' 112' ' ' ASP . 38.5 t80 -64.44 -58.13 7.31 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.495 1.118 . . . . 0.0 111.273 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 106' ' ' ILE . 26.8 m -58.95 -31.94 46.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 O-C-N 121.531 -0.731 . . . . 0.0 110.614 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.32 -52.93 50.7 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 123.828 0.851 . . . . 0.0 109.358 177.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.605 ' OD1' ' HA ' ' A' ' 109' ' ' PHE 0.281 0.4 OUTLIER -67.48 -22.1 65.49 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.329 -177.027 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.53 ' HB2' HD12 ' A' ' 118' ' ' ILE . 0.6 OUTLIER -72.75 -63.7 1.11 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.524 172.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.05 -20.95 27.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.09 -174.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.1 -30.43 60.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.22 40.24 1.83 Allowed Glycine 0 CA--C 1.479 -2.211 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.665 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -117.58 -41.73 2.92 Favored 'General case' 0 N--CA 1.391 -3.391 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.739 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 113' ' ' PHE . 6.6 mt -65.09 141.27 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.723 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -124.26 160.14 53.93 Favored Pre-proline 0 C--N 1.265 -3.091 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.467 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -74.54 147.4 36.03 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 121.374 1.383 . . . . 0.0 110.978 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.4 p -98.94 27.52 4.94 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.663 0.744 . . . . 0.0 110.51 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 3.9 pt -147.8 -41.11 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.121 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -124.08 -175.79 3.33 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.9 t -157.08 178.16 10.67 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -124.16 89.01 52.29 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -88.54 159.25 6.53 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 121.887 1.724 . . . . 0.0 111.046 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.3 mt -114.11 93.13 29.1 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -69.72 166.95 25.81 Favored 'Trans proline' 0 N--CA 1.436 -1.893 0 C-N-CA 121.952 1.768 . . . . 0.0 109.964 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 68.19 115.97 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 O-C-N 124.336 1.022 . . . . 0.0 110.118 -173.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -74.05 104.37 4.86 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.524 -174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -159.84 169.3 23.87 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -123.72 138.45 54.52 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.66 0 CA-C-O 117.96 -1.466 . . . . 0.0 109.971 178.951 . . . . . . . . 0 0 . 1 stop_ save_